
<html lang="en"     class="pb-page"  data-request-id="a6803085-878b-4ca7-b1d2-48e59c15b3ae"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm3006788;requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2012.55.issue-17;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of the First Thumb Pocket 1 NS5B Polymerase Inhibitor (BILB 1941) with Demonstrated Antiviral Activity in Patients Chronically Infected with Genotype 1 Hepatitis C Virus (HCV)" /></meta><meta name="dc.Creator" content="Pierre L.  Beaulieu" /></meta><meta name="dc.Creator" content="Michael  Bös" /></meta><meta name="dc.Creator" content="Michael G.  Cordingley" /></meta><meta name="dc.Creator" content="Catherine  Chabot" /></meta><meta name="dc.Creator" content="Gulrez  Fazal" /></meta><meta name="dc.Creator" content="Michel  Garneau" /></meta><meta name="dc.Creator" content="James R.  Gillard" /></meta><meta name="dc.Creator" content="Eric  Jolicoeur" /></meta><meta name="dc.Creator" content="Steven  LaPlante" /></meta><meta name="dc.Creator" content="Ginette  McKercher" /></meta><meta name="dc.Creator" content="Martin  Poirier" /></meta><meta name="dc.Creator" content="Marc-André  Poupart" /></meta><meta name="dc.Creator" content="Youla S.  Tsantrizos" /></meta><meta name="dc.Creator" content="Jianmin  Duan" /></meta><meta name="dc.Creator" content="George  Kukolj" /></meta><meta name="dc.Description" content="Combinations of direct acting antivirals (DAAs) that have the potential to suppress emergence of resistant virus and that can be used in interferon-sparing regimens represent a preferred option for..." /></meta><meta name="Description" content="Combinations of direct acting antivirals (DAAs) that have the potential to suppress emergence of resistant virus and that can be used in interferon-sparing regimens represent a preferred option for..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 16, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm3006788" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm3006788" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm3006788" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm3006788" /></link>
        
    
    

<title>Discovery of the First Thumb Pocket 1 NS5B Polymerase Inhibitor (BILB 1941) with Demonstrated Antiviral Activity in Patients Chronically Infected with Genotype 1 Hepatitis C Virus (HCV) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm3006788" /></meta><meta property="og:title" content="Discovery of the First Thumb Pocket 1 NS5B Polymerase Inhibitor (BILB 1941) with Demonstrated Antiviral Activity in Patients Chronically Infected with Genotype 1 Hepatitis C Virus (HCV)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0016.jpeg" /></meta><meta property="og:description" content="Combinations of direct acting antivirals (DAAs) that have the potential to suppress emergence of resistant virus and that can be used in interferon-sparing regimens represent a preferred option for the treatment of chronic HCV infection. We have discovered allosteric (thumb pocket 1) non-nucleoside inhibitors of HCV NS5B polymerase that inhibit replication in replicon systems. Herein, we report the late-stage optimization of indole-based inhibitors, which began with the identification of a metabolic liability common to many previously reported inhibitors in this series. By use of parallel synthesis techniques, a sparse matrix of inhibitors was generated that provided a collection of inhibitors satisfying potency criteria and displaying improved in vitro ADME profiles. “Cassette” screening for oral absorption in rat provided a short list of potential development candidates. Further evaluation led to the discovery of the first thumb pocket 1 NS5B inhibitor (BILB 1941) that demonstrated antiviral activity in patients chronically infected with genotype 1 HCV." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm3006788"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm3006788">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm3006788&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm3006788&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm3006788&amp;href=/doi/10.1021/jm3006788" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 7650-7666</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm300663n" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300679u" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/jm501225c"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of the First Thumb Pocket 1 NS5B Polymerase Inhibitor (BILB 1941) with Demonstrated Antiviral Activity in Patients Chronically Infected with Genotype 1 Hepatitis C Virus (HCV)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pierre+L.++Beaulieu">Pierre L. Beaulieu</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++B%C3%B6s">Michael Bös</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+G.++Cordingley">Michael G. Cordingley</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Catherine++Chabot">Catherine Chabot</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gulrez++Fazal">Gulrez Fazal</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michel++Garneau">Michel Garneau</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+R.++Gillard">James R. Gillard</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric++Jolicoeur">Eric Jolicoeur</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++LaPlante">Steven LaPlante</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ginette++McKercher">Ginette McKercher</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Poirier">Martin Poirier</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marc-Andr%C3%A9++Poupart">Marc-André Poupart</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Youla+S.++Tsantrizos">Youla S. Tsantrizos</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jianmin++Duan">Jianmin Duan</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=George++Kukolj">George Kukolj</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec, H7S 2G5, Canada</span></div><div class="corresp-info"><strong>*</strong>Phone: (450) 682 4640. Fax: (450) 682 8434. E-mail: <a href="/cdn-cgi/l/email-protection#95e5fcf0e7e7f0bbf7f0f4e0f9fcf0e0d5f7faf0fde7fcfbf2f0e7b8fcfbf2f0f9fdf0fcf8bbf6faf8"><span class="__cf_email__" data-cfemail="64140d011616014a06010511080d011124060b010c160d0a030116490d0a0301080c010d094a070b09">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm3006788&amp;href=/doi/10.1021%2Fjm3006788" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 7650–7666</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 31, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 May 2012</li><li><span class="item_label"><b>Published</b> online</span>16 August 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 September 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm3006788" title="DOI URL">https://doi.org/10.1021/jm3006788</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7650%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPierre%2BL.%2BBeaulieu%252C%2BMichael%2BB%25C3%25B6s%252C%2BMichael%2BG.%2BCordingley%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D17%26contentID%3Djm3006788%26title%3DDiscovery%2Bof%2Bthe%2BFirst%2BThumb%2BPocket%2B1%2BNS5B%2BPolymerase%2BInhibitor%2B%2528BILB%2B1941%2529%2Bwith%2BDemonstrated%2BAntiviral%2BActivity%2Bin%2BPatients%2BChronically%2BInfected%2Bwith%2BGenotype%2B1%2BHepatitis%2BC%2BVirus%2B%2528HCV%2529%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7666%26publicationDate%3DSeptember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm3006788"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1973</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">33</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm3006788" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of the First Thumb Pocket 1 NS5B Polymerase Inhibitor (BILB 1941) with Demonstrated Antiviral Activity in Patients Chronically Infected with Genotype 1 Hepatitis C Virus (HCV)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Pierre&quot;,&quot;last_name&quot;:&quot;L. Beaulieu&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Bös&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;G. Cordingley&quot;},{&quot;first_name&quot;:&quot;Catherine&quot;,&quot;last_name&quot;:&quot;Chabot&quot;},{&quot;first_name&quot;:&quot;Gulrez&quot;,&quot;last_name&quot;:&quot;Fazal&quot;},{&quot;first_name&quot;:&quot;Michel&quot;,&quot;last_name&quot;:&quot;Garneau&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;R. Gillard&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Jolicoeur&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;LaPlante&quot;},{&quot;first_name&quot;:&quot;Ginette&quot;,&quot;last_name&quot;:&quot;McKercher&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Poirier&quot;},{&quot;first_name&quot;:&quot;Marc-André&quot;,&quot;last_name&quot;:&quot;Poupart&quot;},{&quot;first_name&quot;:&quot;Youla&quot;,&quot;last_name&quot;:&quot;S. Tsantrizos&quot;},{&quot;first_name&quot;:&quot;Jianmin&quot;,&quot;last_name&quot;:&quot;Duan&quot;},{&quot;first_name&quot;:&quot;George&quot;,&quot;last_name&quot;:&quot;Kukolj&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;7650-7666&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm3006788&quot;},&quot;abstract&quot;:&quot;Combinations of direct acting antivirals (DAAs) that have the potential to suppress emergence of resistant virus and that can be used in interferon-sparing regimens represent a preferred option for the treatment of chronic HCV infection. We have discovered allosteric (thumb pocket 1) non-nucleoside inhibitors of HCV NS5B polymerase that inhibit replication in replicon systems. Herein, we report the late-stage optimization of indole-based inhibitors, which began with the identification of a metabolic liability common to many previously reported inhibitors in this series. By use of parallel synthesis techniques, a sparse matrix of inhibitors was generated that provided a collection of inhibitors satisfying potency criteria and displaying improved in vitro ADME profiles. “Cassette” screening for oral absorption in rat provided a short list of potential development candidates. Further evaluation led to the discovery of the first thumb pocket 1 NS5B inhibitor (BILB 1941) that demonstrated antiviral activity in pat&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3006788&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3006788" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3006788&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3006788" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3006788&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3006788" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm3006788&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3006788&amp;href=/doi/10.1021/jm3006788" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm3006788" /></input><a href="/doi/pdf/10.1021/jm3006788" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm3006788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm3006788%26sid%3Dliteratum%253Aachs%26pmid%3D22849725%26genre%3Darticle%26aulast%3DBeaulieu%26date%3D2012%26atitle%3DDiscovery%2Bof%2Bthe%2BFirst%2BThumb%2BPocket%2B1%2BNS5B%2BPolymerase%2BInhibitor%2B%2528BILB%2B1941%2529%2Bwith%2BDemonstrated%2BAntiviral%2BActivity%2Bin%2BPatients%2BChronically%2BInfected%2Bwith%2BGenotype%2B1%2BHepatitis%2BC%2BVirus%2B%2528HCV%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D17%26spage%3D7650%26epage%3D7666%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jmcmar.2012.55.issue-17/production/jmcmar.2012.55.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Combinations of direct acting antivirals (DAAs) that have the potential to suppress emergence of resistant virus and that can be used in interferon-sparing regimens represent a preferred option for the treatment of chronic HCV infection. We have discovered allosteric (thumb pocket 1) non-nucleoside inhibitors of HCV NS5B polymerase that inhibit replication in replicon systems. Herein, we report the late-stage optimization of indole-based inhibitors, which began with the identification of a metabolic liability common to many previously reported inhibitors in this series. By use of parallel synthesis techniques, a sparse matrix of inhibitors was generated that provided a collection of inhibitors satisfying potency criteria and displaying improved in vitro ADME profiles. “Cassette” screening for oral absorption in rat provided a short list of potential development candidates. Further evaluation led to the discovery of the first thumb pocket 1 NS5B inhibitor (BILB 1941) that demonstrated antiviral activity in patients chronically infected with genotype 1 HCV.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63843" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63843" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Hepatitis C virus (HCV) was identified as the ethological agent of non-A/non-B hepatitis in 1989, and current worldwide prevalence of chronic carriers is estimated at 130–170 million people (2–3% of the world population; 5 million in the U.S.).<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> HCV is classified in the hepacivirus genus of the flaviviridae family, and six major genotypes have been characterized in addition to minor variants and a swarm of quasi-species resulting from error-prone replication.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> While the origins of HCV remain unknown, the virus is mostly transmitted through contaminated blood products (e.g., blood transfusions), unsafe medical procedures, and practices among intravenous drug users. Following an acute HCV infection, most individuals will progress to a chronic state and are at risk of developing over time (20–30 years) serious and often fatal liver diseases such as cirrhosis (20%) and hepatocellular carcinomas (2%). Although the incidence of transmission has decreased dramatically, projected mortality from such conditions will increase over the next 20 years as a result of the long incubation period. Rates of HCV-related hepatocellular carcinomas (HCC) and HCV-related mortalities are projected to triple by 2030.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> An estimated 86 000 death/year can be linked to conditions resulting from HCV infection.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> HCV is also the leading cause for liver transplantation in industrialized nations, imposing a significant economic burden on health care systems. Furthermore, such procedures only provide temporary reprieve, as in most cases the transplanted organ becomes reinfected within a year or 2.</div><div class="NLM_p">Until recently, HCV therapy relied on the patient’s ability to mount an immune response against the virus and consisted of a combination of pegylated interferon-α (PegIFN) and ribavirin (RBV), a broad-spectrum antiviral agent. Genotype 1a/1b, which predominates in North America, Europe, and Japan, is most refractory to treatment. With this regimen sustained viral responses (SVRs), a good predictor of cure, rarely exceed 50%.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Furthermore, PegIFN/RBV therapy is associated with severe limiting side effects that lead to significant treatment discontinuations and contraindications that prevent use in 15% of patients.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In the 20 years following the initial discovery of the virus, HCV research has evolved at an unprecedented pace in both academic and industrial laboratories, providing a detailed understanding of the virus life cycle and tools to support drug discovery activities. Most notably, the development of the cell-based replicon system that supports HCV subgenomic RNA replication and the discovery of infectious virus that allows replication of the pathogen in a laboratory environment contributed greatly to this effort.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a> The 9.6 kb single (+)-strand RNA HCV genome encodes both structural and nonstructural (NS2 → NS5) proteins whose functions within a replication complex are essential for viral replication and/or infection.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The NS3/4A protease became one of the initial focuses of drug discovery efforts. Structure-based peptidomimetic strategies soon yielded encouraging results when Boehringer Ingelheim’s celuprivir became the first small molecule drug to demonstrate potent antiviral activity in HCV-infected patients and validated available HCV research tools.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> This milestone was followed by the recent approval in mid-2011 of the first direct acting antiviral (DAA) agents that target NS3/4A. Specifically, two first generation protease inhibitors (bocepravir from Merck and telaprevir from Vertex Pharmaceuticals) have been approved for use in combination with PegIFN/RBV.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Despite improved outcome, these regimens still suffer from the combined side effects of both the PegIFN/RBV-based standard of care (SoC) and the new drugs themselves. In addition, the reduced effectiveness among treatment-experienced and nonresponders to IFN-based therapies and the emergence of virus resistant to the drugs have become significant issues and represent an added layer of complexity for the development of future treatments.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Within the next 2 years, second generation protease inhibitors currently in phase 3 clinical trials in combination with SoC are being explored for more convenient dosing regimens and may have the potential to improve treatment options. These include Boehringer Ingelheim’s faldaprevir and (2<i>R</i>,3a<i>R</i>,10<i>Z</i>,11a<i>S</i>,12a<i>R</i>,14a<i>R</i>)-<i>N</i>-(cyclopropylsulfonyl)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-dioxocyclopenta[<i>c</i>]cyclopropa[g][1,6]diazacyclotetradecine-12a(1<i>H</i>)-carboxamide (TMC435350) from Tibotec.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Most significant, however, is the recent paradigm shift toward the development of interferon-sparing therapies using combination of DAAs with complementary modes-of-action (e.g., protease + NS5B polymerase inhibitors or NS5A ligands as well as nucleoside NS5B + NS5A combinations), which are expected to provide efficacy with improved safety and tolerability while minimizing emergence of resistant virus.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p">By extension of precedent from successful anti-HIV strategies, the HCV NS5B RNA-dependent RNA polymerase (RdRp) target rapidly attracted considerable attention from drug designers. The 65 kDa protein, located at the C-terminal of the HCV-translated polyprotein, plays a central role in the replication of the HCV RNA genome.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The NS5B catalytic machinery has no close mammalian counterpart, making it an attractive target for drug intervention. It functions inside the cell as a component of the HCV replicase complex. The enzyme shares the common folds of other nucleic acid polymerases with characteristic thumb, finger, and palm domains (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> NS5B has revealed itself as the most druggable HCV protein, as reflected by the publication of greater than 400 patent applications covering small molecule inhibitors of this enzyme in the past 15 years.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Not surprisingly, nucleoside analogues (particularly chain-terminating 2′-<i>C</i>-methyl nucleosides) were soon reported to specifically inhibit enzyme activity, and this class of active site directed inhibitors was soon validated in the clinic.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Today, nucleoside NS5B inhibitors continue to provide encouraging results, either in combination with SoC or with complementary DAAs, because of the conserved nature of the nucleotide binding site, high barrier to resistance, and their pan-genotype activity.<a onclick="showRef(event, 'cit14a ref21'); return false;" href="javascript:void(0);" class="ref cit14a ref21">(14a, 21)</a> A parallel effort to nucleoside-based inhibitors began in the late 1990s, when several companies began interrogating their corporate collection for small molecule inhibitors of NS5B activity. During the subsequent years, at least four allosteric sites were uncovered that regulate enzyme function by interfering with conformational changes required during RNA synthesis. Indeed, HCV polymerase is characterized by a β-hairpin loop protruding in the central RNA-binding channel of the enzyme and two additional loops (Λ1 and Λ2) that extend from the fingers to the northern surface of the thumb domain, all of which are thought to be involved in the regulation of RNA synthesis, thus providing opportunities for interfering with enzymatic activity using small molecules (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'cit17c ref18 ref22'); return false;" href="javascript:void(0);" class="ref cit17c ref18 ref22">(17c, 18, 22)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Three dimensional structure of NS5B with inhibitor binding sites. The three-dimensional structure of NS5B is shown in ribbon representation with the palm domain colored in red, the thumb domain in green and the finger domain with the Λ finger loops in blue. Inhibitor binding sites are depicted using CPK models of representative inhibitors: thumb pocket 1 (acetamideindolecarboxylic acid, red), thumb pocket 2 (phenylalanine derivative, magenta), palm site 1 (acylpyrrolidine, orange), palm site 2 (benzofuran derivative, blue), active site (nucleoside analog with two Mg<sup>2+</sup> ions, yellow). Reproduced with permission from <i>Expert Opinion on Therapeutic Patents</i>.<a onclick="showRef(event, 'cit19a'); return false;" href="javascript:void(0);" class="ref cit19a">(19a)</a> Copyright 2009 Informa Healthcare.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The location of NS5B allosteric binding sites is depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, with representative inhibitors bound in their pockets.<a onclick="showRef(event, 'cit19a'); return false;" href="javascript:void(0);" class="ref cit19a">(19a)</a> Two allosteric sites are located in the thumb domain (thumb pockets 1and 2), while two others are located in the palm region (palm sites 1 and 2) near the base of the thumb domain and proximal to the enzyme active site. Binding to any of these allosteric sites blocks initiation of processive RNA synthesis by interfering with protein conformational changes, thus blocking viral replication. Binding of small molecules to these allosteric sites is usually inferred from selection of resistant genomes using the cell-based replicon system and in many cases confirmed with X-ray structural data. Clinical proof of concept in HCV-infected patients has been reported for inhibitors (see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> for example of published representative NS5B inhibitors currently in clinical development) that bind to any of the four allosteric binding sites.<a onclick="showRef(event, 'cit19a cit19c ref23'); return false;" href="javascript:void(0);" class="ref cit19a cit19c ref23">(19a, 19c, 23)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of published representative NS5B inhibitors currently in clinical development.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Over the past years, we and others have been reporting on the discovery and optimization of benzimidazole derivatives that bind to NS5B thumb pocket 1 and block viral replication by interfering with the interaction of the Λ1 finger loop with the northern portion of the thumb domain, preventing formation of a productive conformation that is necessary for the initiation of viral RNA synthesis. This class of inhibitors, which we refer to as “finger loop inhibitors”, was initially discovered in a high-throughput screening campaign (compound <b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Specific and potent inhibitors of NS5B enzymatic activity were rapidly discovered, but benzimidazoles such as <b>2</b> lacked activity in cell-based assays because of the poor permeability associated with the highly ionized structures.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Screening for replacements of the highly polar amino acid derived right-hand side led to the discovery of diamide derivatives with comparable intrinsic biochemical potency and weak cell-based replicon activity (e.g., <b>3</b>),<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> providing a cellular proof of concept for the mechanism by which these inhibitors interfere with HCV replication. Replacement of the benzimidazole core by a more lipophilic indole scaffold provided derivatives such as <b>4</b>, with improved cell permeability and promising efficacy in the subgenomic replicon system. While inhibitors such as <b>4</b> achieved a cell-based potency target (replicon gt1 EC<sub>50</sub> < 100 nM) for further progression, they generally lacked the necessary ADME-PK attributes (e.g., metabolic stability) for selection as development candidates.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. SAR progression of benzimidazole thumb pocket 1 HCV NS5B inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Herein, we report on the late stage optimization of this class of inhibitors. This effort began with the identification of a metabolic liability common to many previously reported inhibitors in this series (e.g., compound <b>4</b>) followed by replacement of the metabolic “hot spot” and the generation of compound matrices combining diverse beneficial structural features at the indole C2 position and the right-hand side of the molecules to identify analogues with optimized properties. This effort, which made extensive use of our parallel synthesis capabilities, provided a collection of molecules that fulfilled potency and selectivity criteria. Following further profiling, molecules with satisfactory in vitro ADME characteristics (particularly metabolic stability and Caco-2 permeability) were screened in “cassette mode” for oral absorption in rat, providing a short list of potential development candidates. Further evaluation led to the identification of <b>D13</b>, the first thumb pocket 1 HCV NS5B clinical candidate to demonstrate efficacy in genotype 1 HCV-infected patients.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16750" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16750" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In recent publications,<a onclick="showRef(event, 'cit28a cit28b'); return false;" href="javascript:void(0);" class="ref cit28a cit28b">(28a, 28b)</a> we described a series of indole diamide derivatives (e.g., compound <b>4</b>) that in cell culture experiments inhibited replication of gt1-HCV subgenomic replicons with EC<sub>50</sub> < 100 nM. However, the majority of compounds in this class exhibited high lipophilicity (calculated log <i>P</i> > 5) with poor aqueous solubility at physiological pH, low metabolic stability in the presence of liver microsome preparations (<i>T</i><sub>1/2</sub> < 60 min), and high in vivo clearance in rat. Attempts to reduce lipophilicity by introducing polar features onto the molecule while improving metabolic stability in some cases generally resulted in reduced Caco-2 permeability, and lack of oral exposure in rat and/or significantly reduced antiviral potency in cell-based assays. In order to identify candidates for advancement into clinical development, we therefore envisaged a stepwise strategy whereby the ADME-PK profile of this class would be improved through identification of metabolic liabilities (hot spots) followed by conservative modifications to address these liabilities while minimizing the impact on other parameters (e.g., potency and Caco-2 permeability). To this end, compound <b>4</b> was incubated with human and rat liver microsome preparations. In each case, a single major metabolite <b>5</b> was detected (indistinguishable by HPLC and MS fragmentation pattern for both species) resulting from hydroxylation of the 3-cyclohexyl ring at an unknown position (lack of further fragmentation precluded further localization of the oxidation site by LC–MS/MS (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Major Metabolic Pathway and MS/MS Fragmentation Pattern for Compound <b>4</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The identification of the cyclohexyl ring as a metabolic hot spot for this class of compound initially presented itself as a significant issue, as early SAR in benzimidazole analogues had shown this position to be extremely sensitive to structural modifications.<a onclick="showRef(event, 'cit25b'); return false;" href="javascript:void(0);" class="ref cit25b">(25b)</a> Indeed, only replacement with cyclopentyl was tolerated, albeit with a 3-fold loss in enzymatic potency. We were therefore encouraged when in the more advanced indole series, the small change in lipophilicity resulting from replacement of the 3-cyclohexyl ring in compound <b>4</b> by a cyclopentyl moiety (compound <b>6</b>; calculated log <i>P</i> of 4.9 and 4.5 for <b>4</b> and <b>6</b>, respectively) resulted in a compound with comparable intrinsic and cell-based potency and considerably improved metabolic stability (HLM <i>T</i><sub>1/2</sub> from 37 to 208 min). Additional metabolite identification studies performed on related analogues revealed that 3-cyclopentylindole derivatives were generally more resistant to phase 1 oxidative metabolism than the corresponding 3-cyclohexyl analogues and potency was usually maintained (results not shown). Our next objective was to apply SAR learnings from the cyclohexylindole series<a onclick="showRef(event, 'cit28a cit28b'); return false;" href="javascript:void(0);" class="ref cit28a cit28b">(28a, 28b)</a> to the 3-cyclopentyl version, with the aim to identify a collection of inhibitors with improved potency (EC<sub>50</sub> < 100 nM) and ADME-PK profiles for advancement into development. In order to accelerate the discovery of such inhibitors, this study was performed using high-throughput synthesis and profiling techniques as outlined in the decision tree shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0005.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Strategy for the Identification of Potent NS5B Inhibitors with Improved ADME-PK Profiles</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of previously established SAR, 3-cyclopentyl-1-methyl-6-indolecarboxylic acid with various C2 substituents (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) and right-hand-side building blocks (Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>) were prepared independently and coupled together to provide compounds for testing (see section <a class="ref internalNav" href="#sec3" aria-label="Chemistry">Chemistry</a> for details).</div><figure id="cht1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. 3-Cyclopentyl-1-methyl-6-indolecarboxylic Acid Building Blocks</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="cht2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Right-Hand-Side Building Blocks for Inhibitor Synthesis</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Upon initial evaluation of a few inhibitors, it became apparent that SAR was directly transferable from the 3-cyclohexylindole series<a onclick="showRef(event, 'cit28a cit28b'); return false;" href="javascript:void(0);" class="ref cit28a cit28b">(28a, 28b)</a> to the corresponding 3-cyclopentyl analogues. Consequently, our strategy for the rapid generation and identification of the most interesting analogues relied on the generation of a sparse matrix of 110 inhibitors using some of the more fruitful previously identified C2-substituted indole and right-hand-side building blocks rather than a full 190 analogue combination matrix of 28 C2 substituents and 8 right-hand-side fragments (as described in Charts <a class="ref internalNav" href="#cht1" aria-label="1">1</a> and <a class="ref internalNav" href="#cht2" aria-label="2">2</a>). Nevertheless, representative compounds were prepared from all possible series in order to ensure that all potentially interesting compounds would be profiled. Replicon gt1b potency for this sparse matrix is depicted in graphical format in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, while potencies for all individual compounds are provided in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> and data for key inhibitors are presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. EC<sub>50</sub> values in the gt1b replicon ranged from 20 to 550 nM, with (<i>S</i>)-cucurbitine <b>A</b> and alkyl/cycloalkyl <b>C</b>, <b>D</b>, and <b>E</b> cinnamic acid right-hand sides consistently providing the most potent analogues. SAR trends at C2 were less apparent, and potent analogues (EC<sub>50</sub> < 100 nM) were identified for most of the 28 indole building blocks except for <b>3</b>–<b>5</b>, <b>11</b>, <b>18</b>, <b>22</b>, <b>25</b>, and <b>26</b>. As seen in previous studies,<a onclick="showRef(event, 'cit28a cit28b'); return false;" href="javascript:void(0);" class="ref cit28a cit28b">(28a, 28b)</a> 3-furyl (building block <b>1</b>), substituted 2-pyridyl (building blocks <b>13</b>–<b>17</b>, <b>19</b>–<b>21</b>), 4-pyridyl (building block <b>24</b>), and some aminothiazolyl (building blocks <b>8</b>, <b>10</b>) C2 substituents provided some of the most potent analogues. In total, 49 inhibitors had EC<sub>50</sub> ≤ 100 nM (35 had EC<sub>50</sub> of 100–150 nM).</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0008.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Replicon 1b potency for a sparse matrix of 110 representative inhibitors. C2 substituents are represented on the <i>X</i>-axis (see Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a> for structures) and are numbered 1–28. Right-hand sides are listed on the <i>Z</i>-axis and are labeled A– H (see Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a> for structures). Genotype 1b replicon potency is displayed on the <i>y</i>-axis in nM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Analogues with cell-based replicon potency EC<sub>50</sub> < 150 nM (84 analogues; see Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) were subsequently evaluated in human and rat liver microsome (HLM/RLM) stability assays and Caco-2 permeability. From this initial profiling, 71 compounds were selected for in vivo profiling in rat. This evaluation was mostly performed using a four-compound “cassette format”, whereby a mixture of four compounds was orally administered to animals at a dose of 3 or 4 mg/kg each. Inhibitor plasma concentrations were determined at 1 h after oral dosing and are reported in graphical format in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> (for comparison purposes, all 4 mg/kg data were normalized to 3 mg/kg and the individual compound data are provided in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). This po dosing method provided a rapid estimate of plasma exposure and provided a short list of 16 potential candidates for further profiling and prioritization (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0009.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibitor plasma concentrations (normalized to a 3 mg/kg dose) following oral dosing in rat as mixtures of 4 compounds. <i>X</i>- and <i>Z</i>-axis are labeled as in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. Inhibitor plasma concentrations (μM units) at 1 h after oral dosing are displayed on the <i>Y</i>-axis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> clearly shows that, except for a few derivatives (compounds <b>C13</b>–<b>16</b>), inhibitors containing the basic cucurbitine fragment or an α,α-dimethylamino acid linker (<b>A</b> and <b>C</b> right-hand sides, respectively) had significantly lower plasma levels than inhibitors containing the 1-aminocyclobutane or 1-aminocyclopentane carboxylic acid fragments (series <b>D</b> and <b>E</b>). Cyclobutane derivatives (right-hand side of <b>D</b>) were particularly well absorbed compared to other series, irrespective of the C2 substituent on the indole scaffold. In terms of individual C2 indole substituents, basic 2-, 3-, and 4-pyridyl and 2-pyridazinyl analogues provided the best plasma exposures, likely because of improved aqueous solubility at low pH. Compounds with the most promising overall profile, based on replicon potency (EC<sub>50</sub> < 100 nM), metabolic stability, Caco-2 permeability, and plasma exposure in rat, are depicted in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Profile of Most Promising Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">1b IC<sub>50</sub> <a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center">1b EC<sub>50</sub> <a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center">HLM <i>T</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center">RLM <i>T</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center">Caco-2(cm/s)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">solubility<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a>(μg/mL)</th><th class="colsep0 rowsep0" align="center">calcd log <i>P</i> <a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">CYP450 2C19/3A4 IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">plasma C<sub>1 h</sub><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>A20</b></td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">>300</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2.9 × 10<sup>–6</sup></td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>C13</b></td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">67</td><td class="colsep0 rowsep0" align="left">208</td><td class="colsep0 rowsep0" align="left">83</td><td class="colsep0 rowsep0" align="left">6.5 × 10<sup>–6</sup></td><td class="colsep0 rowsep0" align="left">92</td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">3.3/7.9</td><td class="colsep0 rowsep0" align="left">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>C16</b></td><td class="colsep0 rowsep0" align="left">71</td><td class="colsep0 rowsep0" align="left">67</td><td class="colsep0 rowsep0" align="left">236</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.8 × 10<sup>–6</sup></td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">5.8</td><td class="colsep0 rowsep0" align="left">1.4/9.4</td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D1</b></td><td class="colsep0 rowsep0" align="left">69</td><td class="colsep0 rowsep0" align="left">67</td><td class="colsep0 rowsep0" align="left">162</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">7.5 × 10<sup>–6</sup></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">5.6</td><td class="colsep0 rowsep0" align="left">3.0/9.2</td><td class="colsep0 rowsep0" align="left">0.45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D12</b></td><td class="colsep0 rowsep0" align="left">690</td><td class="colsep0 rowsep0" align="left">89</td><td class="colsep0 rowsep0" align="left">>300</td><td class="colsep0 rowsep0" align="left">>300</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">7.0</td><td class="colsep0 rowsep0" align="left">2.7/8.3</td><td class="colsep0 rowsep0" align="left">1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D13</b></td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">84</td><td class="colsep0 rowsep0" align="left">85</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">11.2 × 10<sup>–6</sup></td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">2.9/9.5</td><td class="colsep0 rowsep0" align="left">2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D14</b></td><td class="colsep0 rowsep0" align="left">84</td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">53</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">6.9 × 10<sup>–6</sup></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">4.7</td><td class="colsep0 rowsep0" align="left">0.4/5.8</td><td class="colsep0 rowsep0" align="left">6.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D16</b></td><td class="colsep0 rowsep0" align="left">92</td><td class="colsep0 rowsep0" align="left">83</td><td class="colsep0 rowsep0" align="left">>300</td><td class="colsep0 rowsep0" align="left">>300</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">5.8</td><td class="colsep0 rowsep0" align="left">1.0/10.9</td><td class="colsep0 rowsep0" align="left">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D17</b></td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left">76</td><td class="colsep0 rowsep0" align="left">167</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">5.5</td><td class="colsep0 rowsep0" align="left">0.8/6.7</td><td class="colsep0 rowsep0" align="left">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D20</b></td><td class="colsep0 rowsep0" align="left">73</td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">>300</td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">1.8 × 10<sup>–6</sup></td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">>30/7.0</td><td class="colsep0 rowsep0" align="left">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D23</b></td><td class="colsep0 rowsep0" align="left">200</td><td class="colsep0 rowsep0" align="left">82</td><td class="colsep0 rowsep0" align="left">95</td><td class="colsep0 rowsep0" align="left">61</td><td class="colsep0 rowsep0" align="left">1.5 × 10<sup>–6</sup></td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">0.3/1.5</td><td class="colsep0 rowsep0" align="left">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D24</b></td><td class="colsep0 rowsep0" align="left">130</td><td class="colsep0 rowsep0" align="left">67</td><td class="colsep0 rowsep0" align="left">112</td><td class="colsep0 rowsep0" align="left">69</td><td class="colsep0 rowsep0" align="left">2.9 × 10<sup>–6</sup></td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D25</b></td><td class="colsep0 rowsep0" align="left">49</td><td class="colsep0 rowsep0" align="left">94</td><td class="colsep0 rowsep0" align="left">96</td><td class="colsep0 rowsep0" align="left">56</td><td class="colsep0 rowsep0" align="left">10 × 10<sup>–6</sup></td><td class="colsep0 rowsep0" align="left">49</td><td class="colsep0 rowsep0" align="left">4.2</td><td class="colsep0 rowsep0" align="left">5.1/10.6</td><td class="colsep0 rowsep0" align="left">5.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>E13</b></td><td class="colsep0 rowsep0" align="left">45</td><td class="colsep0 rowsep0" align="left">84</td><td class="colsep0 rowsep0" align="left">96</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">12.6 × 10<sup>–6</sup></td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">4.9</td><td class="colsep0 rowsep0" align="left">0.9/6.3</td><td class="colsep0 rowsep0" align="left">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>E16</b></td><td class="colsep0 rowsep0" align="left">98</td><td class="colsep0 rowsep0" align="left">85</td><td class="colsep0 rowsep0" align="left">>300</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">6.2</td><td class="colsep0 rowsep0" align="left">4.3/10.7</td><td class="colsep0 rowsep0" align="left">1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>E24</b></td><td class="colsep0 rowsep0" align="left">66</td><td class="colsep0 rowsep0" align="left">71</td><td class="colsep0 rowsep0" align="left">107</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.8 × 10<sup>–6</sup></td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">2.2/4.3</td><td class="colsep0 rowsep0" align="left">1.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Values are an average of at least two determinations.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">The Caco-2 permeability assay was run without BSA with both chambers at pH 7.4.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Measured on lyophilized, amorphous solids using the 24 h shaking flask method and pH 7.2 phosphate buffer.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">JChem 5.0.0 (<a href="http://www.chemaxon.com" class="extLink">http://www.chemaxon.com</a>).</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last">Following oral administration to rats as mixtures of four compounds. Measured plasma concentrations were normalized to a dose of 3 mg/kg.</p></div></div></div><div class="NLM_p">The most potent compound identified through this work was cucurbitine analogue <b>A20</b> with EC<sub>50</sub> = 20 nM. Unfortunately, this compound did not achieve high plasma levels following rat po cassette dosing (also tested in a single rat PK experiment where <i>C</i><sub>max</sub> = 0.09 μM was obtained at 10 mg/kg; data not shown) and was not pursued further. Four compounds exhibiting submicromolar inhibition of CYP2C19 (also CYP2C9 for <b>D23</b>, data not shown) were also eliminated from further consideration, including <b>D14</b>, which had exhibited the highest plasma exposures in the oral cassette PK screen in rats. Compounds with low aqueous solubility at pH 7.2 (<10 μg/mL) were also deprioritized. The four remaining inhibitors were further profiled in single compound rat PK at an oral dose of 10 mg/kg administered as a suspension (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for details). Oral and iv parameters are presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Single Compound Rat PK Parameters</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">oral parameter (10 mg/kg)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">iv parameter (2 mg/kg)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (μM·h)</th><th class="colsep0 rowsep0" align="center" char=".">MRT (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub>(L/kg)</th><th class="colsep0 rowsep0" align="center" char=".">CL (mL kg<sup>–1</sup> min<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>C13</b></td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">7.2</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">18.2</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D13</b></td><td class="colsep0 rowsep0" align="char" char=".">7.5</td><td class="colsep0 rowsep0" align="char" char=".">22.7</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=".">0.48</td><td class="colsep0 rowsep0" align="char" char=".">8.3</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D20</b></td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="char" char=".">8.4</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D25</b></td><td class="colsep0 rowsep0" align="char" char=".">7.8</td><td class="colsep0 rowsep0" align="char" char=".">17.7</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char=".">0.58</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">41</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Compound dosed as an oral suspension in 0.5% Methocel and 0.3% Tween-80.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Bolus injection prepared in 70% PEG-400.</p></div></div></div><div class="NLM_p">Inhibitors <b>D13</b> and <b>D25</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>), which have comparable replicon potency (EC<sub>50</sub> of 84 and 94 nM, respectively), were identified as the most promising compounds based on plasma exposures and lower iv clearance compared to <b>C13</b> and <b>D20</b> and were advanced into higher species PK profiling in dog and rhesus monkey. The data for the two compounds are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0010.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structure of <b>D13</b> (BILB 1941) and <b>D25</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Dog and Rhesus Monkey PK Profiles for <b>D13</b> and <b>D25</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">oral parameter (10 mg/kg)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">iv parameter (2 mg/kg)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (μM·h)</th><th class="colsep0 rowsep0" align="center" char=".">MRT (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub>(L/kg)</th><th class="colsep0 rowsep0" align="center" char=".">CL (mL kg<sup>–1</sup> min<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D13</b> (dog)</td><td class="colsep0 rowsep0" align="char" char=".">15.3</td><td class="colsep0 rowsep0" align="char" char=".">99</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">0.54</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="char" char=".">64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D25</b> (dog)</td><td class="colsep0 rowsep0" align="char" char=".">10.9</td><td class="colsep0 rowsep0" align="char" char=".">37.4</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">0.75</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D13</b> (monkey)</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">20.5</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="char" char=".">0.70</td><td class="colsep0 rowsep0" align="char" char=".">9.5</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">70</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Compound dosed as an oral suspension in 0.5% Methocel and 0.3% Tween-80.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Bolus injection prepared in 70% PEG-400.</p></div></div></div><div class="NLM_p">As can be seen from Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, <b>D13</b> had a superior dog PK profile with higher plasma exposure and lower clearance than <b>D25</b>. <b>D13</b> also had a good PK profile when administered to rhesus monkeys.</div><div class="NLM_p last">Overall, <b>D13</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) displayed a very consistent cross-species PK profile. Furthermore, a favorable partitioning of the compound between the plasma compartment and the target liver organ was observed in rat (∼9-fold). On the basis of its replicon potency (gt1b/1a EC<sub>50</sub> = 84/153 nM), low serum shift (∼3-fold), and favorable ADME-PK characteristics, <b>D13</b> was advanced into preclinical development and eventually a proof-of-concept clinical trial in gt1 HCV-infected patients.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13865" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13865" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">C2-substituted 3-cyclopentylindole-6-carboxylic acid building blocks shown in Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a> were synthesized in a similar fashion to the corresponding 3-cyclohexyl analogues by one of three methods (A–C) described in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Commercially available indole-6-carboxylic acid <b>7</b> was condensed with cyclopentanone under basic conditions to provide cyclopentene <b>8</b> which was hydrogenated to cyclopentyl intermediate <b>9</b> and dimethylated to provide ester <b>10</b>. Intermediates <b>8</b> and <b>9</b> were processed as crude materials, and purification of <b>10</b> from carried-over impurities (mostly an indole dimer <b>11</b>) was accomplished by trituration. Bromination at C2 using elemental bromine provided key intermediate <b>12</b>. Introduction of the C2 indole substituent was accomplished using one of three cross-coupling methodologies depending on the availability of reagents and scale. For commercially available boronic acids, direct Suzuki–Miyaura cross-coupling to generate building blocks <b>1</b>, <b>2</b>, <b>12</b>, <b>15</b>, <b>27</b>, and <b>28</b> (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) was generally preferred (method A). Alternatively, in cases where the boronic acid was not available or chemically unstable (e.g., 2-pyridyl derivatives), bromide <b>12</b> was converted by metal–halogen exchange to tributylstannyl derivative <b>13</b> that was isolated in good yield and purity after flash chromatography using triethylamine-deactivated silica gel (stannane <b>13</b> is protolytically unstable). Intermediate <b>13</b> underwent Stille cross-coupling with a variety of aryl and heteroaryl bromides to provide C2-substituted indole building blocks <b>4</b>, <b>5</b>, <b>13</b>, <b>14</b>, <b>18</b>, <b>19</b>, <b>22</b>, and <b>25</b> in good yield (method B). Method C was used for similar cases as method B and particularly useful on larger scale to avoid inconveniences associated with the use of large quantities of tin derivatives. In this case, bromide <b>12</b> was converted to a boronate ester through a metal–halogen exchange and cross-coupled in situ to halides using Suzuki–Miyaura conditions. Building blocks <b>4</b>, <b>13</b>, <b>16</b>, <b>17</b>, <b>20</b>, <b>21</b>, <b>23</b>, and <b>24</b>–<b>26</b> were prepared in this fashion.</div><figure id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of C2-Substituted 3-Cyclopentyl-6-indolecarboxylic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) cyclopentanone, KOH, MeOH–water, 75 °C; (b) 20% Pd(OH)<sub>2</sub>/C, MeOH, H<sub>2</sub> (1 atm); (c) K<sub>2</sub>CO<sub>3</sub>, MeI, DMF, rt then NaH, MeI, 0 °C to rt; (d) NaOAc, Br<sub>2</sub>, <i>i</i>-PrOAc, 4 °C; (e) <i>n</i>-BuLi, Bu<sub>3</sub>SnCl, THF, −72 °C to rt. Method A: heteroaryl- or arylboronic acid (1.3 equiv), LiCl (2 equiv), Na<sub>2</sub>CO<sub>3</sub> (2.5 equiv), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.04 equiv), degassed toluene/ethanol/water 1:1:1, reflux overnight under argon; (g) NaOH, THF–MeOH. (h) Method B: heterocycle bromide, Pd(Ph<sub>3</sub>P)<sub>4</sub>, CuI, LiI, P(Ph)<sub>3</sub>, DMF, 100 °C. (i) Method C: <i>n</i>-BuLi, B(OMe)<sub>3</sub>, THF, −71 °C to rt, then Pd(OAc)<sub>2</sub>, P(<i>p</i>-tolyl)<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, heterocycle bromide, MeOH, reflux.</p></p></figure><div class="NLM_p">The synthesis of substituted thiazole building blocks is depicted in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> and makes use of the Hantzsch thiazole synthetic protocol.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Bromide <b>12</b> was converted to bromoketone <b>14</b> by Stille cross-coupling with 1-ethoxytributylvinylstannane followed by bromination under protic conditions. Thiazole-containing building blocks <b>6</b>–<b>11</b> (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a> and others not shown) were then accessed by reaction with various thioamides and thioureas.</div><figure id="sch4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Substituted Thiazolylindole Building Blocks Using the Hantzsch Synthesis (<b>7</b>–<b>11</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 1-ethoxytributylvinylstannane, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, dioxane, 100 °C; (b) <i>N</i>-bromosuccinimide, THF–water, 0 °C; (c) thiourea, <i>i</i>-PrOH or dioxane, 80–100 °C; (d) LiOH, THF–MeOH–water; (e) thioamide, dioxane, 80 °C.</p></p></figure><div class="NLM_p">The synthesis of inhibitors containing a (<i>S</i>)-cucurbitine right-hand side <b>A</b> is detailed in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. The amino functions of (<i>S</i>)-(−)-cucurbitine <b>15</b><a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> were differentially protected as the <i>tert</i>-butoxycarbonyl derivative (Boc) on the pyrrolidine ring nitrogen and an Fmoc carbamate on the remaining amino function (compound <b>16</b>). Carboxylic acid <b>16</b> was then coupled to ethyl 4-aminocinnamate to give amide <b>17</b>. Following cleavage of the Boc protecting group, the pyrrolidine nitrogen was methylated and the Fmoc protecting group removed under standard conditions to provide the right-hand-side fragment <b>A</b>, protected as the ethyl ester (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). Right-hand side <b>B</b> was prepared in a similar fashion starting from commercially available Boc/Fmoc differentially protected 4-aminopiperidine-4-carboxylic acid.</div><figure id="sch5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of (<i>S</i>)-Cucurbitine Right-Hand-Side Fragment <b>A</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Di-<i>tert</i>-butyl dicarbonate, NaOH, THF, rt, then Fmoc-OSu; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (c) 37% aqueous formaldehyde, NaBH<sub>3</sub>CN, EtOH, AcOH; (d) ethyl 4-aminocinnamate, HATU, HOAt, 2,4,6-collidine, DMF, 50 °C; (e) DBU, THF, rt.</p></p></figure><div class="NLM_p">Ethyl 4-aminocinnamate ester building blocks <b>C</b>, <b>D</b>, and <b>E</b> were obtained by condensation of ethyl 4-aminocinnamate with amino acid chlorides <b>18</b>, themselves obtained from commercially available amino acids using the procedure of Rorrer et al., as shown in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Fragment <b>H</b> was prepared in a similar fashion starting from α-methylcinnamic acid <b>19</b> via sequential protection of the acid function and reduction of the nitro group to give aniline <b>20</b>. Coupling with <b>18</b> (<i>n</i> = 1) gave the desired right-hand-side building block <b>H</b>.</div><figure id="sch6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <b>C</b>–<b>E</b> Right-Hand Sides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 2-Oxazolidone, PCl<sub>5</sub>, MeCN, rt; (b) ethyl 4-aminocinnamate, K<sub>3</sub>PO<sub>4</sub>, MeCN, rt; (c) ethyl 5-amino-1-methyl-1<i>H</i>-indole-2-carboxylate, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, rt; (d) CH<sub>2</sub>N<sub>2</sub>, diethyl ether–MeOH, 0 °C; (e) SnCl<sub>2</sub> dihydrate, EtOH, reflux.</p></p></figure><div class="NLM_p">Inhibitors were prepared from indole-6-carboxylic acids (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) and amine fragments <b>A</b>–<b>H</b> (Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>) using standard peptide coupling procedures and purified by reversed-phase HPLC following saponification of the carboxylic ester under basic conditions as described in Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>. Inhibitor characterization data are provided in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div><figure id="sch7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Final Assembly of Inhibitors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) TBTU or HATU, Et<sub>3</sub>N or DIEA, DMSO, rt; (b) LiOH or NaOH, water–DMSO or water–THF–MeOH, rt.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26300" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26300" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The overall ADME-PK profile of indole-based HCV NS5B thumb pocket 1 inhibitors was improved by replacing the 3-cyclohexyl moiety of these inhibitors by a metabolically more stable cyclopentyl group. By use of parallel synthesis techniques, a sparse matrix of more than 100 inhibitors was generated from combinations of C2 indole substituents and amide right-hand sides, approximately 50 of which had gt1b replicon EC<sub>50</sub> < 100 nM. Microsome metabolic stability and Caco-2 permeability filters were then applied to select 71 analogues for oral screening in rat cassettes. Of these, compound <b>D13</b> provided the most optimal balance between antiviral potency (the complete preclinical profile of <b>D13</b> will be reported elsewhere) and a consistent cross-species PK profile and was selected for development followed by a clinical proof-of-concept study in HCV-infected patients.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31512" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31512" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Experimental</h3><div class="NLM_p last">All commercially obtained solvents and reagents were used as received without further purification. All reactions were carried out under an atmosphere of argon. Temperatures are given in °C. Solution percentages express a weight to volume relationship, and solution ratios express a volume to volume relationship, unless stated otherwise. NMR spectra were recorded on a Bruker AVANCE II (400 MHz for <sup>1</sup>H NMR) spectrometer and were referenced to either DMSO-<i>d</i><sub>6</sub> (2.50 ppm) or CDCl<sub>3</sub> (7.27 ppm). Data are reported as follows: chemical shift (ppm), multiplicity (s = singlet, d = doublet, t = triplet, br = broad, m = multiplet), coupling constant (<i>J</i>, reported to the nearest 0.5 Hz), and integration. Mass spectra were obtained from a Micomass AutoSpec instrument using ES as ionization mode. Purification of crude material was performed either by flash column chromatography or by using a CombiFlash Companion using RediSep silica or SilicaSep columns according to preprogrammed gradient and flow rate separation conditions in hexane/EtOAc or DCM/MeOH. The final compounds were purified by preparative HPLC on a Waters 2767 sample manager with pumps 2525, column fluidics organizer (CFO), PDA detector 2996, and MassLynx 4.1 using either a Whatman Partisil 10-ODS-3 column, 2.2 cm × 50 cm or a YMC Combi-Prep ODS-AQ column, 50 mm × 20 mm i.d., S, 5 μm, 120 Å, and a linear gradient program from 2% to 100% AcCN/water (0.06% TFA). Fractions were analyzed by analytical HPLC, and the pure fractions were combined, concentrated, frozen, and lyophilized to yield the desired compound as a neutral entity or the trifluoroacetate salt for basic analogues. Inhibitor HPLC purity was measured by using a Waters Alliance 2695 separation module with a Waters TUV 2487 UV detector. The column was a Combiscreen ODS-AQ, 5 μm, 4.6 mm × 50 mm, linear gradient from 5% to 100% ACN/H<sub>2</sub>O + 0.06% TFA in 10.5 min, detection at 220 nm. All final inhibitors had HPLC homogeneity of ≥95% unless noted otherwise (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 3-(1-Cyclopentenyl)indole-6-carboxylic Acid <b>8</b></h3><div class="NLM_p last">A 3 L three-neck flask equipped with a reflux condenser and mechanical stirrer was charged with indole-6-carboxylic acid <b>7</b> (purchased from Peakdale Intermediates, 220.0 g, 1.365 mol) and KOH pellets (764.45 g, 13.65 mol, 10 equiv). Water (660 mL) and MeOH (660 mL) were added, and the stirred mixture was heated to 75 °C. Cyclopentanone (603.7 mL, 6.825 mol, 5 equiv) was added dropwise over 18 h. The mixture was then stirred for an additional 3 h and cooled to 0 °C. The precipitated potassium salt was collected by filtration and washed with <i>tert</i>-butyl methyl ether (TBME, 2 × 500 mL) to remove cyclopentanone self-condensation byproduct. The brown solid was redissolved in water (2.5 L) and the solution washed with additional TBME (2 × 1 L). Following acidification of the aqueous phase to pH 3 with concentrated HCl (425 mL), the beige precipitate was collected by filtration, washed with water (2 × 1 L), and dried to constant weight under vacuum at 70 °C (279.5 g, 88.9% yield). The crude was used as such in the next step: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.52 (broad s, 1H), 11.50 (s, 1H), 8.02 (d, <i>J</i> = 0.8 Hz, 1H), 7.88 (d, <i>J</i> = 8.6 Hz, 1H), 7.66 (dd, <i>J</i> = 8.4, 1.4 Hz, 1H), 7.57 (d, <i>J</i> = 2.6 Hz, 1H), 6.16 (s, 1H), 2.71 (m, 2H), 2.53 (m, 2H), 1.92 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.2, 136.2, 128.3, 127.5, 123.5, 121.1, 120.3, 119.7, 113.7, 113.0, 38.2, 34.4, 33.2, 22.2. ES-MS(−) <i>m</i>/<i>z</i> 225.9 (M – H).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 3-Cyclopentylindole-6-carboxylic Acid <b>9</b></h3><div class="NLM_p last">Crude cyclopentenylindole <b>8</b> from above (159.56 g, 0.70 mol) was dissolved in MeOH (750 mL), and the solution was purged with argon gas. 20% Pd(OH)<sub>2</sub> on charcoal (Pearlman’s catalyst, 8.0 g) was added, and the suspension was hydrogenated in a Parr apparatus under 50 psi of hydrogen gas for 18 h. After completion, the suspension was again purged with argon, and the catalyst was removed by filtration through a pad of Celite and the solvent removed under reduce pressure. The resulting brown solid was dried at 70 °C under vacuum to constant weight, providing crude cyclopentylindole analogue <b>9</b> as a beige solid (153.2 g): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.40 (broad s, 1H), 11.12 (s, 1H), 7.98 (s, 1H), 7.60 (d, <i>J</i> = 8.3 Hz, 1H), 7.57 (dd, <i>J</i> = 8.3, 1.2 Hz, 1H), 7.34 (d, <i>J</i> = 1.5 Hz, 1H), 3.22 (quintet, <i>J</i> = 7.6 Hz, 1H), 2.09 (m, 2H), 1.77 (m, 2H), 1.64 (m, 4H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.4, 135.8, 130.0, 124.5, 122.9, 119.5, 119.0, 118.4, 113.5, 36.4, 32.9, 24.8. ES-MS(−) <i>m</i>/<i>z</i> 228.0 (M – H).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 3-Cyclopentyl-1-methylindole-6-carboxylic Acid Methyl Ester <b>10</b></h3><div class="NLM_p last">A 3 L three-neck flask equipped with a mechanical stirrer and thermometer was charged with crude 3-cyclopentyl-6-indolecarboxylic acid <b>9</b> (74.00 g, 0.323 mol) and purged with nitrogen. Anhydrous DMF (740 mL) was added and the mixture stirred until dissolution of solids. Anhydrous K<sub>2</sub>CO<sub>3</sub> (66.91 g, 0.484 mol, 1.5 equiv) was added followed by MeI (50 mL, 0.807 mol, 2.5 equiv). After the mixture was stirred at room temperature for 5 h, HPLC analysis indicated complete conversion to the methyl ester. The reaction mixture was cooled in an ice bath, and NaH (95%, oil-free, 10.10 g, 0.42 mol, 1.3 equiv) was added in small portions. After the mixture was stirred for an additional 15 min, the ice bath was removed and the mixture was stirred for an additional 1.5 h at room temperature (no more progress by HPLC). Additional NaH (1.55 g, 65 mmol, 0.2 equiv) and MeI (1.0 mL, 16 mmol, 0.05 equiv) were added, and after the mixture was stirred for an additional 15 min, the reaction was judged to be complete. The reaction mixture was poured into water (4 L) and acidified to pH < 2 with concentrated HCl (85 mL). The solution was adjusted to pH 7 with 4 N NaOH (40 mL), and after the mixture was stirred overnight at room temperature, the precipitated solid was collected by filtration, washed with water (600 mL), and dried to constant weight under vacuum. The crude product (72.9 g) contains a poorly soluble impurity resulting from carried-over dimerization of the indole (impurity <b>11</b>) that was removed by successive triturations with organic solvents as follows: the crude material was triturated with hot MeOH (∼250 mL). After cooling in ice, the solid was collected and redissolved in a minimum amount of hot EtOAc (∼300 mL). After the solution was cooled to room temperature, hexane (1.5 L) was added and the mixture stirred overnight at room temperature. Undissolved solids were removed by filtration and the filtrate was evaporated under reduced pressure to give the desired <i>N</i>-methylindole ester <b>10</b> as a beige solid (47 g, 57% yield): mp 113–114.5 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.02 (s, 1H), 7.64 (d, <i>J</i> = 8.4 Hz, 1H), 7.62 (dd, <i>J</i> = 8.4, 1.0 Hz, 1H), 7.36 (s, 1H), 3.86 (s, 3H), 3.80 (s, 3H), 3.20 (quintet, <i>J</i> = 8.0 Hz, 1H), 2.10 (m, 2H), 1.77 (m, 2H), 1.72–1.55 (m, 4H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.3, 136.1, 130.6, 129.4, 121.9, 118.9, 118.8, 111.6, 51.8, 36.2, 33.0, 32.4, 24.7. ES-MS(−) <i>m</i>/<i>z</i> 227.9 (M – H). Anal. Calcd for C<sub>16</sub>H<sub>19</sub>NO<sub>2</sub>: C, 74.68; H, 7.44; N, 5.44. Found: C, 74.40; H, 7.36; N, 5.42.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2-Bromo-3-cyclopentyl-1-methylindole-6-carboxylic Acid Methyl Ester <b>12</b></h3><div class="NLM_p last"><i>N</i>-Methylindole ester <b>10</b> (80.70 g, 0.31 mol) was dissolved in isopropyl acetate (1.2 L), and the mechanically stirred solution was treated with NaOAc (38.59 g, 0.47 mol, 1.5 equiv) and cooled to 4 °C. Bromine (16.87 mL, 0.33 mol, 1.1 equiv) was added dropwise over 6 min, and the resulting suspension was stirred for an additional 50 min at 13 °C. Additional bromine (3.2 mL, 63 mmol, 0.2 equiv) was then added, and after the mixture was stirred for 20 min, the reaction was determined to be complete (HPLC). The reaction was then quenched by addition of 10% aqueous sodium thiosulfate (125 mL), followed by water (400 mL) and K<sub>2</sub>CO<sub>3</sub> (78 g, 1.8 equiv). The biphasic mixture was stirred for 10 min, and the organic phase was separated. It was washed with 10% sodium thiosulfate solution (80 mL) and 1 M K<sub>2</sub>CO<sub>3</sub> (80 mL) and dried (MgSO<sub>4</sub>). The dried extract was evaporated under reduced pressure to yield a beige solid (109.5 g). The crude material was suspended in MeOH (750 mL) and the mixture refluxed for 30 min. After the mixture was cooled in an ice bath, the beige solid was collected by filtration, washed with cold MeOH (200 mL), and dried to constant weight under vacuum at 60 °C (73.4 g, 79% yield): mp 110–111 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.09 (s, 1H), 7.67 (d, <i>J</i> = 8.4 Hz, 1H), 7.64 (dd, <i>J</i> = 8.4, 1.2 Hz, 1H), 3.87 (s, 3H), 3.80 (s, 3H), 3.26 (quintet, <i>J</i> = 9.8 Hz, 1H), 1.90 (m, 6H), 1.70 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.0, 136.1, 128.5, 122.3, 118.7, 118.4, 117.2, 116.8, 111.9, 51.9, 37.5, 31.9, 31.7, 25.7. ES-MS(+) <i>m</i>/<i>z</i> 336.0 and 338.0 (MH<sup>+</sup>). Anal. Calcd for C<sub>16</sub>H<sub>18</sub>BrNO<sub>2</sub>: C, 57.16; H, 5.40; N, 4.17. Found: C, 57.29; H, 5.25; N, 3.96.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Methyl Ester of 3-Cyclopentyl-2-(3-furyl)-<i>N</i>-methylindole-6-carboxylic Acid (Methyl Ester of Building Block <b>1</b>) via Suzuki–Miyaura Cross-Coupling (Method A)</h3><div class="NLM_p last">2-Bromoindole <b>12</b> (2.03 g, 6.0 mmol) was combined with 3-furylboronic acid (1.014 g, 9.1 mmol), sodium carbonate (1.28 g, 12 mmol), and LiCl (0.51 g, 12 mmol) in a round-bottomed flask equipped with a reflux condenser. Toluene (20 mL), ethanol (20 mL), and water (16 mL) were added, and the dark heterogeneous mixture was degassed by bubbling a stream of argon through the mixture for 15 min. Pd(PPh<sub>3</sub>)<sub>4</sub> (350 mg, 0.3 mmol) was added and the mixture heated to 80 °C under an argon atmosphere. After 3 h (60% conversion by HPLC analysis), another portion of Pd(PPh<sub>3</sub>)<sub>4</sub> (350 mg, 0.3 mmol) was added and heating continued overnight (>90% conversion). The reaction mixture was cooled to room temperature, diluted with EtOAc and the solution washed with saturated aqueous NH<sub>4</sub>Cl and brine. The organic phase was dried (MgSO<sub>4</sub>) and concentrated under reduced pressure to give a residue that was purified by flash chromatography using 1:19 EtOAc/hexane as eluent. The methyl ester of building block <b>1</b> was recovered as a white foam (1.66 g, 57% yield): mp 79–82 °C. <i>R<sub>f</sub></i> = 0.24 (1:19 EtOAc/hexane). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.09 (d, <i>J</i> = 0.9 Hz, 1H), 7.98 (s, 1H), 7.91 (t, <i>J</i> = 1.7 Hz, 1H), 7.69 (d, <i>J</i> = 8.4 Hz, 1H), 7.64 (dd, <i>J</i> = 8.4, 1.3 Hz, 1H), 6.76 (d, <i>J</i> = 1.1 Hz, 1H), 3.87 (s, 3H), 3.67 (s, 3H), 3.13 (m, <i>J</i> = 8.9 Hz, 1H), 1.78 (m, 6H), 1.64 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.2, 144.0, 142.7, 136.5, 132.6, 128.8, 121.9, 119.2, 119.1, 116.8, 115.4, 112.2, 111.8, 51.8, 36.9, 32.8, 30.6, 25.8. ES-MS(+) <i>m</i>/<i>z</i> 324.1 (MH<sup>+</sup>).</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 3-Cyclopentyl-1-methyl-2-tributylstannanyl-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester <b>13</b></h3><div class="NLM_p">A 3 L three-necked flask fitted with a mechanical stirrer, low temperature thermometer, and addition funnel was purged with argon gas. 2-Bromoindole 12 (82.73 g, 246 mmol, 1 equiv) was added followed by anhydrous THF (1 L). The solution was cooled to −72 °C. <i>n</i>-BuLi in hexane (2.5 M, 100 mL, 250 mmol, 1.016 equiv) was added dropwise keeping the internal temperature below −68 °C (35–40 min). After the mixture was stirred for 5 min, HPLC analysis of an aliquot quenched in MeOH showed no more starting material. Bu<sub>3</sub>SnCl (83.41 mL, 308 mmol, 1.25 equiv) was added neat dropwise over 30 min, keeping the internal temperature below −68 °C. The mixture was stirred at −72 °C for 30 min and then allowed to warm to room temperature. Volatiles were removed under reduced pressure, and the residue was dissolved in TBME (1.5 L). The organic phase was washed with a mixture of 5% citric acid (150 mL) and brine (150 mL) and then with 5% NaHCO<sub>3</sub> (150 mL) and brine (150 mL). After a final washing with brine (150 mL), the organic phase was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated to a black viscous oil.</div><div class="NLM_p last">Silica gel (1.2 kg, 230–400 mesh) was slurried with 5% triethylamine in hexane (6 L) and charged into a 12 cm diameter column. The solvent was passed several times through the silica to ensure complete deactivation and then discarded (3.3 L). The crude stannane from above was dissolved in fresh 5% Et<sub>3</sub>N/hexane (200 mL) and charged onto the column. The material was eluted with the same solvent (6 L), and fractions containing the product were pooled. Evaporation of volatiles under reduced pressure gave stannane <b>13</b> as a yellow oil (104.9 g): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.07 (s, 1H), 7.73 (d, <i>J</i> = 8.4 Hz, 1H), 7.66 (d, <i>J</i> = 8.4 Hz, 1H), 3.97 (s, 3H), 3.83 (s, 3H), 3.11 (quintet, <i>J</i> = 9.0 Hz, 1H), 2.09 (m, 2H), 1.97 (m, 4H), 1.78 (m, 2H), 1.58 (m, 6H), 1.38 (m, <i>J</i> = 7.2 Hz, 6H), 1.21 (m, 6H), 0.93 (t, <i>J</i> = 7.2 Hz, 9H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.5, 144.6, 140.4, 129.4, 128.9, 122.2, 119.1, 118.8, 111.5, 51.8, 40.7, 34.0, 33.9, 29.0, 27.3, 26.6, 13.6, 11.5. ES-MS(+) <i>m</i>/<i>z</i> 548.3 (MH<sup>+</sup>).</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Methyl Ester of 3-Cyclopentyl-2-(2-pyridyl)-<i>N</i>-methylindole-6-carboxylic Acid (Methyl Ester of Building Block <b>13</b>) via Stille Cross-Coupling (Method B)</h3><div class="NLM_p">Stannane 13 (104.60 g, 191.5 mmol) was dissolved in dry DMF (500 mL). Triphenylphosphine (50.31 g, 191.8 mmol, 1.0 equiv), CuI (3.653 g, 19.18 mmol, 0.1 equiv), LiCl (16.26 g, 383.6 mmol, 2 equiv), and 2-bromopyridine (23.77 mL, 249.4 mmol, 1.3 equiv) were added. The suspension was purged by bubbling argon through for 45 min. Tetrakistriphenylphosphine Pd<sup>0</sup> (5.00 g, 4.327 mmol, 2.3 mol %) was added and the mixture heated to 100 °C. After the mixture was stirred at that temperature for 2 h, Et<sub>3</sub>N-deactivated TLC analysis indicated complete reaction. The mixture was cooled, and the DMF phase was washed with hexane (3 × 250 mL). DMF (350 mL) was removed under vacuum, and water (1 L) was added followed by TBME (500 mL). A precipitate of triphenylphosphine formed in the biphasic system. It was removed by filtration and washed with TBME. The filtrate and washings from above were combined, and the organic phase was separated. The aqueous phase was extracted again with TBME (2 × 500 mL), and the extracts were combined. After the mixture was washed with brine (300 mL) and dried (MgSO<sub>4</sub>), volatiles were removed to give a dark red syrup.</div><div class="NLM_p last">To the above material was added TBME (100 mL) and hexane (300 mL) and the solution chilled to 0 °C to induce crystallization. The mixture was then further cooled to −20 °C and the solid collected by filtration. It was washed with hexane and dried to give the desired product (28.20 g) as a brown-reddish solid (94–95% homogeneity by HPLC). The filtrate and washings from above were combined, and the remaining product was isolated by chromatography on silica gel (1 kg, 230–400 mesh) using CHCl<sub>3</sub> and then 10–20% EtOAC–CHCl<sub>3</sub> as eluents. Additional product (23.55 g) of comparable homogeneity to the first crop was obtained as a yellow solid (total yield of 51.75 g, 80%): mp 114–115 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.80 (d, <i>J</i> = 4.5 Hz, 1H), 8.14 s, 1H), 7.99 (dd, <i>J</i> = 1.6, 7.6 Hz, 1H), 7.77 (d, <i>J</i> = 8.4 Hz, 1H), 7.68 (d, <i>J</i> = 8.4 Hz, 1H), 7.59 (d, <i>J</i> = 7.6 Hz, 1H), 7.49 (dd, <i>J</i> = 7.6, 4.9 Hz, 1H), 3.89 (s, 3H), 3.69 (s, 3H), 3.14 (m, 1H), 1.88 (m, 6H), 1.62 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.1, 150.2, 149.7, 139.3, 136.8, 136.6, 128.6, 126.2, 123.1, 122.6, 119.8, 119.3, 117.2, 112.1, 51.8, 36.7, 32.8, 30.9, 25.8. ES-MS(+) <i>m</i>/<i>z</i> 335.2 (MH<sup>+</sup>).</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Methyl Ester of 3-Cyclopentyl-2-(2-pyridyl)-<i>N</i>-methylindole-6-carboxylic Acid, Hydrochloride (Methyl Ester of Building Block <b>13</b>) via in Situ Generation of 2-Indole Boronate and Suzuki–Miyura Cross-Coupling (Method C)</h3><div class="NLM_p last"><i>n</i>-Butyllithium (1.6 M in hexane, 97.4 mL, 1.05 equiv) was added to a solution of bromoindole <b>12</b> (50.0 g, 148.7 mmol, 1.00 equiv) in THF (250 mL), maintaining the temperature of the mixture below −71 °C. After the mixture was stirred at this temperature for 10 min, HPLC analysis showed that the starting bromoindole had completely reacted. Trimethyl borate (20.2 mL, 1.2 equiv) was added, maintaining the temperature below −69 °C. After being stirred at this temperature for 0.5 h, the mixture was warmed to 0 °C and stirred for an additional 1 h, when it was allowed to warm to room temperature. HPLC analysis showed the formation of a mixture of the desired boronate and the 2-H indole side product in the ratio 93.9:5.3. To the reaction mixture was added 250 mL of THF (250 mL), tri-<i>p</i>-tolylphosphine (2,72 g, 0.06 equiv), and 2-bromopyridine (28.1 g, 1.2 equiv). The resulting solution was purged with argon for 30 min. Palladium acetate (333.0 mg, 0.01 equiv) was added and the solution stirred for 10 min. Then potassium carbonate (40.9 g, 2 equiv) was added followed by methanol (165 mL). The reaction mixture was then heated at reflux under an argon atmosphere for 4.5 h. HPLC analysis showed that about 1% of the starting boronate was left after 3 and 4.5 h of reaction. The reaction mixture was allowed to cool to room temperature and the solvent removed under reduced pressure. The residue was taken up in MTBE (250 mL) to which was then added water (250 mL), and the biphasic mixture was stirred for 10 min. The layers were then separated, and the organic layer was washed with brine (50 mL), dried over anhydrous magnesium sulfate, and filtered through a glass frit. The filtrate was carefully treated with 4.0 M HCl and 1,4-dioxane solution (50 mL, 1.3 equiv). The solvent was removed under reduced pressure, and MTBE (500 mL) and dichloromethane (450 mL) were added. The mixture was warmed to reflux temperature. Then additional dichloromethane (900 mL) was added and the temperature again raised to reflux in order to achieve complete solution. The mixture was cooled to 10 °C and the solid collected by filtration. The solid product was dried in a vacuum oven at 40 °C to afford 35.6 g of product. The filtrate was evaporated and then treated with a 1:1 mixture of MTBE/DCM (600 mL total volume), cooled to 10 °C and the solid collected by filtration. This material was dried in a vacuum oven to afford a further 11.0 g of product. The combined solids (46.56 g, 84% yield, 94% purity by HPLC) were identical in all respects to material generated using the Stille procedure.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 3-Cyclopentyl-1-methyl-2-pyridin-2-yl-1<i>H</i>-indole-6-carboxylic Acid (Building Block <b>13</b>)</h3><div class="NLM_p last">The two product crops of the methyl ester of building block <b>13</b> from Stille cross-coupling of bromoindole <b>12</b> with 2-bromopyridine (51.0 g, 154.7 mmol) were dissolved in a mixture of THF (100 mL) and MeOH (100 mL), and the solution was heated to 60 °C. Then 5 N NaOH (125 mL) was added portionwise over 15 min and the mixture stirred for 1 h at 60 °C after which HPLC analysis showed complete hydrolysis. The reaction mixture was cooled to room temperature, and organics were removed under reduced pressure to give a pink suspension. Water (1 L) was added and the mixture stirred for 30 min before the solid was removed by filtration. The filtrate was washed with TBME (3 × 250 mL) and hexane (250 mL), and concentrated HCl (40 mL) was added slowly with stirring to the aqueous phase. AcOH (15 mL) was then added slowly to form a white precipitate. After the mixture was stirred for 30 min, the precipitated product was collected by filtration, washed with water, and dried under vacuum at 60 °C (43.2 g, 87% yield): mp 237–238.5 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.61 (broad s, 1H), 8.80 (d, <i>J</i> = 4.3 Hz, 1H), 8.12 (s, 1H), 7.98 (dt, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.74 (d, <i>J</i> = 8.4 Hz, 1H), 7.67 (d, <i>J</i> = 8.2 Hz, 1H), 7.58 (d, <i>J</i> = 7.8 Hz, 1H), 7.48 (dd, <i>J</i> = 7.4, 5.1 Hz, 1H), 3.68 (s, 3H), 3.15 (quintet, <i>J</i> = 9.3 Hz, 1H), 1.89 (m, 6H), 1.62 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.2, 150.3, 149.7, 139.0, 136.8, 136.7, 128.3, 126.2, 123.8, 123.1, 119.64, 119.61, 117.1, 112.2, 36.7, 32.8, 30.8, 25.8. ES-MS(+) <i>m</i>/<i>z</i> 321.2 (MH<sup>+</sup>).</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 1-Chlorocarbonylcyclobutylammonium Chloride <b>18</b> (<i>n</i> = 1)</h3><div class="NLM_p last">A 3 L three-necked flask equipped with a mechanical stirrer was purged with nitrogen and charged with 2-oxazolidone (81.7 g, 938 mmol, 1.22 equiv) and acetonitrile (1.2 L). Phosphorus pentachloride (260 g, 1.25 mol, 1.63 equiv) was added in one portion (no exotherm noticed), and the mixture was stirred 14 h at room temperature. 1-Aminocyclobutanecarboxylic acid (88.5 g, 769 mmol, 1 equiv) was added and the resulting suspension stirred for 22 h. The suspended solid was collected by suction filtration, washed with acetonitrile (200 mL), and dried under vacuum (105.1 g, 80% yield). Anal. Calcd for C<sub>5</sub>H<sub>9</sub>Cl<sub>2</sub>NO: C, 35.32; H, 5.33; N, 8.24. Found: C, 35.54; H, 5.48; N, 8.30. Material partially decomposed upon standing for extended periods of time (>1 month). This procedure was adapted to the preparation of other amino acid chloride hydrochlorides (e.g., derived from 1-aminocyclopentanecarboxylic acid).</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (<i>E</i>)-3-{4-[(1-Aminocyclobutanecarbonyl)amino]phenyl}acrylic Acid Ethyl Ester (Ethyl Ester of Building Block <b>D</b>)</h3><div class="NLM_p last">Acid chloride <b>18</b> (41.1 g, 242 mmol, 1.20 equiv) was suspended in acetonitrile (400 mL), and ethyl 4-aminocinnamate (38.52 g, 201 mmol, 1.0 equiv) was added. After the mixture was stirred for 30 min, HPLC showed 95% conversion. Additional acid chloride (2.70 g, 16 mmol, 0.08 equiv) was added, and after the mixture was stirred for an additional 20 min, conversion was judged to be complete. After the mixture was stirred for an additional 90 min (2.5 h total reaction time), solid K<sub>3</sub>PO<sub>4</sub> (106.9 g, 504 mmol, 2.5 equiv) was added, and after the mixture was stirred for 15 min, the reaction mixture was poured into water (2 L). After the mixture was stirred for 20 min (pH ∼8), the precipitated product was collected by filtration, rinsed with water (250 mL), and dried in vacuum at 60 °C (55.9 g, 96% yield): mp 122–124.5 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.75 (d, <i>J</i> = 8.8 Hz, 2H), 7.66 (d, <i>J</i> = 8.8 Hz, 2H), 7.58 (d, <i>J</i> = 15.9 Hz, 1H), 6.52 (d, <i>J</i> = 16.1 Hz, 1H), 4.18 (q, <i>J</i> = 7.1 Jz, 2H), 2.5 (m, 2H), 1.9 (m, 3H), 1.75 (m, 1H), 1.25 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 175.2, 166.4, 144.0, 141.0, 129.1, 128.7, 119.1, 116.1, 59.8, 59.4, 33.6, 14.2, 13.8. ES-MS(+) <i>m</i>/<i>z</i> 289.1 (MH<sup>+</sup>).</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <b>D13</b> Ethyl Ester</h3><div class="NLM_p last">Indole building block <b>13</b> (43.00 g, 134.2 mmol, 1 equiv) and amine fragment <b>D</b> (40.63 g, 140.9 mmol, 1.05 equiv) were dissolved in DMSO (200 mL), and triethylamine (74.8 mL, 537 mmol, 4 equiv) was added followed by TBTU (64.62 g, 201 mmol, 1.5 equiv). A slight exotherm was noticed. The mixture was stirred for 16 h at room temperature (seemed complete after 2 h as shown by HPLC). The reaction mixture was then added dropwise in a vigorously stirred mixture of water (2 L), NaCl (300 g), and AcOH (40 mL). The precipitated cream-colored solid was centrifuged and the aqueous phase carefully decanted out. The solids were resuspended in a mixture of water (2 L) and NaCl (300 g). The solid material was separated from the water as before, dissolved in EtOAc (1 L), and washed with 1 N NaOH (2 × 250 mL), saturated aqueous NaHCO<sub>3</sub> (250 mL), and brine (250 mL). The extract was dried (MgSO<sub>4</sub>) and evaporated to a yellow paste (the product begins to crystallize during the concentration process). TBME (300 mL) and CHCl<sub>3</sub> (50 mL) were added, and the slurry was heated to 60 °C for 30 min. Hexane (1000 mL) was added portionwise to the hot slurry, and heating continued for an additional 30 min. The mixture was allowed to cool to room temperature and then to 10 °C. The solid ester product (<b>D13</b> ethyl ester) was collected by filtration, washed with 20% TBME in hexane, and dried in vacuum at 60 °C (70.0 g, 88% yield): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.74 (s, 1H), 8.86 (s, 1H), 8.81 (d, <i>J</i> = 3.9 Hz, 1H), 8.22 (s, 1H), 7.99 (dt, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.74–7.54 (m, 8H), 7.49 (dd, <i>J</i> = 7.4, 4.9 Hz, 1H), 6.50 (d, <i>J</i> = 16 Hz, 1H), 4.16 (q, <i>J</i> = 7.0 Hz, 2H), 3.73 (s, 3H), 3.16 (m, 1H), 2.74 (m, 2H), 2.38 (m, 2H), 2.05–1.80 (m, 8H), 1.63 (m, 2H), 1.24 (t, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.2, 166.9, 166.3, 150.5, 149.7, 144.0, 141.4, 138.3, 136.8, 129.0, 128.6, 127.3, 127.0, 126.2, 122.9, 119.4, 119.3, 118.4, 117.0, 116.1, 110.4, 59.84, 59.79, 36.7, 32.9, 31.0, 30.7, 25.8, 15.0, 14.2. ES-MS(+) <i>m</i>/<i>z</i> 591.4 (MH<sup>+</sup>).</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (<i>E</i>)-3-[4-({1-[(3-Cyclopentyl-1-methyl-2-pyridin-2-yl-1<i>H</i>-indole-6-carbonyl)amino]cyclobutanecarbonyl}amino)phenyl]acrylic Acid (<b>D13</b>)</h3><div class="NLM_p"><b>D13</b> ethyl ester (66.00 g) was dissolved in DMSO (200 mL) and the solution heated to 60 °C. Then 5 N NaOH (66 mL, 3 equiv) was added dropwise over 10 min and the mixture heated for an additional 15 min at 60 °C (hydrolysis complete by HPLC). The reaction mixture was cooled to room temperature and added dropwise to a well stirred mixture of water (2 L), NaCl (300 g), and AcOH (25 mL). A precipitate formed in a dark reddish-brown solution. The solid was collected by filtration and washed with water (600 mL). The solid pastelike material was dissolved in EtOAc (1.2 L) and the organic portion washed with brine (2 × 500 mL). After the mixture was dried (Na<sub>2</sub>SO<sub>4</sub>), removal of the solvent under reduced pressure gave a solid that was suspended in absolute EtOH (200 mL). The mixture was warmed with stirring to 65–70 °C. While hot, CHCl<sub>3</sub> (300 mL) was added in portions. The mixture was refluxed until all solids dissolved. The solution was stirred at 65–70 °C, allowing the product to slowly crystallize out. After 1 h, TBME (1 L) was added dropwise (1 h), maintaining a gentle reflux throughout. The thick suspension was stirred for an additional 1 h at reflux and then slowly cooled to room temperature. The solid was collected by filtration, washed with 20% CHCl<sub>3</sub> in TBME (200 mL) and then TBME (2 × 200 mL), and dried under vacuum at 60 °C (53.69 g).</div><div class="NLM_p last">The crude material from above was suspended in absolute EtOH (200 mL) and then warmed to 70 °C. To the suspension was added TBME (1.3 L) in 100 mL portions over 10 min. The mixture was refluxed for 1 h and cooled to room temperature. The cream-colored solid was collected by filtration, washed with TBME (3 × 200 mL), and dried in vacuum at 60 °C for 84 h (50.40 g, 80% yield): mp 252–256 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.22 (broad s, 1H), 9.70 (s, 1H), 8.84 (s, 1H), 8.80 (d, <i>J</i> = 4.7 Hz, 1H), 7.73–7.46 (m, 9H), 6.39 (d, <i>J</i> = 16.0 Hz, 1H), 3.73 (s, 3H), 3.16 (quintet, <i>J</i> = 8.8 Hz, 1H), 2.74 (m, 2H), 2.37 (m, 2H), 1.98 (m, 1H), 1.89 (m, 6H), 1.62 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.2, 167.7, 167.0, 150.5, 149.7, 143.6, 141.3, 138.3, 136.8, 136.7, 128.8, 127.4, 127.1, 126.2, 122.9, 119.5, 119.4, 118.5, 117.2, 117.1, 110.4, 59.9, 36.8, 32.9, 31.0, 30.8, 25.9, 15.1. ES-MS(+) <i>m</i>/<i>z</i> 563.4 (MH<sup>+</sup>).</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-(2-Bromoacetyl)-3-cyclopentyl-1-methyl-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester <b>14</b></h3><div class="NLM_p">To bromoindole <b>12</b> (7.66 g, 23.0 mmol) in dioxane (130 mL) in a 250 mL round-bottomed flask was added 1-ethoxyvinlytributlytin (10.0 g, 28.0 mmol). The mixture was degassed by bubbling argon gas through the homogeneous mixture for a period of 30 min. Di(triphenylphosphine)palladium dichloride (1.3 g, 1.9 mmol) was added and the mixture degassed for a further 10 min. The mixture was then heated to reflux and stirred for 20+ h. The reaction was judged to be complete by TLC, and the mixture was cooled to room temperature. The volatiles were removed under reduced pressure, and the residue was absorbed onto silica gel. The intermediate ethoxyvinylindole was purified by flash chromatography on silica using 4% EtOAc/hexane as eluent to afford 6.49 g of the ethoxyvinylindole derivative that was used directly in the next step.</div><div class="NLM_p last">The ethoxyvinylindole from above was dissolved in THF (65 mL). To this was added water (6.5 mL), and the mixture was cooled in an ice/water bath. <i>N</i>-Bromosuccinimide (3.53 g, 19.8 mmol) was added in small portions over a period of 50 min, and stirring continued for a further 30 min, after which the reaction was judged to be complete by TLC. The mixture was diluted with diethyl ether (200 mL), and water was added (200 mL). The phases were separated, and the aqueous layer was washed with 2 × 80 mL of diethyl ether. The organic portions were combined, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The residue was purified on silica gel, using a 5–15% EtOAc/hexane gradient to provide 5.30 g of bromomethyl ketone <b>14</b> (61% yield for both steps): mp 115–118 °C (dec). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.13 (broad t, <i>J</i> = 0.4 Hz, 1H), 7.79 (dd, <i>J</i> = 8.6, 0.9 Hz, 1H), 7.76 (dd, <i>J</i> = 8.6, 1.3 Hz, 1H), 4.43 (s, 2H), 3.97 (s, 3H), 3.86 (s, 3H), 3.47 (m, <i>J</i> = 8.6 Hz, 1H), 2.15–2.0 (m, 6H), 1.85 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCL<sub>3</sub>) δ 188.5, 167.5, 139.1, 134.4, 127.8, 126.7, 126.1, 122.2, 120.2, 113.1, 52.2, 38.4, 35.0, 34.0, 32.0, 26.7. ES-MS(+) <i>m</i>/<i>z</i> 380, 381 (MH<sup>+</sup>).</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> General Procedure for the Preparation of 2-(2-Substituted-thiazol-4-yl)-3-cyclopentyl-1<i>H</i>-indole-6-carboxylic Acid Building Blocks <b>5</b>–<b>11</b></h3><div class="NLM_p last">Bromomethyl ketone <b>14</b> (1 equiv) was dissolved in isopropanol or dioxane (5–10 mL per mmol of <b>14</b>), and a thiourea, acylthiourea, or thioamide (1.1–1.25 equiv) was added. The mixture was heated to 65–80 °C until reaction was complete as judged by HPLC analysis. Volatiles were removed under reduced pressure, and the residue was purified by flash chromatography or saponified directly using 5 N NaOH or LiOH hydrate in a 1:1 mixture of MeOH and THF at room temperature until complete. Following acidification of the reaction mixture with aqueous HCl, the desired indolecarboxylic acid was isolated by extraction with EtOAc, washed with water and brine, dried (MgSO<sub>4</sub>) and volatiles were removed from the desired product. The crude carboxylic acid derivatives were isolated as amber solids and used directly for coupling with right-hand-side fragments <b>A</b>–<b>H</b> in the usual manner.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (<i>S</i>)-3-(9<i>H</i>-Fluoren-9-ylmethoxycarbonylamino)pyrrolidine-1,3-dicarboxylic Acid 1-<i>tert</i>-Butyl Ester, (<i>S</i>)-<b>16</b></h3><div class="NLM_p last">(S)-Cucurbitine <b>15</b> (0.267 g, 2.05 mmol) was dissolved in THF (15 mL), and 1 N NaOH (4.1 mL, 4.1 mmol) was added followed by Boc<sub>2</sub>O (0.49 g, 2.26 mmol). The reaction mixture was stirred overnight at room temperature, and Fmoc-ONSu (1.038 g, 3.08 mmol) was added. After being stirred at room temperature for an additional 20 h, the reaction mixture was acidified with 1 N HCl and extracted with EtOAc. The extract was washed with brine, dried (MgSO<sub>4</sub>), and concentrated under reduced pressure to give crude material (1.36 g) that was used as such in the next step.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>S</i>)-3-(9<i>H</i>-Fluoren-9-ylmethoxycarbonylamino)-1-methylpyrrolidine-3-carboxylic Acid, (<i>S</i>)-<b>17</b></h3><div class="NLM_p last">The crude material from above (1.36 g) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (4 mL), and TFA (4 mL) was added. The solution was stirred for 45 min at room temperature, and then volatiles were removed under reduced pressure. The residue was dissolved in EtOH (20 mL), and AcOH (1.06 mL, 18.5 mmol) was added followed by 37% aqueous formaldehyde (1 mL, 12.3 mmol) and sodium cyanoborohydride (0.39 g, 6.1 mmol). The reaction mixture was stirred for 1 h at room temperature. (<i>S</i>)-Cucurbitine derivative <b>17</b> was isolated as a white solid TFA salt by semipreparative HPLC using aqueous TFA–acetonitrile gradients (∼400 mg) and was used as such for the next step.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>E</i>)-3-{4-[((<i>S</i>)-3-Amino-1-methylpyrrolidine-3-carbonyl)amino]phenyl}acrylic Acid Ethyl Ester, Fragment A Ethyl Ester</h3><div class="NLM_p last">TFA salt (<i>S</i>)-<b>17</b> (107 mg, 0.22 mmol) and ethyl 4-aminocinnamate (54 mg, 0.28 mmol) were dissolved in DMF (2.5 mL). HATU (128 mg, 0.34 mmol) and HOAt (46 mg, 0.34 mmol) were then added, followed by 2,4,6-collidine (89 μL, 0.67 mmol). The reaction mixture was stirred at 50 °C for 2.5 h after which additional HATU was added to complete the conversion as monitored by HPLC analysis. After completion, the reaction mixture was cooled to room temperature, acidified with a few drops of AcOH and the mixture purified by semipreparative HPLC to provide fragment <b>A</b> as a yellowish TFA salt (91 mg, 62% yield).</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>E</i>)-3-(4-Aminophenyl)-2-methylacrylic Acid, Methyl Ester (<b>20</b>)</h3><div class="NLM_p last">α-Methyl-4-nitrocinnamic acid <b>19</b> (53 mg, 0.25 mmol) was dissolved in EtOAc and MeOH, and a solution of CH<sub>2</sub>N<sub>2</sub> in Et<sub>2</sub>O was added until a persistent yellow color was observed. A couple of drops of AcOH were added to destroy the excess CH<sub>2</sub>N<sub>2</sub>. The mixture was diluted with EtOAc, and the organic layer was washed with H<sub>2</sub>O, aqueous NaOH (1 N), and brine, dried over anhydrous MgSO<sub>4</sub>, and concentrated to dryness. The residue was redissolved in EtOH (2 mL). SnCl<sub>2</sub>·2H<sub>2</sub>O (289 mg, 1.28 mmol) was added, and the reaction mixture was heated to reflux for 1 h. The mixture was cooled to room temperature, diluted with EtOAc, and quenched by the addition of aqueous, saturated NaHCO<sub>3</sub>. The organic layer was separated, washed with brine, dried over anhydrous MgSO<sub>4</sub>, and concentrated to dryness to give the title compound (40 mg) as a yellow solid. ES<sup>+</sup> MS <i>m</i>/<i>z</i>: 206.0 (M + H)<sup>+</sup>. ES<sup>–</sup> MS <i>m</i>/<i>z</i>: 204.0 (M – H)<sup>−</sup>.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Biological Testing</h3><div class="NLM_p last">Inhibition of HCV polymerase activity in a biochemical assay was performed using an NS5BΔ21 construct as previously described.<a onclick="showRef(event, 'cit25a'); return false;" href="javascript:void(0);" class="ref cit25a">(25a)</a> Reported values are the average of duplicate measurements. EC<sub>50</sub> determinations in the cell-based 1b replicon assay were performed in duplicate using RT-PCR for RNA quantification as described elsewhere.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Pharmacokinetic Experiments</h3><div class="NLM_p">All protocols involving animal experimentation were reviewed and approved by the respective Animal Care and Use Committee of each test facility. In-life procedures were in compliance with the Guide for the Care and Use of Laboratory Animals from the Canadian Council of Animal Care. All rat PK studies were performed at Boehringer Ingelheim (Canada) Ltd. PK studies in dogs and monkeys were performed at LAB Pre-Clinical Research International Inc., Laval, Quebec, Canada. All chemicals used were reagent grade or better.</div><div class="NLM_p">Animals were starved overnight and then dosed either at the iv dose of 2 mg/kg (in 70% PEG400) or at the oral dose of 10 mg/kg (in a suspension containing 0.3% Tween-80 and 0.5% Methocel). In the cassette screen experiments, each “cassette” containing four compounds at 4 mg/kg for each compound was dosed to two rats. Blood samples collected from all time points were placed on ice and then centrifuged at 4 °C. The plasma was separated and stored frozen at approximately −20 °C until analysis.</div><div class="NLM_p last">Plasma samples were extracted by solid phase extraction using Waters Oasis HLB 60 mg cartridges. Samples were injected on an HPLC system (Waters Alliance 2690 or 600E system controller with 717+ autosampler and 625 pump) using a Waters XTerra C8 column (2.1 mm × 100 mm, 5 μm). Detection was performed using UV diode array (Waters PDA 996) between 200 and 400 nm with quantitative determination made by peak height at the wavelength representing the best signal-to-noise ratio. Calibration standards were prepared in blank plasma. The calibration curve was linear to cover the time–concentration curve with a <i>r</i><sup>2</sup> > 0.99 and a limit of quantification (LOQ) at 6 ng/mL. The temporal profiles of drug concentrations in plasma were analyzed by noncompartmental methods using WinNonlin (version 3.1; Scientific Consulting, Inc., Cary, NC).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40"><a href="/doi/suppl/10.1021/jm3006788">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61387" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61387" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The enzymatic and 1b replicon potencies of all compounds displayed in graphical format in Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, human and rat liver microsome stability, Caco-2 permeability and plasma concentrations following oral dosing in rats, mass spectral and HPLC homogeneity data, and <sup>1</sup>H NMR spectra for all inhibitors. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3006788/suppl_file/jm3006788_si_001.pdf">jm3006788_si_001.pdf (3.49 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm3006788" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62670" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62670" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pierre L. Beaulieu</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Boehringer Ingelheim
(Canada) Ltd., 2100 Cunard Street, Laval, Quebec, H7S
2G5, Canada</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e2928b87909087cc808783978e8b8797a2808d878a908b8c858790cf8b8c85878e8a878b8fcc818d8f"><span class="__cf_email__" data-cfemail="e7978e82959582c9858286928b8e8292a78588828f958e89808295ca8e8980828b8f828e8ac984888a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Bös</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Boehringer Ingelheim
(Canada) Ltd., 2100 Cunard Street, Laval, Quebec, H7S
2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael G. Cordingley</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Boehringer Ingelheim
(Canada) Ltd., 2100 Cunard Street, Laval, Quebec, H7S
2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Catherine Chabot</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Boehringer Ingelheim
(Canada) Ltd., 2100 Cunard Street, Laval, Quebec, H7S
2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gulrez Fazal</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Boehringer Ingelheim
(Canada) Ltd., 2100 Cunard Street, Laval, Quebec, H7S
2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michel Garneau</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Boehringer Ingelheim
(Canada) Ltd., 2100 Cunard Street, Laval, Quebec, H7S
2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James R. Gillard</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Boehringer Ingelheim
(Canada) Ltd., 2100 Cunard Street, Laval, Quebec, H7S
2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Jolicoeur</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Boehringer Ingelheim
(Canada) Ltd., 2100 Cunard Street, Laval, Quebec, H7S
2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven LaPlante</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Boehringer Ingelheim
(Canada) Ltd., 2100 Cunard Street, Laval, Quebec, H7S
2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ginette McKercher</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Boehringer Ingelheim
(Canada) Ltd., 2100 Cunard Street, Laval, Quebec, H7S
2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Poirier</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Boehringer Ingelheim
(Canada) Ltd., 2100 Cunard Street, Laval, Quebec, H7S
2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc-André Poupart</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Boehringer Ingelheim
(Canada) Ltd., 2100 Cunard Street, Laval, Quebec, H7S
2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Youla S. Tsantrizos</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Boehringer Ingelheim
(Canada) Ltd., 2100 Cunard Street, Laval, Quebec, H7S
2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianmin Duan</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Boehringer Ingelheim
(Canada) Ltd., 2100 Cunard Street, Laval, Quebec, H7S
2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">George Kukolj</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Boehringer Ingelheim
(Canada) Ltd., 2100 Cunard Street, Laval, Quebec, H7S
2G5, Canada</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1123e3146-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28458" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28458" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the following colleagues from Boehringer Ingelheim (Canada) Ltd. who participated in generating the data presented in this paper and contributed to the discovery of BILB 1941: Nathalie Dansereau, Lisette Lagacée, Martin Marquis, and Charles Pellerin for IC<sub>50</sub> and EC<sub>50</sub> determinations; Josie De Marte, Francine Liard, Hélène Montpetit, and Christine Zouki for ADME-PK support; Norman Aubry, Colette Boucher, Graham McGibbon, and Serge Valois for analytical support; Paul C. Anderson and Daniel Lamarre for helpful discussions.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i42" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i42"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i43" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i43"> Abbreviations Used</h2><tr><td class="NLM_term">HCV</td><td class="NLM_def"><p class="first last">hepatitis C virus</p></td></tr><tr><td class="NLM_term">DAA</td><td class="NLM_def"><p class="first last">direct acting antiviral</p></td></tr><tr><td class="NLM_term">HCC</td><td class="NLM_def"><p class="first last">hepatocellular carcinoma</p></td></tr><tr><td class="NLM_term">PegIFN</td><td class="NLM_def"><p class="first last">pegylated interferon</p></td></tr><tr><td class="NLM_term">RBV</td><td class="NLM_def"><p class="first last">ribavirin</p></td></tr><tr><td class="NLM_term">gt1</td><td class="NLM_def"><p class="first last">genotype 1</p></td></tr><tr><td class="NLM_term">SVR</td><td class="NLM_def"><p class="first last">sustained viral response</p></td></tr><tr><td class="NLM_term">SoC</td><td class="NLM_def"><p class="first last">standard of care</p></td></tr><tr><td class="NLM_term">RdRp</td><td class="NLM_def"><p class="first last">RNA-dependent RNA polymerase</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsome</p></td></tr><tr><td class="NLM_term">BSA</td><td class="NLM_def"><p class="first last">bovine serum albumin</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P-450</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">TBME</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyl methyl ether</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last"><i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′<i>-</i>tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HOAt</td><td class="NLM_def"><p class="first last">1-hydroxy-7-azabenzotriazole</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06474" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06474" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 34 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Choo, Q.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overby, L .R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, M.</span><span> </span><span class="NLM_article-title">Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">244</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1126%2Fscience.2523562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=2523562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADyaL1MXit1Khtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=1989&pages=359-362&author=Q.-L.+Chooauthor=G.+Kuoauthor=A.+J.+Weinerauthor=L+.R.+Overbyauthor=D.+W.+Bradleyauthor=M.+Houghton&title=Isolation+of+a+cDNA+clone+derived+from+a+blood-borne+non-A%2C+non-B+viral+hepatitis+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome</span></div><div class="casAuthors">Choo, Qui Lim; Kuo, George; Weiner, Amy J.; Overby, Lacy R.; Bradley, Daniel W.; Houghton, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">4902</span>),
    <span class="NLM_cas:pages">359-62</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A random-primed cDNA library was constructed from plasma contg. the uncharacterized non-A, non-B hepatitis (NANBH) agent and screened with serum from a patient diagnosed with NANBH.  A cDNA clone was isolated that was shown to encode an antigen assocd. specifically with NANBH infections.  This clone is not derived from host DNA but from an RNA mol. present in NANBH infections that consists of ≥10,000 nucleotides, and that is pos.-stranded with respect to the encoded NANBH antigen.  These data indicate that this clone is derived from the genome of the NANBH agent and are consistent with the agent being similar to the togaviridae or flaviviridae.  This mol. approach should be of great value in the isolation and characterization of other unidentified infectious agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqorpVFx7nEkrVg90H21EOLACvtfcHk0lh9inOSMoaz4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXit1Khtrk%253D&md5=25161cf212790856dd29d3aaf78f20b8</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.2523562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2523562%26sid%3Dliteratum%253Aachs%26aulast%3DChoo%26aufirst%3DQ.-L.%26aulast%3DKuo%26aufirst%3DG.%26aulast%3DWeiner%26aufirst%3DA.%2BJ.%26aulast%3DOverby%26aufirst%3DL%2B.R.%26aulast%3DBradley%26aufirst%3DD.%2BW.%26aulast%3DHoughton%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520cDNA%2520clone%2520derived%2520from%2520a%2520blood-borne%2520non-A%252C%2520non-B%2520viral%2520hepatitis%2520genome%26jtitle%3DScience%26date%3D1989%26volume%3D244%26spage%3D359%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Lavanchy, D.</span><span> </span><span class="NLM_article-title">Evolving epidemiology of hepatitis C virus</span> <span class="citation_source-journal">Clin. Microbiol. Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1111%2Fj.1469-0691.2010.03432.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=21091831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A280%3ADC%252BC3M7islSrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=107-115&author=D.+Lavanchy&title=Evolving+epidemiology+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Evolving epidemiology of hepatitis C virus</span></div><div class="casAuthors">Lavanchy D</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">More than 20 years after the discovery of the hepatitis C virus (HCV), it is now well established that HCV is of global importance affecting all countries, leading to a major global health problem that requires widespread active interventions for its prevention and control.  Chronic hepatitis C was linked to the development of cirrhosis and hepatocellular carcinoma in many areas of the world.  Current epidemiological assessments have identified complex patterns with highly variable local prevalence rates between countries and within countries.  HCV infection patterns have not significantly changed in most parts of the world since 1997, when first analyzed, partly due to the lack of new and more accurate data.  The assessment of the national HCV prevalence and transmission modes should be completed to enable national authorities to prioritize preventive measures and to make the most appropriate use of available resources.  The 'patchy' epidemiological situation in some areas will continue to complicate the task of the establishment of global, regional and national base line data.  The present assessment finds a global prevalence of 2.35%, affecting 160 million chronically infected individuals.  There is an urgent need for more accurate Information on the costs and burden of HCV to society.  Twenty-one year after the discovery of HCV, the assessment is far from being complete and little progress has been made in the past 10 years in many countries.  In some countries significant increases have been reported and this may also apply to countries were insufficient data exist.  A safe and efficient vaccine against HCV is urgently needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRYetk_zmER_suCWE5mhx1RfW6udTcc2ebo-n0_URf-SLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7islSrtQ%253D%253D&md5=b77d9df38203d7a5dd060cc1bc3bc487</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1469-0691.2010.03432.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1469-0691.2010.03432.x%26sid%3Dliteratum%253Aachs%26aulast%3DLavanchy%26aufirst%3DD.%26atitle%3DEvolving%2520epidemiology%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DClin.%2520Microbiol.%2520Infect.%26date%3D2011%26volume%3D17%26spage%3D107%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Simmonds, P.</span><span> </span><span class="NLM_article-title">Genetic diversity and evolution of hepatitis C virus—15 years on</span> <span class="citation_source-journal">J. Gen. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">3173</span><span class="NLM_x">–</span> <span class="NLM_lpage">3188</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1099%2Fvir.0.80401-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=15483230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVSmsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2004&pages=3173-3188&author=P.+Simmonds&title=Genetic+diversity+and+evolution+of+hepatitis+C+virus%E2%80%9415+years+on"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic diversity and evolution of hepatitis C virus - 15 years on</span></div><div class="casAuthors">Simmonds, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3173-3188</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">A review.  In the 15 years since the discovery of hepatitis C virus (HCV), much has been learned about its role as a major causative agent of human liver disease and its ability to persist in the face of host-cell defenses and the immune system.  This review describes what is known about the diversity of HCV, the current classification of HCV genotypes within the family Flaviviridae and how this genetic diversity contributes to its pathogenesis.  On one hand, diversification of HCV was constrained by its intimate adaptation to its host.  Despite the >30% nucleotide sequence divergence between genotypes, HCV variants nevertheless remain remarkably similar in their transmission dynamics, persistence and disease development.  Nowhere is this more evident than in the evolutionary conservation of numerous evasion methods to counteract the cell's innate antiviral defense pathways; this series of highly complex virus-host interactions may represent key components in establishing its ecol. niche in the human liver.  On the other hand, the mutability and large population size of HCV enables it to respond very rapidly to new selection pressures, manifested by immune-driven changes in T- and B-cell epitopes that are encountered on transmission between individuals with different antigen-recognition repertoires.  If human immunodeficiency virus type 1 is a precedent, future therapies that target virus protease or polymerase enzymes may also select very rapidly for antiviral-resistant mutants.  These contrasting aspects of conservatism and adaptability provide a fascinating paradigm in which to explore the complex selection pressures that underlie the evolution of HCV and other persistent viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotwOpXQZprmrVg90H21EOLACvtfcHk0liHB9yFSbs7Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVSmsr0%253D&md5=a07b3411b6b18b5e7ab3cf9bc3b89026</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1099%2Fvir.0.80401-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fvir.0.80401-0%26sid%3Dliteratum%253Aachs%26aulast%3DSimmonds%26aufirst%3DP.%26atitle%3DGenetic%2520diversity%2520and%2520evolution%2520of%2520hepatitis%2520C%2520virus%25E2%2580%259415%2520years%2520on%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2004%26volume%3D85%26spage%3D3173%26epage%3D3188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wise, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bialek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorvillo, F.</span><span> </span><span class="NLM_article-title">Changing trends in hepatitis C-related mortality in the United States, 1995–2004</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1128</span><span class="NLM_x">–</span> <span class="NLM_lpage">1135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=1128-1135&author=M.+Wiseauthor=S.+Bialekauthor=L.+Finelliauthor=B.+Bellauthor=F.+Sorvillo&title=Changing+trends+in+hepatitis+C-related+mortality+in+the+United+States%2C+1995%E2%80%932004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWise%26aufirst%3DM.%26aulast%3DBialek%26aufirst%3DS.%26aulast%3DFinelli%26aufirst%3DL.%26aulast%3DBell%26aufirst%3DB.%26aulast%3DSorvillo%26aufirst%3DF.%26atitle%3DChanging%2520trends%2520in%2520hepatitis%2520C-related%2520mortality%2520in%2520the%2520United%2520States%252C%25201995%25E2%2580%25932004%26jtitle%3DHepatology%26date%3D2008%26volume%3D47%26spage%3D1128%26epage%3D1135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Davis, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, D. M.</span><span> </span><span class="NLM_article-title">Projecting future complications of chronic hepatitis C in the United States</span> <span class="citation_source-journal">Liver Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1053%2Fjlts.2003.50073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=12682882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A280%3ADC%252BD3s7msV2jsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=331-338&author=G.+L.+Davisauthor=J.+E.+Albrightauthor=S.+F.+Cookauthor=D.+M.+Rosenberg&title=Projecting+future+complications+of+chronic+hepatitis+C+in+the+United+States"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Projecting future complications of chronic hepatitis C in the United States</span></div><div class="casAuthors">Davis Gary L; Albright James E; Cook Suzanne F; Rosenberg Daniel M</div><div class="citationInfo"><span class="NLM_cas:title">Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">331-8</span>
        ISSN:<span class="NLM_cas:issn">1527-6465</span>.
    </div><div class="casAbstract">Chronic hepatitis C virus (HCV) infection is common and often results in slowly progressive liver disease.  Although acute hepatitis C is now uncommon, most patients with acute infection have developed chronic hepatitis, and, therefore, the pool of infected patients is large.  We used a modification of a previously described natural history model for HCV infection to project the number of cases of HCV infection, cirrhosis, and liver failure over the next 40 years.  The model estimated the prevalence of HCV infection in the United States was 3.07 x 10(6) in 1993 (compared with an adjusted National Health and Nutrition Evaluation Survey (NHANES) III estimate of 2.8 to 3.5 x 10(6)).  A gradual decline in the prevalence of infection should occur by year 2040 because of aging and natural deaths among the infected pool.  However, as the duration of infection increases in the surviving cohort, the proportion with cirrhosis will increase from 16% to 32% by 2020 in an untreated population.  Complications of cirrhosis also will increase dramatically over the next 20 years: hepatic decompensation (up 106%), hepatocellular carcinoma (up 81%), and liver-related deaths (up 180%).  Although current treatment regimens eradicate HCV in over 50% of cases, many more patients would need to be treated to significantly impact disease progression.  Identification and treatment of every case of HCV infection (with or without cirrhosis) would reduce the number of cases of decompensated cirrhosis by almost half after 20 years.  Despite the declining incidence of acute HCV infection, chronic hepatitis C is common.  The prevalence of cirrhosis and the incidence of its complications will increase over the next 10 to 20 years, because the duration of infection increases among those with chronic hepatitis C.  These data emphasize the need for greater access to transplantation by expansion of the donor pool, increasing use of split livers and living donors, and novel options such as xenotransplantation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTewSKnpArRW-xsqfvU0ziafW6udTcc2ea3boiv5xwDdLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7msV2jsQ%253D%253D&md5=933b3e1540d1375bccbd1ade430ab7fb</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1053%2Fjlts.2003.50073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fjlts.2003.50073%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DG.%2BL.%26aulast%3DAlbright%26aufirst%3DJ.%2BE.%26aulast%3DCook%26aufirst%3DS.%2BF.%26aulast%3DRosenberg%26aufirst%3DD.%2BM.%26atitle%3DProjecting%2520future%2520complications%2520of%2520chronic%2520hepatitis%2520C%2520in%2520the%2520United%2520States%26jtitle%3DLiver%2520Transplant.%26date%3D2003%26volume%3D9%26spage%3D331%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bosetti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucchini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zatonski, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Vecchia, C.</span><span> </span><span class="NLM_article-title">Worldwide mortality from cirrhosis: an update to 2002</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">839</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1016%2Fj.jhep.2007.01.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=17336419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A280%3ADC%252BD2s3hsVKksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=827-839&author=C.+Bosettiauthor=F.+Leviauthor=F.+Lucchiniauthor=W.+A.+Zatonskiauthor=E.+Negriauthor=C.+La+Vecchia&title=Worldwide+mortality+from+cirrhosis%3A+an+update+to+2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Worldwide mortality from cirrhosis: an update to 2002</span></div><div class="casAuthors">Bosetti Cristina; Levi Fabio; Lucchini Franca; Zatonski Witold A; Negri Eva; La Vecchia Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of hepatology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">827-39</span>
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    </div><div class="casAbstract">BACKGROUND/AIMS:  Cirrhosis mortality has registered large changes over the last few decades.  METHODS:  Age-standardized (world standard) cirrhosis mortality rates per 100,000 were computed for 41 countries worldwide over the period 1980-2002 using data from the WHO mortality database.  RESULTS:  In the early 1980s, the highest rates were in Mexico, Chile (around 55/100,000 men and over 14/100,000 women), France, Italy, Portugal, Austria, Hungary and Romania (around 30-35/100,000 men and 10-15/100,000 women).  Mortality from cirrhosis has been steadily declining in most countries worldwide since the mid or late 1970s (annual percent change, APC, between -5% and -1.5% in the last decade only for both sexes).  In southern Europe, rates in the early 2000s were less than halved compared to earlier decades.  In contrast, rates have been rising in Eastern European countries to reach extremely high values in the mid 1990s, and declined only thereafter.  In the UK rates were still steadily rising (APC around +7% in men and +3% in women from England and Wales, and +9% in men and +7% in women from Scotland).  CONCLUSIONS:  Mortality from cirrhosis shows favourable trends in most countries of the world, following the reduction in alcohol consumption and hepatitis B and C virus infection.  The steady upward trends observed over more recent calendar periods in the UK and central and eastern European countries are attributed to the persistent increase in the prevalence of alcohol consumption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRG0hN2BXnnh8vLc4ARHEmzfW6udTcc2ea3boiv5xwDdLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3hsVKksg%253D%253D&md5=87b57db620702efdc8f3013eec4de21d</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2007.01.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2007.01.025%26sid%3Dliteratum%253Aachs%26aulast%3DBosetti%26aufirst%3DC.%26aulast%3DLevi%26aufirst%3DF.%26aulast%3DLucchini%26aufirst%3DF.%26aulast%3DZatonski%26aufirst%3DW.%2BA.%26aulast%3DNegri%26aufirst%3DE.%26aulast%3DLa%2BVecchia%26aufirst%3DC.%26atitle%3DWorldwide%2520mortality%2520from%2520cirrhosis%253A%2520an%2520update%2520to%25202002%26jtitle%3DJ.%2520Hepatol.%26date%3D2007%26volume%3D46%26spage%3D827%26epage%3D839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wise, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bialek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorvillo, F.</span><span> </span><span class="NLM_article-title">Changing trends in hepatitis C-related mortality in the United States</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1128</span><span class="NLM_x">–</span> <span class="NLM_lpage">1135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=1128-1135&author=M.+Wiseauthor=S.+Bialekauthor=L.+Finelliauthor=B.+P.+Bellauthor=F.+Sorvillo&title=Changing+trends+in+hepatitis+C-related+mortality+in+the+United+States"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWise%26aufirst%3DM.%26aulast%3DBialek%26aufirst%3DS.%26aulast%3DFinelli%26aufirst%3DL.%26aulast%3DBell%26aufirst%3DB.%2BP.%26aulast%3DSorvillo%26aufirst%3DF.%26atitle%3DChanging%2520trends%2520in%2520hepatitis%2520C-related%2520mortality%2520in%2520the%2520United%2520States%26jtitle%3DHepatology%26date%3D2008%26volume%3D47%26spage%3D1128%26epage%3D1135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Davila, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaib, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGlynn, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Serag, H. B.</span><span> </span><span class="NLM_article-title">Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">1372</span><span class="NLM_x">–</span> <span class="NLM_lpage">1380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2004&pages=1372-1380&author=J.+A.+Davilaauthor=R.+O.+Morganauthor=Y.+Shaibauthor=K.+A.+McGlynnauthor=H.+B.+El-Serag&title=Hepatitis+C+infection+and+the+increasing+incidence+of+hepatocellular+carcinoma%3A+a+population-based+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavila%26aufirst%3DJ.%2BA.%26aulast%3DMorgan%26aufirst%3DR.%2BO.%26aulast%3DShaib%26aufirst%3DY.%26aulast%3DMcGlynn%26aufirst%3DK.%2BA.%26aulast%3DEl-Serag%26aufirst%3DH.%2BB.%26atitle%3DHepatitis%2520C%2520infection%2520and%2520the%2520increasing%2520incidence%2520of%2520hepatocellular%2520carcinoma%253A%2520a%2520population-based%2520study%26jtitle%3DGastroenterology%26date%3D2004%26volume%3D127%26spage%3D1372%26epage%3D1380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fried, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonçales, F. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haüssinger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diago, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carosi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhumeaux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craxi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span> </span><span class="NLM_article-title">Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">982</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1056%2FNEJMoa020047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=12324553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BD38Xnt12rtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2002&pages=975-982&author=M.+W.+Friedauthor=M.+L.+Shiffmanauthor=K.+R.+Reddyauthor=C.+Smithauthor=G.+Marinosauthor=F.+L.+Gon%C3%A7alesauthor=D.+Ha%C3%BCssingerauthor=M.+Diagoauthor=G.+Carosiauthor=D.+Dhumeauxauthor=A.+Craxiauthor=A.+Linauthor=J.+Hoffmanauthor=J.+Yu&title=Peginterferon+alfa-2a+plus+ribavirin+for+chronic+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection</span></div><div class="casAuthors">Fried, Michael W.; Shiffman, Mitchell L.; Reddy, K. Rajender; Smith, Coleman; Marinos, George; Goncales, Fernando L., Jr.; Haussinger, Dieter; Diago, Moises; Carosi, Giampiero; Dhumeaux, Daniel; Craxi, Antonio; Lin, Amy; Hoffman, Joseph; Yu, Jian</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">975-982</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Treatment with peginterferon alfa-2a alone produces significantly higher sustained virol. responses than treatment with interferon alfa-2a alone in patients with chronic hepatitis C virus (HCV) infection.  We compared the efficacy and safety of peginterferon alfa-2a plus ribavirin, interferon alfa-2b plus ribavirin, and peginterferon alfa-2a alone in the initial treatment of chronic hepatitis C.  Methods: A total of 1121 patients were randomly assigned to treatment and received at least one dose of study medication, consisting of 180 μg of peginterferon alfa-2a once weekly plus daily ribavirin (1000 or 1200 mg, depending on body wt.), weekly peginterferon alfa-2a plus daily placebo, or 3 million units of interferon alfa-2b thrice weekly plus daily ribavirin for 48 wk.  Results: A significantly higher proportion of patients who received peginterferon alfa-2a plus ribavirin had a sustained virol. response (defined as the absence of detectable HCV RNA 24 wk after cessation of therapy) than of patients who received interferon alfa-2b plus ribavirin (56 % vs. 44 %, P<0.001) or peginterferon alfa-2a alone (56 % vs. 29 %, P<0.001).  The proportions of patients with HCV genotype 1 who had sustained virol. responses were 46 %, 36 %, and 21 %, resp., for the three regimens.  Among patients with HCV genotype 1 and high base-line levels of HCV RNA, the proportions of those with sustained virol. responses were 41 %, 33 %, and 13 %, resp.  The overall safety profiles of the three treatment regimens were similar; the incidence of influenza-like symptoms and depression was lower in the groups receiving peginterferon alfa-2a than in the group receiving interferon alfa-2b plus ribavirin.  Conclusions: In patients with chronic hepatitis C, once-weekly peginterferon alfa-2a plus ribavirin was tolerated as well as interferon alfa-2b plus ribavirin and produced significant improvements in the rate of sustained virol. response, as compared with interferon alfa-2b plus ribavirin or peginterferon alfa-2a alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqblwkeNXWJzbVg90H21EOLACvtfcHk0lgNf5LfRgQGGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xnt12rtb0%253D&md5=2fd959d790b9505384fbd26ef44b2963</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa020047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa020047%26sid%3Dliteratum%253Aachs%26aulast%3DFried%26aufirst%3DM.%2BW.%26aulast%3DShiffman%26aufirst%3DM.%2BL.%26aulast%3DReddy%26aufirst%3DK.%2BR.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DMarinos%26aufirst%3DG.%26aulast%3DGon%25C3%25A7ales%26aufirst%3DF.%2BL.%26aulast%3DHa%25C3%25BCssinger%26aufirst%3DD.%26aulast%3DDiago%26aufirst%3DM.%26aulast%3DCarosi%26aufirst%3DG.%26aulast%3DDhumeaux%26aufirst%3DD.%26aulast%3DCraxi%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DJ.%26atitle%3DPeginterferon%2520alfa-2a%2520plus%2520ribavirin%2520for%2520chronic%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D347%26spage%3D975%26epage%3D982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moeller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinrichsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauss, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarrazin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hueppe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zehnter, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manns, M. P.</span><span> </span><span class="NLM_article-title">Expert opinion on the treatment of patients with chronic hepatitis C</span> <span class="citation_source-journal">J. Viral Hepatitis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1111%2Fj.1365-2893.2008.01012.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=18761607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ht1Crtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=75-90&author=S.+Zeuzemauthor=T.+Bergauthor=B.+Moellerauthor=H.+Hinrichsenauthor=S.+Maussauthor=H.+Wedemeyerauthor=C.+Sarrazinauthor=D.+Hueppeauthor=E.+Zehnterauthor=M.+P.+Manns&title=Expert+opinion+on+the+treatment+of+patients+with+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Expert opinion on the treatment of patients with chronic hepatitis C</span></div><div class="casAuthors">Zeuzem S; Berg T; Moeller B; Hinrichsen H; Mauss S; Wedemeyer H; Sarrazin C; Hueppe D; Zehnter E; Manns M P</div><div class="citationInfo"><span class="NLM_cas:title">Journal of viral hepatitis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">75-90</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The current preferred treatment for patients with hepatitis C virus (HCV) is combination therapy consisting of pegylated interferon alfa and ribavirin (RBV) for 24-48 weeks.  Although this approach appears to be highly effective for patients with HCV genotypes 2 or 3, who have a sustained virological response (SVR) of approximately 80%, the treatment algorithm is less effective for patients with HCV genotype 1, as these patients have SVR rates of just 40-50%.  In order to improve treatment outcomes, this article explores potential approaches for the optimization of treatment for patients with HCV genotype 1: considering shorter treatment periods for patients with a rapid virological response (RVR), increasing treatment periods for slow responders, and increasing RBV dose are all suggestions.  Results from clinical trials suggest that approximately 20% of the HCV genotype 1-infected population are slow responders, and around 15% of all HCV genotype-1 infected patients could benefit from a shorter treatment duration without compromising the SVR rate.  Interest has also focused on whether treatment duration could be individualized in some patients with genotype 2 and 3 infection.  Here all the findings from recent studies are translated into practical advice, to help practitioners make evidence-based treatment decisions in everyday clinical practice.  Although there are areas where currently available data do not provide conclusive evidence to suggest amending treatment approaches, there is clearly potential for individualized treatment in all aspects of hepatitis treatment in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6UQwwDsewsuQ4Pl9hzjQhfW6udTcc2eb0RDt5JwFW6Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ht1Crtg%253D%253D&md5=6bb4b656592a11243b42540f5a090e9e</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2893.2008.01012.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2893.2008.01012.x%26sid%3Dliteratum%253Aachs%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DBerg%26aufirst%3DT.%26aulast%3DMoeller%26aufirst%3DB.%26aulast%3DHinrichsen%26aufirst%3DH.%26aulast%3DMauss%26aufirst%3DS.%26aulast%3DWedemeyer%26aufirst%3DH.%26aulast%3DSarrazin%26aufirst%3DC.%26aulast%3DHueppe%26aufirst%3DD.%26aulast%3DZehnter%26aufirst%3DE.%26aulast%3DManns%26aufirst%3DM.%2BP.%26atitle%3DExpert%2520opinion%2520on%2520the%2520treatment%2520of%2520patients%2520with%2520chronic%2520hepatitis%2520C%26jtitle%3DJ.%2520Viral%2520Hepatitis%26date%3D2009%26volume%3D16%26spage%3D75%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span> National Institutes of Health consensus development conference statement: management of hepatitis C 2002 (June 10–12, 2002).  <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">2082</span><span class="NLM_x">–</span> <span class="NLM_lpage">2099</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+National+Institutes+of+Health+consensus+development+conference+statement%3A+management+of+hepatitis+C+2002+%28June+10%E2%80%9312%2C+2002%29.+Gastroenterology+2002%2C+123%2C+2082%E2%80%932099."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DGastroenterology%26date%3D2002%26volume%3D123%26spage%3D2082%26epage%3D2099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Manns, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockstroh, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoulim, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, M.</span><span> </span><span class="NLM_article-title">The way forward in HCV treatment—finding the right path</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">991</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=991-1000&author=M.+P.+Mannsauthor=G.+R.+Fosterauthor=J.+K.+Rockstrohauthor=S.+Zeuzemauthor=F.+Zoulimauthor=M.+Houghton&title=The+way+forward+in+HCV+treatment%E2%80%94finding+the+right+path"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%2BP.%26aulast%3DFoster%26aufirst%3DG.%2BR.%26aulast%3DRockstroh%26aufirst%3DJ.%2BK.%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DZoulim%26aufirst%3DF.%26aulast%3DHoughton%26aufirst%3DM.%26atitle%3DThe%2520way%2520forward%2520in%2520HCV%2520treatment%25E2%2580%2594finding%2520the%2520right%2520path%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D991%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Björnsson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbaan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oksanen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frydén, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalgård, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalaitzakis, E.</span><span> </span><span class="NLM_article-title">Health-related quality of life in patients with different stages of liver disease induced by hepatitis C</span> <span class="citation_source-journal">Scand. J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">878</span><span class="NLM_x">–</span> <span class="NLM_lpage">887</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1080%2F00365520902898135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=19437190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A280%3ADC%252BD1MjmsFSgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=878-887&author=E.+Bj%C3%B6rnssonauthor=H.+Verbaanauthor=A.+Oksanenauthor=A.+Fryd%C3%A9nauthor=J.+Johanssonauthor=S.+Fribergauthor=O.+Dalg%C3%A5rdauthor=E.+Kalaitzakis&title=Health-related+quality+of+life+in+patients+with+different+stages+of+liver+disease+induced+by+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Health-related quality of life in patients with different stages of liver disease induced by hepatitis C</span></div><div class="casAuthors">Bjornsson Einar; Verbaan Hans; Oksanen Antti; Fryden Aril; Johansson Jonas; Friberg Sarah; Dalgard Olav; Kalaitzakis Evangelos</div><div class="citationInfo"><span class="NLM_cas:title">Scandinavian journal of gastroenterology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">878-87</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Patients with hepatitis C have been shown to have impaired health-related quality of life (HRQoL).  The aim of this study was to determine HRQoL in patients in different stages of hepatitis C virus (HCV) and to compare HRQoL in HCV cirrhosis with non-HCV-induced cirrhosis.  MATERIAL AND METHODS:  Out of 489 consecutive patients who fulfilled the inclusion criteria, 472 (96%) agreed to participate in the study: 158 patients with mild/moderate fibrosis with chronic hepatitis C (CHC group), 76 patients with HCV compensated cirrhosis (CC), 53 patients with HCV decompensated (DC) cirrhosis, 52 non-cirrhotic patients with sustained viral response (SVR), and a control group consisting of 32 patients with non-HCV CC and 101 with non-HCV DC who completed the Short Form-36 (SF-36) and EQ-5D questionnaire.  RESULTS:  The CHC group had significantly lower SF-36 scores than healthy controls, with the exception of scores for the dimensions physical function and bodily pain.  HCV patients with DC had lower scores in all SF-36 dimensions in comparison with those of the CHC group, as well as in physical and mental component summaries (p<0.001).  In comparison with the CHC group, the HCV CC group had lower scores on the SF-36 general health dimension (p<0.05) and lower SF-36 physical component summary (PCS) scores (p<0.05).  No major differences were seen in patients with HCV- and non-HCV-induced cirrhosis.  CONCLUSIONS:  Impairment in HRQoL in patients with HCV was associated with the severity of liver disease, patients with decompensated cirrhosis exhibiting the highest impairment in HRQoL.  The etiology of liver disease does not seem to be important in determining HRQoL in cirrhosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUqk0W5YvA7IUSrryheKE6fW6udTcc2eb78e7Ojy2kiLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjmsFSgsg%253D%253D&md5=32e1b0115a5f839a29b8f028b1145faa</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1080%2F00365520902898135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00365520902898135%26sid%3Dliteratum%253Aachs%26aulast%3DBj%25C3%25B6rnsson%26aufirst%3DE.%26aulast%3DVerbaan%26aufirst%3DH.%26aulast%3DOksanen%26aufirst%3DA.%26aulast%3DFryd%25C3%25A9n%26aufirst%3DA.%26aulast%3DJohansson%26aufirst%3DJ.%26aulast%3DFriberg%26aufirst%3DS.%26aulast%3DDalg%25C3%25A5rd%26aufirst%3DO.%26aulast%3DKalaitzakis%26aufirst%3DE.%26atitle%3DHealth-related%2520quality%2520of%2520life%2520in%2520patients%2520with%2520different%2520stages%2520of%2520liver%2520disease%2520induced%2520by%2520hepatitis%2520C%26jtitle%3DScand.%2520J.%2520Gastroenterol.%26date%3D2009%26volume%3D44%26spage%3D878%26epage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Lohmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Körner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herian, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theilmann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1126%2Fscience.285.5424.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=10390360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=110-113&author=V.+Lohmannauthor=F.+K%C3%B6rnerauthor=J.+O.+Kochauthor=U.+Herianauthor=L.+Theilmannauthor=R.+Bartenschlager&title=Replication+of+subgenomic+hepatitis+C+virus+RNAs+in+a+hepatoma+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span></div><div class="casAuthors">Lohmann, V.; Korner, F.; Koch, J.-O.; Herian, U.; Theilmann, L.; Bartenschlager, R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">5424</span>),
    <span class="NLM_cas:pages">110-113</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">An estd. 170 million persons worldwide are infected with hepatitis C virus (HCV), a major cause of chronic liver disease.  Despite increasing knowledge of genome structure and individual viral proteins, studies on virus replication and pathogenesis have been hampered by the lack of reliable and efficient cell culture systems.  A full-length consensus genome was cloned from viral RNA isolated from an infected human liver and used to construct subgenomic selectable replicons.  Upon transfection into a human hepatoma cell line, these RNAs replicated to high levels, permitting metabolic radiolabeling of viral RNA and proteins.  This work defines the structure of HCV replicons functional in cell culture and provides the basis for a long-sought cellular system that should allow detailed mol. studies of HCV and the development of antiviral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7X754RT8y1LVg90H21EOLACvtfcHk0lhI4l7pklUCeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D&md5=b075621b316209ecf4498c9b5b33e4b5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.285.5424.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.285.5424.110%26sid%3Dliteratum%253Aachs%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DK%25C3%25B6rner%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DJ.%2BO.%26aulast%3DHerian%26aufirst%3DU.%26aulast%3DTheilmann%26aufirst%3DL.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DReplication%2520of%2520subgenomic%2520hepatitis%2520C%2520virus%2520RNAs%2520in%2520a%2520hepatoma%2520cell%2520line%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D110%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wakita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietschmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Date, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murthy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habermann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kräusslich, H.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizokami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, T. G.</span><span> </span><span class="NLM_article-title">Production of infectious hepatitis C virus in tissue culture from a cloned viral genome</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1038%2Fnm1268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=15951748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmt1aju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=791-796&author=T.+Wakitaauthor=T.+Pietschmannauthor=T.+Katoauthor=T.+Dateauthor=M.+Miyamotoauthor=Z.+Zhaoauthor=K.+Murthyauthor=A.+Habermannauthor=H.-G.+Kr%C3%A4usslichauthor=M.+Mizokamiauthor=R.+Bartenschlagerauthor=T.+G.+Liang&title=Production+of+infectious+hepatitis+C+virus+in+tissue+culture+from+a+cloned+viral+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Production of infectious hepatitis C virus in tissue culture from a cloned viral genome</span></div><div class="casAuthors">Wakita, Takaji; Pietschmann, Thomas; Kato, Takanobu; Date, Tomoko; Miyamoto, Michiko; Zhao, Zijiang; Murthy, Krishna; Habermann, Anja; Kraeusslich, Hans-Georg; Mizokami, Masashi; Bartenschlager, Ralf; Liang, T. Jake</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">791-796</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection causes chronic liver diseases and is a global public health problem.  Detailed analyses of HCV have been hampered by the lack of viral culture systems.  Subgenomic replicons of the JFH1 genotype 2a strain cloned from an individual with fulminant hepatitis replicate efficiently in cell culture.  Here we show that the JFH1 genome replicates efficiently and supports secretion of viral particles after transfection into a human hepatoma cell line (Huh7).  Particles have a d. of about 1.15-1.17 g/mL and a spherical morphol. with an av. diam. of about 55 nm.  Secreted virus is infectious for Huh7 cells and infectivity can be neutralized by CD81-specific antibodies and by Igs from chronically infected individuals.  The cell culture-generated HCV is infectious for chimpanzee.  This system provides a powerful tool for studying the viral life cycle and developing antiviral strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqra8QhVAEyJ7Vg90H21EOLACvtfcHk0lhI4l7pklUCeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmt1aju7c%253D&md5=91235eedec98d1b3d6a4bc4bc68f6d11</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1038%2Fnm1268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1268%26sid%3Dliteratum%253Aachs%26aulast%3DWakita%26aufirst%3DT.%26aulast%3DPietschmann%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DDate%26aufirst%3DT.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DMurthy%26aufirst%3DK.%26aulast%3DHabermann%26aufirst%3DA.%26aulast%3DKr%25C3%25A4usslich%26aufirst%3DH.-G.%26aulast%3DMizokami%26aufirst%3DM.%26aulast%3DBartenschlager%26aufirst%3DR.%26aulast%3DLiang%26aufirst%3DT.%2BG.%26atitle%3DProduction%2520of%2520infectious%2520hepatitis%2520C%2520virus%2520in%2520tissue%2520culture%2520from%2520a%2520cloned%2520viral%2520genome%26jtitle%3DNat.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D791%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lindenbach, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syder, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wölk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellinghuisen, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hynes, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeating, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">623</span><span class="NLM_x">–</span> <span class="NLM_lpage">626</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Lindenbach%2C+B.+D.%3B+Evans%2C+M.+J.%3B+Syder%2C+A.+J.%3B+W%C3%B6lk%2C+B.%3B+Tellinghuisen%2C+T.+L.%3B+Liu%2C+C.+C.%3B+Maruyama%2C+T.%3B+Hynes%2C+R.+O.%3B+Burton%2C+D.+R.%3B+McKeating%2C+J.+A.%3B+Rice%2C+C.+M.Science+2005%2C+309%2C+623%E2%80%93626"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindenbach%26aufirst%3DB.%2BD.%26aulast%3DEvans%26aufirst%3DM.%2BJ.%26aulast%3DSyder%26aufirst%3DA.%2BJ.%26aulast%3DW%25C3%25B6lk%26aufirst%3DB.%26aulast%3DTellinghuisen%26aufirst%3DT.%2BL.%26aulast%3DLiu%26aufirst%3DC.%2BC.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DHynes%26aufirst%3DR.%2BO.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DMcKeating%26aufirst%3DJ.%2BA.%26aulast%3DRice%26aufirst%3DC.%2BM.%26jtitle%3DScience%26date%3D2005%26volume%3D309%26spage%3D623%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Tan, S.-L.; He, Y.</span> <span class="citation_source-book">Hepatitis C: Antiviral Drug Discovery and Development</span>; <span class="NLM_publisher-name">Caister Academic Press</span>: <span class="NLM_publisher-loc">Norwich, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.-L.+Tan&author=Y.+He&title=Hepatitis+C%3A+Antiviral+Drug+Discovery+and+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DS.-L.%26btitle%3DHepatitis%2520C%253A%2520Antiviral%2520Drug%2520Discovery%2520and%2520Development%26pub%3DCaister%2520Academic%2520Press%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Lindenbach, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Unraveling hepatitis C virus replication from genome to function</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">938</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=933-938&author=B.+D.+Lindenbachauthor=C.+M.+Rice&title=Unraveling+hepatitis+C+virus+replication+from+genome+to+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindenbach%26aufirst%3DB.%2BD.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DUnraveling%2520hepatitis%2520C%2520virus%2520replication%2520from%2520genome%2520to%2520function%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D933%26epage%3D938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hinrichsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentjens, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calleja, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forns, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erhardt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cröenlein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaves, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C. −L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nehmiz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, G. G.</span><span> </span><span class="NLM_article-title">Short-term antiviral efficacy of BILN 2061, a HCV serine protease inhibitor, in hepatitis C genotype 1 patients</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">1347</span><span class="NLM_x">–</span> <span class="NLM_lpage">1355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2004&pages=1347-1355&author=H.+Hinrichsenauthor=Y.+Benhamouauthor=H.+Wedemeyerauthor=M.+Reiserauthor=R.+E.+Sentjensauthor=J.+L.+Callejaauthor=X.+Fornsauthor=A.+Erhardtauthor=J.+Cr%C3%B6enleinauthor=R.+Chavesauthor=C.+%E2%88%92L.+Yongauthor=G.+Nehmizauthor=G.+G.+Steinmann&title=Short-term+antiviral+efficacy+of+BILN+2061%2C+a+HCV+serine+protease+inhibitor%2C+in+hepatitis+C+genotype+1+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHinrichsen%26aufirst%3DH.%26aulast%3DBenhamou%26aufirst%3DY.%26aulast%3DWedemeyer%26aufirst%3DH.%26aulast%3DReiser%26aufirst%3DM.%26aulast%3DSentjens%26aufirst%3DR.%2BE.%26aulast%3DCalleja%26aufirst%3DJ.%2BL.%26aulast%3DForns%26aufirst%3DX.%26aulast%3DErhardt%26aufirst%3DA.%26aulast%3DCr%25C3%25B6enlein%26aufirst%3DJ.%26aulast%3DChaves%26aufirst%3DR.%26aulast%3DYong%26aufirst%3DC.%2B%25E2%2588%2592L.%26aulast%3DNehmiz%26aufirst%3DG.%26aulast%3DSteinmann%26aufirst%3DG.%2BG.%26atitle%3DShort-term%2520antiviral%2520efficacy%2520of%2520BILN%25202061%252C%2520a%2520HCV%2520serine%2520protease%2520inhibitor%252C%2520in%2520hepatitis%2520C%2520genotype%25201%2520patients%26jtitle%3DGastroenterology%26date%3D2004%26volume%3D127%26spage%3D1347%26epage%3D1355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bös, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacé, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentjens, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St George, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoneau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weldon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span> </span><span class="NLM_article-title">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1038%2Fnature02099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=14578911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2003&pages=186-189&author=D.+Lamarreauthor=P.+C.+Andersonauthor=M.+Baileyauthor=P.+Beaulieuauthor=G.+Bolgerauthor=P.+Bonneauauthor=M.+B%C3%B6sauthor=D.+R.+Cameronauthor=M.+Cartierauthor=M.+G.+Cordingleyauthor=A.-M.+Faucherauthor=N.+Goudreauauthor=S.+H.+Kawaiauthor=G.+Kukoljauthor=L.+Lagac%C3%A9author=S.+R.+LaPlanteauthor=H.+Narjesauthor=M.-A.+Poupartauthor=J.+Rancourtauthor=R.+E.+Sentjensauthor=R.+St+Georgeauthor=B.+Simoneauauthor=G.+Steinmannauthor=D.+Thibeaultauthor=Y.+Tsantrizosauthor=S.+M.+Weldonauthor=C.-L.+Yongauthor=M.+Llin%C3%A0s-Brunet&title=An+NS3+protease+inhibitor+with+antiviral+effects+in+humans+infected+with+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span></div><div class="casAuthors">Lamarre, Daniel; Anderson, Paul C.; Bailey, Murray; Beaulieu, Pierre; Bolger, Gordon; Bonneau, Pierre; Boes, Michael; Cameron, Dale R.; Cartier, Mireille; Cordingley, Michael G.; Faucher, Anne-Marie; Goudreau, Nathalie; Kawai, Stephen H.; Kukolj, George; Lagace, Lisette; LaPlante, Steven R.; Narjes, Hans; Poupart, Marc-Andre; Rancourt, Jean; Sentjens, Roel E.; St. George, Roger; Simoneau, Bruno; Steinmann, Gerhard; Thibeault, Diane; Tsantrizos, Youla S.; Weldon, Steven M.; Yong, Chan-Loi; Llinas-Brunet, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">6963</span>),
    <span class="NLM_cas:pages">186-189</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is a serious cause of chronic liver disease worldwide with more than 170 million infected individuals at risk of developing significant morbidity and mortality.  Current interferon-based therapies are suboptimal esp. in patients infected with HCV genotype 1, and they are poorly tolerated, highlighting the unmet medical need for new therapeutics.  The HCV-encoded NS3 protease is essential for viral replication and has long been considered an attractive target for therapeutic intervention in HCV-infected patients.  Here we identify a class of specific and potent NS3 protease inhibitors and report the evaluation of BILN 2061, a small mol. inhibitor biol. available through oral ingestion and the first of its class in human trials.  Administration of BILN 2061 to patients infected with HCV genotype 1 for 2 days resulted in an impressive redn. of HCV RNA plasma levels, and established proof-of-concept in humans for an HCV NS3 protease inhibitor.  Our results further illustrate the potential of the viral-enzyme-targeted drug discovery approach for the development of new HCV therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPnVapDO21RLVg90H21EOLACvtfcHk0lgsr-qlXQ_S7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D&md5=36db818d5af257d3ebeef1a061ca68cb</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1038%2Fnature02099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02099%26sid%3Dliteratum%253Aachs%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DP.%2BC.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DBeaulieu%26aufirst%3DP.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DB%25C3%25B6s%26aufirst%3DM.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DCartier%26aufirst%3DM.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLagac%25C3%25A9%26aufirst%3DL.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DNarjes%26aufirst%3DH.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DSentjens%26aufirst%3DR.%2BE.%26aulast%3DSt%2BGeorge%26aufirst%3DR.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DSteinmann%26aufirst%3DG.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DTsantrizos%26aufirst%3DY.%26aulast%3DWeldon%26aufirst%3DS.%2BM.%26aulast%3DYong%26aufirst%3DC.-L.%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26atitle%3DAn%2520NS3%2520protease%2520inhibitor%2520with%2520antiviral%2520effects%2520in%2520humans%2520infected%2520with%2520hepatitis%2520C%2520virus%26jtitle%3DNature%26date%3D2003%26volume%3D426%26spage%3D186%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gentile, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carleo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgia, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaldo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgia, G.</span><span> </span><span class="NLM_article-title">The efficacy and safety of telaprevir: a new protease inhibitor against hepatitis C virus</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=151-159&author=I.+Gentileauthor=M.+A.+Carleoauthor=F.+Borgiaauthor=G.+Castaldoauthor=G.+Borgia&title=The+efficacy+and+safety+of+telaprevir%3A+a+new+protease+inhibitor+against+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGentile%26aufirst%3DI.%26aulast%3DCarleo%26aufirst%3DM.%2BA.%26aulast%3DBorgia%26aufirst%3DF.%26aulast%3DCastaldo%26aufirst%3DG.%26aulast%3DBorgia%26aufirst%3DG.%26atitle%3DThe%2520efficacy%2520and%2520safety%2520of%2520telaprevir%253A%2520a%2520new%2520protease%2520inhibitor%2520against%2520hepatitis%2520C%2520virus%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D19%26spage%3D151%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kwong, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, P.</span><span> </span><span class="NLM_article-title">Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">1003</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1038%2Fnbt.2020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=22068541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVCntLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=993-1003&author=D.+A.+Kwongauthor=R.+S.+Kauffmanauthor=P.+Mueller&title=Discovery+and+development+of+telaprevir%3A+an+NS3-4A+protease+inhibitor+for+treating+genotype+1+chronic+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus</span></div><div class="casAuthors">Kwong, Ann D.; Kauffman, Robert S.; Hurter, Patricia; Mueller, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">993-1003</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Infection with hepatitis C virus (HCV) is a major medical problem with over 170 million people infected worldwide.  Substantial morbidity and mortality are assocd. with hepatic manifestations (cirrhosis and hepatocellular carcinoma), which develop with increasing frequency in people infected with HCV for more than 20 years.  Less well known is the burden of HCV disease assocd. with extrahepatic manifestations (diabetes, B-cell proliferative disorders, depression, cognitive disorders, arthritis and Sjoegren's syndrome).  For patients infected with genotype 1 HCV, treatment with polyethylene glycol decorated interferon (peginterferon) α and ribavirin (PR) is assocd. with a low (40-50%) success rate, substantial treatment-limiting side effects and a long (48-wk) duration of treatment.  In the past 15 years, major scientific advances have enabled the development of new classes of HCV therapy, the direct-acting antiviral agents, also known as specifically targeted antiviral therapy for hepatitis C (STAT-C).  In combination with PR, the HCV NS3-4A protease inhibitor telaprevir has recently been approved for treatment of genotype 1 chronic HCV in the United States, Canada, European Union and Japan.  Compared with PR, telaprevir combination therapy offers significantly improved viral cure rates and the possibility of shortened treatment duration for diverse patient populations.  Developers of innovative drugs have to blaze a new path with few validated sign posts to guide the way.  Indeed, telaprevir's development was once put on hold because of its performance in a std. IC50 assay.  Data from new hypotheses and novel expts. were required to justify further investment and reduce risk that the drug might fail in the clinic.  In addn., the poor drug-like properties of telaprevir were a formidable hurdle, which the manufg. and formulation teams had to overcome to make the drug.  Finally, novel clin. trial designs were developed to improve efficacy and shorten treatment in parallel instead of sequentially.  Lessons learned from the development of telaprevir suggest that makers of innovative medicines cannot rely solely on traditional drug discovery metrics, but must develop innovative, scientifically guided pathways for success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodUEHshXTAvbVg90H21EOLACvtfcHk0lgwguL9pTHdAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVCntLvJ&md5=952966419a2e72107550d0a63c337ae4</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2020%26sid%3Dliteratum%253Aachs%26aulast%3DKwong%26aufirst%3DD.%2BA.%26aulast%3DKauffman%26aufirst%3DR.%2BS.%26aulast%3DMueller%26aufirst%3DP.%26atitle%3DDiscovery%2520and%2520development%2520of%2520telaprevir%253A%2520an%2520NS3-4A%2520protease%2520inhibitor%2520for%2520treating%2520genotype%25201%2520chronic%2520hepatitis%2520C%2520virus%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D993%26epage%3D1003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Berman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwo, P. Y.</span><span> </span><span class="NLM_article-title">Boceprevir, an NS3 protease inhibitor of HCV</span> <span class="citation_source-journal">Clin. Liver Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=429-439&author=K.+Bermanauthor=P.+Y.+Kwo&title=Boceprevir%2C+an+NS3+protease+inhibitor+of+HCV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DK.%26aulast%3DKwo%26aufirst%3DP.%2BY.%26atitle%3DBoceprevir%252C%2520an%2520NS3%2520protease%2520inhibitor%2520of%2520HCV%26jtitle%3DClin.%2520Liver%2520Dis.%26date%3D2009%26volume%3D13%26spage%3D429%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Asselah, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellin, P.</span><span> </span><span class="NLM_article-title">New direct-acting antivirals combination for the treatment of chronic hepatitis C</span> <span class="citation_source-journal">Liver Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=68-77&author=T.+Asselahauthor=P.+Marcellin&title=New+direct-acting+antivirals+combination+for+the+treatment+of+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAsselah%26aufirst%3DT.%26aulast%3DMarcellin%26aufirst%3DP.%26atitle%3DNew%2520direct-acting%2520antivirals%2520combination%2520for%2520the%2520treatment%2520of%2520chronic%2520hepatitis%2520C%26jtitle%3DLiver%2520Int.%26date%3D2011%26volume%3D31%26spage%3D68%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sarrazin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span> </span><span class="NLM_article-title">Resistance to direct antiviral agents in patients with hepatitis C virus infection</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">447</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2010&pages=447-462&author=C.+Sarrazinauthor=S.+Zeuzem&title=Resistance+to+direct+antiviral+agents+in+patients+with+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarrazin%26aufirst%3DC.%26aulast%3DZeuzem%26aufirst%3DS.%26atitle%3DResistance%2520to%2520direct%2520antiviral%2520agents%2520in%2520patients%2520with%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DGastroenterology%26date%3D2010%26volume%3D138%26spage%3D447%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gaudieri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfafferott, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaughan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollison, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furrer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Günthard, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freitas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klenerman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, M.</span><span> </span><span class="NLM_article-title">Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1069</span><span class="NLM_x">–</span> <span class="NLM_lpage">1082</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=1069-1082&author=S.+Gaudieriauthor=A.+Rauchauthor=K.+Pfafferottauthor=E.+Barnesauthor=W.+Chengauthor=G.+McCaughanauthor=N.+Shackelauthor=G.+P.+Jeffreyauthor=L.+Mollisonauthor=R.+Bakerauthor=H.+Furrerauthor=H.+F.+G%C3%BCnthardauthor=E.+Freitasauthor=I.+Humphreysauthor=P.+Klenermanauthor=S.+Mallalauthor=I.+Jamesauthor=S.+Robertsauthor=D.+Nolanauthor=M.+Lucas&title=Hepatitis+C+virus+drug+resistance+and+immune-driven+adaptations%3A+relevance+to+new+antiviral+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGaudieri%26aufirst%3DS.%26aulast%3DRauch%26aufirst%3DA.%26aulast%3DPfafferott%26aufirst%3DK.%26aulast%3DBarnes%26aufirst%3DE.%26aulast%3DCheng%26aufirst%3DW.%26aulast%3DMcCaughan%26aufirst%3DG.%26aulast%3DShackel%26aufirst%3DN.%26aulast%3DJeffrey%26aufirst%3DG.%2BP.%26aulast%3DMollison%26aufirst%3DL.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DFurrer%26aufirst%3DH.%26aulast%3DG%25C3%25BCnthard%26aufirst%3DH.%2BF.%26aulast%3DFreitas%26aufirst%3DE.%26aulast%3DHumphreys%26aufirst%3DI.%26aulast%3DKlenerman%26aufirst%3DP.%26aulast%3DMallal%26aufirst%3DS.%26aulast%3DJames%26aufirst%3DI.%26aulast%3DRoberts%26aufirst%3DS.%26aulast%3DNolan%26aufirst%3DD.%26aulast%3DLucas%26aufirst%3DM.%26atitle%3DHepatitis%2520C%2520virus%2520drug%2520resistance%2520and%2520immune-driven%2520adaptations%253A%2520relevance%2520to%2520new%2520antiviral%2520therapy%26jtitle%3DHepatology%26date%3D2009%26volume%3D49%26spage%3D1069%26epage%3D1082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bethell, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacé, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Preclinical characterization of BI 201335, a C-terminal carboxylic acid inhibitor of the hepatitis C virus NS3-NS4A protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4611</span><span class="NLM_x">–</span> <span class="NLM_lpage">4618</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=4611-4618&author=P.+W.+Whiteauthor=M.+Llin%C3%A0s-Brunetauthor=M.+Amadauthor=R.+C.+Bethellauthor=G.+Bolgerauthor=M.+G.+Cordingleyauthor=J.+Duanauthor=M.+Garneauauthor=L.+Lagac%C3%A9author=D.+Thibeaultauthor=G.+Kukolj&title=Preclinical+characterization+of+BI+201335%2C+a+C-terminal+carboxylic+acid+inhibitor+of+the+hepatitis+C+virus+NS3-NS4A+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26aulast%3DAmad%26aufirst%3DM.%26aulast%3DBethell%26aufirst%3DR.%2BC.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DLagac%25C3%25A9%26aufirst%3DL.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DPreclinical%2520characterization%2520of%2520BI%2520201335%252C%2520a%2520C-terminal%2520carboxylic%2520acid%2520inhibitor%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3-NS4A%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D4611%26epage%3D4618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbinnen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholliers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeiren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, Å.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">In vitro activity and preclinical profile of TMC435350, a potent hepatitis C virus protease inhibitor</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1377</span><span class="NLM_x">–</span> <span class="NLM_lpage">1385</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=1377-1385&author=T.-I.+Linauthor=O.+Lenzauthor=G.+Fanningauthor=T.+Verbinnenauthor=F.+Delouvroyauthor=A.+Scholliersauthor=K.+Vermeirenauthor=%C3%85.+Rosenquistauthor=M.+Edlundauthor=B.+Samuelssonauthor=L.+Vrangauthor=H.+de+Kockauthor=P.+Wigerinckauthor=P.+Raboissonauthor=K.+Simmen&title=In+vitro+activity+and+preclinical+profile+of+TMC435350%2C+a+potent+hepatitis+C+virus+protease+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DFanning%26aufirst%3DG.%26aulast%3DVerbinnen%26aufirst%3DT.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DScholliers%26aufirst%3DA.%26aulast%3DVermeiren%26aufirst%3DK.%26aulast%3DRosenquist%26aufirst%3D%25C3%2585.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DIn%2520vitro%2520activity%2520and%2520preclinical%2520profile%2520of%2520TMC435350%252C%2520a%2520potent%2520hepatitis%2520C%2520virus%2520protease%2520inhibitor%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D1377%26epage%3D1385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Soriano, V.</span><span> </span><span class="NLM_article-title">A new era for hepatitis C—new diagnostics tools and new weapons</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">441</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300098k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=440-441&author=V.+Soriano&title=A+new+era+for+hepatitis+C%E2%80%94new+diagnostics+tools+and+new+weapons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fml300098k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300098k%26sid%3Dliteratum%253Aachs%26aulast%3DSoriano%26aufirst%3DV.%26atitle%3DA%2520new%2520era%2520for%2520hepatitis%2520C%25E2%2580%2594new%2520diagnostics%2520tools%2520and%2520new%2520weapons%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D440%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gane, D.</span><span> </span><span class="NLM_article-title">Future hepatitis C virus treatment: interferon-sparing combinations</span> <span class="citation_source-journal">Liver Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=62-67&author=D.+Gane&title=Future+hepatitis+C+virus+treatment%3A+interferon-sparing+combinations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGane%26aufirst%3DD.%26atitle%3DFuture%2520hepatitis%2520C%2520virus%2520treatment%253A%2520interferon-sparing%2520combinations%26jtitle%3DLiver%2520Int.%26date%3D2011%26volume%3D31%26spage%3D62%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cordek, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bechtel, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maynard, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazmierski, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, C. E.</span><span> </span><span class="NLM_article-title">Targeting the NS5A protein on HCV: an emerging option</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">691</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1358%2Fdof.2011.036.09.1641618" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=23378700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1eis7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=691-711&author=D.+G.+Cordekauthor=J.+T.+Bechtelauthor=A.+T.+Maynardauthor=W.+M.+Kazmierskiauthor=C.+E.+Cameron&title=Targeting+the+NS5A+protein+on+HCV%3A+an+emerging+option"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16cR"><div class="casContent"><span class="casTitleNuber">16c</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the protein NS5A protein of HCV: an emerging option</span></div><div class="casAuthors">Cordek, D. G.; Bechtel, J. T.; Maynard, A. T.; Kazmierski, W. M.; Cameron, C. E.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">691-711</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Hepatitis C virus (HCV) infects more than 3% of the world's population, leading to an increased risk of cirrhosis and hepatocellular carcinoma.  The current std. of care, a combination of pegylated interferon alfa and ribavirin, is poorly tolerated and often ineffective against the most prevalent genotype of the virus, genotype 7.  The very recent approval of boceprevir and telaprevir, two HCV protease inhibitors, promises to significantly improve treatment options and outcomes.  In addn. to the viral protease NS3 and the viral polymerase NS5B, direct-acting antivirals are now in development against NS5A.  A multifunctional phosphoprotein, NS5A is essential to HCV genome replication, but has no known enzymic function.  Here we report how the design of small-mol. inhibitors against NS5A has evolved from promising monomers to highly potent dimeric compds. effective against many HCV genotypes.  We also highlight recent clin. data and how the inhibitors may bind to NS5A, itself capable of forming dimers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2lefIUXhmK7Vg90H21EOLACvtfcHk0ljaX3gPp2aQaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1eis7nE&md5=7e779d99491df4f8631c7848cb9e56dc</span></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1358%2Fdof.2011.036.09.1641618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2011.036.09.1641618%26sid%3Dliteratum%253Aachs%26aulast%3DCordek%26aufirst%3DD.%2BG.%26aulast%3DBechtel%26aufirst%3DJ.%2BT.%26aulast%3DMaynard%26aufirst%3DA.%2BT.%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DCameron%26aufirst%3DC.%2BE.%26atitle%3DTargeting%2520the%2520NS5A%2520protein%2520on%2520HCV%253A%2520an%2520emerging%2520option%26jtitle%3DDrugs%2520Future%26date%3D2011%26volume%3D36%26spage%3D691%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sulkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinestrosa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thuluvath, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lok, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wind-Rotolo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hindes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symonds, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquinelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D.</span><span> </span><span class="NLM_article-title">Potent viral suppression with all-oral combination of daclatasvir (NS5A inhibitor) and GS-7977 (NS5B inhibitor), ± ribavirin, in treatment-naive patients with chronic HCV GT1, 2, or 3</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S560</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=S560&issue=Suppl.+2&author=M.+Sulkowskiauthor=D.+Gardinerauthor=E.+Lawitzauthor=F.+Hinestrosaauthor=D.+Nelsonauthor=P.+Thuluvathauthor=M.+Rodriguez-Torresauthor=A.+Lokauthor=H.+Schwartzauthor=K.+R.+Reddyauthor=T.+Eleyauthor=M.+Wind-Rotoloauthor=J.-P.+Huangauthor=M.+Gaoauthor=F.+McPheeauthor=R.+Hindesauthor=B.+Symondsauthor=C.+Pasquinelliauthor=D.+Grasela&title=Potent+viral+suppression+with+all-oral+combination+of+daclatasvir+%28NS5A+inhibitor%29+and+GS-7977+%28NS5B+inhibitor%29%2C+%C2%B1+ribavirin%2C+in+treatment-naive+patients+with+chronic+HCV+GT1%2C+2%2C+or+3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSulkowski%26aufirst%3DM.%26aulast%3DGardiner%26aufirst%3DD.%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DHinestrosa%26aufirst%3DF.%26aulast%3DNelson%26aufirst%3DD.%26aulast%3DThuluvath%26aufirst%3DP.%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26aulast%3DLok%26aufirst%3DA.%26aulast%3DSchwartz%26aufirst%3DH.%26aulast%3DReddy%26aufirst%3DK.%2BR.%26aulast%3DEley%26aufirst%3DT.%26aulast%3DWind-Rotolo%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DJ.-P.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DHindes%26aufirst%3DR.%26aulast%3DSymonds%26aufirst%3DB.%26aulast%3DPasquinelli%26aufirst%3DC.%26aulast%3DGrasela%26aufirst%3DD.%26atitle%3DPotent%2520viral%2520suppression%2520with%2520all-oral%2520combination%2520of%2520daclatasvir%2520%2528NS5A%2520inhibitor%2529%2520and%2520GS-7977%2520%2528NS5B%2520inhibitor%2529%252C%2520%25C2%25B1%2520ribavirin%252C%2520in%2520treatment-naive%2520patients%2520with%2520chronic%2520HCV%2520GT1%252C%25202%252C%2520or%25203%26jtitle%3DJ.%2520Hepatol.%26date%3D2012%26volume%3D56%26issue%3DSuppl.%25202%26spage%3DS560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kolykhalov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihalik, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstone, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′-nontranslated region are essential for virus replication in vivo</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">2046</span><span class="NLM_x">–</span> <span class="NLM_lpage">2051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1128%2FJVI.74.4.2046-2051.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=10644379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptlGitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=2046-2051&author=A.+A.+Kolykhalovauthor=K.+Mihalikauthor=S.+M.+Feinstoneauthor=C.+M.+Rice&title=Hepatitis+C+virus-encoded+enzymatic+activities+and+conserved+RNA+elements+in+the+3%E2%80%B2-nontranslated+region+are+essential+for+virus+replication+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo</span></div><div class="casAuthors">Kolykhalov, Alexander A.; Mihalik, Kathy; Feinstone, Stephen M.; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2046-2051</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is a widespread major human health concern.  Significant obstacles in the study of this virus include the absence of a reliable tissue culture system and a small-animal model.  Recently, full-length HCV cDNA clones were constructed and HCV infection was successfully initiated in 2 chimpanzees by intrahepatic injection of in vitro-transcribed RNA.  In order to validate potential targets for development of anti-HCV therapeutics, 6 mutant derivs. of this prototype infectious clone were constructed.  Four clones contained point mutations ablating the activity of the NS2-3 protease, the NS3-4A serine protease, the NS3 NTPase/helicase, and the NS5B polymerase.  Two addnl. clones contained deletions encompassing all or part of the highly conserved 98-base sequence at the 3' terminus of the HCV genome RNA.  The RNA transcript from each of the 6 clones was injected intrahepatically into a chimpanzee.  No signs of HCV infection were detected in the 8 mo following the injection.  Inoculation of the same animal with nonmutant RNA transcripts resulted in productive HCV infection, as evidenced by viremia, elevated serum alanine aminotransferase, and HCV-specific seroconversion.  These data suggest that these 4 HCV-encoded enzymic activities and the conserved 3' terminal RNA element are essential for productive replication in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcxsUWOuM9sLVg90H21EOLACvtfcHk0lhXwAyUzui8EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptlGitA%253D%253D&md5=69facc6778408ae96f31373f78c06600</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1128%2FJVI.74.4.2046-2051.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.74.4.2046-2051.2000%26sid%3Dliteratum%253Aachs%26aulast%3DKolykhalov%26aufirst%3DA.%2BA.%26aulast%3DMihalik%26aufirst%3DK.%26aulast%3DFeinstone%26aufirst%3DS.%2BM.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DHepatitis%2520C%2520virus-encoded%2520enzymatic%2520activities%2520and%2520conserved%2520RNA%2520elements%2520in%2520the%25203%25E2%2580%25B2-nontranslated%2520region%2520are%2520essential%2520for%2520virus%2520replication%2520in%2520vivo%26jtitle%3DJ.%2520Virol.%26date%3D2000%26volume%3D74%26spage%3D2046%26epage%3D2051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chinnaswamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarbrough, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palaninathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, C. T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijayaraghavan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demeler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchettini, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, C. C.</span><span> </span><span class="NLM_article-title">A locking mechanism regulates RNA synthesis and host protein interaction by the hepatitis C virus polymerase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">20535</span><span class="NLM_x">–</span> <span class="NLM_lpage">20546</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=20535-20546&author=S.+Chinnaswamyauthor=I.+Yarbroughauthor=S.+Palaninathanauthor=C.+T.+R.+Kumarauthor=V.+Vijayaraghavanauthor=B.+Demelerauthor=S.+M.+Lemonauthor=J.+C.+Sacchettiniauthor=C.+C.+Kao&title=A+locking+mechanism+regulates+RNA+synthesis+and+host+protein+interaction+by+the+hepatitis+C+virus+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChinnaswamy%26aufirst%3DS.%26aulast%3DYarbrough%26aufirst%3DI.%26aulast%3DPalaninathan%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DC.%2BT.%2BR.%26aulast%3DVijayaraghavan%26aufirst%3DV.%26aulast%3DDemeler%26aufirst%3DB.%26aulast%3DLemon%26aufirst%3DS.%2BM.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DKao%26aufirst%3DC.%2BC.%26atitle%3DA%2520locking%2520mechanism%2520regulates%2520RNA%2520synthesis%2520and%2520host%2520protein%2520interaction%2520by%2520the%2520hepatitis%2520C%2520virus%2520polymerase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D20535%26epage%3D20546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Harrus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed-El-Sayed, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simister, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triconnet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagedorn, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahias, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Astier-Gin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bressanelli, S.</span><span> </span><span class="NLM_article-title">Further insights into the roles of GTP and the C-terminus of the hepatitis C virus polymerase in the initiation of RNA synthesis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">32906</span><span class="NLM_x">–</span> <span class="NLM_lpage">32918</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=32906-32918&author=D.+Harrusauthor=N.+Ahmed-El-Sayedauthor=P.+C.+Simisterauthor=S.+Millerauthor=M.+Triconnetauthor=C.+H.+Hagedornauthor=K.+Mahiasauthor=F.+A.+Reyauthor=T.+Astier-Ginauthor=S.+Bressanelli&title=Further+insights+into+the+roles+of+GTP+and+the+C-terminus+of+the+hepatitis+C+virus+polymerase+in+the+initiation+of+RNA+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarrus%26aufirst%3DD.%26aulast%3DAhmed-El-Sayed%26aufirst%3DN.%26aulast%3DSimister%26aufirst%3DP.%2BC.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DTriconnet%26aufirst%3DM.%26aulast%3DHagedorn%26aufirst%3DC.%2BH.%26aulast%3DMahias%26aufirst%3DK.%26aulast%3DRey%26aufirst%3DF.%2BA.%26aulast%3DAstier-Gin%26aufirst%3DT.%26aulast%3DBressanelli%26aufirst%3DS.%26atitle%3DFurther%2520insights%2520into%2520the%2520roles%2520of%2520GTP%2520and%2520the%2520C-terminus%2520of%2520the%2520hepatitis%2520C%2520virus%2520polymerase%2520in%2520the%2520initiation%2520of%2520RNA%2520synthesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D32906%26epage%3D32918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Bressanelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roussel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Incitti, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitale, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, F. A.</span><span> </span><span class="NLM_article-title">Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">13034</span><span class="NLM_x">–</span> <span class="NLM_lpage">13039</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1073%2Fpnas.96.23.13034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=10557268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADyaK1MXns1Gmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=13034-13039&author=S.+Bressanelliauthor=L.+Tomeiauthor=A.+Rousselauthor=I.+Incittiauthor=R.+L.+Vitaleauthor=M.+Mathieuauthor=R.+De+Francescoauthor=F.+A.+Rey&title=Crystal+structure+of+the+RNA-dependent+RNA+polymerase+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus</span></div><div class="casAuthors">Bressanelli, Stephane; Tomei, Licia; Roussel, Alain; Incitti, Ilario; Vitale, Rosa Letizia; Mathieu, Magali; De Francesco, Raffaele; Rey, Felix A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">13034-13039</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The crystal structure of the RNA-dependent RNA polymerase (RNA replicase) (I) of hepatitis C virus, a major human pathogen, is reported to 2.8 Å resoln.  I is a key target for developing specific antiviral therapy.  The structure of the catalytic domain contained 531 residues folded in the characteristic fingers, palm, and thumb subdomains.  The fingers subdomain contained a region, the "fingertips," that shared the same fold with reverse transcriptases.  Superposition to the available structures of the latter showed that residues from the palm and fingertips were structurally equiv.  In addn., it showed that hepatitis C virus I was crystd. in a closed fingers conformation, similar to HIV-1 reverse transcriptase in ternary complex with DNA and dTTP.  This superposition revealed the majority of the amino acid residues of the hepatitis C virus enzyme that are likely to be implicated in binding to the replicating RNA mol. and to the incoming NTP.  It also suggested a rearrangement of the thumb domain as well as a possible concerted movement of thumb and fingertips during translocation of the RNA template-primer in successive polymn. rounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoMMlZvielKLVg90H21EOLACvtfcHk0lhXwAyUzui8EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXns1Gmsrk%253D&md5=2ba97997c8a8e24c0db560260fb5ea9a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.23.13034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.23.13034%26sid%3Dliteratum%253Aachs%26aulast%3DBressanelli%26aufirst%3DS.%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DRoussel%26aufirst%3DA.%26aulast%3DIncitti%26aufirst%3DI.%26aulast%3DVitale%26aufirst%3DR.%2BL.%26aulast%3DMathieu%26aufirst%3DM.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DRey%26aufirst%3DF.%2BA.%26atitle%3DCrystal%2520structure%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D13034%26epage%3D13039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="note"><p class="first last">For reviews on NS5B inhibitors see, for example, the following: </p></div><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1517%2F13543770802672598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVCks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=145-164&author=P.+L.+Beaulieu&title=Recent+advances+in+the+development+of+NS5B+polymerase+inhibitors+for+the+treatment+of+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection</span></div><div class="casAuthors">Beaulieu, Pierre L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-164</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  170 To 200 million people worldwide are believed to suffer from chronic hepatitis C virus (HCV) infection, a blood-born disease that targets the liver and progresses to organ cirrhosis and primary cancer in a significant proportion of patients.  The currently available treatment has limited efficacy and suffers from restricting side effects.  HCV infection is the principal cause of liver transplant in industrialized nations and between 8000 and 10,000 deaths result annually from the disease in the United States alone.  Virus-specific, more efficacious, and better-tolerated anti-HCV therapies are thus required to address the unmet medical need.  Objective: To review progress achieved since 2005 in the development of HCV NS5B polymerase inhibitors as potential therapy for the treatment of HCV infection with a primary focus on available patent and medical literature.  Results/conclusion: Several classes of small-mol. inhibitors of HCV NS5B have progressed into clin. development and demonstrated efficacy in reducing viral load in infected patients.  The results so far provide an encouraging foundation for the development of novel, more tolerable therapies and addressing emergence of resistance through combination of antiviral agents with complementary mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo8VVFJs4oSbVg90H21EOLACvtfcHk0lgtws6W5KB10Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVCks74%253D&md5=64b78562e2b4e3e8a166fdabf14f7efe</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1517%2F13543770802672598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770802672598%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520NS5B%2520polymerase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D145%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Watkins, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, L. S.</span><span> </span><span class="NLM_article-title">HCV NS5B polymerase inhibitors</span> <span class="citation_source-journal">Cur. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=20597029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSju7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=441-465&author=W.+J.+Watkinsauthor=A.+S.+Rayauthor=L.+S.+Chong&title=HCV+NS5B+polymerase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">HCV NS5B polymerase inhibitors</span></div><div class="casAuthors">Watkins, William J.; Ray, Adrian S.; Chong, Lee S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-465</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">2040-3437</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  In the past decade, intensive efforts have focused on the discovery of both nucleos(t)ide and non-nucleoside inhibitors of the HCV NS5B polymerase.  These efforts have resulted in several promising agents advancing in clin. development.  This review traces the history of optimization of the chem. series that have led to the development of clin. candidates, and summarizes recent developments in the field, with emphasis on clin. efficacy and impact for future combination studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf6PfCo0V5R7Vg90H21EOLACvtfcHk0lgtws6W5KB10Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSju7zJ&md5=f0e5144b72864e6eb1a2f4b13b1b916e</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DW.%2BJ.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DChong%26aufirst%3DL.%2BS.%26atitle%3DHCV%2520NS5B%2520polymerase%2520inhibitors%26jtitle%3DCur.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2010%26volume%3D13%26spage%3D441%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sofia, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, B. S.</span><span> </span><span class="NLM_article-title">Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2532</span><span class="NLM_x">–</span> <span class="NLM_lpage">2531</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2532-2531&author=M.+J.+Sofiaauthor=W.+Changauthor=P.+A.+Furmanauthor=R.+T.+Mosleyauthor=B.+S.+Ross&title=Nucleoside%2C+nucleotide%2C+and+non-nucleoside+inhibitors+of+hepatitis+C+virus+NS5B+RNA-dependent+RNA-polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DMosley%26aufirst%3DR.%2BT.%26aulast%3DRoss%26aufirst%3DB.%2BS.%26atitle%3DNucleoside%252C%2520nucleotide%252C%2520and%2520non-nucleoside%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS5B%2520RNA-dependent%2520RNA-polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2532%26epage%3D2531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Brown, N. A.</span><span> </span><span class="NLM_article-title">Progress towards improving antiviral therapy for hepatitis C virus polymerase inhibitors. Part 1: nucleoside analogues</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">709</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=709-725&author=N.+A.+Brown&title=Progress+towards+improving+antiviral+therapy+for+hepatitis+C+virus+polymerase+inhibitors.+Part+1%3A+nucleoside+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DN.%2BA.%26atitle%3DProgress%2520towards%2520improving%2520antiviral%2520therapy%2520for%2520hepatitis%2520C%2520virus%2520polymerase%2520inhibitors.%2520Part%25201%253A%2520nucleoside%2520analogues%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D18%26spage%3D709%26epage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Furman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, E.</span><span> </span><span class="NLM_article-title">Nucleoside analog inhibitors of hepatitis C virus replication: recent advances, challenges and trends</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1429</span><span class="NLM_x">–</span> <span class="NLM_lpage">1452</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.4155%2Ffmc.09.88" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=21426058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFSit77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=1429-1452&author=P.+A.+Furmanauthor=A.+M.+Lamauthor=E.+Murakami&title=Nucleoside+analog+inhibitors+of+hepatitis+C+virus+replication%3A+recent+advances%2C+challenges+and+trends"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleoside analog inhibitors of hepatitis C viral replication: recent advances, challenges and trends</span></div><div class="casAuthors">Furman, Phillip A.; Lam, Angela M.; Murakami, Eisuke</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1429-1452</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Chronic hepatitis C virus (HCV) infection is a global health problem, with over 170 million people infected worldwide.  The current therapy, pegylated interferon (PEG-IFN) plus ribavirin (RBV), provides only approx. a 40% sustained virol. response (undetectable HCV RNA for greater than 24 wk after cessation of therapy), in genotype I-infected individuals.  In addn. to the limited sustained virol. response, PEG-IFN/RBV treatment is assocd. with serious adverse effects.  Nucleosides have long been the cornerstone of antiviral therapy because of their proven efficacy and high barrier to resistance.  Through the use of surrogate viruses or the HCV subgenomic replicon, several classes of nucleoside analogs or their monophosphate prodrugs have been identified that inhibit HCV RNA replication.  Nucleoside analogs that possess the 2'-C-Me modification vary in their ability to be phosphorylated and to act as alternative substrate inhibitors of the HCV RNA polymerase.  Herein, we discuss various classes of nucleoside inhibitors, with a focus on available structure-activity relationships, their mode of action and resistance profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuFIjUiU5KFbVg90H21EOLACvtfcHk0lgtws6W5KB10Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFSit77F&md5=d512189b8d8f1380f8bc10a5c0438c1c</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.4155%2Ffmc.09.88&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.09.88%26sid%3Dliteratum%253Aachs%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DMurakami%26aufirst%3DE.%26atitle%3DNucleoside%2520analog%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520replication%253A%2520recent%2520advances%252C%2520challenges%2520and%2520trends%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2009%26volume%3D1%26spage%3D1429%26epage%3D1452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sofia, M. J.</span><span> </span><span class="NLM_article-title">Nucleotide prodrugs for HCV therapy</span> <span class="citation_source-journal">Antiviral Chem. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=23-49&author=M.+J.+Sofia&title=Nucleotide+prodrugs+for+HCV+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26atitle%3DNucleotide%2520prodrugs%2520for%2520HCV%2520therapy%26jtitle%3DAntiviral%2520Chem.%2520Chemother.%26date%3D2011%26volume%3D22%26spage%3D23%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyaguru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nájera, I.</span><span> </span><span class="NLM_article-title">In vitro selected Con1 subgenomic replicons resistant to 2′-<i>C</i>-methyl-cytidine or to R1479 show lack of cross-resistance</span> <span class="citation_source-journal">Virology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x">, </span> <span class="NLM_fpage">340</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2006&pages=340-348&author=S.+Le+Pogamauthor=W.-R.+Jiangauthor=V.+Levequeauthor=S.+Rajyaguruauthor=H.+Maauthor=H.+Kangauthor=S.+Jiangauthor=M.+Singerauthor=S.+Aliauthor=K.+Klumppauthor=D.+Smithauthor=J.+Symonsauthor=N.+Cammackauthor=I.+N%C3%A1jera&title=In+vitro+selected+Con1+subgenomic+replicons+resistant+to+2%E2%80%B2-C-methyl-cytidine+or+to+R1479+show+lack+of+cross-resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DW.-R.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DSinger%26aufirst%3DM.%26aulast%3DAli%26aufirst%3DS.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DSymons%26aufirst%3DJ.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DN%25C3%25A1jera%26aufirst%3DI.%26atitle%3DIn%2520vitro%2520selected%2520Con1%2520subgenomic%2520replicons%2520resistant%2520to%25202%25E2%2580%25B2-C-methyl-cytidine%2520or%2520to%2520R1479%2520show%2520lack%2520of%2520cross-resistance%26jtitle%3DVirology%26date%3D2006%26volume%3D351%26spage%3D340%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McCown, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyaguru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nájera, I.</span><span> </span><span class="NLM_article-title">The hepatitis C virus replicon presents a higher barrier to resistance to nucleoside analogs than to non-nucleoside polymerase or protease inhibitors</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1604</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=1604-1612&author=M.+F.+McCownauthor=S.+Rajyaguruauthor=S.+Le+Pogamauthor=S.+Aliauthor=W.-R.+Jiangauthor=H.+Kangauthor=J.+Symonsauthor=N.+Cammackauthor=I.+N%C3%A1jera&title=The+hepatitis+C+virus+replicon+presents+a+higher+barrier+to+resistance+to+nucleoside+analogs+than+to+non-nucleoside+polymerase+or+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCown%26aufirst%3DM.%2BF.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DAli%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DW.-R.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DSymons%26aufirst%3DJ.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DN%25C3%25A1jera%26aufirst%3DI.%26atitle%3DThe%2520hepatitis%2520C%2520virus%2520replicon%2520presents%2520a%2520higher%2520barrier%2520to%2520resistance%2520to%2520nucleoside%2520analogs%2520than%2520to%2520non-nucleoside%2520polymerase%2520or%2520protease%2520inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D1604%26epage%3D1612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seshaadri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewing, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symonds, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLaRosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nájera, I.</span><span> </span><span class="NLM_article-title">RG1728 alone or in combination with pegylated interferon-α2a and ribavirin prevents hepatitis C virus (HCV) replication and selection of resistant variants in HCV-infected patients</span> <span class="citation_source-journal">J. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">1510</span><span class="NLM_x">–</span> <span class="NLM_lpage">1519</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1086%2F656774" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=20942646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOns73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2010&pages=1510-1519&author=S.+Le+Pogamauthor=A.+Seshaadriauthor=A.+Ewingauthor=H.+Kangauthor=A.+Kosakaauthor=J.-M.+Yanauthor=M.+Berreyauthor=B.+Symondsauthor=A.+DeLaRosaauthor=N.+Cammackauthor=I.+N%C3%A1jera&title=RG1728+alone+or+in+combination+with+pegylated+interferon-%CE%B12a+and+ribavirin+prevents+hepatitis+C+virus+%28HCV%29+replication+and+selection+of+resistant+variants+in+HCV-infected+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">RG7128 alone or in combination with pegylated interferon-α2a and ribavirin prevents hepatitis C virus (HCV) replication and selection of resistant variants in HCV-infected patients</span></div><div class="casAuthors">Le Pogam, Sophie; Seshaadri, Amritha; Ewing, Aren; Kang, Hyunsoon; Kosaka, Alan; Yan, Jun-Mei; Berrey, Michelle; Symonds, Bill; de la Rosa, Abel; Cammack, Nick; Najera, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1510-1519</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Introduction: RG7128 (prodrug of PSI-6130) shows potent antiviral efficacy in patients infected with hepatitis C virus (HCV) genotypes 1, 2, or 3, with mean viral load decreases of 2.7 and 5 log10 IU/mL, resp., assocd. with 1500-mg doses twice daily after monotherapy for 2 wk and with 1000-mg and 1500-mg doses twice daily after treatment in combination with the std. of care (SOC) for 4 wk.  Results: From 32 patients treated with RG7128 monotherapy for 2 wk, marginal viral load rebound was obsd. in 3 HCV genotype 1-infected patients, whereas partial response was obsd. in 2 genotype 1-infected patients.  From 85 patients receiving RG7128 in combination with SOC, 1 HCV genotype 1-infected patient experienced a viral rebound, and 2 genotype 3-infected patients experienced a transient rebound.  Five genotype 1-infected patients had an HCV load of >1000 IU/mL at the end of 4-wk treatment.  No viral resistance was obsd., per NS5B sequencing and phenotypic studies.  PSI-6130 resistance substitution sS282T needs to be bpresent at levels of ≥90% within a patient's quasispecies to confer low-level resistance.  No evidence of S282T was found by population or clonal sequence analyses.  Conclusions: The requirement for a predominant S282T mutant quasispecies, its low replication capacity, and the low-level resistance it confers probably contribute to the lack of RG7128 resistance obsd. in HCV-infected patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDyELFs5GZmLVg90H21EOLACvtfcHk0lhlIq-kmjY-NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOns73J&md5=09a1bed4eb0f3a1ed2a35051eafaac7e</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1086%2F656774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F656774%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DSeshaadri%26aufirst%3DA.%26aulast%3DEwing%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DKosaka%26aufirst%3DA.%26aulast%3DYan%26aufirst%3DJ.-M.%26aulast%3DBerrey%26aufirst%3DM.%26aulast%3DSymonds%26aufirst%3DB.%26aulast%3DDeLaRosa%26aufirst%3DA.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DN%25C3%25A1jera%26aufirst%3DI.%26atitle%3DRG1728%2520alone%2520or%2520in%2520combination%2520with%2520pegylated%2520interferon-%25CE%25B12a%2520and%2520ribavirin%2520prevents%2520hepatitis%2520C%2520virus%2520%2528HCV%2529%2520replication%2520and%2520selection%2520of%2520resistant%2520variants%2520in%2520HCV-infected%2520patients%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2010%26volume%3D202%26spage%3D1510%26epage%3D1519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Gane, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stedman, C. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angus, Q. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritchie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elston, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ipe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morcos, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baher, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nájera, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopatin, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrey, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradford, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laughlin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shulman, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. F.</span><span> </span><span class="NLM_article-title">Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomized, double-blind, placebo-controlled, dose-escalation trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">1467</span><span class="NLM_x">–</span> <span class="NLM_lpage">1475</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=2010&pages=1467-1475&author=E.+J.+Ganeauthor=S.+K.+Robertsauthor=C.+A.+M.+Stedmanauthor=Q.+W.+Angusauthor=B.+Ritchieauthor=R.+Elstonauthor=D.+Ipeauthor=P.+N.+Morcosauthor=L.+Baherauthor=I.+N%C3%A1jeraauthor=T.+Chuauthor=U.+Lopatinauthor=M.+M.+Berreyauthor=W.+Bradfordauthor=M.+Laughlinauthor=N.+S.+Shulmanauthor=P.+F.+Smith&title=Oral+combination+therapy+with+a+nucleoside+polymerase+inhibitor+%28RG7128%29+and+danoprevir+for+chronic+hepatitis+C+genotype+1+infection+%28INFORM-1%29%3A+a+randomized%2C+double-blind%2C+placebo-controlled%2C+dose-escalation+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGane%26aufirst%3DE.%2BJ.%26aulast%3DRoberts%26aufirst%3DS.%2BK.%26aulast%3DStedman%26aufirst%3DC.%2BA.%2BM.%26aulast%3DAngus%26aufirst%3DQ.%2BW.%26aulast%3DRitchie%26aufirst%3DB.%26aulast%3DElston%26aufirst%3DR.%26aulast%3DIpe%26aufirst%3DD.%26aulast%3DMorcos%26aufirst%3DP.%2BN.%26aulast%3DBaher%26aufirst%3DL.%26aulast%3DN%25C3%25A1jera%26aufirst%3DI.%26aulast%3DChu%26aufirst%3DT.%26aulast%3DLopatin%26aufirst%3DU.%26aulast%3DBerrey%26aufirst%3DM.%2BM.%26aulast%3DBradford%26aufirst%3DW.%26aulast%3DLaughlin%26aufirst%3DM.%26aulast%3DShulman%26aufirst%3DN.%2BS.%26aulast%3DSmith%26aufirst%3DP.%2BF.%26atitle%3DOral%2520combination%2520therapy%2520with%2520a%2520nucleoside%2520polymerase%2520inhibitor%2520%2528RG7128%2529%2520and%2520danoprevir%2520for%2520chronic%2520hepatitis%2520C%2520genotype%25201%2520infection%2520%2528INFORM-1%2529%253A%2520a%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%252C%2520dose-escalation%2520trial%26jtitle%3DLancet%26date%3D2010%26volume%3D376%26spage%3D1467%26epage%3D1475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chinnaswamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujisaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, C. C.</span><span> </span><span class="NLM_article-title">Regulation of de novo-initiated RNA synthesis in hepatitis C virus RNA-dependent RNA polymerase by intermolecular interactions</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">5923</span><span class="NLM_x">–</span> <span class="NLM_lpage">5935</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1128%2FJVI.02446-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=20375156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsFKnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2010&pages=5923-5935&author=S.+Chinnaswamyauthor=A.+Muraliauthor=P.+Liauthor=K.+Fujisakiauthor=C.+C.+Kao&title=Regulation+of+de+novo-initiated+RNA+synthesis+in+hepatitis+C+virus+RNA-dependent+RNA+polymerase+by+intermolecular+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of de novo-initiated RNA synthesis in hepatitis C virus RNA-dependent RNA polymerase by intermolecular interactions</span></div><div class="casAuthors">Chinnaswamy, S.; Murali, A.; Li, P.; Fujisaki, K.; Kao, C. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5923-5935</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) has been proposed to change conformations in assocn. with RNA synthesis and to interact with cellular proteins.  In vitro, the RdRp can initiate de novo from the ends of single-stranded RNA or extend a primed RNA template.  The interactions between the Δ1 loop and thumb domain in NS5B are required for de novo initiation, although it is unclear whether these interactions are within an NS5B monomer or are part of a higher-order NS5B oligomeric complex.  This work seeks to address how polymerase conformation and/or oligomerization affects de novo initiation.  It has been shown that an increasing enzyme concn. increases de novo initiation by the genotype 1b and 2a RdRps while primer extension reactions are not affected or inhibited under similar conditions.  Initiation-defective mutants of the HCV polymerase can increase de novo initiation by the wild-type (WT) polymerase.  GTP was also found to stimulate de novo initiation.  The results support a model in which the de novo initiation-competent conformation of the RdRp is stimulated by oligomeric contacts between individual subunits.  Using electron microscopy and single-mol. reconstruction, visualization of the low-resoln. conformations of a dimer of a de novo initiation-competent HCV RdRp was attempted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAwIMqPQPIRLVg90H21EOLACvtfcHk0lhlIq-kmjY-NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsFKnsrw%253D&md5=2cceff47be925af979644d56d4e3b499</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1128%2FJVI.02446-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02446-09%26sid%3Dliteratum%253Aachs%26aulast%3DChinnaswamy%26aufirst%3DS.%26aulast%3DMurali%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DFujisaki%26aufirst%3DK.%26aulast%3DKao%26aufirst%3DC.%2BC.%26atitle%3DRegulation%2520of%2520de%2520novo-initiated%2520RNA%2520synthesis%2520in%2520hepatitis%2520C%2520virus%2520RNA-dependent%2520RNA%2520polymerase%2520by%2520intermolecular%2520interactions%26jtitle%3DJ.%2520Virol.%26date%3D2010%26volume%3D84%26spage%3D5923%26epage%3D5935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rigat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudyma, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentles, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beno, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S. B.</span><span> </span><span class="NLM_article-title">Ligand-induced changes in hepatitis C virus NS5B polymerase structure</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2010&pages=197-206&author=K.+Rigatauthor=Y.+Wangauthor=T.+W.+Hudymaauthor=M.+Dingauthor=X.+Zhengauthor=R.+G.+Gentlesauthor=B.+R.+Benoauthor=M.+Gaoauthor=S.+B.+Roberts&title=Ligand-induced+changes+in+hepatitis+C+virus+NS5B+polymerase+structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRigat%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHudyma%26aufirst%3DT.%2BW.%26aulast%3DDing%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DGentles%26aufirst%3DR.%2BG.%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DRoberts%26aufirst%3DS.%2BB.%26atitle%3DLigand-induced%2520changes%2520in%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%2520structure%26jtitle%3DAntiviral%2520Res.%26date%3D2010%26volume%3D88%26spage%3D197%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, S. T.</span><span> </span><span class="NLM_article-title">Non-nucleoside inhibitors of hepatitis C virus polymerase: current progress and future challenges</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.4155%2Ffmc.09.148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=21426049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVWgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=121-141&author=H.+Liauthor=S.+T.+Shi&title=Non-nucleoside+inhibitors+of+hepatitis+C+virus+polymerase%3A+current+progress+and+future+challenges"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Non-nucleoside inhibitors of hepatitis C virus polymerase: current progress and future challenges</span></div><div class="casAuthors">Li, Hui; Shi, Stephanie T.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">121-141</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The current std. of care for hepatitis C virus (HCV) infection is a combination of PEGylated interferon and ribavirin, which offer limited efficacy and significant side effects.  Novel HCV-specific inhibitors, including those directed at the viral polymerase, have become the focus of HCV drug-discovery efforts in the past decade.  In addn. to the active site targeted by traditional nucleoside inhibitors, at least four different allosteric-binding sites have been reported for the HCV polymerase, which offer ample opportunities for small-mol. inhibitors.  In this review, we summarize the recent progress in the discovery of non-nucleoside HCV polymerase inhibitors with a focus on novel chem. matters, their clin. efficacy, safety and potential for combination therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnYvEwqRM0-bVg90H21EOLACvtfcHk0lhMggIMtddo0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVWgug%253D%253D&md5=311bcf9ff7adf740674c2d8333fb25c2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4155%2Ffmc.09.148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.09.148%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DShi%26aufirst%3DS.%2BT.%26atitle%3DNon-nucleoside%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520polymerase%253A%2520current%2520progress%2520and%2520future%2520challenges%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2010%26volume%3D2%26spage%3D121%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sofia, M. J.; Furman, P. A.; Symonds, W. T.</span><span> </span><span class="NLM_article-title">2′-<i>F</i>-2′-<i>C</i>-Methyl Nucleosides and Nucleotides for the Treatment of Hepatitis C Virus: From Discovery to the Clinic</span>. In  <span class="citation_source-book">Accounts in Drug Discovery: Case Studies in Medicinal Chemistry</span>; <span class="NLM_contrib-group">Barrish, J. C.; Carter, P. H.; Cheng, P. T. W.; Zhaler, R.</span>, Eds.; <span class="NLM_publisher-name">Royal Society of Chemistry</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">4</span>, pp  <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1039%2F9781849731980-00238" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=238-266&author=M.+J.+Sofia&author=P.+A.+Furman&author=W.+T.+Symondsauthor=J.+C.+Barrish&author=P.+H.+Carter&author=P.+T.+W.+Cheng&author=R.+Zhaler&title=Accounts+in+Drug+Discovery%3A+Case+Studies+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1039%2F9781849731980-00238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849731980-00238%26sid%3Dliteratum%253Aachs%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26atitle%3D2%25E2%2580%25B2-F-2%25E2%2580%25B2-C-Methyl%2520Nucleosides%2520and%2520Nucleotides%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C%2520Virus%253A%2520From%2520Discovery%2520to%2520the%2520Clinic%26btitle%3DAccounts%2520in%2520Drug%2520Discovery%253A%2520Case%2520Studies%2520in%2520Medicinal%2520Chemistry%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26pub%3DRoyal%2520Society%2520of%2520Chemistry%26date%3D2010%26volume%3D4%26spage%3D238%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhou, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietropaolo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan-Bolyai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayers, D.</span><span> </span><span class="NLM_article-title">Safety and pharmacokinetics of IDX184, a liver-targeted nucleotide polymerase inhibitor of hepatitis C virus, in healthy subjects</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">76</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=76-81&author=X.+J.+Zhouauthor=K.+Pietropaoloauthor=J.+Chenauthor=S.+Khanauthor=J.+Sullivan-Bolyaiauthor=D.+Mayers&title=Safety+and+pharmacokinetics+of+IDX184%2C+a+liver-targeted+nucleotide+polymerase+inhibitor+of+hepatitis+C+virus%2C+in+healthy+subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DX.%2BJ.%26aulast%3DPietropaolo%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DSullivan-Bolyai%26aufirst%3DJ.%26aulast%3DMayers%26aufirst%3DD.%26atitle%3DSafety%2520and%2520pharmacokinetics%2520of%2520IDX184%252C%2520a%2520liver-targeted%2520nucleotide%2520polymerase%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%252C%2520in%2520healthy%2520subjects%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2011%26volume%3D55%26spage%3D76%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sofia, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagaratham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachakonda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espiritu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steuer, H. M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span> </span><span class="NLM_article-title">Discovery of a β-<span class="smallcaps smallerCapital">d</span>-2′-deoxy-2′-α-fluoro-2′-β-<i>C</i>-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7202</span><span class="NLM_x">–</span> <span class="NLM_lpage">7218</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100863x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7202-7218&author=M.+J.+Sofiaauthor=D.+Baoauthor=W.+Changauthor=J.+Duauthor=D.+Nagarathamauthor=S.+Rachakondaauthor=P.+G.+Reddyauthor=B.+S.+Rossauthor=P.+Wangauthor=H.-R.+Zhangauthor=S.+Bansalauthor=C.+Espirituauthor=M.+Keilmanauthor=A.+M.+Lamauthor=H.+M.+M.+Steuerauthor=C.+Niuauthor=M.+J.+Ottoauthor=P.+A.+Furman&title=Discovery+of+a+%CE%B2-d-2%E2%80%B2-deoxy-2%E2%80%B2-%CE%B1-fluoro-2%E2%80%B2-%CE%B2-C-methyluridine+nucleotide+prodrug+%28PSI-7977%29+for+the+treatment+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24cR"><div class="casContent"><span class="casTitleNuber">24c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a β-D-2'-Deoxy-2'-α-fluoro-2'-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus</span></div><div class="casAuthors">Sofia, Michael J.; Bao, Donghui; Chang, Wonsuk; Du, Jinfa; Nagarathnam, Dhanapalan; Rachakonda, Suguna; Reddy, P. Ganapati; Ross, Bruce S.; Wang, Peiyuan; Zhang, Hai-Ren; Bansal, Shalini; Espiritu, Christine; Keilman, Meg; Lam, Angela M.; Steuer, Holly M. Micolochick; Niu, Congrong; Otto, Michael J.; Furman, Phillip A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7202-7218</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) is a global health problem requiring novel approaches for effective treatment of this disease.  The HCV NS5B polymerase has been demonstrated to be a viable target for the development of HCV therapies.  β-D-2'-Deoxy-2'-α-fluoro-2'-β-C-Me nucleosides are selective inhibitors of the HCV NS5B polymerase and have demonstrated potent activity in the clinic.  Phosphoramidate prodrugs of the 5'-phosphate deriv. of the β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine nucleoside were prepd. and showed significant potency in the HCV subgenomic replicon assay (<1 μM) and produced high levels of triphosphate 6 in primary hepatocytes and in the livers of rats, dogs, and monkeys when administered in vivo.  The single diastereomer 51 of diastereomeric mixt. 14 was crystd., and an X-ray structure was detd. establishing the phosphoramidate stereochem. as Sp, thus correlating for the first time the stereochem. of a phosphoramidate prodrug with biol. activity.  51 (PSI-7977) was selected as a clin. development candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWAkLi9-odWbVg90H21EOLACvtfcHk0lhMggIMtddo0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtb%252FO&md5=33d371e557e9d70562a326f97798f45c</span></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=10.1021%2Fjm100863x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100863x%26sid%3Dliteratum%253Aachs%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DBao%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DNagaratham%26aufirst%3DD.%26aulast%3DRachakonda%26aufirst%3DS.%26aulast%3DReddy%26aufirst%3DP.%2BG.%26aulast%3DRoss%26aufirst%3DB.%2BS.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DH.-R.%26aulast%3DBansal%26aufirst%3DS.%26aulast%3DEspiritu%26aufirst%3DC.%26aulast%3DKeilman%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DSteuer%26aufirst%3DH.%2BM.%2BM.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DDiscovery%2520of%2520a%2520%25CE%25B2-d-2%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-%25CE%25B1-fluoro-2%25E2%2580%25B2-%25CE%25B2-C-methyluridine%2520nucleotide%2520prodrug%2520%2528PSI-7977%2529%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7202%26epage%3D7218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madela, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aljarah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernachio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorovits, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganguly, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolykhalov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muhammad, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patti, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, G.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of a novel double prodrug: INX-08189. A new clinical candidate for hepatitis C virus</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4850</span><span class="NLM_x">–</span> <span class="NLM_lpage">4854</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4850-4854&author=C.+McGuiganauthor=K.+Madelaauthor=M.+Aljarahauthor=A.+Gillesauthor=A.+Brancaleauthor=N.+Zontaauthor=S.+Chamberlainauthor=J.+Vernachioauthor=J.+Hutchinsauthor=A.+Hallauthor=B.+Amesauthor=E.+Gorovitsauthor=B.+Gangulyauthor=A.+Kolykhalovauthor=J.+Wangauthor=J.+Muhammadauthor=J.+M.+Pattiauthor=G.+Henson&title=Design%2C+synthesis+and+evaluation+of+a+novel+double+prodrug%3A+INX-08189.+A+new+clinical+candidate+for+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DMadela%26aufirst%3DK.%26aulast%3DAljarah%26aufirst%3DM.%26aulast%3DGilles%26aufirst%3DA.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DZonta%26aufirst%3DN.%26aulast%3DChamberlain%26aufirst%3DS.%26aulast%3DVernachio%26aufirst%3DJ.%26aulast%3DHutchins%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DA.%26aulast%3DAmes%26aufirst%3DB.%26aulast%3DGorovits%26aufirst%3DE.%26aulast%3DGanguly%26aufirst%3DB.%26aulast%3DKolykhalov%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMuhammad%26aufirst%3DJ.%26aulast%3DPatti%26aufirst%3DJ.%2BM.%26aulast%3DHenson%26aufirst%3DG.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520a%2520novel%2520double%2520prodrug%253A%2520INX-08189.%2520A%2520new%2520clinical%2520candidate%2520for%2520hepatitis%2520C%2520virus%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4850%26epage%3D4854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kadow, J. F.; Gentles, R.; Ding, M.; Bender, J.; Bergstrom, C.; Grant-Young, K.; Hewawasam, P.; Hudyma, T.; Martin, S.; Nickel, A.; Regueiro-Ren, A.; Tu, Y.; Yang, Z.; Yeung, K.-S.; Zheng, X.; Chen, B.-C.; Chao, S.; Sun, J.-H.; Li, J.; Mathur, A.; Smith, D.; Wu, D.-R.; Beno, B.; Hanumegowda, U.; Knipe, J.; Parker, D. D.; Zhuo, X.; Lemm, J.; Liu, M.; Pelosi, L.; Rigat, K.; Voss, S.; Wang; Y.; Wang, Y.-K.; Colonno, R.; Gao, M.; Roberts, S. B.; Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Discovery of BMS-791325, an Allosteric NS5B Replicase Inhibitor for the Treatment of Hepatitis C</span>. Presented at the 243rd National Meeting of the American Chemical Society, San Diego, CA, March 25–29, 2012; MEDI-23.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kadow%2C+J.+F.%3B+Gentles%2C+R.%3B+Ding%2C+M.%3B+Bender%2C+J.%3B+Bergstrom%2C+C.%3B+Grant-Young%2C+K.%3B+Hewawasam%2C+P.%3B+Hudyma%2C+T.%3B+Martin%2C+S.%3B+Nickel%2C+A.%3B+Regueiro-Ren%2C+A.%3B+Tu%2C+Y.%3B+Yang%2C+Z.%3B+Yeung%2C+K.-S.%3B+Zheng%2C+X.%3B+Chen%2C+B.-C.%3B+Chao%2C+S.%3B+Sun%2C+J.-H.%3B+Li%2C+J.%3B+Mathur%2C+A.%3B+Smith%2C+D.%3B+Wu%2C+D.-R.%3B+Beno%2C+B.%3B+Hanumegowda%2C+U.%3B+Knipe%2C+J.%3B+Parker%2C+D.+D.%3B+Zhuo%2C+X.%3B+Lemm%2C+J.%3B+Liu%2C+M.%3B+Pelosi%2C+L.%3B+Rigat%2C+K.%3B+Voss%2C+S.%3B+Wang%3B+Y.%3B+Wang%2C+Y.-K.%3B+Colonno%2C+R.%3B+Gao%2C+M.%3B+Roberts%2C+S.+B.%3B+Meanwell%2C+N.+A.+Discovery+of+BMS-791325%2C+an+Allosteric+NS5B+Replicase+Inhibitor+for+the+Treatment+of+Hepatitis+C.+Presented+at+the+243rd+National+Meeting+of+the+American+Chemical+Society%2C+San+Diego%2C+CA%2C+March+25%E2%80%9329%2C+2012%3B+MEDI-23."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26atitle%3DDiscovery%2520of%2520BMS-791325%252C%2520an%2520Allosteric%2520NS5B%2520Replicase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Vendeville, S.; Lin, T.-I.; Hu, L.; Tahn, A.; MgGowan, D.; Cummings, M. D.; Amssoms, K.; Last, S.; Devogelaere, B.; Rouan, M.-C.; Vigen, L.; Berke, J. M.; Dehertogh, P.; Fransen, E.; Cleiren, E.; van der Heim, L.; Fanning, G.; Van Emeien, K.; Nyanguile, O.; Simmen, K.; Raboisson, P.</span><span> </span><span class="NLM_article-title">Discovery of the Clinical Candidate TMC 647055, a Non-Nucleoside Inhibitor of the Hepatitis C Virus NS5B Polymerase</span>. Presented at the 18th International Symposium on Hepatitis C Virus and Related Viruses, Seattle, WA, Sept 8–12, 2011; Abstract P1.33.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Vendeville%2C+S.%3B+Lin%2C+T.-I.%3B+Hu%2C+L.%3B+Tahn%2C+A.%3B+MgGowan%2C+D.%3B+Cummings%2C+M.+D.%3B+Amssoms%2C+K.%3B+Last%2C+S.%3B+Devogelaere%2C+B.%3B+Rouan%2C+M.-C.%3B+Vigen%2C+L.%3B+Berke%2C+J.+M.%3B+Dehertogh%2C+P.%3B+Fransen%2C+E.%3B+Cleiren%2C+E.%3B+van+der+Heim%2C+L.%3B+Fanning%2C+G.%3B+Van+Emeien%2C+K.%3B+Nyanguile%2C+O.%3B+Simmen%2C+K.%3B+Raboisson%2C+P.+Discovery+of+the+Clinical+Candidate+TMC+647055%2C+a+Non-Nucleoside+Inhibitor+of+the+Hepatitis+C+Virus+NS5B+Polymerase.+Presented+at+the+18th+International+Symposium+on+Hepatitis+C+Virus+and+Related+Viruses%2C+Seattle%2C+WA%2C+Sept+8%E2%80%9312%2C+2011%3B+Abstract+P1.33."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DVendeville%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520the%2520Clinical%2520Candidate%2520TMC%2520647055%252C%2520a%2520Non-Nucleoside%2520Inhibitor%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS5B%2520Polymerase" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Rosario, M.; Chauret, N.; George, S.; Kieffer, T. L.; Koziel, M. J.; Nicolas, O.; Proulx, L.</span><span> </span><span class="NLM_article-title">Therapies for Treating Hepatitis C Virus Infection</span>. Patent WO 2011/094489, August 4,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=M.+Rosario&author=N.+Chauret&author=S.+George&author=T.+L.+Kieffer&author=M.+J.+Koziel&author=O.+Nicolas&author=L.+Proulx&title=Therapies+for+Treating+Hepatitis+C+Virus+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRosario%26aufirst%3DM.%26atitle%3DTherapies%2520for%2520Treating%2520Hepatitis%2520C%2520Virus%2520Infection%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatlock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludlum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drowns, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahavendran, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skor, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlihy, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parge, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span> </span><span class="NLM_article-title">Discovery of (<i>R</i>)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5,<i>a</i>]-pyrimidin-2-yl)methyl-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1255</span><span class="NLM_x">–</span> <span class="NLM_lpage">1258</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8014537" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1255-1258&author=H.+Liauthor=J.+Tatlockauthor=A.+Lintonauthor=J.+Gonzalezauthor=T.+Jewellauthor=L.+Patelauthor=S.+Ludlumauthor=M.+Drownsauthor=S.+V.+Rahavendranauthor=H.+Skorauthor=R.+Hunterauthor=S.+T.+Shiauthor=K.+J.+Herlihyauthor=H.+Pargeauthor=M.+Hickeyauthor=X.+Yuauthor=F.+Chauauthor=J.+Nonomiyaauthor=C.+Lewis&title=Discovery+of+%28R%29-6-cyclopentyl-6-%282-%282%2C6-diethylpyridin-4-yl%29ethyl%29-3-%28%285%2C7-dimethyl-%5B1%2C2%2C4%5Dtriazolo%5B1%2C5%2Ca%5D-pyrimidin-2-yl%29methyl-4-hydroxy-5%2C6-dihydropyran-2-one+%28PF-00868554%29+as+a+potent+and+orally+available+hepatitis+C+virus+polymerase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24h&amp;dbid=16384&amp;doi=10.1021%2Fjm8014537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8014537%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DTatlock%26aufirst%3DJ.%26aulast%3DLinton%26aufirst%3DA.%26aulast%3DGonzalez%26aufirst%3DJ.%26aulast%3DJewell%26aufirst%3DT.%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DLudlum%26aufirst%3DS.%26aulast%3DDrowns%26aufirst%3DM.%26aulast%3DRahavendran%26aufirst%3DS.%2BV.%26aulast%3DSkor%26aufirst%3DH.%26aulast%3DHunter%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DS.%2BT.%26aulast%3DHerlihy%26aufirst%3DK.%2BJ.%26aulast%3DParge%26aufirst%3DH.%26aulast%3DHickey%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DChau%26aufirst%3DF.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520%2528R%2529-6-cyclopentyl-6-%25282-%25282%252C6-diethylpyridin-4-yl%2529ethyl%2529-3-%2528%25285%252C7-dimethyl-%255B1%252C2%252C4%255Dtriazolo%255B1%252C5%252Ca%255D-pyrimidin-2-yl%2529methyl-4-hydroxy-5%252C6-dihydropyran-2-one%2520%2528PF-00868554%2529%2520as%2520a%2520potent%2520and%2520orally%2520available%2520hepatitis%2520C%2520virus%2520polymerase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1255%26epage%3D1258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Tran, C. V.; Ruebsam, F.; Murphy, D. E.; Dragovich, P.; Zhou, Y.; Chen, L.; Kuccera, D.</span><span> </span><span class="NLM_article-title">5,6-Dihydro-1<i>H</i>-pyridin-2-one compounds</span>. Patent 7,939,524, May 10,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">, </span>(see also <a href="http://www.ama-assn.org/resources/doc/usan/lomibuvir.pdf" class="extLink">www.ama-assn.org/resources/doc/usan/lomibuvir.pdf</a>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=C.+V.+Tran&author=F.+Ruebsam&author=D.+E.+Murphy&author=P.+Dragovich&author=Y.+Zhou&author=L.+Chen&author=D.+Kuccera&title=5%2C6-Dihydro-1H-pyridin-2-one+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DC.%2BV.%26atitle%3D5%252C6-Dihydro-1H-pyridin-2-one%2520compounds%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellerin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thauvette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Specific inhibitors of HCV polymerase identified using a NS5B with lower affinity for template/primer substrate</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=422-431&author=G.+McKercherauthor=P.+L.+Beaulieuauthor=D.+Lamarreauthor=S.+LaPlanteauthor=S.+Lefebvreauthor=C.+Pellerinauthor=L.+Thauvetteauthor=G.+Kukolj&title=Specific+inhibitors+of+HCV+polymerase+identified+using+a+NS5B+with+lower+affinity+for+template%2Fprimer+substrate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DLaPlante%26aufirst%3DS.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DPellerin%26aufirst%3DC.%26aulast%3DThauvette%26aufirst%3DL.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DSpecific%2520inhibitors%2520of%2520HCV%2520polymerase%2520identified%2520using%2520a%2520NS5B%2520with%2520lower%2520affinity%2520for%2520template%252Fprimer%2520substrate%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2004%26volume%3D32%26spage%3D422%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bös, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellerin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=119-124&author=P.+L.+Beaulieuauthor=M.+B%C3%B6sauthor=Y.+Bousquetauthor=G.+Fazalauthor=J.+Gauthierauthor=J.+Gillardauthor=S.+Gouletauthor=S.+LaPlanteauthor=M.-A.+Poupartauthor=S.+Lefebvreauthor=G.+McKercherauthor=C.+Pellerinauthor=V.+Austelauthor=G.+Kukolj&title=Non-nucleoside+inhibitors+of+the+hepatitis+C+virus+NS5B+polymerase%3A+discovery+and+preliminary+SAR+of+benzimidazole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DB%25C3%25B6s%26aufirst%3DM.%26aulast%3DBousquet%26aufirst%3DY.%26aulast%3DFazal%26aufirst%3DG.%26aulast%3DGauthier%26aufirst%3DJ.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DLaPlante%26aufirst%3DS.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DPellerin%26aufirst%3DC.%26aulast%3DAustel%26aufirst%3DV.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DNon-nucleoside%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%253A%2520discovery%2520and%2520preliminary%2520SAR%2520of%2520benzimidazole%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D119%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Finger loop inhibitors of the HCV NS5B polymerase: discovery and prospects for new HCV therapy</span> <span class="citation_source-journal">Cur. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">626</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=17002222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsFKnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=618-626&author=P.+L.+Beaulieu&title=Finger+loop+inhibitors+of+the+HCV+NS5B+polymerase%3A+discovery+and+prospects+for+new+HCV+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25cR"><div class="casContent"><span class="casTitleNuber">25c</span><div class="casTitle"><span class="NLM_cas:atitle">Finger loop inhibitors of the HCV NS5B polymerase: discovery and prospects for new HCV therapy</span></div><div class="casAuthors">Beaulieu, Pierre L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">618-626</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  The hepatitis C virus (HCV) infects millions of people worldwide and currently available therapies suffer from limited efficacy and severe side effects.  This review describes the discovery of a novel class of non-nucleoside HCV non-structural protein 5B (NS5B) polymerase inhibitors that inhibit the replication of viral RNA by binding to an allosteric site on the enzyme.  Initial lead compds. based on a benzimidazole scaffold were optimized yielding novel indole derivs. with sub-micromolar activity in a cell-based replicon assay.  X-ray crystallog. studies suggest that inhibitor binding interferes with the conformational movements of the protein that are necessary for enzyme activity.  Finger loop inhibitors of HCV NS5B show potential for the development of novel anti-HCV therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs1lsx4pWbFbVg90H21EOLACvtfcHk0lgRgGwbymOFYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsFKnur8%253D&md5=a4ad9761721b5f8078d39484850b0c3d</span></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DFinger%2520loop%2520inhibitors%2520of%2520the%2520HCV%2520NS5B%2520polymerase%253A%2520discovery%2520and%2520prospects%2520for%2520new%2520HCV%2520therapy%26jtitle%3DCur.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D9%26spage%3D618%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Hirashima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noji, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, H.</span><span> </span><span class="NLM_article-title">Benzimidazole derivatives bearing substituted biphenyls as hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors: structure–activity relationship studies and identification of a potent and highly selective inhibitor JTK-109</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4721</span><span class="NLM_x">–</span> <span class="NLM_lpage">4736</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060269e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4721-4736&author=S.+Hirashimaauthor=T.+Suzukiauthor=T.+Ishidaauthor=S.+Nojiauthor=S.+Yataauthor=I.+Andoauthor=M.+Komatsuauthor=S.+Ikedaauthor=H.+Hashimoto&title=Benzimidazole+derivatives+bearing+substituted+biphenyls+as+hepatitis+C+virus+NS5B+RNA-dependent+RNA+polymerase+inhibitors%3A+structure%E2%80%93activity+relationship+studies+and+identification+of+a+potent+and+highly+selective+inhibitor+JTK-109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25d&amp;dbid=16384&amp;doi=10.1021%2Fjm060269e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060269e%26sid%3Dliteratum%253Aachs%26aulast%3DHirashima%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DIshida%26aufirst%3DT.%26aulast%3DNoji%26aufirst%3DS.%26aulast%3DYata%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DI.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DH.%26atitle%3DBenzimidazole%2520derivatives%2520bearing%2520substituted%2520biphenyls%2520as%2520hepatitis%2520C%2520virus%2520NS5B%2520RNA-dependent%2520RNA%2520polymerase%2520inhibitors%253A%2520structure%25E2%2580%2593activity%2520relationship%2520studies%2520and%2520identification%2520of%2520a%2520potent%2520and%2520highly%2520selective%2520inhibitor%2520JTK-109%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4721%26epage%3D4736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Narjes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescenzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colarusso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Rosario, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stansfield, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conte, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ercolani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaramella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palumbi, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meuleman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux-Roels, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baiocco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span> </span><span class="NLM_article-title">Discovery of (7<i>R</i>)-14-cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl)amino}-7,8-dihydro-6<i>H</i>-indolo[1,2-<i>e</i>][1,5]benzoxazocine-1-carboxylic acid (MK-3281), a potent and orally bioavailable finger-loop inhibitor of the hepatitis C virus NS5B polymerase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013105" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=289-301&author=F.+Narjesauthor=B.+Crescenziauthor=M.+Ferraraauthor=J.+Habermannauthor=S.+Colarussoauthor=M.+del+Rosarioauthor=R.+Ferreiraauthor=I.+Stansfieldauthor=A.+C.+Mackayauthor=I.+Conteauthor=C.+Ercolaniauthor=S.+Zaramellaauthor=M.-C.+Palumbiauthor=P.+Meulemanauthor=G.+Leroux-Roelsauthor=C.+Guilianoauthor=F.+Fioreauthor=S.+Di+Marcoauthor=P.+Baioccoauthor=U.+Kochauthor=G.+Migliaccioauthor=S.+Altamuraauthor=R.+Lauferauthor=R.+De+Francescoauthor=M.+Rowley&title=Discovery+of+%287R%29-14-cyclohexyl-7-%7B%5B2-%28dimethylamino%29ethyl%5D%28methyl%29amino%7D-7%2C8-dihydro-6H-indolo%5B1%2C2-e%5D%5B1%2C5%5Dbenzoxazocine-1-carboxylic+acid+%28MK-3281%29%2C+a+potent+and+orally+bioavailable+finger-loop+inhibitor+of+the+hepatitis+C+virus+NS5B+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25e&amp;dbid=16384&amp;doi=10.1021%2Fjm1013105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013105%26sid%3Dliteratum%253Aachs%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DHabermann%26aufirst%3DJ.%26aulast%3DColarusso%26aufirst%3DS.%26aulast%3Ddel%2BRosario%26aufirst%3DM.%26aulast%3DFerreira%26aufirst%3DR.%26aulast%3DStansfield%26aufirst%3DI.%26aulast%3DMackay%26aufirst%3DA.%2BC.%26aulast%3DConte%26aufirst%3DI.%26aulast%3DErcolani%26aufirst%3DC.%26aulast%3DZaramella%26aufirst%3DS.%26aulast%3DPalumbi%26aufirst%3DM.-C.%26aulast%3DMeuleman%26aufirst%3DP.%26aulast%3DLeroux-Roels%26aufirst%3DG.%26aulast%3DGuiliano%26aufirst%3DC.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DDi%2BMarco%26aufirst%3DS.%26aulast%3DBaiocco%26aufirst%3DP.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DMigliaccio%26aufirst%3DG.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DRowley%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520%25287R%2529-14-cyclohexyl-7-%257B%255B2-%2528dimethylamino%2529ethyl%255D%2528methyl%2529amino%257D-7%252C8-dihydro-6H-indolo%255B1%252C2-e%255D%255B1%252C5%255Dbenzoxazocine-1-carboxylic%2520acid%2520%2528MK-3281%2529%252C%2520a%2520potent%2520and%2520orally%2520bioavailable%2520finger-loop%2520inhibitor%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D289%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudyma, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poss, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadow, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camac, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheriff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beno, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigat, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridell, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voss, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelosi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentles, R. G.</span><span> </span><span class="NLM_article-title">Syntheses and intitial evaluation of a series of indolo-fused heterocyclic inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virus</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2925</span><span class="NLM_x">–</span> <span class="NLM_lpage">2929</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2925-2929&author=X.+Zhengauthor=T.+W.+Hudymaauthor=S.+W.+Martinauthor=C.+Bergstromauthor=M.+Dingauthor=F.+Heauthor=J.+Romineauthor=M.+A.+Possauthor=J.+F.+Kadowauthor=C.-H.+Changauthor=J.+Wanauthor=M.+R.+Witmerauthor=P.+Morinauthor=D.+M.+Camacauthor=S.+Sheriffauthor=B.+R.+Benoauthor=K.+L.+Rigatauthor=Y.-K.+Wangauthor=F.+Fridellauthor=J.+Lemmauthor=D.+Qiuauthor=M.+Liuauthor=S.+Vossauthor=L.+Pelosiauthor=S.+B.+Robertsauthor=M.+Gaoauthor=J.+Knipeauthor=R.+G.+Gentles&title=Syntheses+and+intitial+evaluation+of+a+series+of+indolo-fused+heterocyclic+inhibitors+of+the+polymerase+enzyme+%28NS5B%29+of+the+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DHudyma%26aufirst%3DT.%2BW.%26aulast%3DMartin%26aufirst%3DS.%2BW.%26aulast%3DBergstrom%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DRomine%26aufirst%3DJ.%26aulast%3DPoss%26aufirst%3DM.%2BA.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26aulast%3DChang%26aufirst%3DC.-H.%26aulast%3DWan%26aufirst%3DJ.%26aulast%3DWitmer%26aufirst%3DM.%2BR.%26aulast%3DMorin%26aufirst%3DP.%26aulast%3DCamac%26aufirst%3DD.%2BM.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DRigat%26aufirst%3DK.%2BL.%26aulast%3DWang%26aufirst%3DY.-K.%26aulast%3DFridell%26aufirst%3DF.%26aulast%3DLemm%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DVoss%26aufirst%3DS.%26aulast%3DPelosi%26aufirst%3DL.%26aulast%3DRoberts%26aufirst%3DS.%2BB.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DKnipe%26aufirst%3DJ.%26aulast%3DGentles%26aufirst%3DR.%2BG.%26atitle%3DSyntheses%2520and%2520intitial%2520evaluation%2520of%2520a%2520series%2520of%2520indolo-fused%2520heterocyclic%2520inhibitors%2520of%2520the%2520polymerase%2520enzyme%2520%2528NS5B%2529%2520of%2520the%2520hepatitis%2520C%2520virus%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2925%26epage%3D2929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bös, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeRoy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valois, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">971</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=967-971&author=P.+L.+Beaulieuauthor=M.+B%C3%B6sauthor=Y.+Bousquetauthor=P.+DeRoyauthor=G.+Fazalauthor=J.+Gauthierauthor=J.+Gillardauthor=S.+Gouletauthor=G.+McKercherauthor=M.-A.+Poupartauthor=S.+Valoisauthor=G.+Kukolj&title=Non-nucleoside+inhibitors+of+the+hepatitis+C+virus+NS5B+polymerase%3A+discovery+of+benzimidazole+5-carboxylic+amide+derivatives+with+low-nanomolar+potency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DB%25C3%25B6s%26aufirst%3DM.%26aulast%3DBousquet%26aufirst%3DY.%26aulast%3DDeRoy%26aufirst%3DP.%26aulast%3DFazal%26aufirst%3DG.%26aulast%3DGauthier%26aufirst%3DJ.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DValois%26aufirst%3DS.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DNon-nucleoside%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%253A%2520discovery%2520of%2520benzimidazole%25205-carboxylic%2520amide%2520derivatives%2520with%2520low-nanomolar%2520potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D967%26epage%3D971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellerin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valois, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Non-nucleoside benzimidazole-based allosteric inhibitors of the hepatitis C virus NS5B polymerase: inhibition of subgenomic hepatitis C virus RNA replicons in Huh-7 cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6884</span><span class="NLM_x">–</span> <span class="NLM_lpage">6892</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040134d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6884-6892&author=P.+L.+Beaulieuauthor=Y.+Bousquetauthor=J.+Gauthierauthor=J.+Gillardauthor=M.+Marquisauthor=G.+McKercherauthor=C.+Pellerinauthor=S.+Valoisauthor=G.+Kukolj&title=Non-nucleoside+benzimidazole-based+allosteric+inhibitors+of+the+hepatitis+C+virus+NS5B+polymerase%3A+inhibition+of+subgenomic+hepatitis+C+virus+RNA+replicons+in+Huh-7+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1021%2Fjm040134d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040134d%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DBousquet%26aufirst%3DY.%26aulast%3DGauthier%26aufirst%3DJ.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DMarquis%26aufirst%3DM.%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DPellerin%26aufirst%3DC.%26aulast%3DValois%26aufirst%3DS.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DNon-nucleoside%2520benzimidazole-based%2520allosteric%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%253A%2520inhibition%2520of%2520subgenomic%2520hepatitis%2520C%2520virus%2520RNA%2520replicons%2520in%2520Huh-7%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6884%26epage%3D6892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakalian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubry, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferland, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Binding mode determination of benzimidazole inhibitors of the hepatitis C virus RNA polymerase by a structure and dynamics startegy</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4306</span><span class="NLM_x">–</span> <span class="NLM_lpage">4311</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=4306-4311&author=S.+R.+LaPlanteauthor=A.+Jakalianauthor=N.+Aubryauthor=Y.+Bousquetauthor=J.-M.+Ferlandauthor=J.+Gillardauthor=S.+Lefebvreauthor=M.+Poirierauthor=Y.+S.+Tsantrizosauthor=G.+Kukoljauthor=P.+L.+Beaulieu&title=Binding+mode+determination+of+benzimidazole+inhibitors+of+the+hepatitis+C+virus+RNA+polymerase+by+a+structure+and+dynamics+startegy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DJakalian%26aufirst%3DA.%26aulast%3DAubry%26aufirst%3DN.%26aulast%3DBousquet%26aufirst%3DY.%26aulast%3DFerland%26aufirst%3DJ.-M.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DBinding%2520mode%2520determination%2520of%2520benzimidazole%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520RNA%2520polymerase%2520by%2520a%2520structure%2520and%2520dynamics%2520startegy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2004%26volume%3D43%26spage%3D4306%26epage%3D4311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Discovery of benzimidazole-diamide finger loop (thumb pocket 1) allosteric inhibitors of HCV NS5B polymerase: implementing parallel synthesis for rapid linker optimization</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=196-200&author=S.+Gouletauthor=M.-A.+Poupartauthor=J.+Gillardauthor=M.+Poirierauthor=G.+Kukoljauthor=P.+L.+Beaulieu&title=Discovery+of+benzimidazole-diamide+finger+loop+%28thumb+pocket+1%29+allosteric+inhibitors+of+HCV+NS5B+polymerase%3A+implementing+parallel+synthesis+for+rapid+linker+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DDiscovery%2520of%2520benzimidazole-diamide%2520finger%2520loop%2520%2528thumb%2520pocket%25201%2529%2520allosteric%2520inhibitors%2520of%2520HCV%2520NS5B%2520polymerase%253A%2520implementing%2520parallel%2520synthesis%2520for%2520rapid%2520linker%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D196%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGibbon, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefèbvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thauvette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Binding site characterization and resistance to a class of non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">39260</span><span class="NLM_x">–</span> <span class="NLM_lpage">39267</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=39260-39267&author=G.+Kukoljauthor=G.+A.+McGibbonauthor=G.+McKercherauthor=M.+Marquisauthor=S.+Lef%C3%A8bvreauthor=L.+Thauvetteauthor=J.+Gauthierauthor=S.+Gouletauthor=M.-A.+Poupartauthor=P.+L.+Beaulieu&title=Binding+site+characterization+and+resistance+to+a+class+of+non-nucleoside+inhibitors+of+the+hepatitis+C+virus+NS5B+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DMcGibbon%26aufirst%3DG.%2BA.%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DMarquis%26aufirst%3DM.%26aulast%3DLef%25C3%25A8bvre%26aufirst%3DS.%26aulast%3DThauvette%26aufirst%3DL.%26aulast%3DGauthier%26aufirst%3DJ.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DBinding%2520site%2520characterization%2520and%2520resistance%2520to%2520a%2520class%2520of%2520non-nucleoside%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D39260%26epage%3D39267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolicoeur, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span> </span><span class="NLM_article-title">From benzimidazole to indole 5-carboxamide thumb pocket 1 inhibitors of HCV NS5B polymerase. Part 1: Indole C-2 SAR and discovery of diamide derivatives with nanomolar potency in cell-based subgenomic replicons</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3658</span><span class="NLM_x">–</span> <span class="NLM_lpage">3663</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3658-3663&author=P.+L.+Beaulieuauthor=J.+Gillardauthor=E.+Jolicoeurauthor=J.+Duanauthor=M.+Garneauauthor=G.+Kukoljauthor=M.-A.+Poupart&title=From+benzimidazole+to+indole+5-carboxamide+thumb+pocket+1+inhibitors+of+HCV+NS5B+polymerase.+Part+1%3A+Indole+C-2+SAR+and+discovery+of+diamide+derivatives+with+nanomolar+potency+in+cell-based+subgenomic+replicons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DJolicoeur%26aufirst%3DE.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DPoupart%26aufirst%3DM.-A.%26atitle%3DFrom%2520benzimidazole%2520to%2520indole%25205-carboxamide%2520thumb%2520pocket%25201%2520inhibitors%2520of%2520HCV%2520NS5B%2520polymerase.%2520Part%25201%253A%2520Indole%2520C-2%2520SAR%2520and%2520discovery%2520of%2520diamide%2520derivatives%2520with%2520nanomolar%2520potency%2520in%2520cell-based%2520subgenomic%2520replicons%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3658%26epage%3D3663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolicoeur, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stammers, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span> </span><span class="NLM_article-title">Indole 5-carboxamide thumb pocket 1 inhibitors of HCV NS5B polymerase with nanomolar potency in cell-based subgenomic replicons (part 2): central amino acid linker and right-hand-side SAR studies</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3664</span><span class="NLM_x">–</span> <span class="NLM_lpage">3670</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3664-3670&author=P.+L.+Beaulieuauthor=C.+Chabotauthor=J.+Duanauthor=M.+Garneauauthor=J.+Gillardauthor=E.+Jolicoeurauthor=M.+Poirierauthor=M.-A.+Poupartauthor=T.+A.+Stammersauthor=G.+Kukoljauthor=Y.+S.+Tsantrizos&title=Indole+5-carboxamide+thumb+pocket+1+inhibitors+of+HCV+NS5B+polymerase+with+nanomolar+potency+in+cell-based+subgenomic+replicons+%28part+2%29%3A+central+amino+acid+linker+and+right-hand-side+SAR+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DChabot%26aufirst%3DC.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DJolicoeur%26aufirst%3DE.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DStammers%26aufirst%3DT.%2BA.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26atitle%3DIndole%25205-carboxamide%2520thumb%2520pocket%25201%2520inhibitors%2520of%2520HCV%2520NS5B%2520polymerase%2520with%2520nanomolar%2520potency%2520in%2520cell-based%2520subgenomic%2520replicons%2520%2528part%25202%2529%253A%2520central%2520amino%2520acid%2520linker%2520and%2520right-hand-side%2520SAR%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3664%26epage%3D3670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakalian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubry, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulombe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brochu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Importance of ligand bioactive conformation in the discovery of potent indole-diamide inhibitors of the hepatitis C virus NS5B</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">15204</span><span class="NLM_x">–</span> <span class="NLM_lpage">15212</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja101358s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=15204-15212&author=S.+R.+LaPlanteauthor=J.+R.+Gillardauthor=A.+Jakalianauthor=N.+Aubryauthor=R.+Coulombeauthor=C.+Brochuauthor=Y.+S.+Tsantrizosauthor=M.+Poirierauthor=G.+Kukoljauthor=P.+L.+Beaulieu&title=Importance+of+ligand+bioactive+conformation+in+the+discovery+of+potent+indole-diamide+inhibitors+of+the+hepatitis+C+virus+NS5B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28c&amp;dbid=16384&amp;doi=10.1021%2Fja101358s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja101358s%26sid%3Dliteratum%253Aachs%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DGillard%26aufirst%3DJ.%2BR.%26aulast%3DJakalian%26aufirst%3DA.%26aulast%3DAubry%26aufirst%3DN.%26aulast%3DCoulombe%26aufirst%3DR.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DImportance%2520of%2520ligand%2520bioactive%2520conformation%2520in%2520the%2520discovery%2520of%2520potent%2520indole-diamide%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D15204%26epage%3D15212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Erhardt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forns, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pol, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calleja, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spangenberg, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Samaniego, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enriquez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiegand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nehmiz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffgen, J.</span><span> </span><span class="NLM_article-title">Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment</span> <span class="citation_source-journal">Antiviral Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=23-32&author=A.+Erhardtauthor=K.+Deterdingauthor=Y.+Benhamouauthor=M.+Reiserauthor=X.+Fornsauthor=S.+Polauthor=J.+L.+Callejaauthor=S.+Rossauthor=H.+C.+Spangenbergauthor=J.+Garcia-Samaniegoauthor=M.+Fuchsauthor=J.+Enriquezauthor=J.+Wiegandauthor=J.+Sternauthor=K.+Wuauthor=G.+Kukoljauthor=M.+Marquisauthor=P.+Beaulieuauthor=G.+Nehmizauthor=J.+Steffgen&title=Safety%2C+pharmacokinetics+and+antiviral+effect+of+BILB+1941%2C+a+novel+hepatitis+C+virus+RNA+polymerase+inhibitor%2C+after+5+days+oral+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DErhardt%26aufirst%3DA.%26aulast%3DDeterding%26aufirst%3DK.%26aulast%3DBenhamou%26aufirst%3DY.%26aulast%3DReiser%26aufirst%3DM.%26aulast%3DForns%26aufirst%3DX.%26aulast%3DPol%26aufirst%3DS.%26aulast%3DCalleja%26aufirst%3DJ.%2BL.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DSpangenberg%26aufirst%3DH.%2BC.%26aulast%3DGarcia-Samaniego%26aufirst%3DJ.%26aulast%3DFuchs%26aufirst%3DM.%26aulast%3DEnriquez%26aufirst%3DJ.%26aulast%3DWiegand%26aufirst%3DJ.%26aulast%3DStern%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DK.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DMarquis%26aufirst%3DM.%26aulast%3DBeaulieu%26aufirst%3DP.%26aulast%3DNehmiz%26aufirst%3DG.%26aulast%3DSteffgen%26aufirst%3DJ.%26atitle%3DSafety%252C%2520pharmacokinetics%2520and%2520antiviral%2520effect%2520of%2520BILB%25201941%252C%2520a%2520novel%2520hepatitis%2520C%2520virus%2520RNA%2520polymerase%2520inhibitor%252C%2520after%25205%2520days%2520oral%2520treatment%26jtitle%3DAntiviral%2520Ther.%26date%3D2009%26volume%3D14%26spage%3D23%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bykowski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brochu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansereau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duceppe, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haché, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakalian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacé, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perreault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stammers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thauvette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warrington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Improved replicon cellular activity of non-nucleoside allosteric inhibitors of HCV NS5B polymerase: from benzimidazole to indole scaffolds</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4987</span><span class="NLM_x">–</span> <span class="NLM_lpage">4993</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4987-4993&author=P.+L.+Beaulieuauthor=J.+Gillardauthor=D.+Bykowskiauthor=C.+Brochuauthor=N.+Dansereauauthor=J.-S.+Duceppeauthor=B.+Hach%C3%A9author=A.+Jakalianauthor=L.+Lagac%C3%A9author=S.+LaPlanteauthor=G.+McKercherauthor=E.+Moreauauthor=S.+Perreaultauthor=T.+Stammersauthor=L.+Thauvetteauthor=J.+Warringtonauthor=G.+Kukolj&title=Improved+replicon+cellular+activity+of+non-nucleoside+allosteric+inhibitors+of+HCV+NS5B+polymerase%3A+from+benzimidazole+to+indole+scaffolds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DBykowski%26aufirst%3DD.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DDansereau%26aufirst%3DN.%26aulast%3DDuceppe%26aufirst%3DJ.-S.%26aulast%3DHach%25C3%25A9%26aufirst%3DB.%26aulast%3DJakalian%26aufirst%3DA.%26aulast%3DLagac%25C3%25A9%26aufirst%3DL.%26aulast%3DLaPlante%26aufirst%3DS.%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DMoreau%26aufirst%3DE.%26aulast%3DPerreault%26aufirst%3DS.%26aulast%3DStammers%26aufirst%3DT.%26aulast%3DThauvette%26aufirst%3DL.%26aulast%3DWarrington%26aufirst%3DJ.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DImproved%2520replicon%2520cellular%2520activity%2520of%2520non-nucleoside%2520allosteric%2520inhibitors%2520of%2520HCV%2520NS5B%2520polymerase%253A%2520from%2520benzimidazole%2520to%2520indole%2520scaffolds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4987%26epage%3D4993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vernin, G.</span> In  <span class="citation_source-book">Thiazole and Its Derivatives</span>; <span class="NLM_contrib-group">Metzger, J. V.</span>, Ed.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1979</span><span class="NLM_x">; </span>Part 1, Chapter 2.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1979&author=G.+Verninauthor=J.+V.+Metzger&title=Thiazole+and+Its+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DVernin%26aufirst%3DG.%26btitle%3DThiazole%2520and%2520Its%2520Derivatives%26aulast%3DMetzger%26aufirst%3DJ.%2BV.%26pub%3DWiley%26date%3D1979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Paik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, T. H.</span><span> </span><span class="NLM_article-title">A facile synthesis of (−)-cucurbitine</span> <span class="citation_source-journal">Bull. Korean Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BD3cXpslGltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=131-132&author=S.+Paikauthor=H.+S.+Kwakauthor=T.+H.+Park&title=A+facile+synthesis+of+%28%E2%88%92%29-cucurbitine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A facile synthesis of (-)-cucurbitine</span></div><div class="casAuthors">Paik, Seunguk; Kwak, Hyung Sub; Park, Tae Ho</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the Korean Chemical Society</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">131-132</span>CODEN:
                <span class="NLM_cas:coden">BKCSDE</span>;
        ISSN:<span class="NLM_cas:issn">0253-2964</span>.
    
            (<span class="NLM_cas:orgname">Korean Chemical Society</span>)
        </div><div class="casAbstract">A practical stereoselective synthesis of cucurbitine is reported which uses trans-4-hydroxy-L-proline as chiral template, the Bucherer-Bergs reaction for the prepn. of the diastereoselective spirohydantoin of 4-oxoprolinate and selective decarboxylation of the proline unit.  The free amino and carboxylic groups of α-amino acid chains are essential for decarboxylation of intermediate spiroproline, which gives the pyrrolidine HCl salt (65%).  Hydrolysis of pyrrolidine hydrochloride provided synthetic (-)-cucurbitine (60% after ion chromatog.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxV1HWKUCqSLVg90H21EOLACvtfcHk0ljsHt9kO6OuFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXpslGltw%253D%253D&md5=29bb35cb69aea0e217c8af39b5c8f1e1</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaik%26aufirst%3DS.%26aulast%3DKwak%26aufirst%3DH.%2BS.%26aulast%3DPark%26aufirst%3DT.%2BH.%26atitle%3DA%2520facile%2520synthesis%2520of%2520%2528%25E2%2588%2592%2529-cucurbitine%26jtitle%3DBull.%2520Korean%2520Chem.%2520Soc.%26date%3D2000%26volume%3D21%26spage%3D131%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Rorrer, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connors, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. W.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uffelman, E. S.</span><span> </span><span class="NLM_article-title">A convenient new route to tetradentate and pentadentate macrocyclic tetraamide ligands</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1157</span><span class="NLM_x">–</span> <span class="NLM_lpage">1159</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol990155f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=1157-1159&author=L.+C.+Rorrerauthor=S.+D.+Hopkinsauthor=M.+K.+Connorsauthor=D.+W.+Leeauthor=M.+V.+Smithauthor=H.+J.+Rhodesauthor=E.+S.+Uffelman&title=A+convenient+new+route+to+tetradentate+and+pentadentate+macrocyclic+tetraamide+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fol990155f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol990155f%26sid%3Dliteratum%253Aachs%26aulast%3DRorrer%26aufirst%3DL.%2BC.%26aulast%3DHopkins%26aufirst%3DS.%2BD.%26aulast%3DConnors%26aufirst%3DM.%2BK.%26aulast%3DLee%26aufirst%3DD.%2BW.%26aulast%3DSmith%26aufirst%3DM.%2BV.%26aulast%3DRhodes%26aufirst%3DH.%2BJ.%26aulast%3DUffelman%26aufirst%3DE.%2BS.%26atitle%3DA%2520convenient%2520new%2520route%2520to%2520tetradentate%2520and%2520pentadentate%2520macrocyclic%2520tetraamide%2520ligands%26jtitle%3DOrg.%2520Lett.%26date%3D1999%26volume%3D1%26spage%3D1157%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Beaulieu, P. L.; Fazal, G.; Goulet, S.; Kukolj, G.; Poirier, M.; Tsantrizos, Y.; Jolicoeur, E.; Gillard, J.; Poupart, M.-A.; Rancourt, J.</span> Patent WO 03/010141,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Beaulieu%2C+P.+L.%3B+Fazal%2C+G.%3B+Goulet%2C+S.%3B+Kukolj%2C+G.%3B+Poirier%2C+M.%3B+Tsantrizos%2C+Y.%3B+Jolicoeur%2C+E.%3B+Gillard%2C+J.%3B+Poupart%2C+M.-A.%3B+Rancourt%2C+J.+Patent+WO+03%2F010141%2C+2003."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4a','cit4b'],'ref5':['cit5a','cit5b','cit5c'],'ref6':['cit6a','cit6b'],'ref7':['cit7a','cit7b','cit7c'],'ref8':['cit8'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b'],'ref13':['cit13a','cit13b','cit13c','cit13d'],'ref14':['cit14a','cit14b'],'ref15':['cit15a','cit15b'],'ref16':['cit16a','cit16b','cit16c','cit16d'],'ref17':['cit17a','cit17b','cit17c'],'ref18':['cit18'],'ref19':['cit19a','cit19b','cit19c'],'ref20':['cit20a','cit20b','cit20c'],'ref21':['cit21a','cit21b','cit21c','cit21d'],'ref22':['cit22a','cit22b'],'ref23':['cit23'],'ref24':['cit24a','cit24b','cit24c','cit24d','cit24e','cit24f','cit24g','cit24h','cit24i'],'ref25':['cit25a','cit25b','cit25c','cit25d','cit25e','cit25f'],'ref26':['cit26a','cit26b','cit26c'],'ref27':['cit27a','cit27b'],'ref28':['cit28a','cit28b','cit28c'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31a'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 33 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yuto Yamaberi, Ryo Eto, Tomohiro Umeno, Takuma Kato, Mitsunobu Doi, Hidetomo Yokoo, Makoto Oba, <span class="NLM_string-name hlFld-ContribAuthor">Masakazu Tanaka</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of (S)-(−)-Cucurbitine and Conformation of Its Homopeptides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (11)
                                     , 4358-4362. <a href="https://doi.org/10.1021/acs.orglett.1c01291" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c01291</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c01291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c01291%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252B%252528S%252529-%252528%2525E2%252588%252592%252529-Cucurbitine%252Band%252BConformation%252Bof%252BIts%252BHomopeptides%26aulast%3DYamaberi%26aufirst%3DYuto%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D15042021%26date%3D12052021%26volume%3D23%26issue%3D11%26spage%3D4358%26epage%3D4362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hu  Li</span>, <span class="hlFld-ContribAuthor ">Anders  Riisager</span>, <span class="hlFld-ContribAuthor ">Shunmugavel  Saravanamurugan</span>, <span class="hlFld-ContribAuthor ">Ashok  Pandey</span>, <span class="hlFld-ContribAuthor ">Rajender S.  Sangwan</span>, <span class="hlFld-ContribAuthor ">Song  Yang</span>, and <span class="hlFld-ContribAuthor ">Rafael  Luque</span>  . </span><span class="cited-content_cbyCitation_article-title">Carbon-Increasing Catalytic Strategies for Upgrading Biomass into Energy-Intensive Fuels and Chemicals. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2018,</strong> <em>8 </em>
                                    (1)
                                     , 148-187. <a href="https://doi.org/10.1021/acscatal.7b02577" title="DOI URL">https://doi.org/10.1021/acscatal.7b02577</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.7b02577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.7b02577%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DCarbon-Increasing%252BCatalytic%252BStrategies%252Bfor%252BUpgrading%252BBiomass%252Binto%252BEnergy-Intensive%252BFuels%252Band%252BChemicals%26aulast%3DLi%26aufirst%3DHu%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D02082017%26date%3D06112017%26date%3D01122017%26date%3D05012018%26date%3D15112017%26volume%3D8%26issue%3D1%26spage%3D148%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark A. T.  Blaskovich</span>  . </span><span class="cited-content_cbyCitation_article-title">Unusual Amino Acids in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (24)
                                     , 10807-10836. <a href="https://doi.org/10.1021/acs.jmedchem.6b00319" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00319%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUnusual%252BAmino%252BAcids%252Bin%252BMedicinal%252BChemistry%26aulast%3DBlaskovich%26aufirst%3DMark%2BA.%2BT.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D02032016%26date%3D30092016%26date%3D22122016%26date%3D02092016%26volume%3D59%26issue%3D24%26spage%3D10807%26epage%3D10836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierre L.  Beaulieu</span>, <span class="hlFld-ContribAuthor ">Paul C.  Anderson</span>, <span class="hlFld-ContribAuthor ">Richard  Bethell</span>, <span class="hlFld-ContribAuthor ">Michael  Bös</span>, <span class="hlFld-ContribAuthor ">Yves  Bousquet</span>, <span class="hlFld-ContribAuthor ">Christian  Brochu</span>, <span class="hlFld-ContribAuthor ">Michael G.  Cordingley</span>, <span class="hlFld-ContribAuthor ">Gulrez  Fazal</span>, <span class="hlFld-ContribAuthor ">Michel  Garneau</span>, <span class="hlFld-ContribAuthor ">James R.  Gillard</span>, <span class="hlFld-ContribAuthor ">Stephen  Kawai</span>, <span class="hlFld-ContribAuthor ">Martin  Marquis</span>, <span class="hlFld-ContribAuthor ">Ginette  McKercher</span>, <span class="hlFld-ContribAuthor ">Marc-André  Poupart</span>, <span class="hlFld-ContribAuthor ">Timothy  Stammers</span>, <span class="hlFld-ContribAuthor ">Bounkham  Thavonekham</span>, <span class="hlFld-ContribAuthor ">Dominik  Wernic</span>, <span class="hlFld-ContribAuthor ">Jianmin  Duan</span>, and <span class="hlFld-ContribAuthor ">George  Kukolj</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of BI 207524, an Indole Diamide NS5B Thumb Pocket 1 Inhibitor with Improved Potency for the Potential Treatment of Chronic Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (23)
                                     , 10130-10143. <a href="https://doi.org/10.1021/jm501532z" title="DOI URL">https://doi.org/10.1021/jm501532z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501532z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501532z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BBI%252B207524%25252C%252Ban%252BIndole%252BDiamide%252BNS5B%252BThumb%252BPocket%252B1%252BInhibitor%252Bwith%252BImproved%252BPotency%252Bfor%252Bthe%252BPotential%252BTreatment%252Bof%252BChronic%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DBeaulieu%26aufirst%3DPierre%2BL.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D05102014%26date%3D25112014%26date%3D11122014%26date%3D13112014%26volume%3D57%26issue%3D23%26spage%3D10130%26epage%3D10143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongda  Zhang</span>, <span class="hlFld-ContribAuthor ">Bruce Z.  Lu</span>, <span class="hlFld-ContribAuthor ">Guisheng  Li</span>, <span class="hlFld-ContribAuthor ">Sonia  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Jonathan  Tan</span>, <span class="hlFld-ContribAuthor ">Han-Xun  Wei</span>, <span class="hlFld-ContribAuthor ">Jianxiu  Liu</span>, <span class="hlFld-ContribAuthor ">Frank  Roschangar</span>, <span class="hlFld-ContribAuthor ">Fei  Ding</span>, <span class="hlFld-ContribAuthor ">Wenyi  Zhao</span>, <span class="hlFld-ContribAuthor ">Bo  Qu</span>, <span class="hlFld-ContribAuthor ">Diana  Reeves</span>, <span class="hlFld-ContribAuthor ">Nelu  Grinberg</span>, <span class="hlFld-ContribAuthor ">Heewon  Lee</span>, <span class="hlFld-ContribAuthor ">Golo  Heckmann</span>, <span class="hlFld-ContribAuthor ">Oliver  Niemeier</span>, <span class="hlFld-ContribAuthor ">Michael  Brenner</span>, <span class="hlFld-ContribAuthor ">Youla  Tsantrizos</span>, <span class="hlFld-ContribAuthor ">Pierre L.  Beaulieu</span>, <span class="hlFld-ContribAuthor ">Azad  Hossain</span>, <span class="hlFld-ContribAuthor ">Nathan  Yee</span>, <span class="hlFld-ContribAuthor ">Vittorio  Farina</span>, and <span class="hlFld-ContribAuthor ">Chris H.  Senanayake</span>  . </span><span class="cited-content_cbyCitation_article-title">A Highly Concise and Convergent Synthesis of HCV Polymerase Inhibitor Deleobuvir (BI 207127): Application of a One-Pot Borylation–Suzuki Coupling Reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2014,</strong> <em>16 </em>
                                    (17)
                                     , 4558-4561. <a href="https://doi.org/10.1021/ol5021114" title="DOI URL">https://doi.org/10.1021/ol5021114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol5021114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol5021114%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DA%252BHighly%252BConcise%252Band%252BConvergent%252BSynthesis%252Bof%252BHCV%252BPolymerase%252BInhibitor%252BDeleobuvir%252B%252528BI%252B207127%252529%25253A%252BApplication%252Bof%252Ba%252BOne-Pot%252BBorylation%2525E2%252580%252593Suzuki%252BCoupling%252BReaction%26aulast%3DZhang%26aufirst%3DYongda%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D17072014%26date%3D08082014%26date%3D05092014%26volume%3D16%26issue%3D17%26spage%3D4558%26epage%3D4561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven R.  LaPlante</span>, <span class="hlFld-ContribAuthor ">Michael  Bös</span>, <span class="hlFld-ContribAuthor ">Christian  Brochu</span>, <span class="hlFld-ContribAuthor ">Catherine  Chabot</span>, <span class="hlFld-ContribAuthor ">René  Coulombe</span>, <span class="hlFld-ContribAuthor ">James R.  Gillard</span>, <span class="hlFld-ContribAuthor ">Araz  Jakalian</span>, <span class="hlFld-ContribAuthor ">Martin  Poirier</span>, <span class="hlFld-ContribAuthor ">Jean  Rancourt</span>, <span class="hlFld-ContribAuthor ">Timothy  Stammers</span>, <span class="hlFld-ContribAuthor ">Bounkham  Thavonekham</span>, <span class="hlFld-ContribAuthor ">Pierre L.  Beaulieu</span>, <span class="hlFld-ContribAuthor ">George  Kukolj</span>, and <span class="hlFld-ContribAuthor ">Youla S.  Tsantrizos</span>  . </span><span class="cited-content_cbyCitation_article-title">Conformation-Based Restrictions and Scaffold Replacements in the Design of Hepatitis C Virus Polymerase Inhibitors: Discovery of Deleobuvir (BI 207127). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 1845-1854. <a href="https://doi.org/10.1021/jm4011862" title="DOI URL">https://doi.org/10.1021/jm4011862</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4011862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4011862%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DConformation-Based%252BRestrictions%252Band%252BScaffold%252BReplacements%252Bin%252Bthe%252BDesign%252Bof%252BHepatitis%252BC%252BVirus%252BPolymerase%252BInhibitors%25253A%252BDiscovery%252Bof%252BDeleobuvir%252B%252528BI%252B207127%252529%26aulast%3DLaPlante%26aufirst%3DSteven%2BR.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D23082013%26date%3D11112013%26date%3D13032014%26date%3D25102013%26volume%3D57%26issue%3D5%26spage%3D1845%26epage%3D1854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maxwell D.  Cummings</span>, <span class="hlFld-ContribAuthor ">Tse-I  Lin</span>, <span class="hlFld-ContribAuthor ">Lili  Hu</span>, <span class="hlFld-ContribAuthor ">Abdellah  Tahri</span>, <span class="hlFld-ContribAuthor ">David  McGowan</span>, <span class="hlFld-ContribAuthor ">Katie  Amssoms</span>, <span class="hlFld-ContribAuthor ">Stefaan  Last</span>, <span class="hlFld-ContribAuthor ">Benoit  Devogelaere</span>, <span class="hlFld-ContribAuthor ">Marie-Claude  Rouan</span>, <span class="hlFld-ContribAuthor ">Leen  Vijgen</span>, <span class="hlFld-ContribAuthor ">Jan Martin  Berke</span>, <span class="hlFld-ContribAuthor ">Pascale  Dehertogh</span>, <span class="hlFld-ContribAuthor ">Els  Fransen</span>, <span class="hlFld-ContribAuthor ">Erna  Cleiren</span>, <span class="hlFld-ContribAuthor ">Liesbet  van der Helm</span>, <span class="hlFld-ContribAuthor ">Gregory  Fanning</span>, <span class="hlFld-ContribAuthor ">Origène  Nyanguile</span>, <span class="hlFld-ContribAuthor ">Kenny  Simmen</span>, <span class="hlFld-ContribAuthor ">Pieter  Van Remoortere</span>, <span class="hlFld-ContribAuthor ">Pierre  Raboisson</span>, and <span class="hlFld-ContribAuthor ">Sandrine  Vendeville</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Early Development of TMC647055, a Non-Nucleoside Inhibitor of the Hepatitis C Virus NS5B Polymerase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 1880-1892. <a href="https://doi.org/10.1021/jm401396p" title="DOI URL">https://doi.org/10.1021/jm401396p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401396p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401396p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BEarly%252BDevelopment%252Bof%252BTMC647055%25252C%252Ba%252BNon-Nucleoside%252BInhibitor%252Bof%252Bthe%252BHepatitis%252BC%252BVirus%252BNS5B%252BPolymerase%26aulast%3DCummings%26aufirst%3DMaxwell%2BD.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D10092013%26date%3D08112013%26date%3D13032014%26date%3D21102013%26volume%3D57%26issue%3D5%26spage%3D1880%26epage%3D1892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen D.  Ramgren</span> and <span class="hlFld-ContribAuthor ">Neil K.  Garg</span>  . </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Acetylation of Arenes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2014,</strong> <em>16 </em>
                                    (3)
                                     , 824-827. <a href="https://doi.org/10.1021/ol403570z" title="DOI URL">https://doi.org/10.1021/ol403570z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol403570z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol403570z%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPalladium-Catalyzed%252BAcetylation%252Bof%252BArenes%26aulast%3DRamgren%26aufirst%3DStephen%2BD.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D10122013%26date%3D09012014%26date%3D07022014%26volume%3D16%26issue%3D3%26spage%3D824%26epage%3D827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masami  Kuriyama</span>, <span class="hlFld-ContribAuthor ">Seira  Matsuo</span>, <span class="hlFld-ContribAuthor ">Mina  Shinozawa</span>, and <span class="hlFld-ContribAuthor ">Osamu  Onomura</span>  . </span><span class="cited-content_cbyCitation_article-title">Ether-Imidazolium Carbenes for Suzuki–Miyaura Cross-Coupling of Heteroaryl Chlorides with Aryl/Heteroarylboron Reagents. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2013,</strong> <em>15 </em>
                                    (11)
                                     , 2716-2719. <a href="https://doi.org/10.1021/ol4010189" title="DOI URL">https://doi.org/10.1021/ol4010189</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol4010189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol4010189%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DEther-Imidazolium%252BCarbenes%252Bfor%252BSuzuki%2525E2%252580%252593Miyaura%252BCross-Coupling%252Bof%252BHeteroaryl%252BChlorides%252Bwith%252BAryl%25252FHeteroarylboron%252BReagents%26aulast%3DKuriyama%26aufirst%3DMasami%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D12042013%26date%3D28052013%26date%3D07062013%26volume%3D15%26issue%3D11%26spage%3D2716%26epage%3D2719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryoya  Iioka</span>, <span class="hlFld-ContribAuthor ">Kohei  Yorozu</span>, <span class="hlFld-ContribAuthor ">Yoko  Sakai</span>, <span class="hlFld-ContribAuthor ">Rika  Kawai</span>, <span class="hlFld-ContribAuthor ">Noriyuki  Hatae</span>, <span class="hlFld-ContribAuthor ">Katsuki  Takashima</span>, <span class="hlFld-ContribAuthor ">Genzoh  Tanabe</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Wasada</span>, <span class="hlFld-ContribAuthor ">Mitsuhiro  Yoshimatsu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Azepino[1,2‐
              a
              ]indole‐10‐amines via [6+1] Annulation of Ynenitriles with Reformatsky Reagent. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>2021 </em>
                                    (10)
                                     , 1553-1558. <a href="https://doi.org/10.1002/ejoc.202100021" title="DOI URL">https://doi.org/10.1002/ejoc.202100021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202100021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202100021%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BAzepino%25255B1%25252C2%2525E2%252580%252590%252Ba%252B%25255Dindole%2525E2%252580%25259010%2525E2%252580%252590amines%252Bvia%252B%25255B6%25252B1%25255D%252BAnnulation%252Bof%252BYnenitriles%252Bwith%252BReformatsky%252BReagent%26aulast%3DIioka%26aufirst%3DRyoya%26date%3D2021%26date%3D2021%26volume%3D2021%26issue%3D10%26spage%3D1553%26epage%3D1558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei  Ye</span>, <span class="hlFld-ContribAuthor ">Jing  Huang</span>, <span class="hlFld-ContribAuthor ">Hongbo  Wang</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Kehao  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting epigenetic machinery: Emerging novel allosteric inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2019,</strong> <em>204 </em>, 107406. <a href="https://doi.org/10.1016/j.pharmthera.2019.107406" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2019.107406</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2019.107406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2019.107406%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DTargeting%252Bepigenetic%252Bmachinery%25253A%252BEmerging%252Bnovel%252Ballosteric%252Binhibitors%26aulast%3DYe%26aufirst%3DFei%26date%3D2019%26volume%3D204%26spage%3D107406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William J.  Watkins</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of HCV NS5B Non-nucleoside Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 171-191. <a href="https://doi.org/10.1007/7355_2018_35" title="DOI URL">https://doi.org/10.1007/7355_2018_35</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2018_35&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2018_35%26sid%3Dliteratum%253Aachs%26atitle%3DEvolution%252Bof%252BHCV%252BNS5B%252BNon-nucleoside%252BInhibitors%26aulast%3DWatkins%26aufirst%3DWilliam%2BJ.%26date%3D2019%26date%3D2019%26spage%3D171%26epage%3D191%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHCV%25253A%252BThe%252BJourney%252Bfrom%252BDiscovery%252Bto%252Ba%252BCure%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2019%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Navriti  Chadha</span>, <span class="hlFld-ContribAuthor ">Om  Silakari</span>. </span><span class="cited-content_cbyCitation_article-title">Indoles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 285-321. <a href="https://doi.org/10.1016/B978-0-08-102083-8.00008-X" title="DOI URL">https://doi.org/10.1016/B978-0-08-102083-8.00008-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-102083-8.00008-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-102083-8.00008-X%26sid%3Dliteratum%253Aachs%26atitle%3DIndoles%26aulast%3DChadha%26aufirst%3DNavriti%26date%3D2018%26spage%3D285%26epage%3D321%26pub%3DElsevier%26atitle%3DKey%252BHeterocycle%252BCores%252Bfor%252BDesigning%252BMultitargeting%252BMolecules%26date%3D2018%26volume%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Navriti  Chadha</span>, <span class="hlFld-ContribAuthor ">Om  Silakari</span>. </span><span class="cited-content_cbyCitation_article-title">Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>134 </em>, 159-184. <a href="https://doi.org/10.1016/j.ejmech.2017.04.003" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.04.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.04.003%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIndoles%252Bas%252Btherapeutics%252Bof%252Binterest%252Bin%252Bmedicinal%252Bchemistry%25253A%252BBird%252527s%252Beye%252Bview%26aulast%3DChadha%26aufirst%3DNavriti%26date%3D2017%26volume%3D134%26spage%3D159%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bianca  Heinrich</span>, <span class="hlFld-ContribAuthor ">John P.  Bilello</span>. </span><span class="cited-content_cbyCitation_article-title">HCV Drug Resistance. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 579-609. <a href="https://doi.org/10.1007/978-3-319-46718-4_39" title="DOI URL">https://doi.org/10.1007/978-3-319-46718-4_39</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-46718-4_39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-46718-4_39%26sid%3Dliteratum%253Aachs%26atitle%3DHCV%252BDrug%252BResistance%26aulast%3DHeinrich%26aufirst%3DBianca%26date%3D2017%26date%3D2017%26spage%3D579%26epage%3D609%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DAntimicrobial%252BDrug%252BResistance%26aulast%3DMayers%26aufirst%3DDouglas%2BL.%26date%3D2017%26volume%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N.A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 553-627. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12406-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12406-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12406-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12406-0%26sid%3Dliteratum%253Aachs%26atitle%3DDirect-Acting%252BAntiviral%252BAgents%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DMeanwell%26aufirst%3DN.A.%26date%3D2017%26spage%3D553%26epage%3D627%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Debasis  Das</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Development of HCV NS5B Polymerase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 189-219. <a href="https://doi.org/10.1016/B978-0-12-809712-0.00008-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-809712-0.00008-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-809712-0.00008-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-809712-0.00008-3%26sid%3Dliteratum%253Aachs%26atitle%3DDesign%252Band%252BDevelopment%252Bof%252BHCV%252BNS5B%252BPolymerase%252BInhibitors%26aulast%3DDas%26aufirst%3DDebasis%26date%3D2017%26spage%3D189%26epage%3D219%26pub%3DElsevier%26atitle%3DViral%252BProteases%252Band%252BTheir%252BInhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena  Maftei</span>, <span class="hlFld-ContribAuthor ">Catalin V.  Maftei</span>, <span class="hlFld-ContribAuthor ">Peter G.  Jones</span>, <span class="hlFld-ContribAuthor ">Matthias  Freytag</span>, <span class="hlFld-ContribAuthor ">M. Heiko  Franz</span>, <span class="hlFld-ContribAuthor ">Gerhard  Kelter</span>, <span class="hlFld-ContribAuthor ">Heinz-Herbert  Fiebig</span>, <span class="hlFld-ContribAuthor ">Matthias  Tamm</span>, <span class="hlFld-ContribAuthor ">Ion  Neda</span>. </span><span class="cited-content_cbyCitation_article-title">Trifluoromethylpyridine-Substituted
              N
              -Heterocyclic Carbenes Related to Natural Products: Synthesis, Structure, and Potential Antitumor Activity of some Corresponding Gold(I), Rhodium(I), and Iridium(I) Complexes. </span><span class="cited-content_cbyCitation_journal-name">Helvetica Chimica Acta</span><span> <strong>2016,</strong> <em>99 </em>
                                    (6)
                                     , 469-481. <a href="https://doi.org/10.1002/hlca.201500529" title="DOI URL">https://doi.org/10.1002/hlca.201500529</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hlca.201500529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhlca.201500529%26sid%3Dliteratum%253Aachs%26jtitle%3DHelvetica%2520Chimica%2520Acta%26atitle%3DTrifluoromethylpyridine-Substituted%252BN%252B-Heterocyclic%252BCarbenes%252BRelated%252Bto%252BNatural%252BProducts%25253A%252BSynthesis%25252C%252BStructure%25252C%252Band%252BPotential%252BAntitumor%252BActivity%252Bof%252Bsome%252BCorresponding%252BGold%252528I%252529%25252C%252BRhodium%252528I%252529%25252C%252Band%252BIridium%252528I%252529%252BComplexes%26aulast%3DMaftei%26aufirst%3DElena%26date%3D2016%26date%3D2016%26volume%3D99%26issue%3D6%26spage%3D469%26epage%3D481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amel  Meguellati</span>, <span class="hlFld-ContribAuthor ">Abdelhakim  Ahmed-Belkacem</span>, <span class="hlFld-ContribAuthor ">Alessandra  Nurisso</span>, <span class="hlFld-ContribAuthor ">Wei  Yi</span>, <span class="hlFld-ContribAuthor ">Rozenn  Brillet</span>, <span class="hlFld-ContribAuthor ">Nawel  Berqouch</span>, <span class="hlFld-ContribAuthor ">Laura  Chavoutier</span>, <span class="hlFld-ContribAuthor ">Antoine  Fortuné</span>, <span class="hlFld-ContribAuthor ">Jean-Michel  Pawlotsky</span>, <span class="hlFld-ContribAuthor ">Ahcène  Boumendjel</span>, <span class="hlFld-ContribAuthor ">Marine  Peuchmaur</span>. </span><span class="cited-content_cbyCitation_article-title">New pseudodimeric aurones as palm pocket inhibitors of Hepatitis C virus RNA-dependent RNA polymerase. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>115 </em>, 217-229. <a href="https://doi.org/10.1016/j.ejmech.2016.03.005" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.03.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.03.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bpseudodimeric%252Baurones%252Bas%252Bpalm%252Bpocket%252Binhibitors%252Bof%252BHepatitis%252BC%252Bvirus%252BRNA-dependent%252BRNA%252Bpolymerase%26aulast%3DMeguellati%26aufirst%3DAmel%26date%3D2016%26volume%3D115%26spage%3D217%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Can  Zhao</span>, <span class="hlFld-ContribAuthor ">Yinhu  Wang</span>, <span class="hlFld-ContribAuthor ">Shutao  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances on the synthesis of hepatitis C virus NS5B RNA-dependent RNA-polymerase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>102 </em>, 188-214. <a href="https://doi.org/10.1016/j.ejmech.2015.07.046" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.07.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.07.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.07.046%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bon%252Bthe%252Bsynthesis%252Bof%252Bhepatitis%252BC%252Bvirus%252BNS5B%252BRNA-dependent%252BRNA-polymerase%252Binhibitors%26aulast%3DZhao%26aufirst%3DCan%26date%3D2015%26volume%3D102%26spage%3D188%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amaravadhi  Harikishore</span>, <span class="hlFld-ContribAuthor ">Enlin  Li</span>, <span class="hlFld-ContribAuthor ">Jia Jun  Lee</span>, <span class="hlFld-ContribAuthor ">Nam-Joon  Cho</span>, <span class="hlFld-ContribAuthor ">Ho Sup  Yoon</span>. </span><span class="cited-content_cbyCitation_article-title">Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2015,</strong> <em>19 </em>
                                    (3)
                                     , 529-539. <a href="https://doi.org/10.1007/s11030-015-9591-5" title="DOI URL">https://doi.org/10.1007/s11030-015-9591-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-015-9591-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-015-9591-5%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DCombination%252Bof%252Bpharmacophore%252Bhypothesis%252Band%252Bmolecular%252Bdocking%252Bto%252Bidentify%252Bnovel%252Binhibitors%252Bof%252BHCV%252BNS5B%252Bpolymerase%26aulast%3DHarikishore%26aufirst%3DAmaravadhi%26date%3D2015%26date%3D2015%26volume%3D19%26issue%3D3%26spage%3D529%26epage%3D539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabao  Zhao</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xuemei  Jiang</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of HCV NS5B thumb site I inhibitors: Core-refining from benzimidazole to indole scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>94 </em>, 218-228. <a href="https://doi.org/10.1016/j.ejmech.2015.03.012" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.03.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.03.012%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BHCV%252BNS5B%252Bthumb%252Bsite%252BI%252Binhibitors%25253A%252BCore-refining%252Bfrom%252Bbenzimidazole%252Bto%252Bindole%252Bscaffold%26aulast%3DZhao%26aufirst%3DFabao%26date%3D2015%26volume%3D94%26spage%3D218%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierre L.  Beaulieu</span>, <span class="hlFld-ContribAuthor ">Gordon  Bolger</span>, <span class="hlFld-ContribAuthor ">Martin  Duplessis</span>, <span class="hlFld-ContribAuthor ">Alexandre  Gagnon</span>, <span class="hlFld-ContribAuthor ">Michel  Garneau</span>, <span class="hlFld-ContribAuthor ">Timothy  Stammers</span>, <span class="hlFld-ContribAuthor ">George  Kukolj</span>, <span class="hlFld-ContribAuthor ">Jianmin  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Aza follow-ups to BI 207524, a thumb pocket 1 HCV NS5B polymerase inhibitor. Part 1: Mitigating the genotoxic liability of an aniline metabolite. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (5)
                                     , 1135-1139. <a href="https://doi.org/10.1016/j.bmcl.2014.12.028" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.12.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.12.028%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAza%252Bfollow-ups%252Bto%252BBI%252B207524%25252C%252Ba%252Bthumb%252Bpocket%252B1%252BHCV%252BNS5B%252Bpolymerase%252Binhibitor.%252BPart%252B1%25253A%252BMitigating%252Bthe%252Bgenotoxic%252Bliability%252Bof%252Ban%252Baniline%252Bmetabolite%26aulast%3DBeaulieu%26aufirst%3DPierre%2BL.%26date%3D2015%26volume%3D25%26issue%3D5%26spage%3D1135%26epage%3D1139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierre L.  Beaulieu</span>, <span class="hlFld-ContribAuthor ">Gordon  Bolger</span>, <span class="hlFld-ContribAuthor ">Dan  Deon</span>, <span class="hlFld-ContribAuthor ">Martin  Duplessis</span>, <span class="hlFld-ContribAuthor ">Gulrez  Fazal</span>, <span class="hlFld-ContribAuthor ">Alexandre  Gagnon</span>, <span class="hlFld-ContribAuthor ">Michel  Garneau</span>, <span class="hlFld-ContribAuthor ">Steven  LaPlante</span>, <span class="hlFld-ContribAuthor ">Timothy  Stammers</span>, <span class="hlFld-ContribAuthor ">George  Kukolj</span>, <span class="hlFld-ContribAuthor ">Jianmin  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-parameter optimization of aza-follow-ups to BI 207524, a thumb pocket 1 HCV NS5B polymerase inhibitor. Part 2: Impact of lipophilicity on promiscuity and in vivo toxicity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (5)
                                     , 1140-1145. <a href="https://doi.org/10.1016/j.bmcl.2014.12.078" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.12.078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.12.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.12.078%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DMulti-parameter%252Boptimization%252Bof%252Baza-follow-ups%252Bto%252BBI%252B207524%25252C%252Ba%252Bthumb%252Bpocket%252B1%252BHCV%252BNS5B%252Bpolymerase%252Binhibitor.%252BPart%252B2%25253A%252BImpact%252Bof%252Blipophilicity%252Bon%252Bpromiscuity%252Band%252Bin%252Bvivo%252Btoxicity%26aulast%3DBeaulieu%26aufirst%3DPierre%2BL.%26date%3D2015%26volume%3D25%26issue%3D5%26spage%3D1140%26epage%3D1145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierre L.  Beaulieu</span>, <span class="hlFld-ContribAuthor ">Josie  De Marte</span>, <span class="hlFld-ContribAuthor ">Michel  Garneau</span>, <span class="hlFld-ContribAuthor ">Laibin  Luo</span>, <span class="hlFld-ContribAuthor ">Timothy  Stammers</span>, <span class="hlFld-ContribAuthor ">Chitra  Telang</span>, <span class="hlFld-ContribAuthor ">Dominik  Wernic</span>, <span class="hlFld-ContribAuthor ">George  Kukolj</span>, <span class="hlFld-ContribAuthor ">Jianmin  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">A prodrug strategy for the oral delivery of a poorly soluble HCV NS5B thumb pocket 1 polymerase inhibitor using self-emulsifying drug delivery systems (SEDDS). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (2)
                                     , 210-215. <a href="https://doi.org/10.1016/j.bmcl.2014.11.071" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.11.071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.11.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.11.071%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bprodrug%252Bstrategy%252Bfor%252Bthe%252Boral%252Bdelivery%252Bof%252Ba%252Bpoorly%252Bsoluble%252BHCV%252BNS5B%252Bthumb%252Bpocket%252B1%252Bpolymerase%252Binhibitor%252Busing%252Bself-emulsifying%252Bdrug%252Bdelivery%252Bsystems%252B%252528SEDDS%252529%26aulast%3DBeaulieu%26aufirst%3DPierre%2BL.%26date%3D2015%26volume%3D25%26issue%3D2%26spage%3D210%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming-Zhi  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiong  Chen</span>, <span class="hlFld-ContribAuthor ">Guang-Fu  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">A review on recent developments of indole-containing antiviral agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>89 </em>, 421-441. <a href="https://doi.org/10.1016/j.ejmech.2014.10.065" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.10.065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.10.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.10.065%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Breview%252Bon%252Brecent%252Bdevelopments%252Bof%252Bindole-containing%252Bantiviral%252Bagents%26aulast%3DZhang%26aufirst%3DMing-Zhi%26date%3D2015%26volume%3D89%26spage%3D421%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amir  Taheri</span>, <span class="hlFld-ContribAuthor ">Bingbing  Lai</span>, <span class="hlFld-ContribAuthor ">Cheng  Cheng</span>, <span class="hlFld-ContribAuthor ">Yanlong  Gu</span>. </span><span class="cited-content_cbyCitation_article-title">Brønsted acid ionic liquid-catalyzed reductive Friedel–Crafts alkylation of indoles and cyclic ketones without using an external reductant. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2015,</strong> <em>17 </em>
                                    (2)
                                     , 812-816. <a href="https://doi.org/10.1039/C4GC01299B" title="DOI URL">https://doi.org/10.1039/C4GC01299B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4GC01299B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4GC01299B%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DBr%2525C3%2525B8nsted%252Bacid%252Bionic%252Bliquid-catalyzed%252Breductive%252BFriedel%2525E2%252580%252593Crafts%252Balkylation%252Bof%252Bindoles%252Band%252Bcyclic%252Bketones%252Bwithout%252Busing%252Ban%252Bexternal%252Breductant%26aulast%3DTaheri%26aufirst%3DAmir%26date%3D2015%26date%3D2015%26volume%3D17%26issue%3D2%26spage%3D812%26epage%3D816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masami  Kuriyama</span>, <span class="hlFld-ContribAuthor ">Ryuichi  Shirai</span>, <span class="hlFld-ContribAuthor ">Osamu  Onomura</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Functionalized NHC Ligands for Transition Metal-Catalyzed Arylation Reactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Synthetic Organic Chemistry, Japan</span><span> <strong>2015,</strong> <em>73 </em>
                                    (4)
                                     , 361-371. <a href="https://doi.org/10.5059/yukigoseikyokaishi.73.361" title="DOI URL">https://doi.org/10.5059/yukigoseikyokaishi.73.361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5059/yukigoseikyokaishi.73.361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5059%2Fyukigoseikyokaishi.73.361%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Synthetic%2520Organic%2520Chemistry%252C%2520Japan%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BFunctionalized%252BNHC%252BLigands%252Bfor%252BTransition%252BMetal-Catalyzed%252BArylation%252BReactions%26aulast%3DKuriyama%26aufirst%3DMasami%26date%3D2015%26volume%3D73%26issue%3D4%26spage%3D361%26epage%3D371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asta  Žukauskaitė</span>, <span class="hlFld-ContribAuthor ">Alessandro  Moretto</span>, <span class="hlFld-ContribAuthor ">Cristina  Peggion</span>, <span class="hlFld-ContribAuthor ">Marta  De Zotti</span>, <span class="hlFld-ContribAuthor ">Algirdas  Šačkus</span>, <span class="hlFld-ContribAuthor ">Fernando  Formaggio</span>, <span class="hlFld-ContribAuthor ">Norbert  De Kimpe</span>, <span class="hlFld-ContribAuthor ">Sven  Mangelinckx</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Conformational Study of Model Peptides Containing
              N
              -Substituted 3-Aminoazetidine-3-carboxylic Acids. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>2014 </em>
                                    (11)
                                     , 2312-2321. <a href="https://doi.org/10.1002/ejoc.201301741" title="DOI URL">https://doi.org/10.1002/ejoc.201301741</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201301741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201301741%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Band%252BConformational%252BStudy%252Bof%252BModel%252BPeptides%252BContaining%252BN%252B-Substituted%252B3-Aminoazetidine-3-carboxylic%252BAcids%26aulast%3D%25C5%25BDukauskait%25C4%2597%26aufirst%3DAsta%26date%3D2014%26date%3D2014%26volume%3D2014%26issue%3D11%26spage%3D2312%26epage%3D2321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy A.  Stammers</span>, <span class="hlFld-ContribAuthor ">René  Coulombe</span>, <span class="hlFld-ContribAuthor ">Martin  Duplessis</span>, <span class="hlFld-ContribAuthor ">Gulrez  Fazal</span>, <span class="hlFld-ContribAuthor ">Alexandre  Gagnon</span>, <span class="hlFld-ContribAuthor ">Michel  Garneau</span>, <span class="hlFld-ContribAuthor ">Sylvie  Goulet</span>, <span class="hlFld-ContribAuthor ">Araz  Jakalian</span>, <span class="hlFld-ContribAuthor ">Steven  LaPlante</span>, <span class="hlFld-ContribAuthor ">Jean  Rancourt</span>, <span class="hlFld-ContribAuthor ">Bounkham  Thavonekham</span>, <span class="hlFld-ContribAuthor ">Dominik  Wernic</span>, <span class="hlFld-ContribAuthor ">George  Kukolj</span>, <span class="hlFld-ContribAuthor ">Pierre L.  Beaulieu</span>. </span><span class="cited-content_cbyCitation_article-title">Anthranilic acid-based Thumb Pocket 2 HCV NS5B polymerase inhibitors with sub-micromolar potency in the cell-based replicon assay. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (24)
                                     , 6879-6885. <a href="https://doi.org/10.1016/j.bmcl.2013.09.102" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.09.102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.09.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.09.102%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAnthranilic%252Bacid-based%252BThumb%252BPocket%252B2%252BHCV%252BNS5B%252Bpolymerase%252Binhibitors%252Bwith%252Bsub-micromolar%252Bpotency%252Bin%252Bthe%252Bcell-based%252Breplicon%252Bassay%26aulast%3DStammers%26aufirst%3DTimothy%2BA.%26date%3D2013%26volume%3D23%26issue%3D24%26spage%3D6879%26epage%3D6885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy A.  Stammers</span>, <span class="hlFld-ContribAuthor ">René  Coulombe</span>, <span class="hlFld-ContribAuthor ">Jean  Rancourt</span>, <span class="hlFld-ContribAuthor ">Bounkham  Thavonekham</span>, <span class="hlFld-ContribAuthor ">Gulrez  Fazal</span>, <span class="hlFld-ContribAuthor ">Sylvie  Goulet</span>, <span class="hlFld-ContribAuthor ">Araz  Jakalian</span>, <span class="hlFld-ContribAuthor ">Dominic  Wernic</span>, <span class="hlFld-ContribAuthor ">Youla  Tsantrizos</span>, <span class="hlFld-ContribAuthor ">Marc-André  Poupart</span>, <span class="hlFld-ContribAuthor ">Michael  Bös</span>, <span class="hlFld-ContribAuthor ">Ginette  McKercher</span>, <span class="hlFld-ContribAuthor ">Louise  Thauvette</span>, <span class="hlFld-ContribAuthor ">George  Kukolj</span>, <span class="hlFld-ContribAuthor ">Pierre L.  Beaulieu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a novel series of non-nucleoside thumb pocket 2 HCV NS5B polymerase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (9)
                                     , 2585-2589. <a href="https://doi.org/10.1016/j.bmcl.2013.02.110" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.02.110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.02.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.02.110%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252Bnovel%252Bseries%252Bof%252Bnon-nucleoside%252Bthumb%252Bpocket%252B2%252BHCV%252BNS5B%252Bpolymerase%252Binhibitors%26aulast%3DStammers%26aufirst%3DTimothy%2BA.%26date%3D2013%26volume%3D23%26issue%3D9%26spage%3D2585%26epage%3D2589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leen  Delang</span>, <span class="hlFld-ContribAuthor ">Johan  Neyts</span>, <span class="hlFld-ContribAuthor ">Inge  Vliegen</span>, <span class="hlFld-ContribAuthor ">Sergio  Abrignani</span>, <span class="hlFld-ContribAuthor ">Petra  Neddermann</span>, <span class="hlFld-ContribAuthor ">Raffaele  De Francesco</span>. </span><span class="cited-content_cbyCitation_article-title">Hepatitis C Virus-Specific Directly Acting Antiviral Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 289-320. <a href="https://doi.org/10.1007/978-3-642-27340-7_12" title="DOI URL">https://doi.org/10.1007/978-3-642-27340-7_12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-642-27340-7_12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-642-27340-7_12%26sid%3Dliteratum%253Aachs%26atitle%3DHepatitis%252BC%252BVirus-Specific%252BDirectly%252BActing%252BAntiviral%252BDrugs%26aulast%3DDelang%26aufirst%3DLeen%26date%3D2013%26spage%3D289%26epage%3D320%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DHepatitis%252BC%252BVirus%25253A%252BFrom%252BMolecular%252BVirology%252Bto%252BAntiviral%252BTherapy%26aulast%3DBartenschlager%26aufirst%3DRalf%26date%3D2013%26volume%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierre L.  Beaulieu</span>, <span class="hlFld-ContribAuthor ">René  Coulombe</span>, <span class="hlFld-ContribAuthor ">James  Gillard</span>, <span class="hlFld-ContribAuthor ">Christian  Brochu</span>, <span class="hlFld-ContribAuthor ">Jianmin  Duan</span>, <span class="hlFld-ContribAuthor ">Michel  Garneau</span>, <span class="hlFld-ContribAuthor ">Eric  Jolicoeur</span>, <span class="hlFld-ContribAuthor ">Peter  Kuhn</span>, <span class="hlFld-ContribAuthor ">Marc-André  Poupart</span>, <span class="hlFld-ContribAuthor ">Jean  Rancourt</span>, <span class="hlFld-ContribAuthor ">Timothy A.  Stammers</span>, <span class="hlFld-ContribAuthor ">Bounkham  Thavonekham</span>, <span class="hlFld-ContribAuthor ">George  Kukolj</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric
              N-
              acetamide-indole-6-carboxylic acid thumb pocket 1 inhibitors of hepatitis C virus NS5B polymerase — Acylsulfonamides and acylsulfamides as carboxylic acid replacements. </span><span class="cited-content_cbyCitation_journal-name">Canadian Journal of Chemistry</span><span> <strong>2013,</strong> <em>91 </em>
                                    (1)
                                     , 66-81. <a href="https://doi.org/10.1139/cjc-2012-0319" title="DOI URL">https://doi.org/10.1139/cjc-2012-0319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1139/cjc-2012-0319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1139%2Fcjc-2012-0319%26sid%3Dliteratum%253Aachs%26jtitle%3DCanadian%2520Journal%2520of%2520Chemistry%26atitle%3DAllosteric%252BN-%252Bacetamide-indole-6-carboxylic%252Bacid%252Bthumb%252Bpocket%252B1%252Binhibitors%252Bof%252Bhepatitis%252BC%252Bvirus%252BNS5B%252Bpolymerase%2525C2%2525A0%2525E2%252580%252594%252BAcylsulfonamides%252Band%252Bacylsulfamides%252Bas%252Bcarboxylic%252Bacid%252Breplacements%26aulast%3DBeaulieu%26aufirst%3DPierre%2BL.%26date%3D2013%26volume%3D91%26issue%3D1%26spage%3D66%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Three dimensional structure of NS5B with inhibitor binding sites. The three-dimensional structure of NS5B is shown in ribbon representation with the palm domain colored in red, the thumb domain in green and the finger domain with the Λ finger loops in blue. Inhibitor binding sites are depicted using CPK models of representative inhibitors: thumb pocket 1 (acetamideindolecarboxylic acid, red), thumb pocket 2 (phenylalanine derivative, magenta), palm site 1 (acylpyrrolidine, orange), palm site 2 (benzofuran derivative, blue), active site (nucleoside analog with two Mg<sup>2+</sup> ions, yellow). Reproduced with permission from <i>Expert Opinion on Therapeutic Patents</i>.<a onclick="showRef(event, 'cit19a'); return false;" href="javascript:void(0);" class="ref cit19a">(19a)</a> Copyright 2009 Informa Healthcare.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of published representative NS5B inhibitors currently in clinical development.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. SAR progression of benzimidazole thumb pocket 1 HCV NS5B inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Major Metabolic Pathway and MS/MS Fragmentation Pattern for Compound <b>4</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0005.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Strategy for the Identification of Potent NS5B Inhibitors with Improved ADME-PK Profiles</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. 3-Cyclopentyl-1-methyl-6-indolecarboxylic Acid Building Blocks</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Right-Hand-Side Building Blocks for Inhibitor Synthesis</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0008.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Replicon 1b potency for a sparse matrix of 110 representative inhibitors. C2 substituents are represented on the <i>X</i>-axis (see Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a> for structures) and are numbered 1–28. Right-hand sides are listed on the <i>Z</i>-axis and are labeled A– H (see Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a> for structures). Genotype 1b replicon potency is displayed on the <i>y</i>-axis in nM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0009.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibitor plasma concentrations (normalized to a 3 mg/kg dose) following oral dosing in rat as mixtures of 4 compounds. <i>X</i>- and <i>Z</i>-axis are labeled as in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. Inhibitor plasma concentrations (μM units) at 1 h after oral dosing are displayed on the <i>Y</i>-axis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0010.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structure of <b>D13</b> (BILB 1941) and <b>D25</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of C2-Substituted 3-Cyclopentyl-6-indolecarboxylic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) cyclopentanone, KOH, MeOH–water, 75 °C; (b) 20% Pd(OH)<sub>2</sub>/C, MeOH, H<sub>2</sub> (1 atm); (c) K<sub>2</sub>CO<sub>3</sub>, MeI, DMF, rt then NaH, MeI, 0 °C to rt; (d) NaOAc, Br<sub>2</sub>, <i>i</i>-PrOAc, 4 °C; (e) <i>n</i>-BuLi, Bu<sub>3</sub>SnCl, THF, −72 °C to rt. Method A: heteroaryl- or arylboronic acid (1.3 equiv), LiCl (2 equiv), Na<sub>2</sub>CO<sub>3</sub> (2.5 equiv), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.04 equiv), degassed toluene/ethanol/water 1:1:1, reflux overnight under argon; (g) NaOH, THF–MeOH. (h) Method B: heterocycle bromide, Pd(Ph<sub>3</sub>P)<sub>4</sub>, CuI, LiI, P(Ph)<sub>3</sub>, DMF, 100 °C. (i) Method C: <i>n</i>-BuLi, B(OMe)<sub>3</sub>, THF, −71 °C to rt, then Pd(OAc)<sub>2</sub>, P(<i>p</i>-tolyl)<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, heterocycle bromide, MeOH, reflux.</p></p></figure><figure data-id="sch4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Substituted Thiazolylindole Building Blocks Using the Hantzsch Synthesis (<b>7</b>–<b>11</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 1-ethoxytributylvinylstannane, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, dioxane, 100 °C; (b) <i>N</i>-bromosuccinimide, THF–water, 0 °C; (c) thiourea, <i>i</i>-PrOH or dioxane, 80–100 °C; (d) LiOH, THF–MeOH–water; (e) thioamide, dioxane, 80 °C.</p></p></figure><figure data-id="sch5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of (<i>S</i>)-Cucurbitine Right-Hand-Side Fragment <b>A</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Di-<i>tert</i>-butyl dicarbonate, NaOH, THF, rt, then Fmoc-OSu; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (c) 37% aqueous formaldehyde, NaBH<sub>3</sub>CN, EtOH, AcOH; (d) ethyl 4-aminocinnamate, HATU, HOAt, 2,4,6-collidine, DMF, 50 °C; (e) DBU, THF, rt.</p></p></figure><figure data-id="sch6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <b>C</b>–<b>E</b> Right-Hand Sides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 2-Oxazolidone, PCl<sub>5</sub>, MeCN, rt; (b) ethyl 4-aminocinnamate, K<sub>3</sub>PO<sub>4</sub>, MeCN, rt; (c) ethyl 5-amino-1-methyl-1<i>H</i>-indole-2-carboxylate, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, rt; (d) CH<sub>2</sub>N<sub>2</sub>, diethyl ether–MeOH, 0 °C; (e) SnCl<sub>2</sub> dihydrate, EtOH, reflux.</p></p></figure><figure data-id="sch7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/medium/jm-2012-006788_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Final Assembly of Inhibitors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3006788/production/images/large/jm-2012-006788_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3006788&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) TBTU or HATU, Et<sub>3</sub>N or DIEA, DMSO, rt; (b) LiOH or NaOH, water–DMSO or water–THF–MeOH, rt.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86856" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86856" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 34 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Choo, Q.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overby, L .R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, M.</span><span> </span><span class="NLM_article-title">Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">244</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1126%2Fscience.2523562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=2523562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADyaL1MXit1Khtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=1989&pages=359-362&author=Q.-L.+Chooauthor=G.+Kuoauthor=A.+J.+Weinerauthor=L+.R.+Overbyauthor=D.+W.+Bradleyauthor=M.+Houghton&title=Isolation+of+a+cDNA+clone+derived+from+a+blood-borne+non-A%2C+non-B+viral+hepatitis+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome</span></div><div class="casAuthors">Choo, Qui Lim; Kuo, George; Weiner, Amy J.; Overby, Lacy R.; Bradley, Daniel W.; Houghton, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">4902</span>),
    <span class="NLM_cas:pages">359-62</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A random-primed cDNA library was constructed from plasma contg. the uncharacterized non-A, non-B hepatitis (NANBH) agent and screened with serum from a patient diagnosed with NANBH.  A cDNA clone was isolated that was shown to encode an antigen assocd. specifically with NANBH infections.  This clone is not derived from host DNA but from an RNA mol. present in NANBH infections that consists of ≥10,000 nucleotides, and that is pos.-stranded with respect to the encoded NANBH antigen.  These data indicate that this clone is derived from the genome of the NANBH agent and are consistent with the agent being similar to the togaviridae or flaviviridae.  This mol. approach should be of great value in the isolation and characterization of other unidentified infectious agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqorpVFx7nEkrVg90H21EOLACvtfcHk0lhFjTI5O_cEUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXit1Khtrk%253D&md5=25161cf212790856dd29d3aaf78f20b8</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.2523562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2523562%26sid%3Dliteratum%253Aachs%26aulast%3DChoo%26aufirst%3DQ.-L.%26aulast%3DKuo%26aufirst%3DG.%26aulast%3DWeiner%26aufirst%3DA.%2BJ.%26aulast%3DOverby%26aufirst%3DL%2B.R.%26aulast%3DBradley%26aufirst%3DD.%2BW.%26aulast%3DHoughton%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520cDNA%2520clone%2520derived%2520from%2520a%2520blood-borne%2520non-A%252C%2520non-B%2520viral%2520hepatitis%2520genome%26jtitle%3DScience%26date%3D1989%26volume%3D244%26spage%3D359%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Lavanchy, D.</span><span> </span><span class="NLM_article-title">Evolving epidemiology of hepatitis C virus</span> <span class="citation_source-journal">Clin. Microbiol. Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1111%2Fj.1469-0691.2010.03432.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=21091831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A280%3ADC%252BC3M7islSrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=107-115&author=D.+Lavanchy&title=Evolving+epidemiology+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Evolving epidemiology of hepatitis C virus</span></div><div class="casAuthors">Lavanchy D</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">More than 20 years after the discovery of the hepatitis C virus (HCV), it is now well established that HCV is of global importance affecting all countries, leading to a major global health problem that requires widespread active interventions for its prevention and control.  Chronic hepatitis C was linked to the development of cirrhosis and hepatocellular carcinoma in many areas of the world.  Current epidemiological assessments have identified complex patterns with highly variable local prevalence rates between countries and within countries.  HCV infection patterns have not significantly changed in most parts of the world since 1997, when first analyzed, partly due to the lack of new and more accurate data.  The assessment of the national HCV prevalence and transmission modes should be completed to enable national authorities to prioritize preventive measures and to make the most appropriate use of available resources.  The 'patchy' epidemiological situation in some areas will continue to complicate the task of the establishment of global, regional and national base line data.  The present assessment finds a global prevalence of 2.35%, affecting 160 million chronically infected individuals.  There is an urgent need for more accurate Information on the costs and burden of HCV to society.  Twenty-one year after the discovery of HCV, the assessment is far from being complete and little progress has been made in the past 10 years in many countries.  In some countries significant increases have been reported and this may also apply to countries were insufficient data exist.  A safe and efficient vaccine against HCV is urgently needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRYetk_zmER_suCWE5mhx1RfW6udTcc2ebyugygQCuHb7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7islSrtQ%253D%253D&md5=b77d9df38203d7a5dd060cc1bc3bc487</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1469-0691.2010.03432.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1469-0691.2010.03432.x%26sid%3Dliteratum%253Aachs%26aulast%3DLavanchy%26aufirst%3DD.%26atitle%3DEvolving%2520epidemiology%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DClin.%2520Microbiol.%2520Infect.%26date%3D2011%26volume%3D17%26spage%3D107%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Simmonds, P.</span><span> </span><span class="NLM_article-title">Genetic diversity and evolution of hepatitis C virus—15 years on</span> <span class="citation_source-journal">J. Gen. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">3173</span><span class="NLM_x">–</span> <span class="NLM_lpage">3188</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1099%2Fvir.0.80401-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=15483230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVSmsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2004&pages=3173-3188&author=P.+Simmonds&title=Genetic+diversity+and+evolution+of+hepatitis+C+virus%E2%80%9415+years+on"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic diversity and evolution of hepatitis C virus - 15 years on</span></div><div class="casAuthors">Simmonds, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3173-3188</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">A review.  In the 15 years since the discovery of hepatitis C virus (HCV), much has been learned about its role as a major causative agent of human liver disease and its ability to persist in the face of host-cell defenses and the immune system.  This review describes what is known about the diversity of HCV, the current classification of HCV genotypes within the family Flaviviridae and how this genetic diversity contributes to its pathogenesis.  On one hand, diversification of HCV was constrained by its intimate adaptation to its host.  Despite the >30% nucleotide sequence divergence between genotypes, HCV variants nevertheless remain remarkably similar in their transmission dynamics, persistence and disease development.  Nowhere is this more evident than in the evolutionary conservation of numerous evasion methods to counteract the cell's innate antiviral defense pathways; this series of highly complex virus-host interactions may represent key components in establishing its ecol. niche in the human liver.  On the other hand, the mutability and large population size of HCV enables it to respond very rapidly to new selection pressures, manifested by immune-driven changes in T- and B-cell epitopes that are encountered on transmission between individuals with different antigen-recognition repertoires.  If human immunodeficiency virus type 1 is a precedent, future therapies that target virus protease or polymerase enzymes may also select very rapidly for antiviral-resistant mutants.  These contrasting aspects of conservatism and adaptability provide a fascinating paradigm in which to explore the complex selection pressures that underlie the evolution of HCV and other persistent viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotwOpXQZprmrVg90H21EOLACvtfcHk0lgP7dQxlAO0gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVSmsr0%253D&md5=a07b3411b6b18b5e7ab3cf9bc3b89026</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1099%2Fvir.0.80401-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fvir.0.80401-0%26sid%3Dliteratum%253Aachs%26aulast%3DSimmonds%26aufirst%3DP.%26atitle%3DGenetic%2520diversity%2520and%2520evolution%2520of%2520hepatitis%2520C%2520virus%25E2%2580%259415%2520years%2520on%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2004%26volume%3D85%26spage%3D3173%26epage%3D3188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wise, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bialek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorvillo, F.</span><span> </span><span class="NLM_article-title">Changing trends in hepatitis C-related mortality in the United States, 1995–2004</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1128</span><span class="NLM_x">–</span> <span class="NLM_lpage">1135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=1128-1135&author=M.+Wiseauthor=S.+Bialekauthor=L.+Finelliauthor=B.+Bellauthor=F.+Sorvillo&title=Changing+trends+in+hepatitis+C-related+mortality+in+the+United+States%2C+1995%E2%80%932004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWise%26aufirst%3DM.%26aulast%3DBialek%26aufirst%3DS.%26aulast%3DFinelli%26aufirst%3DL.%26aulast%3DBell%26aufirst%3DB.%26aulast%3DSorvillo%26aufirst%3DF.%26atitle%3DChanging%2520trends%2520in%2520hepatitis%2520C-related%2520mortality%2520in%2520the%2520United%2520States%252C%25201995%25E2%2580%25932004%26jtitle%3DHepatology%26date%3D2008%26volume%3D47%26spage%3D1128%26epage%3D1135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Davis, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, D. M.</span><span> </span><span class="NLM_article-title">Projecting future complications of chronic hepatitis C in the United States</span> <span class="citation_source-journal">Liver Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1053%2Fjlts.2003.50073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=12682882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A280%3ADC%252BD3s7msV2jsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=331-338&author=G.+L.+Davisauthor=J.+E.+Albrightauthor=S.+F.+Cookauthor=D.+M.+Rosenberg&title=Projecting+future+complications+of+chronic+hepatitis+C+in+the+United+States"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Projecting future complications of chronic hepatitis C in the United States</span></div><div class="casAuthors">Davis Gary L; Albright James E; Cook Suzanne F; Rosenberg Daniel M</div><div class="citationInfo"><span class="NLM_cas:title">Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">331-8</span>
        ISSN:<span class="NLM_cas:issn">1527-6465</span>.
    </div><div class="casAbstract">Chronic hepatitis C virus (HCV) infection is common and often results in slowly progressive liver disease.  Although acute hepatitis C is now uncommon, most patients with acute infection have developed chronic hepatitis, and, therefore, the pool of infected patients is large.  We used a modification of a previously described natural history model for HCV infection to project the number of cases of HCV infection, cirrhosis, and liver failure over the next 40 years.  The model estimated the prevalence of HCV infection in the United States was 3.07 x 10(6) in 1993 (compared with an adjusted National Health and Nutrition Evaluation Survey (NHANES) III estimate of 2.8 to 3.5 x 10(6)).  A gradual decline in the prevalence of infection should occur by year 2040 because of aging and natural deaths among the infected pool.  However, as the duration of infection increases in the surviving cohort, the proportion with cirrhosis will increase from 16% to 32% by 2020 in an untreated population.  Complications of cirrhosis also will increase dramatically over the next 20 years: hepatic decompensation (up 106%), hepatocellular carcinoma (up 81%), and liver-related deaths (up 180%).  Although current treatment regimens eradicate HCV in over 50% of cases, many more patients would need to be treated to significantly impact disease progression.  Identification and treatment of every case of HCV infection (with or without cirrhosis) would reduce the number of cases of decompensated cirrhosis by almost half after 20 years.  Despite the declining incidence of acute HCV infection, chronic hepatitis C is common.  The prevalence of cirrhosis and the incidence of its complications will increase over the next 10 to 20 years, because the duration of infection increases among those with chronic hepatitis C.  These data emphasize the need for greater access to transplantation by expansion of the donor pool, increasing use of split livers and living donors, and novel options such as xenotransplantation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTewSKnpArRW-xsqfvU0ziafW6udTcc2ebT9KX3eCRlRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7msV2jsQ%253D%253D&md5=933b3e1540d1375bccbd1ade430ab7fb</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1053%2Fjlts.2003.50073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fjlts.2003.50073%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DG.%2BL.%26aulast%3DAlbright%26aufirst%3DJ.%2BE.%26aulast%3DCook%26aufirst%3DS.%2BF.%26aulast%3DRosenberg%26aufirst%3DD.%2BM.%26atitle%3DProjecting%2520future%2520complications%2520of%2520chronic%2520hepatitis%2520C%2520in%2520the%2520United%2520States%26jtitle%3DLiver%2520Transplant.%26date%3D2003%26volume%3D9%26spage%3D331%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bosetti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucchini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zatonski, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Vecchia, C.</span><span> </span><span class="NLM_article-title">Worldwide mortality from cirrhosis: an update to 2002</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">839</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1016%2Fj.jhep.2007.01.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=17336419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A280%3ADC%252BD2s3hsVKksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=827-839&author=C.+Bosettiauthor=F.+Leviauthor=F.+Lucchiniauthor=W.+A.+Zatonskiauthor=E.+Negriauthor=C.+La+Vecchia&title=Worldwide+mortality+from+cirrhosis%3A+an+update+to+2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Worldwide mortality from cirrhosis: an update to 2002</span></div><div class="casAuthors">Bosetti Cristina; Levi Fabio; Lucchini Franca; Zatonski Witold A; Negri Eva; La Vecchia Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of hepatology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">827-39</span>
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    </div><div class="casAbstract">BACKGROUND/AIMS:  Cirrhosis mortality has registered large changes over the last few decades.  METHODS:  Age-standardized (world standard) cirrhosis mortality rates per 100,000 were computed for 41 countries worldwide over the period 1980-2002 using data from the WHO mortality database.  RESULTS:  In the early 1980s, the highest rates were in Mexico, Chile (around 55/100,000 men and over 14/100,000 women), France, Italy, Portugal, Austria, Hungary and Romania (around 30-35/100,000 men and 10-15/100,000 women).  Mortality from cirrhosis has been steadily declining in most countries worldwide since the mid or late 1970s (annual percent change, APC, between -5% and -1.5% in the last decade only for both sexes).  In southern Europe, rates in the early 2000s were less than halved compared to earlier decades.  In contrast, rates have been rising in Eastern European countries to reach extremely high values in the mid 1990s, and declined only thereafter.  In the UK rates were still steadily rising (APC around +7% in men and +3% in women from England and Wales, and +9% in men and +7% in women from Scotland).  CONCLUSIONS:  Mortality from cirrhosis shows favourable trends in most countries of the world, following the reduction in alcohol consumption and hepatitis B and C virus infection.  The steady upward trends observed over more recent calendar periods in the UK and central and eastern European countries are attributed to the persistent increase in the prevalence of alcohol consumption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRG0hN2BXnnh8vLc4ARHEmzfW6udTcc2ebT9KX3eCRlRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3hsVKksg%253D%253D&md5=87b57db620702efdc8f3013eec4de21d</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2007.01.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2007.01.025%26sid%3Dliteratum%253Aachs%26aulast%3DBosetti%26aufirst%3DC.%26aulast%3DLevi%26aufirst%3DF.%26aulast%3DLucchini%26aufirst%3DF.%26aulast%3DZatonski%26aufirst%3DW.%2BA.%26aulast%3DNegri%26aufirst%3DE.%26aulast%3DLa%2BVecchia%26aufirst%3DC.%26atitle%3DWorldwide%2520mortality%2520from%2520cirrhosis%253A%2520an%2520update%2520to%25202002%26jtitle%3DJ.%2520Hepatol.%26date%3D2007%26volume%3D46%26spage%3D827%26epage%3D839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wise, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bialek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorvillo, F.</span><span> </span><span class="NLM_article-title">Changing trends in hepatitis C-related mortality in the United States</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1128</span><span class="NLM_x">–</span> <span class="NLM_lpage">1135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=1128-1135&author=M.+Wiseauthor=S.+Bialekauthor=L.+Finelliauthor=B.+P.+Bellauthor=F.+Sorvillo&title=Changing+trends+in+hepatitis+C-related+mortality+in+the+United+States"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWise%26aufirst%3DM.%26aulast%3DBialek%26aufirst%3DS.%26aulast%3DFinelli%26aufirst%3DL.%26aulast%3DBell%26aufirst%3DB.%2BP.%26aulast%3DSorvillo%26aufirst%3DF.%26atitle%3DChanging%2520trends%2520in%2520hepatitis%2520C-related%2520mortality%2520in%2520the%2520United%2520States%26jtitle%3DHepatology%26date%3D2008%26volume%3D47%26spage%3D1128%26epage%3D1135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Davila, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaib, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGlynn, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Serag, H. B.</span><span> </span><span class="NLM_article-title">Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">1372</span><span class="NLM_x">–</span> <span class="NLM_lpage">1380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2004&pages=1372-1380&author=J.+A.+Davilaauthor=R.+O.+Morganauthor=Y.+Shaibauthor=K.+A.+McGlynnauthor=H.+B.+El-Serag&title=Hepatitis+C+infection+and+the+increasing+incidence+of+hepatocellular+carcinoma%3A+a+population-based+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavila%26aufirst%3DJ.%2BA.%26aulast%3DMorgan%26aufirst%3DR.%2BO.%26aulast%3DShaib%26aufirst%3DY.%26aulast%3DMcGlynn%26aufirst%3DK.%2BA.%26aulast%3DEl-Serag%26aufirst%3DH.%2BB.%26atitle%3DHepatitis%2520C%2520infection%2520and%2520the%2520increasing%2520incidence%2520of%2520hepatocellular%2520carcinoma%253A%2520a%2520population-based%2520study%26jtitle%3DGastroenterology%26date%3D2004%26volume%3D127%26spage%3D1372%26epage%3D1380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fried, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonçales, F. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haüssinger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diago, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carosi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhumeaux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craxi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span> </span><span class="NLM_article-title">Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">982</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1056%2FNEJMoa020047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=12324553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BD38Xnt12rtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2002&pages=975-982&author=M.+W.+Friedauthor=M.+L.+Shiffmanauthor=K.+R.+Reddyauthor=C.+Smithauthor=G.+Marinosauthor=F.+L.+Gon%C3%A7alesauthor=D.+Ha%C3%BCssingerauthor=M.+Diagoauthor=G.+Carosiauthor=D.+Dhumeauxauthor=A.+Craxiauthor=A.+Linauthor=J.+Hoffmanauthor=J.+Yu&title=Peginterferon+alfa-2a+plus+ribavirin+for+chronic+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection</span></div><div class="casAuthors">Fried, Michael W.; Shiffman, Mitchell L.; Reddy, K. Rajender; Smith, Coleman; Marinos, George; Goncales, Fernando L., Jr.; Haussinger, Dieter; Diago, Moises; Carosi, Giampiero; Dhumeaux, Daniel; Craxi, Antonio; Lin, Amy; Hoffman, Joseph; Yu, Jian</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">975-982</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Treatment with peginterferon alfa-2a alone produces significantly higher sustained virol. responses than treatment with interferon alfa-2a alone in patients with chronic hepatitis C virus (HCV) infection.  We compared the efficacy and safety of peginterferon alfa-2a plus ribavirin, interferon alfa-2b plus ribavirin, and peginterferon alfa-2a alone in the initial treatment of chronic hepatitis C.  Methods: A total of 1121 patients were randomly assigned to treatment and received at least one dose of study medication, consisting of 180 μg of peginterferon alfa-2a once weekly plus daily ribavirin (1000 or 1200 mg, depending on body wt.), weekly peginterferon alfa-2a plus daily placebo, or 3 million units of interferon alfa-2b thrice weekly plus daily ribavirin for 48 wk.  Results: A significantly higher proportion of patients who received peginterferon alfa-2a plus ribavirin had a sustained virol. response (defined as the absence of detectable HCV RNA 24 wk after cessation of therapy) than of patients who received interferon alfa-2b plus ribavirin (56 % vs. 44 %, P<0.001) or peginterferon alfa-2a alone (56 % vs. 29 %, P<0.001).  The proportions of patients with HCV genotype 1 who had sustained virol. responses were 46 %, 36 %, and 21 %, resp., for the three regimens.  Among patients with HCV genotype 1 and high base-line levels of HCV RNA, the proportions of those with sustained virol. responses were 41 %, 33 %, and 13 %, resp.  The overall safety profiles of the three treatment regimens were similar; the incidence of influenza-like symptoms and depression was lower in the groups receiving peginterferon alfa-2a than in the group receiving interferon alfa-2b plus ribavirin.  Conclusions: In patients with chronic hepatitis C, once-weekly peginterferon alfa-2a plus ribavirin was tolerated as well as interferon alfa-2b plus ribavirin and produced significant improvements in the rate of sustained virol. response, as compared with interferon alfa-2b plus ribavirin or peginterferon alfa-2a alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqblwkeNXWJzbVg90H21EOLACvtfcHk0lgXhld47S2IIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xnt12rtb0%253D&md5=2fd959d790b9505384fbd26ef44b2963</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa020047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa020047%26sid%3Dliteratum%253Aachs%26aulast%3DFried%26aufirst%3DM.%2BW.%26aulast%3DShiffman%26aufirst%3DM.%2BL.%26aulast%3DReddy%26aufirst%3DK.%2BR.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DMarinos%26aufirst%3DG.%26aulast%3DGon%25C3%25A7ales%26aufirst%3DF.%2BL.%26aulast%3DHa%25C3%25BCssinger%26aufirst%3DD.%26aulast%3DDiago%26aufirst%3DM.%26aulast%3DCarosi%26aufirst%3DG.%26aulast%3DDhumeaux%26aufirst%3DD.%26aulast%3DCraxi%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DJ.%26atitle%3DPeginterferon%2520alfa-2a%2520plus%2520ribavirin%2520for%2520chronic%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D347%26spage%3D975%26epage%3D982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moeller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinrichsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauss, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarrazin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hueppe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zehnter, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manns, M. P.</span><span> </span><span class="NLM_article-title">Expert opinion on the treatment of patients with chronic hepatitis C</span> <span class="citation_source-journal">J. Viral Hepatitis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1111%2Fj.1365-2893.2008.01012.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=18761607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ht1Crtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=75-90&author=S.+Zeuzemauthor=T.+Bergauthor=B.+Moellerauthor=H.+Hinrichsenauthor=S.+Maussauthor=H.+Wedemeyerauthor=C.+Sarrazinauthor=D.+Hueppeauthor=E.+Zehnterauthor=M.+P.+Manns&title=Expert+opinion+on+the+treatment+of+patients+with+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Expert opinion on the treatment of patients with chronic hepatitis C</span></div><div class="casAuthors">Zeuzem S; Berg T; Moeller B; Hinrichsen H; Mauss S; Wedemeyer H; Sarrazin C; Hueppe D; Zehnter E; Manns M P</div><div class="citationInfo"><span class="NLM_cas:title">Journal of viral hepatitis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">75-90</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The current preferred treatment for patients with hepatitis C virus (HCV) is combination therapy consisting of pegylated interferon alfa and ribavirin (RBV) for 24-48 weeks.  Although this approach appears to be highly effective for patients with HCV genotypes 2 or 3, who have a sustained virological response (SVR) of approximately 80%, the treatment algorithm is less effective for patients with HCV genotype 1, as these patients have SVR rates of just 40-50%.  In order to improve treatment outcomes, this article explores potential approaches for the optimization of treatment for patients with HCV genotype 1: considering shorter treatment periods for patients with a rapid virological response (RVR), increasing treatment periods for slow responders, and increasing RBV dose are all suggestions.  Results from clinical trials suggest that approximately 20% of the HCV genotype 1-infected population are slow responders, and around 15% of all HCV genotype-1 infected patients could benefit from a shorter treatment duration without compromising the SVR rate.  Interest has also focused on whether treatment duration could be individualized in some patients with genotype 2 and 3 infection.  Here all the findings from recent studies are translated into practical advice, to help practitioners make evidence-based treatment decisions in everyday clinical practice.  Although there are areas where currently available data do not provide conclusive evidence to suggest amending treatment approaches, there is clearly potential for individualized treatment in all aspects of hepatitis treatment in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6UQwwDsewsuQ4Pl9hzjQhfW6udTcc2ebcnEHW2WdQD7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ht1Crtg%253D%253D&md5=6bb4b656592a11243b42540f5a090e9e</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2893.2008.01012.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2893.2008.01012.x%26sid%3Dliteratum%253Aachs%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DBerg%26aufirst%3DT.%26aulast%3DMoeller%26aufirst%3DB.%26aulast%3DHinrichsen%26aufirst%3DH.%26aulast%3DMauss%26aufirst%3DS.%26aulast%3DWedemeyer%26aufirst%3DH.%26aulast%3DSarrazin%26aufirst%3DC.%26aulast%3DHueppe%26aufirst%3DD.%26aulast%3DZehnter%26aufirst%3DE.%26aulast%3DManns%26aufirst%3DM.%2BP.%26atitle%3DExpert%2520opinion%2520on%2520the%2520treatment%2520of%2520patients%2520with%2520chronic%2520hepatitis%2520C%26jtitle%3DJ.%2520Viral%2520Hepatitis%26date%3D2009%26volume%3D16%26spage%3D75%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span> National Institutes of Health consensus development conference statement: management of hepatitis C 2002 (June 10–12, 2002).  <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">2082</span><span class="NLM_x">–</span> <span class="NLM_lpage">2099</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+National+Institutes+of+Health+consensus+development+conference+statement%3A+management+of+hepatitis+C+2002+%28June+10%E2%80%9312%2C+2002%29.+Gastroenterology+2002%2C+123%2C+2082%E2%80%932099."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DGastroenterology%26date%3D2002%26volume%3D123%26spage%3D2082%26epage%3D2099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Manns, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockstroh, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoulim, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, M.</span><span> </span><span class="NLM_article-title">The way forward in HCV treatment—finding the right path</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">991</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=991-1000&author=M.+P.+Mannsauthor=G.+R.+Fosterauthor=J.+K.+Rockstrohauthor=S.+Zeuzemauthor=F.+Zoulimauthor=M.+Houghton&title=The+way+forward+in+HCV+treatment%E2%80%94finding+the+right+path"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%2BP.%26aulast%3DFoster%26aufirst%3DG.%2BR.%26aulast%3DRockstroh%26aufirst%3DJ.%2BK.%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DZoulim%26aufirst%3DF.%26aulast%3DHoughton%26aufirst%3DM.%26atitle%3DThe%2520way%2520forward%2520in%2520HCV%2520treatment%25E2%2580%2594finding%2520the%2520right%2520path%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D991%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Björnsson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbaan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oksanen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frydén, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalgård, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalaitzakis, E.</span><span> </span><span class="NLM_article-title">Health-related quality of life in patients with different stages of liver disease induced by hepatitis C</span> <span class="citation_source-journal">Scand. J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">878</span><span class="NLM_x">–</span> <span class="NLM_lpage">887</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1080%2F00365520902898135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=19437190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A280%3ADC%252BD1MjmsFSgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=878-887&author=E.+Bj%C3%B6rnssonauthor=H.+Verbaanauthor=A.+Oksanenauthor=A.+Fryd%C3%A9nauthor=J.+Johanssonauthor=S.+Fribergauthor=O.+Dalg%C3%A5rdauthor=E.+Kalaitzakis&title=Health-related+quality+of+life+in+patients+with+different+stages+of+liver+disease+induced+by+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Health-related quality of life in patients with different stages of liver disease induced by hepatitis C</span></div><div class="casAuthors">Bjornsson Einar; Verbaan Hans; Oksanen Antti; Fryden Aril; Johansson Jonas; Friberg Sarah; Dalgard Olav; Kalaitzakis Evangelos</div><div class="citationInfo"><span class="NLM_cas:title">Scandinavian journal of gastroenterology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">878-87</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Patients with hepatitis C have been shown to have impaired health-related quality of life (HRQoL).  The aim of this study was to determine HRQoL in patients in different stages of hepatitis C virus (HCV) and to compare HRQoL in HCV cirrhosis with non-HCV-induced cirrhosis.  MATERIAL AND METHODS:  Out of 489 consecutive patients who fulfilled the inclusion criteria, 472 (96%) agreed to participate in the study: 158 patients with mild/moderate fibrosis with chronic hepatitis C (CHC group), 76 patients with HCV compensated cirrhosis (CC), 53 patients with HCV decompensated (DC) cirrhosis, 52 non-cirrhotic patients with sustained viral response (SVR), and a control group consisting of 32 patients with non-HCV CC and 101 with non-HCV DC who completed the Short Form-36 (SF-36) and EQ-5D questionnaire.  RESULTS:  The CHC group had significantly lower SF-36 scores than healthy controls, with the exception of scores for the dimensions physical function and bodily pain.  HCV patients with DC had lower scores in all SF-36 dimensions in comparison with those of the CHC group, as well as in physical and mental component summaries (p<0.001).  In comparison with the CHC group, the HCV CC group had lower scores on the SF-36 general health dimension (p<0.05) and lower SF-36 physical component summary (PCS) scores (p<0.05).  No major differences were seen in patients with HCV- and non-HCV-induced cirrhosis.  CONCLUSIONS:  Impairment in HRQoL in patients with HCV was associated with the severity of liver disease, patients with decompensated cirrhosis exhibiting the highest impairment in HRQoL.  The etiology of liver disease does not seem to be important in determining HRQoL in cirrhosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUqk0W5YvA7IUSrryheKE6fW6udTcc2eapledShmaNlbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjmsFSgsg%253D%253D&md5=32e1b0115a5f839a29b8f028b1145faa</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1080%2F00365520902898135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00365520902898135%26sid%3Dliteratum%253Aachs%26aulast%3DBj%25C3%25B6rnsson%26aufirst%3DE.%26aulast%3DVerbaan%26aufirst%3DH.%26aulast%3DOksanen%26aufirst%3DA.%26aulast%3DFryd%25C3%25A9n%26aufirst%3DA.%26aulast%3DJohansson%26aufirst%3DJ.%26aulast%3DFriberg%26aufirst%3DS.%26aulast%3DDalg%25C3%25A5rd%26aufirst%3DO.%26aulast%3DKalaitzakis%26aufirst%3DE.%26atitle%3DHealth-related%2520quality%2520of%2520life%2520in%2520patients%2520with%2520different%2520stages%2520of%2520liver%2520disease%2520induced%2520by%2520hepatitis%2520C%26jtitle%3DScand.%2520J.%2520Gastroenterol.%26date%3D2009%26volume%3D44%26spage%3D878%26epage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Lohmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Körner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herian, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theilmann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1126%2Fscience.285.5424.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=10390360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=110-113&author=V.+Lohmannauthor=F.+K%C3%B6rnerauthor=J.+O.+Kochauthor=U.+Herianauthor=L.+Theilmannauthor=R.+Bartenschlager&title=Replication+of+subgenomic+hepatitis+C+virus+RNAs+in+a+hepatoma+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span></div><div class="casAuthors">Lohmann, V.; Korner, F.; Koch, J.-O.; Herian, U.; Theilmann, L.; Bartenschlager, R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">5424</span>),
    <span class="NLM_cas:pages">110-113</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">An estd. 170 million persons worldwide are infected with hepatitis C virus (HCV), a major cause of chronic liver disease.  Despite increasing knowledge of genome structure and individual viral proteins, studies on virus replication and pathogenesis have been hampered by the lack of reliable and efficient cell culture systems.  A full-length consensus genome was cloned from viral RNA isolated from an infected human liver and used to construct subgenomic selectable replicons.  Upon transfection into a human hepatoma cell line, these RNAs replicated to high levels, permitting metabolic radiolabeling of viral RNA and proteins.  This work defines the structure of HCV replicons functional in cell culture and provides the basis for a long-sought cellular system that should allow detailed mol. studies of HCV and the development of antiviral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7X754RT8y1LVg90H21EOLACvtfcHk0licxtZu1NTZXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D&md5=b075621b316209ecf4498c9b5b33e4b5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.285.5424.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.285.5424.110%26sid%3Dliteratum%253Aachs%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DK%25C3%25B6rner%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DJ.%2BO.%26aulast%3DHerian%26aufirst%3DU.%26aulast%3DTheilmann%26aufirst%3DL.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DReplication%2520of%2520subgenomic%2520hepatitis%2520C%2520virus%2520RNAs%2520in%2520a%2520hepatoma%2520cell%2520line%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D110%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wakita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietschmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Date, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murthy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habermann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kräusslich, H.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizokami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, T. G.</span><span> </span><span class="NLM_article-title">Production of infectious hepatitis C virus in tissue culture from a cloned viral genome</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1038%2Fnm1268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=15951748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmt1aju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=791-796&author=T.+Wakitaauthor=T.+Pietschmannauthor=T.+Katoauthor=T.+Dateauthor=M.+Miyamotoauthor=Z.+Zhaoauthor=K.+Murthyauthor=A.+Habermannauthor=H.-G.+Kr%C3%A4usslichauthor=M.+Mizokamiauthor=R.+Bartenschlagerauthor=T.+G.+Liang&title=Production+of+infectious+hepatitis+C+virus+in+tissue+culture+from+a+cloned+viral+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Production of infectious hepatitis C virus in tissue culture from a cloned viral genome</span></div><div class="casAuthors">Wakita, Takaji; Pietschmann, Thomas; Kato, Takanobu; Date, Tomoko; Miyamoto, Michiko; Zhao, Zijiang; Murthy, Krishna; Habermann, Anja; Kraeusslich, Hans-Georg; Mizokami, Masashi; Bartenschlager, Ralf; Liang, T. Jake</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">791-796</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection causes chronic liver diseases and is a global public health problem.  Detailed analyses of HCV have been hampered by the lack of viral culture systems.  Subgenomic replicons of the JFH1 genotype 2a strain cloned from an individual with fulminant hepatitis replicate efficiently in cell culture.  Here we show that the JFH1 genome replicates efficiently and supports secretion of viral particles after transfection into a human hepatoma cell line (Huh7).  Particles have a d. of about 1.15-1.17 g/mL and a spherical morphol. with an av. diam. of about 55 nm.  Secreted virus is infectious for Huh7 cells and infectivity can be neutralized by CD81-specific antibodies and by Igs from chronically infected individuals.  The cell culture-generated HCV is infectious for chimpanzee.  This system provides a powerful tool for studying the viral life cycle and developing antiviral strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqra8QhVAEyJ7Vg90H21EOLACvtfcHk0licxtZu1NTZXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmt1aju7c%253D&md5=91235eedec98d1b3d6a4bc4bc68f6d11</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1038%2Fnm1268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1268%26sid%3Dliteratum%253Aachs%26aulast%3DWakita%26aufirst%3DT.%26aulast%3DPietschmann%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DDate%26aufirst%3DT.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DMurthy%26aufirst%3DK.%26aulast%3DHabermann%26aufirst%3DA.%26aulast%3DKr%25C3%25A4usslich%26aufirst%3DH.-G.%26aulast%3DMizokami%26aufirst%3DM.%26aulast%3DBartenschlager%26aufirst%3DR.%26aulast%3DLiang%26aufirst%3DT.%2BG.%26atitle%3DProduction%2520of%2520infectious%2520hepatitis%2520C%2520virus%2520in%2520tissue%2520culture%2520from%2520a%2520cloned%2520viral%2520genome%26jtitle%3DNat.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D791%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lindenbach, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syder, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wölk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellinghuisen, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hynes, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeating, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">623</span><span class="NLM_x">–</span> <span class="NLM_lpage">626</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Lindenbach%2C+B.+D.%3B+Evans%2C+M.+J.%3B+Syder%2C+A.+J.%3B+W%C3%B6lk%2C+B.%3B+Tellinghuisen%2C+T.+L.%3B+Liu%2C+C.+C.%3B+Maruyama%2C+T.%3B+Hynes%2C+R.+O.%3B+Burton%2C+D.+R.%3B+McKeating%2C+J.+A.%3B+Rice%2C+C.+M.Science+2005%2C+309%2C+623%E2%80%93626"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindenbach%26aufirst%3DB.%2BD.%26aulast%3DEvans%26aufirst%3DM.%2BJ.%26aulast%3DSyder%26aufirst%3DA.%2BJ.%26aulast%3DW%25C3%25B6lk%26aufirst%3DB.%26aulast%3DTellinghuisen%26aufirst%3DT.%2BL.%26aulast%3DLiu%26aufirst%3DC.%2BC.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DHynes%26aufirst%3DR.%2BO.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DMcKeating%26aufirst%3DJ.%2BA.%26aulast%3DRice%26aufirst%3DC.%2BM.%26jtitle%3DScience%26date%3D2005%26volume%3D309%26spage%3D623%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Tan, S.-L.; He, Y.</span> <span class="citation_source-book">Hepatitis C: Antiviral Drug Discovery and Development</span>; <span class="NLM_publisher-name">Caister Academic Press</span>: <span class="NLM_publisher-loc">Norwich, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.-L.+Tan&author=Y.+He&title=Hepatitis+C%3A+Antiviral+Drug+Discovery+and+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DS.-L.%26btitle%3DHepatitis%2520C%253A%2520Antiviral%2520Drug%2520Discovery%2520and%2520Development%26pub%3DCaister%2520Academic%2520Press%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Lindenbach, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Unraveling hepatitis C virus replication from genome to function</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">938</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=933-938&author=B.+D.+Lindenbachauthor=C.+M.+Rice&title=Unraveling+hepatitis+C+virus+replication+from+genome+to+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindenbach%26aufirst%3DB.%2BD.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DUnraveling%2520hepatitis%2520C%2520virus%2520replication%2520from%2520genome%2520to%2520function%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D933%26epage%3D938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hinrichsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentjens, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calleja, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forns, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erhardt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cröenlein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaves, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C. −L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nehmiz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, G. G.</span><span> </span><span class="NLM_article-title">Short-term antiviral efficacy of BILN 2061, a HCV serine protease inhibitor, in hepatitis C genotype 1 patients</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">1347</span><span class="NLM_x">–</span> <span class="NLM_lpage">1355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2004&pages=1347-1355&author=H.+Hinrichsenauthor=Y.+Benhamouauthor=H.+Wedemeyerauthor=M.+Reiserauthor=R.+E.+Sentjensauthor=J.+L.+Callejaauthor=X.+Fornsauthor=A.+Erhardtauthor=J.+Cr%C3%B6enleinauthor=R.+Chavesauthor=C.+%E2%88%92L.+Yongauthor=G.+Nehmizauthor=G.+G.+Steinmann&title=Short-term+antiviral+efficacy+of+BILN+2061%2C+a+HCV+serine+protease+inhibitor%2C+in+hepatitis+C+genotype+1+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHinrichsen%26aufirst%3DH.%26aulast%3DBenhamou%26aufirst%3DY.%26aulast%3DWedemeyer%26aufirst%3DH.%26aulast%3DReiser%26aufirst%3DM.%26aulast%3DSentjens%26aufirst%3DR.%2BE.%26aulast%3DCalleja%26aufirst%3DJ.%2BL.%26aulast%3DForns%26aufirst%3DX.%26aulast%3DErhardt%26aufirst%3DA.%26aulast%3DCr%25C3%25B6enlein%26aufirst%3DJ.%26aulast%3DChaves%26aufirst%3DR.%26aulast%3DYong%26aufirst%3DC.%2B%25E2%2588%2592L.%26aulast%3DNehmiz%26aufirst%3DG.%26aulast%3DSteinmann%26aufirst%3DG.%2BG.%26atitle%3DShort-term%2520antiviral%2520efficacy%2520of%2520BILN%25202061%252C%2520a%2520HCV%2520serine%2520protease%2520inhibitor%252C%2520in%2520hepatitis%2520C%2520genotype%25201%2520patients%26jtitle%3DGastroenterology%26date%3D2004%26volume%3D127%26spage%3D1347%26epage%3D1355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bös, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacé, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentjens, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St George, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoneau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weldon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span> </span><span class="NLM_article-title">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1038%2Fnature02099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=14578911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2003&pages=186-189&author=D.+Lamarreauthor=P.+C.+Andersonauthor=M.+Baileyauthor=P.+Beaulieuauthor=G.+Bolgerauthor=P.+Bonneauauthor=M.+B%C3%B6sauthor=D.+R.+Cameronauthor=M.+Cartierauthor=M.+G.+Cordingleyauthor=A.-M.+Faucherauthor=N.+Goudreauauthor=S.+H.+Kawaiauthor=G.+Kukoljauthor=L.+Lagac%C3%A9author=S.+R.+LaPlanteauthor=H.+Narjesauthor=M.-A.+Poupartauthor=J.+Rancourtauthor=R.+E.+Sentjensauthor=R.+St+Georgeauthor=B.+Simoneauauthor=G.+Steinmannauthor=D.+Thibeaultauthor=Y.+Tsantrizosauthor=S.+M.+Weldonauthor=C.-L.+Yongauthor=M.+Llin%C3%A0s-Brunet&title=An+NS3+protease+inhibitor+with+antiviral+effects+in+humans+infected+with+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span></div><div class="casAuthors">Lamarre, Daniel; Anderson, Paul C.; Bailey, Murray; Beaulieu, Pierre; Bolger, Gordon; Bonneau, Pierre; Boes, Michael; Cameron, Dale R.; Cartier, Mireille; Cordingley, Michael G.; Faucher, Anne-Marie; Goudreau, Nathalie; Kawai, Stephen H.; Kukolj, George; Lagace, Lisette; LaPlante, Steven R.; Narjes, Hans; Poupart, Marc-Andre; Rancourt, Jean; Sentjens, Roel E.; St. George, Roger; Simoneau, Bruno; Steinmann, Gerhard; Thibeault, Diane; Tsantrizos, Youla S.; Weldon, Steven M.; Yong, Chan-Loi; Llinas-Brunet, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">6963</span>),
    <span class="NLM_cas:pages">186-189</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is a serious cause of chronic liver disease worldwide with more than 170 million infected individuals at risk of developing significant morbidity and mortality.  Current interferon-based therapies are suboptimal esp. in patients infected with HCV genotype 1, and they are poorly tolerated, highlighting the unmet medical need for new therapeutics.  The HCV-encoded NS3 protease is essential for viral replication and has long been considered an attractive target for therapeutic intervention in HCV-infected patients.  Here we identify a class of specific and potent NS3 protease inhibitors and report the evaluation of BILN 2061, a small mol. inhibitor biol. available through oral ingestion and the first of its class in human trials.  Administration of BILN 2061 to patients infected with HCV genotype 1 for 2 days resulted in an impressive redn. of HCV RNA plasma levels, and established proof-of-concept in humans for an HCV NS3 protease inhibitor.  Our results further illustrate the potential of the viral-enzyme-targeted drug discovery approach for the development of new HCV therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPnVapDO21RLVg90H21EOLACvtfcHk0lheD1GPOLnQaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D&md5=36db818d5af257d3ebeef1a061ca68cb</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1038%2Fnature02099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02099%26sid%3Dliteratum%253Aachs%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DP.%2BC.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DBeaulieu%26aufirst%3DP.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DB%25C3%25B6s%26aufirst%3DM.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DCartier%26aufirst%3DM.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLagac%25C3%25A9%26aufirst%3DL.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DNarjes%26aufirst%3DH.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DSentjens%26aufirst%3DR.%2BE.%26aulast%3DSt%2BGeorge%26aufirst%3DR.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DSteinmann%26aufirst%3DG.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DTsantrizos%26aufirst%3DY.%26aulast%3DWeldon%26aufirst%3DS.%2BM.%26aulast%3DYong%26aufirst%3DC.-L.%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26atitle%3DAn%2520NS3%2520protease%2520inhibitor%2520with%2520antiviral%2520effects%2520in%2520humans%2520infected%2520with%2520hepatitis%2520C%2520virus%26jtitle%3DNature%26date%3D2003%26volume%3D426%26spage%3D186%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gentile, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carleo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgia, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaldo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgia, G.</span><span> </span><span class="NLM_article-title">The efficacy and safety of telaprevir: a new protease inhibitor against hepatitis C virus</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=151-159&author=I.+Gentileauthor=M.+A.+Carleoauthor=F.+Borgiaauthor=G.+Castaldoauthor=G.+Borgia&title=The+efficacy+and+safety+of+telaprevir%3A+a+new+protease+inhibitor+against+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGentile%26aufirst%3DI.%26aulast%3DCarleo%26aufirst%3DM.%2BA.%26aulast%3DBorgia%26aufirst%3DF.%26aulast%3DCastaldo%26aufirst%3DG.%26aulast%3DBorgia%26aufirst%3DG.%26atitle%3DThe%2520efficacy%2520and%2520safety%2520of%2520telaprevir%253A%2520a%2520new%2520protease%2520inhibitor%2520against%2520hepatitis%2520C%2520virus%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D19%26spage%3D151%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kwong, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, P.</span><span> </span><span class="NLM_article-title">Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">1003</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1038%2Fnbt.2020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=22068541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVCntLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=993-1003&author=D.+A.+Kwongauthor=R.+S.+Kauffmanauthor=P.+Mueller&title=Discovery+and+development+of+telaprevir%3A+an+NS3-4A+protease+inhibitor+for+treating+genotype+1+chronic+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus</span></div><div class="casAuthors">Kwong, Ann D.; Kauffman, Robert S.; Hurter, Patricia; Mueller, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">993-1003</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Infection with hepatitis C virus (HCV) is a major medical problem with over 170 million people infected worldwide.  Substantial morbidity and mortality are assocd. with hepatic manifestations (cirrhosis and hepatocellular carcinoma), which develop with increasing frequency in people infected with HCV for more than 20 years.  Less well known is the burden of HCV disease assocd. with extrahepatic manifestations (diabetes, B-cell proliferative disorders, depression, cognitive disorders, arthritis and Sjoegren's syndrome).  For patients infected with genotype 1 HCV, treatment with polyethylene glycol decorated interferon (peginterferon) α and ribavirin (PR) is assocd. with a low (40-50%) success rate, substantial treatment-limiting side effects and a long (48-wk) duration of treatment.  In the past 15 years, major scientific advances have enabled the development of new classes of HCV therapy, the direct-acting antiviral agents, also known as specifically targeted antiviral therapy for hepatitis C (STAT-C).  In combination with PR, the HCV NS3-4A protease inhibitor telaprevir has recently been approved for treatment of genotype 1 chronic HCV in the United States, Canada, European Union and Japan.  Compared with PR, telaprevir combination therapy offers significantly improved viral cure rates and the possibility of shortened treatment duration for diverse patient populations.  Developers of innovative drugs have to blaze a new path with few validated sign posts to guide the way.  Indeed, telaprevir's development was once put on hold because of its performance in a std. IC50 assay.  Data from new hypotheses and novel expts. were required to justify further investment and reduce risk that the drug might fail in the clinic.  In addn., the poor drug-like properties of telaprevir were a formidable hurdle, which the manufg. and formulation teams had to overcome to make the drug.  Finally, novel clin. trial designs were developed to improve efficacy and shorten treatment in parallel instead of sequentially.  Lessons learned from the development of telaprevir suggest that makers of innovative medicines cannot rely solely on traditional drug discovery metrics, but must develop innovative, scientifically guided pathways for success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodUEHshXTAvbVg90H21EOLACvtfcHk0lif0PGYBaFIFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVCntLvJ&md5=952966419a2e72107550d0a63c337ae4</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2020%26sid%3Dliteratum%253Aachs%26aulast%3DKwong%26aufirst%3DD.%2BA.%26aulast%3DKauffman%26aufirst%3DR.%2BS.%26aulast%3DMueller%26aufirst%3DP.%26atitle%3DDiscovery%2520and%2520development%2520of%2520telaprevir%253A%2520an%2520NS3-4A%2520protease%2520inhibitor%2520for%2520treating%2520genotype%25201%2520chronic%2520hepatitis%2520C%2520virus%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D993%26epage%3D1003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Berman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwo, P. Y.</span><span> </span><span class="NLM_article-title">Boceprevir, an NS3 protease inhibitor of HCV</span> <span class="citation_source-journal">Clin. Liver Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=429-439&author=K.+Bermanauthor=P.+Y.+Kwo&title=Boceprevir%2C+an+NS3+protease+inhibitor+of+HCV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DK.%26aulast%3DKwo%26aufirst%3DP.%2BY.%26atitle%3DBoceprevir%252C%2520an%2520NS3%2520protease%2520inhibitor%2520of%2520HCV%26jtitle%3DClin.%2520Liver%2520Dis.%26date%3D2009%26volume%3D13%26spage%3D429%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Asselah, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellin, P.</span><span> </span><span class="NLM_article-title">New direct-acting antivirals combination for the treatment of chronic hepatitis C</span> <span class="citation_source-journal">Liver Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=68-77&author=T.+Asselahauthor=P.+Marcellin&title=New+direct-acting+antivirals+combination+for+the+treatment+of+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAsselah%26aufirst%3DT.%26aulast%3DMarcellin%26aufirst%3DP.%26atitle%3DNew%2520direct-acting%2520antivirals%2520combination%2520for%2520the%2520treatment%2520of%2520chronic%2520hepatitis%2520C%26jtitle%3DLiver%2520Int.%26date%3D2011%26volume%3D31%26spage%3D68%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sarrazin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span> </span><span class="NLM_article-title">Resistance to direct antiviral agents in patients with hepatitis C virus infection</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">447</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2010&pages=447-462&author=C.+Sarrazinauthor=S.+Zeuzem&title=Resistance+to+direct+antiviral+agents+in+patients+with+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarrazin%26aufirst%3DC.%26aulast%3DZeuzem%26aufirst%3DS.%26atitle%3DResistance%2520to%2520direct%2520antiviral%2520agents%2520in%2520patients%2520with%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DGastroenterology%26date%3D2010%26volume%3D138%26spage%3D447%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gaudieri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfafferott, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaughan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollison, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furrer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Günthard, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freitas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klenerman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, M.</span><span> </span><span class="NLM_article-title">Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1069</span><span class="NLM_x">–</span> <span class="NLM_lpage">1082</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=1069-1082&author=S.+Gaudieriauthor=A.+Rauchauthor=K.+Pfafferottauthor=E.+Barnesauthor=W.+Chengauthor=G.+McCaughanauthor=N.+Shackelauthor=G.+P.+Jeffreyauthor=L.+Mollisonauthor=R.+Bakerauthor=H.+Furrerauthor=H.+F.+G%C3%BCnthardauthor=E.+Freitasauthor=I.+Humphreysauthor=P.+Klenermanauthor=S.+Mallalauthor=I.+Jamesauthor=S.+Robertsauthor=D.+Nolanauthor=M.+Lucas&title=Hepatitis+C+virus+drug+resistance+and+immune-driven+adaptations%3A+relevance+to+new+antiviral+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGaudieri%26aufirst%3DS.%26aulast%3DRauch%26aufirst%3DA.%26aulast%3DPfafferott%26aufirst%3DK.%26aulast%3DBarnes%26aufirst%3DE.%26aulast%3DCheng%26aufirst%3DW.%26aulast%3DMcCaughan%26aufirst%3DG.%26aulast%3DShackel%26aufirst%3DN.%26aulast%3DJeffrey%26aufirst%3DG.%2BP.%26aulast%3DMollison%26aufirst%3DL.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DFurrer%26aufirst%3DH.%26aulast%3DG%25C3%25BCnthard%26aufirst%3DH.%2BF.%26aulast%3DFreitas%26aufirst%3DE.%26aulast%3DHumphreys%26aufirst%3DI.%26aulast%3DKlenerman%26aufirst%3DP.%26aulast%3DMallal%26aufirst%3DS.%26aulast%3DJames%26aufirst%3DI.%26aulast%3DRoberts%26aufirst%3DS.%26aulast%3DNolan%26aufirst%3DD.%26aulast%3DLucas%26aufirst%3DM.%26atitle%3DHepatitis%2520C%2520virus%2520drug%2520resistance%2520and%2520immune-driven%2520adaptations%253A%2520relevance%2520to%2520new%2520antiviral%2520therapy%26jtitle%3DHepatology%26date%3D2009%26volume%3D49%26spage%3D1069%26epage%3D1082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bethell, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacé, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Preclinical characterization of BI 201335, a C-terminal carboxylic acid inhibitor of the hepatitis C virus NS3-NS4A protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4611</span><span class="NLM_x">–</span> <span class="NLM_lpage">4618</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=4611-4618&author=P.+W.+Whiteauthor=M.+Llin%C3%A0s-Brunetauthor=M.+Amadauthor=R.+C.+Bethellauthor=G.+Bolgerauthor=M.+G.+Cordingleyauthor=J.+Duanauthor=M.+Garneauauthor=L.+Lagac%C3%A9author=D.+Thibeaultauthor=G.+Kukolj&title=Preclinical+characterization+of+BI+201335%2C+a+C-terminal+carboxylic+acid+inhibitor+of+the+hepatitis+C+virus+NS3-NS4A+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26aulast%3DAmad%26aufirst%3DM.%26aulast%3DBethell%26aufirst%3DR.%2BC.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DLagac%25C3%25A9%26aufirst%3DL.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DPreclinical%2520characterization%2520of%2520BI%2520201335%252C%2520a%2520C-terminal%2520carboxylic%2520acid%2520inhibitor%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3-NS4A%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D4611%26epage%3D4618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbinnen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholliers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeiren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, Å.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">In vitro activity and preclinical profile of TMC435350, a potent hepatitis C virus protease inhibitor</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1377</span><span class="NLM_x">–</span> <span class="NLM_lpage">1385</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=1377-1385&author=T.-I.+Linauthor=O.+Lenzauthor=G.+Fanningauthor=T.+Verbinnenauthor=F.+Delouvroyauthor=A.+Scholliersauthor=K.+Vermeirenauthor=%C3%85.+Rosenquistauthor=M.+Edlundauthor=B.+Samuelssonauthor=L.+Vrangauthor=H.+de+Kockauthor=P.+Wigerinckauthor=P.+Raboissonauthor=K.+Simmen&title=In+vitro+activity+and+preclinical+profile+of+TMC435350%2C+a+potent+hepatitis+C+virus+protease+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DFanning%26aufirst%3DG.%26aulast%3DVerbinnen%26aufirst%3DT.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DScholliers%26aufirst%3DA.%26aulast%3DVermeiren%26aufirst%3DK.%26aulast%3DRosenquist%26aufirst%3D%25C3%2585.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DIn%2520vitro%2520activity%2520and%2520preclinical%2520profile%2520of%2520TMC435350%252C%2520a%2520potent%2520hepatitis%2520C%2520virus%2520protease%2520inhibitor%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D1377%26epage%3D1385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Soriano, V.</span><span> </span><span class="NLM_article-title">A new era for hepatitis C—new diagnostics tools and new weapons</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">441</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300098k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=440-441&author=V.+Soriano&title=A+new+era+for+hepatitis+C%E2%80%94new+diagnostics+tools+and+new+weapons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fml300098k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300098k%26sid%3Dliteratum%253Aachs%26aulast%3DSoriano%26aufirst%3DV.%26atitle%3DA%2520new%2520era%2520for%2520hepatitis%2520C%25E2%2580%2594new%2520diagnostics%2520tools%2520and%2520new%2520weapons%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D440%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gane, D.</span><span> </span><span class="NLM_article-title">Future hepatitis C virus treatment: interferon-sparing combinations</span> <span class="citation_source-journal">Liver Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=62-67&author=D.+Gane&title=Future+hepatitis+C+virus+treatment%3A+interferon-sparing+combinations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGane%26aufirst%3DD.%26atitle%3DFuture%2520hepatitis%2520C%2520virus%2520treatment%253A%2520interferon-sparing%2520combinations%26jtitle%3DLiver%2520Int.%26date%3D2011%26volume%3D31%26spage%3D62%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cordek, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bechtel, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maynard, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazmierski, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, C. E.</span><span> </span><span class="NLM_article-title">Targeting the NS5A protein on HCV: an emerging option</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">691</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1358%2Fdof.2011.036.09.1641618" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=23378700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1eis7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=691-711&author=D.+G.+Cordekauthor=J.+T.+Bechtelauthor=A.+T.+Maynardauthor=W.+M.+Kazmierskiauthor=C.+E.+Cameron&title=Targeting+the+NS5A+protein+on+HCV%3A+an+emerging+option"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16cR"><div class="casContent"><span class="casTitleNuber">16c</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the protein NS5A protein of HCV: an emerging option</span></div><div class="casAuthors">Cordek, D. G.; Bechtel, J. T.; Maynard, A. T.; Kazmierski, W. M.; Cameron, C. E.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">691-711</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Hepatitis C virus (HCV) infects more than 3% of the world's population, leading to an increased risk of cirrhosis and hepatocellular carcinoma.  The current std. of care, a combination of pegylated interferon alfa and ribavirin, is poorly tolerated and often ineffective against the most prevalent genotype of the virus, genotype 7.  The very recent approval of boceprevir and telaprevir, two HCV protease inhibitors, promises to significantly improve treatment options and outcomes.  In addn. to the viral protease NS3 and the viral polymerase NS5B, direct-acting antivirals are now in development against NS5A.  A multifunctional phosphoprotein, NS5A is essential to HCV genome replication, but has no known enzymic function.  Here we report how the design of small-mol. inhibitors against NS5A has evolved from promising monomers to highly potent dimeric compds. effective against many HCV genotypes.  We also highlight recent clin. data and how the inhibitors may bind to NS5A, itself capable of forming dimers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2lefIUXhmK7Vg90H21EOLACvtfcHk0lgVQpeIx-jHkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1eis7nE&md5=7e779d99491df4f8631c7848cb9e56dc</span></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1358%2Fdof.2011.036.09.1641618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2011.036.09.1641618%26sid%3Dliteratum%253Aachs%26aulast%3DCordek%26aufirst%3DD.%2BG.%26aulast%3DBechtel%26aufirst%3DJ.%2BT.%26aulast%3DMaynard%26aufirst%3DA.%2BT.%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DCameron%26aufirst%3DC.%2BE.%26atitle%3DTargeting%2520the%2520NS5A%2520protein%2520on%2520HCV%253A%2520an%2520emerging%2520option%26jtitle%3DDrugs%2520Future%26date%3D2011%26volume%3D36%26spage%3D691%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sulkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinestrosa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thuluvath, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lok, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wind-Rotolo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hindes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symonds, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquinelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D.</span><span> </span><span class="NLM_article-title">Potent viral suppression with all-oral combination of daclatasvir (NS5A inhibitor) and GS-7977 (NS5B inhibitor), ± ribavirin, in treatment-naive patients with chronic HCV GT1, 2, or 3</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S560</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=S560&issue=Suppl.+2&author=M.+Sulkowskiauthor=D.+Gardinerauthor=E.+Lawitzauthor=F.+Hinestrosaauthor=D.+Nelsonauthor=P.+Thuluvathauthor=M.+Rodriguez-Torresauthor=A.+Lokauthor=H.+Schwartzauthor=K.+R.+Reddyauthor=T.+Eleyauthor=M.+Wind-Rotoloauthor=J.-P.+Huangauthor=M.+Gaoauthor=F.+McPheeauthor=R.+Hindesauthor=B.+Symondsauthor=C.+Pasquinelliauthor=D.+Grasela&title=Potent+viral+suppression+with+all-oral+combination+of+daclatasvir+%28NS5A+inhibitor%29+and+GS-7977+%28NS5B+inhibitor%29%2C+%C2%B1+ribavirin%2C+in+treatment-naive+patients+with+chronic+HCV+GT1%2C+2%2C+or+3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSulkowski%26aufirst%3DM.%26aulast%3DGardiner%26aufirst%3DD.%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DHinestrosa%26aufirst%3DF.%26aulast%3DNelson%26aufirst%3DD.%26aulast%3DThuluvath%26aufirst%3DP.%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26aulast%3DLok%26aufirst%3DA.%26aulast%3DSchwartz%26aufirst%3DH.%26aulast%3DReddy%26aufirst%3DK.%2BR.%26aulast%3DEley%26aufirst%3DT.%26aulast%3DWind-Rotolo%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DJ.-P.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DHindes%26aufirst%3DR.%26aulast%3DSymonds%26aufirst%3DB.%26aulast%3DPasquinelli%26aufirst%3DC.%26aulast%3DGrasela%26aufirst%3DD.%26atitle%3DPotent%2520viral%2520suppression%2520with%2520all-oral%2520combination%2520of%2520daclatasvir%2520%2528NS5A%2520inhibitor%2529%2520and%2520GS-7977%2520%2528NS5B%2520inhibitor%2529%252C%2520%25C2%25B1%2520ribavirin%252C%2520in%2520treatment-naive%2520patients%2520with%2520chronic%2520HCV%2520GT1%252C%25202%252C%2520or%25203%26jtitle%3DJ.%2520Hepatol.%26date%3D2012%26volume%3D56%26issue%3DSuppl.%25202%26spage%3DS560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kolykhalov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihalik, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstone, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′-nontranslated region are essential for virus replication in vivo</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">2046</span><span class="NLM_x">–</span> <span class="NLM_lpage">2051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1128%2FJVI.74.4.2046-2051.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=10644379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptlGitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=2046-2051&author=A.+A.+Kolykhalovauthor=K.+Mihalikauthor=S.+M.+Feinstoneauthor=C.+M.+Rice&title=Hepatitis+C+virus-encoded+enzymatic+activities+and+conserved+RNA+elements+in+the+3%E2%80%B2-nontranslated+region+are+essential+for+virus+replication+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo</span></div><div class="casAuthors">Kolykhalov, Alexander A.; Mihalik, Kathy; Feinstone, Stephen M.; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2046-2051</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is a widespread major human health concern.  Significant obstacles in the study of this virus include the absence of a reliable tissue culture system and a small-animal model.  Recently, full-length HCV cDNA clones were constructed and HCV infection was successfully initiated in 2 chimpanzees by intrahepatic injection of in vitro-transcribed RNA.  In order to validate potential targets for development of anti-HCV therapeutics, 6 mutant derivs. of this prototype infectious clone were constructed.  Four clones contained point mutations ablating the activity of the NS2-3 protease, the NS3-4A serine protease, the NS3 NTPase/helicase, and the NS5B polymerase.  Two addnl. clones contained deletions encompassing all or part of the highly conserved 98-base sequence at the 3' terminus of the HCV genome RNA.  The RNA transcript from each of the 6 clones was injected intrahepatically into a chimpanzee.  No signs of HCV infection were detected in the 8 mo following the injection.  Inoculation of the same animal with nonmutant RNA transcripts resulted in productive HCV infection, as evidenced by viremia, elevated serum alanine aminotransferase, and HCV-specific seroconversion.  These data suggest that these 4 HCV-encoded enzymic activities and the conserved 3' terminal RNA element are essential for productive replication in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcxsUWOuM9sLVg90H21EOLACvtfcHk0lgVQpeIx-jHkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptlGitA%253D%253D&md5=69facc6778408ae96f31373f78c06600</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1128%2FJVI.74.4.2046-2051.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.74.4.2046-2051.2000%26sid%3Dliteratum%253Aachs%26aulast%3DKolykhalov%26aufirst%3DA.%2BA.%26aulast%3DMihalik%26aufirst%3DK.%26aulast%3DFeinstone%26aufirst%3DS.%2BM.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DHepatitis%2520C%2520virus-encoded%2520enzymatic%2520activities%2520and%2520conserved%2520RNA%2520elements%2520in%2520the%25203%25E2%2580%25B2-nontranslated%2520region%2520are%2520essential%2520for%2520virus%2520replication%2520in%2520vivo%26jtitle%3DJ.%2520Virol.%26date%3D2000%26volume%3D74%26spage%3D2046%26epage%3D2051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chinnaswamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarbrough, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palaninathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, C. T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijayaraghavan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demeler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchettini, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, C. C.</span><span> </span><span class="NLM_article-title">A locking mechanism regulates RNA synthesis and host protein interaction by the hepatitis C virus polymerase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">20535</span><span class="NLM_x">–</span> <span class="NLM_lpage">20546</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=20535-20546&author=S.+Chinnaswamyauthor=I.+Yarbroughauthor=S.+Palaninathanauthor=C.+T.+R.+Kumarauthor=V.+Vijayaraghavanauthor=B.+Demelerauthor=S.+M.+Lemonauthor=J.+C.+Sacchettiniauthor=C.+C.+Kao&title=A+locking+mechanism+regulates+RNA+synthesis+and+host+protein+interaction+by+the+hepatitis+C+virus+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChinnaswamy%26aufirst%3DS.%26aulast%3DYarbrough%26aufirst%3DI.%26aulast%3DPalaninathan%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DC.%2BT.%2BR.%26aulast%3DVijayaraghavan%26aufirst%3DV.%26aulast%3DDemeler%26aufirst%3DB.%26aulast%3DLemon%26aufirst%3DS.%2BM.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DKao%26aufirst%3DC.%2BC.%26atitle%3DA%2520locking%2520mechanism%2520regulates%2520RNA%2520synthesis%2520and%2520host%2520protein%2520interaction%2520by%2520the%2520hepatitis%2520C%2520virus%2520polymerase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D20535%26epage%3D20546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Harrus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed-El-Sayed, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simister, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triconnet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagedorn, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahias, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Astier-Gin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bressanelli, S.</span><span> </span><span class="NLM_article-title">Further insights into the roles of GTP and the C-terminus of the hepatitis C virus polymerase in the initiation of RNA synthesis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">32906</span><span class="NLM_x">–</span> <span class="NLM_lpage">32918</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=32906-32918&author=D.+Harrusauthor=N.+Ahmed-El-Sayedauthor=P.+C.+Simisterauthor=S.+Millerauthor=M.+Triconnetauthor=C.+H.+Hagedornauthor=K.+Mahiasauthor=F.+A.+Reyauthor=T.+Astier-Ginauthor=S.+Bressanelli&title=Further+insights+into+the+roles+of+GTP+and+the+C-terminus+of+the+hepatitis+C+virus+polymerase+in+the+initiation+of+RNA+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarrus%26aufirst%3DD.%26aulast%3DAhmed-El-Sayed%26aufirst%3DN.%26aulast%3DSimister%26aufirst%3DP.%2BC.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DTriconnet%26aufirst%3DM.%26aulast%3DHagedorn%26aufirst%3DC.%2BH.%26aulast%3DMahias%26aufirst%3DK.%26aulast%3DRey%26aufirst%3DF.%2BA.%26aulast%3DAstier-Gin%26aufirst%3DT.%26aulast%3DBressanelli%26aufirst%3DS.%26atitle%3DFurther%2520insights%2520into%2520the%2520roles%2520of%2520GTP%2520and%2520the%2520C-terminus%2520of%2520the%2520hepatitis%2520C%2520virus%2520polymerase%2520in%2520the%2520initiation%2520of%2520RNA%2520synthesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D32906%26epage%3D32918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Bressanelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roussel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Incitti, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitale, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, F. A.</span><span> </span><span class="NLM_article-title">Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">13034</span><span class="NLM_x">–</span> <span class="NLM_lpage">13039</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1073%2Fpnas.96.23.13034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=10557268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADyaK1MXns1Gmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=13034-13039&author=S.+Bressanelliauthor=L.+Tomeiauthor=A.+Rousselauthor=I.+Incittiauthor=R.+L.+Vitaleauthor=M.+Mathieuauthor=R.+De+Francescoauthor=F.+A.+Rey&title=Crystal+structure+of+the+RNA-dependent+RNA+polymerase+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus</span></div><div class="casAuthors">Bressanelli, Stephane; Tomei, Licia; Roussel, Alain; Incitti, Ilario; Vitale, Rosa Letizia; Mathieu, Magali; De Francesco, Raffaele; Rey, Felix A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">13034-13039</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The crystal structure of the RNA-dependent RNA polymerase (RNA replicase) (I) of hepatitis C virus, a major human pathogen, is reported to 2.8 Å resoln.  I is a key target for developing specific antiviral therapy.  The structure of the catalytic domain contained 531 residues folded in the characteristic fingers, palm, and thumb subdomains.  The fingers subdomain contained a region, the "fingertips," that shared the same fold with reverse transcriptases.  Superposition to the available structures of the latter showed that residues from the palm and fingertips were structurally equiv.  In addn., it showed that hepatitis C virus I was crystd. in a closed fingers conformation, similar to HIV-1 reverse transcriptase in ternary complex with DNA and dTTP.  This superposition revealed the majority of the amino acid residues of the hepatitis C virus enzyme that are likely to be implicated in binding to the replicating RNA mol. and to the incoming NTP.  It also suggested a rearrangement of the thumb domain as well as a possible concerted movement of thumb and fingertips during translocation of the RNA template-primer in successive polymn. rounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoMMlZvielKLVg90H21EOLACvtfcHk0lj0T9b-ie5PpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXns1Gmsrk%253D&md5=2ba97997c8a8e24c0db560260fb5ea9a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.23.13034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.23.13034%26sid%3Dliteratum%253Aachs%26aulast%3DBressanelli%26aufirst%3DS.%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DRoussel%26aufirst%3DA.%26aulast%3DIncitti%26aufirst%3DI.%26aulast%3DVitale%26aufirst%3DR.%2BL.%26aulast%3DMathieu%26aufirst%3DM.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DRey%26aufirst%3DF.%2BA.%26atitle%3DCrystal%2520structure%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D13034%26epage%3D13039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="note"><p class="first last">For reviews on NS5B inhibitors see, for example, the following: </p></div><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1517%2F13543770802672598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVCks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=145-164&author=P.+L.+Beaulieu&title=Recent+advances+in+the+development+of+NS5B+polymerase+inhibitors+for+the+treatment+of+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection</span></div><div class="casAuthors">Beaulieu, Pierre L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-164</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  170 To 200 million people worldwide are believed to suffer from chronic hepatitis C virus (HCV) infection, a blood-born disease that targets the liver and progresses to organ cirrhosis and primary cancer in a significant proportion of patients.  The currently available treatment has limited efficacy and suffers from restricting side effects.  HCV infection is the principal cause of liver transplant in industrialized nations and between 8000 and 10,000 deaths result annually from the disease in the United States alone.  Virus-specific, more efficacious, and better-tolerated anti-HCV therapies are thus required to address the unmet medical need.  Objective: To review progress achieved since 2005 in the development of HCV NS5B polymerase inhibitors as potential therapy for the treatment of HCV infection with a primary focus on available patent and medical literature.  Results/conclusion: Several classes of small-mol. inhibitors of HCV NS5B have progressed into clin. development and demonstrated efficacy in reducing viral load in infected patients.  The results so far provide an encouraging foundation for the development of novel, more tolerable therapies and addressing emergence of resistance through combination of antiviral agents with complementary mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo8VVFJs4oSbVg90H21EOLACvtfcHk0lj0T9b-ie5PpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVCks74%253D&md5=64b78562e2b4e3e8a166fdabf14f7efe</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1517%2F13543770802672598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770802672598%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520NS5B%2520polymerase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D145%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Watkins, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, L. S.</span><span> </span><span class="NLM_article-title">HCV NS5B polymerase inhibitors</span> <span class="citation_source-journal">Cur. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=20597029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSju7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=441-465&author=W.+J.+Watkinsauthor=A.+S.+Rayauthor=L.+S.+Chong&title=HCV+NS5B+polymerase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">HCV NS5B polymerase inhibitors</span></div><div class="casAuthors">Watkins, William J.; Ray, Adrian S.; Chong, Lee S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-465</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">2040-3437</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  In the past decade, intensive efforts have focused on the discovery of both nucleos(t)ide and non-nucleoside inhibitors of the HCV NS5B polymerase.  These efforts have resulted in several promising agents advancing in clin. development.  This review traces the history of optimization of the chem. series that have led to the development of clin. candidates, and summarizes recent developments in the field, with emphasis on clin. efficacy and impact for future combination studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf6PfCo0V5R7Vg90H21EOLACvtfcHk0lj0T9b-ie5PpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSju7zJ&md5=f0e5144b72864e6eb1a2f4b13b1b916e</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DW.%2BJ.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DChong%26aufirst%3DL.%2BS.%26atitle%3DHCV%2520NS5B%2520polymerase%2520inhibitors%26jtitle%3DCur.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2010%26volume%3D13%26spage%3D441%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sofia, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, B. S.</span><span> </span><span class="NLM_article-title">Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2532</span><span class="NLM_x">–</span> <span class="NLM_lpage">2531</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2532-2531&author=M.+J.+Sofiaauthor=W.+Changauthor=P.+A.+Furmanauthor=R.+T.+Mosleyauthor=B.+S.+Ross&title=Nucleoside%2C+nucleotide%2C+and+non-nucleoside+inhibitors+of+hepatitis+C+virus+NS5B+RNA-dependent+RNA-polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DMosley%26aufirst%3DR.%2BT.%26aulast%3DRoss%26aufirst%3DB.%2BS.%26atitle%3DNucleoside%252C%2520nucleotide%252C%2520and%2520non-nucleoside%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS5B%2520RNA-dependent%2520RNA-polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2532%26epage%3D2531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Brown, N. A.</span><span> </span><span class="NLM_article-title">Progress towards improving antiviral therapy for hepatitis C virus polymerase inhibitors. Part 1: nucleoside analogues</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">709</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=709-725&author=N.+A.+Brown&title=Progress+towards+improving+antiviral+therapy+for+hepatitis+C+virus+polymerase+inhibitors.+Part+1%3A+nucleoside+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DN.%2BA.%26atitle%3DProgress%2520towards%2520improving%2520antiviral%2520therapy%2520for%2520hepatitis%2520C%2520virus%2520polymerase%2520inhibitors.%2520Part%25201%253A%2520nucleoside%2520analogues%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D18%26spage%3D709%26epage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Furman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, E.</span><span> </span><span class="NLM_article-title">Nucleoside analog inhibitors of hepatitis C virus replication: recent advances, challenges and trends</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1429</span><span class="NLM_x">–</span> <span class="NLM_lpage">1452</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.4155%2Ffmc.09.88" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=21426058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFSit77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=1429-1452&author=P.+A.+Furmanauthor=A.+M.+Lamauthor=E.+Murakami&title=Nucleoside+analog+inhibitors+of+hepatitis+C+virus+replication%3A+recent+advances%2C+challenges+and+trends"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleoside analog inhibitors of hepatitis C viral replication: recent advances, challenges and trends</span></div><div class="casAuthors">Furman, Phillip A.; Lam, Angela M.; Murakami, Eisuke</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1429-1452</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Chronic hepatitis C virus (HCV) infection is a global health problem, with over 170 million people infected worldwide.  The current therapy, pegylated interferon (PEG-IFN) plus ribavirin (RBV), provides only approx. a 40% sustained virol. response (undetectable HCV RNA for greater than 24 wk after cessation of therapy), in genotype I-infected individuals.  In addn. to the limited sustained virol. response, PEG-IFN/RBV treatment is assocd. with serious adverse effects.  Nucleosides have long been the cornerstone of antiviral therapy because of their proven efficacy and high barrier to resistance.  Through the use of surrogate viruses or the HCV subgenomic replicon, several classes of nucleoside analogs or their monophosphate prodrugs have been identified that inhibit HCV RNA replication.  Nucleoside analogs that possess the 2'-C-Me modification vary in their ability to be phosphorylated and to act as alternative substrate inhibitors of the HCV RNA polymerase.  Herein, we discuss various classes of nucleoside inhibitors, with a focus on available structure-activity relationships, their mode of action and resistance profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuFIjUiU5KFbVg90H21EOLACvtfcHk0liFwO1mdYpa0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFSit77F&md5=d512189b8d8f1380f8bc10a5c0438c1c</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.4155%2Ffmc.09.88&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.09.88%26sid%3Dliteratum%253Aachs%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DMurakami%26aufirst%3DE.%26atitle%3DNucleoside%2520analog%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520replication%253A%2520recent%2520advances%252C%2520challenges%2520and%2520trends%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2009%26volume%3D1%26spage%3D1429%26epage%3D1452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sofia, M. J.</span><span> </span><span class="NLM_article-title">Nucleotide prodrugs for HCV therapy</span> <span class="citation_source-journal">Antiviral Chem. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=23-49&author=M.+J.+Sofia&title=Nucleotide+prodrugs+for+HCV+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26atitle%3DNucleotide%2520prodrugs%2520for%2520HCV%2520therapy%26jtitle%3DAntiviral%2520Chem.%2520Chemother.%26date%3D2011%26volume%3D22%26spage%3D23%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyaguru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nájera, I.</span><span> </span><span class="NLM_article-title">In vitro selected Con1 subgenomic replicons resistant to 2′-<i>C</i>-methyl-cytidine or to R1479 show lack of cross-resistance</span> <span class="citation_source-journal">Virology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x">, </span> <span class="NLM_fpage">340</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2006&pages=340-348&author=S.+Le+Pogamauthor=W.-R.+Jiangauthor=V.+Levequeauthor=S.+Rajyaguruauthor=H.+Maauthor=H.+Kangauthor=S.+Jiangauthor=M.+Singerauthor=S.+Aliauthor=K.+Klumppauthor=D.+Smithauthor=J.+Symonsauthor=N.+Cammackauthor=I.+N%C3%A1jera&title=In+vitro+selected+Con1+subgenomic+replicons+resistant+to+2%E2%80%B2-C-methyl-cytidine+or+to+R1479+show+lack+of+cross-resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DW.-R.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DSinger%26aufirst%3DM.%26aulast%3DAli%26aufirst%3DS.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DSymons%26aufirst%3DJ.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DN%25C3%25A1jera%26aufirst%3DI.%26atitle%3DIn%2520vitro%2520selected%2520Con1%2520subgenomic%2520replicons%2520resistant%2520to%25202%25E2%2580%25B2-C-methyl-cytidine%2520or%2520to%2520R1479%2520show%2520lack%2520of%2520cross-resistance%26jtitle%3DVirology%26date%3D2006%26volume%3D351%26spage%3D340%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McCown, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyaguru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nájera, I.</span><span> </span><span class="NLM_article-title">The hepatitis C virus replicon presents a higher barrier to resistance to nucleoside analogs than to non-nucleoside polymerase or protease inhibitors</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1604</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=1604-1612&author=M.+F.+McCownauthor=S.+Rajyaguruauthor=S.+Le+Pogamauthor=S.+Aliauthor=W.-R.+Jiangauthor=H.+Kangauthor=J.+Symonsauthor=N.+Cammackauthor=I.+N%C3%A1jera&title=The+hepatitis+C+virus+replicon+presents+a+higher+barrier+to+resistance+to+nucleoside+analogs+than+to+non-nucleoside+polymerase+or+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCown%26aufirst%3DM.%2BF.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DAli%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DW.-R.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DSymons%26aufirst%3DJ.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DN%25C3%25A1jera%26aufirst%3DI.%26atitle%3DThe%2520hepatitis%2520C%2520virus%2520replicon%2520presents%2520a%2520higher%2520barrier%2520to%2520resistance%2520to%2520nucleoside%2520analogs%2520than%2520to%2520non-nucleoside%2520polymerase%2520or%2520protease%2520inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D1604%26epage%3D1612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seshaadri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewing, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symonds, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLaRosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nájera, I.</span><span> </span><span class="NLM_article-title">RG1728 alone or in combination with pegylated interferon-α2a and ribavirin prevents hepatitis C virus (HCV) replication and selection of resistant variants in HCV-infected patients</span> <span class="citation_source-journal">J. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">1510</span><span class="NLM_x">–</span> <span class="NLM_lpage">1519</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1086%2F656774" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=20942646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOns73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2010&pages=1510-1519&author=S.+Le+Pogamauthor=A.+Seshaadriauthor=A.+Ewingauthor=H.+Kangauthor=A.+Kosakaauthor=J.-M.+Yanauthor=M.+Berreyauthor=B.+Symondsauthor=A.+DeLaRosaauthor=N.+Cammackauthor=I.+N%C3%A1jera&title=RG1728+alone+or+in+combination+with+pegylated+interferon-%CE%B12a+and+ribavirin+prevents+hepatitis+C+virus+%28HCV%29+replication+and+selection+of+resistant+variants+in+HCV-infected+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">RG7128 alone or in combination with pegylated interferon-α2a and ribavirin prevents hepatitis C virus (HCV) replication and selection of resistant variants in HCV-infected patients</span></div><div class="casAuthors">Le Pogam, Sophie; Seshaadri, Amritha; Ewing, Aren; Kang, Hyunsoon; Kosaka, Alan; Yan, Jun-Mei; Berrey, Michelle; Symonds, Bill; de la Rosa, Abel; Cammack, Nick; Najera, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1510-1519</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Introduction: RG7128 (prodrug of PSI-6130) shows potent antiviral efficacy in patients infected with hepatitis C virus (HCV) genotypes 1, 2, or 3, with mean viral load decreases of 2.7 and 5 log10 IU/mL, resp., assocd. with 1500-mg doses twice daily after monotherapy for 2 wk and with 1000-mg and 1500-mg doses twice daily after treatment in combination with the std. of care (SOC) for 4 wk.  Results: From 32 patients treated with RG7128 monotherapy for 2 wk, marginal viral load rebound was obsd. in 3 HCV genotype 1-infected patients, whereas partial response was obsd. in 2 genotype 1-infected patients.  From 85 patients receiving RG7128 in combination with SOC, 1 HCV genotype 1-infected patient experienced a viral rebound, and 2 genotype 3-infected patients experienced a transient rebound.  Five genotype 1-infected patients had an HCV load of >1000 IU/mL at the end of 4-wk treatment.  No viral resistance was obsd., per NS5B sequencing and phenotypic studies.  PSI-6130 resistance substitution sS282T needs to be bpresent at levels of ≥90% within a patient's quasispecies to confer low-level resistance.  No evidence of S282T was found by population or clonal sequence analyses.  Conclusions: The requirement for a predominant S282T mutant quasispecies, its low replication capacity, and the low-level resistance it confers probably contribute to the lack of RG7128 resistance obsd. in HCV-infected patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDyELFs5GZmLVg90H21EOLACvtfcHk0liFwO1mdYpa0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOns73J&md5=09a1bed4eb0f3a1ed2a35051eafaac7e</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1086%2F656774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F656774%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DSeshaadri%26aufirst%3DA.%26aulast%3DEwing%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DKosaka%26aufirst%3DA.%26aulast%3DYan%26aufirst%3DJ.-M.%26aulast%3DBerrey%26aufirst%3DM.%26aulast%3DSymonds%26aufirst%3DB.%26aulast%3DDeLaRosa%26aufirst%3DA.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DN%25C3%25A1jera%26aufirst%3DI.%26atitle%3DRG1728%2520alone%2520or%2520in%2520combination%2520with%2520pegylated%2520interferon-%25CE%25B12a%2520and%2520ribavirin%2520prevents%2520hepatitis%2520C%2520virus%2520%2528HCV%2529%2520replication%2520and%2520selection%2520of%2520resistant%2520variants%2520in%2520HCV-infected%2520patients%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2010%26volume%3D202%26spage%3D1510%26epage%3D1519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Gane, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stedman, C. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angus, Q. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritchie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elston, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ipe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morcos, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baher, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nájera, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopatin, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrey, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradford, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laughlin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shulman, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. F.</span><span> </span><span class="NLM_article-title">Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomized, double-blind, placebo-controlled, dose-escalation trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">1467</span><span class="NLM_x">–</span> <span class="NLM_lpage">1475</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=2010&pages=1467-1475&author=E.+J.+Ganeauthor=S.+K.+Robertsauthor=C.+A.+M.+Stedmanauthor=Q.+W.+Angusauthor=B.+Ritchieauthor=R.+Elstonauthor=D.+Ipeauthor=P.+N.+Morcosauthor=L.+Baherauthor=I.+N%C3%A1jeraauthor=T.+Chuauthor=U.+Lopatinauthor=M.+M.+Berreyauthor=W.+Bradfordauthor=M.+Laughlinauthor=N.+S.+Shulmanauthor=P.+F.+Smith&title=Oral+combination+therapy+with+a+nucleoside+polymerase+inhibitor+%28RG7128%29+and+danoprevir+for+chronic+hepatitis+C+genotype+1+infection+%28INFORM-1%29%3A+a+randomized%2C+double-blind%2C+placebo-controlled%2C+dose-escalation+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGane%26aufirst%3DE.%2BJ.%26aulast%3DRoberts%26aufirst%3DS.%2BK.%26aulast%3DStedman%26aufirst%3DC.%2BA.%2BM.%26aulast%3DAngus%26aufirst%3DQ.%2BW.%26aulast%3DRitchie%26aufirst%3DB.%26aulast%3DElston%26aufirst%3DR.%26aulast%3DIpe%26aufirst%3DD.%26aulast%3DMorcos%26aufirst%3DP.%2BN.%26aulast%3DBaher%26aufirst%3DL.%26aulast%3DN%25C3%25A1jera%26aufirst%3DI.%26aulast%3DChu%26aufirst%3DT.%26aulast%3DLopatin%26aufirst%3DU.%26aulast%3DBerrey%26aufirst%3DM.%2BM.%26aulast%3DBradford%26aufirst%3DW.%26aulast%3DLaughlin%26aufirst%3DM.%26aulast%3DShulman%26aufirst%3DN.%2BS.%26aulast%3DSmith%26aufirst%3DP.%2BF.%26atitle%3DOral%2520combination%2520therapy%2520with%2520a%2520nucleoside%2520polymerase%2520inhibitor%2520%2528RG7128%2529%2520and%2520danoprevir%2520for%2520chronic%2520hepatitis%2520C%2520genotype%25201%2520infection%2520%2528INFORM-1%2529%253A%2520a%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%252C%2520dose-escalation%2520trial%26jtitle%3DLancet%26date%3D2010%26volume%3D376%26spage%3D1467%26epage%3D1475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chinnaswamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujisaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, C. C.</span><span> </span><span class="NLM_article-title">Regulation of de novo-initiated RNA synthesis in hepatitis C virus RNA-dependent RNA polymerase by intermolecular interactions</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">5923</span><span class="NLM_x">–</span> <span class="NLM_lpage">5935</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1128%2FJVI.02446-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=20375156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsFKnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2010&pages=5923-5935&author=S.+Chinnaswamyauthor=A.+Muraliauthor=P.+Liauthor=K.+Fujisakiauthor=C.+C.+Kao&title=Regulation+of+de+novo-initiated+RNA+synthesis+in+hepatitis+C+virus+RNA-dependent+RNA+polymerase+by+intermolecular+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of de novo-initiated RNA synthesis in hepatitis C virus RNA-dependent RNA polymerase by intermolecular interactions</span></div><div class="casAuthors">Chinnaswamy, S.; Murali, A.; Li, P.; Fujisaki, K.; Kao, C. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5923-5935</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) has been proposed to change conformations in assocn. with RNA synthesis and to interact with cellular proteins.  In vitro, the RdRp can initiate de novo from the ends of single-stranded RNA or extend a primed RNA template.  The interactions between the Δ1 loop and thumb domain in NS5B are required for de novo initiation, although it is unclear whether these interactions are within an NS5B monomer or are part of a higher-order NS5B oligomeric complex.  This work seeks to address how polymerase conformation and/or oligomerization affects de novo initiation.  It has been shown that an increasing enzyme concn. increases de novo initiation by the genotype 1b and 2a RdRps while primer extension reactions are not affected or inhibited under similar conditions.  Initiation-defective mutants of the HCV polymerase can increase de novo initiation by the wild-type (WT) polymerase.  GTP was also found to stimulate de novo initiation.  The results support a model in which the de novo initiation-competent conformation of the RdRp is stimulated by oligomeric contacts between individual subunits.  Using electron microscopy and single-mol. reconstruction, visualization of the low-resoln. conformations of a dimer of a de novo initiation-competent HCV RdRp was attempted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAwIMqPQPIRLVg90H21EOLACvtfcHk0lgnA2ViHTHS6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsFKnsrw%253D&md5=2cceff47be925af979644d56d4e3b499</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1128%2FJVI.02446-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02446-09%26sid%3Dliteratum%253Aachs%26aulast%3DChinnaswamy%26aufirst%3DS.%26aulast%3DMurali%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DFujisaki%26aufirst%3DK.%26aulast%3DKao%26aufirst%3DC.%2BC.%26atitle%3DRegulation%2520of%2520de%2520novo-initiated%2520RNA%2520synthesis%2520in%2520hepatitis%2520C%2520virus%2520RNA-dependent%2520RNA%2520polymerase%2520by%2520intermolecular%2520interactions%26jtitle%3DJ.%2520Virol.%26date%3D2010%26volume%3D84%26spage%3D5923%26epage%3D5935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rigat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudyma, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentles, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beno, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S. B.</span><span> </span><span class="NLM_article-title">Ligand-induced changes in hepatitis C virus NS5B polymerase structure</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2010&pages=197-206&author=K.+Rigatauthor=Y.+Wangauthor=T.+W.+Hudymaauthor=M.+Dingauthor=X.+Zhengauthor=R.+G.+Gentlesauthor=B.+R.+Benoauthor=M.+Gaoauthor=S.+B.+Roberts&title=Ligand-induced+changes+in+hepatitis+C+virus+NS5B+polymerase+structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRigat%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHudyma%26aufirst%3DT.%2BW.%26aulast%3DDing%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DGentles%26aufirst%3DR.%2BG.%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DRoberts%26aufirst%3DS.%2BB.%26atitle%3DLigand-induced%2520changes%2520in%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%2520structure%26jtitle%3DAntiviral%2520Res.%26date%3D2010%26volume%3D88%26spage%3D197%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, S. T.</span><span> </span><span class="NLM_article-title">Non-nucleoside inhibitors of hepatitis C virus polymerase: current progress and future challenges</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.4155%2Ffmc.09.148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=21426049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVWgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=121-141&author=H.+Liauthor=S.+T.+Shi&title=Non-nucleoside+inhibitors+of+hepatitis+C+virus+polymerase%3A+current+progress+and+future+challenges"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Non-nucleoside inhibitors of hepatitis C virus polymerase: current progress and future challenges</span></div><div class="casAuthors">Li, Hui; Shi, Stephanie T.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">121-141</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The current std. of care for hepatitis C virus (HCV) infection is a combination of PEGylated interferon and ribavirin, which offer limited efficacy and significant side effects.  Novel HCV-specific inhibitors, including those directed at the viral polymerase, have become the focus of HCV drug-discovery efforts in the past decade.  In addn. to the active site targeted by traditional nucleoside inhibitors, at least four different allosteric-binding sites have been reported for the HCV polymerase, which offer ample opportunities for small-mol. inhibitors.  In this review, we summarize the recent progress in the discovery of non-nucleoside HCV polymerase inhibitors with a focus on novel chem. matters, their clin. efficacy, safety and potential for combination therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnYvEwqRM0-bVg90H21EOLACvtfcHk0lgnA2ViHTHS6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVWgug%253D%253D&md5=311bcf9ff7adf740674c2d8333fb25c2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4155%2Ffmc.09.148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.09.148%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DShi%26aufirst%3DS.%2BT.%26atitle%3DNon-nucleoside%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520polymerase%253A%2520current%2520progress%2520and%2520future%2520challenges%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2010%26volume%3D2%26spage%3D121%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sofia, M. J.; Furman, P. A.; Symonds, W. T.</span><span> </span><span class="NLM_article-title">2′-<i>F</i>-2′-<i>C</i>-Methyl Nucleosides and Nucleotides for the Treatment of Hepatitis C Virus: From Discovery to the Clinic</span>. In  <span class="citation_source-book">Accounts in Drug Discovery: Case Studies in Medicinal Chemistry</span>; <span class="NLM_contrib-group">Barrish, J. C.; Carter, P. H.; Cheng, P. T. W.; Zhaler, R.</span>, Eds.; <span class="NLM_publisher-name">Royal Society of Chemistry</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">4</span>, pp  <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Fjm3006788&amp;key=10.1039%2F9781849731980-00238" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=238-266&author=M.+J.+Sofia&author=P.+A.+Furman&author=W.+T.+Symondsauthor=J.+C.+Barrish&author=P.+H.+Carter&author=P.+T.+W.+Cheng&author=R.+Zhaler&title=Accounts+in+Drug+Discovery%3A+Case+Studies+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1039%2F9781849731980-00238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849731980-00238%26sid%3Dliteratum%253Aachs%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26atitle%3D2%25E2%2580%25B2-F-2%25E2%2580%25B2-C-Methyl%2520Nucleosides%2520and%2520Nucleotides%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C%2520Virus%253A%2520From%2520Discovery%2520to%2520the%2520Clinic%26btitle%3DAccounts%2520in%2520Drug%2520Discovery%253A%2520Case%2520Studies%2520in%2520Medicinal%2520Chemistry%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26pub%3DRoyal%2520Society%2520of%2520Chemistry%26date%3D2010%26volume%3D4%26spage%3D238%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhou, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietropaolo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan-Bolyai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayers, D.</span><span> </span><span class="NLM_article-title">Safety and pharmacokinetics of IDX184, a liver-targeted nucleotide polymerase inhibitor of hepatitis C virus, in healthy subjects</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">76</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=76-81&author=X.+J.+Zhouauthor=K.+Pietropaoloauthor=J.+Chenauthor=S.+Khanauthor=J.+Sullivan-Bolyaiauthor=D.+Mayers&title=Safety+and+pharmacokinetics+of+IDX184%2C+a+liver-targeted+nucleotide+polymerase+inhibitor+of+hepatitis+C+virus%2C+in+healthy+subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DX.%2BJ.%26aulast%3DPietropaolo%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DSullivan-Bolyai%26aufirst%3DJ.%26aulast%3DMayers%26aufirst%3DD.%26atitle%3DSafety%2520and%2520pharmacokinetics%2520of%2520IDX184%252C%2520a%2520liver-targeted%2520nucleotide%2520polymerase%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%252C%2520in%2520healthy%2520subjects%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2011%26volume%3D55%26spage%3D76%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sofia, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagaratham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachakonda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espiritu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steuer, H. M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span> </span><span class="NLM_article-title">Discovery of a β-<span class="smallcaps smallerCapital">d</span>-2′-deoxy-2′-α-fluoro-2′-β-<i>C</i>-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7202</span><span class="NLM_x">–</span> <span class="NLM_lpage">7218</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100863x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7202-7218&author=M.+J.+Sofiaauthor=D.+Baoauthor=W.+Changauthor=J.+Duauthor=D.+Nagarathamauthor=S.+Rachakondaauthor=P.+G.+Reddyauthor=B.+S.+Rossauthor=P.+Wangauthor=H.-R.+Zhangauthor=S.+Bansalauthor=C.+Espirituauthor=M.+Keilmanauthor=A.+M.+Lamauthor=H.+M.+M.+Steuerauthor=C.+Niuauthor=M.+J.+Ottoauthor=P.+A.+Furman&title=Discovery+of+a+%CE%B2-d-2%E2%80%B2-deoxy-2%E2%80%B2-%CE%B1-fluoro-2%E2%80%B2-%CE%B2-C-methyluridine+nucleotide+prodrug+%28PSI-7977%29+for+the+treatment+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24cR"><div class="casContent"><span class="casTitleNuber">24c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a β-D-2'-Deoxy-2'-α-fluoro-2'-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus</span></div><div class="casAuthors">Sofia, Michael J.; Bao, Donghui; Chang, Wonsuk; Du, Jinfa; Nagarathnam, Dhanapalan; Rachakonda, Suguna; Reddy, P. Ganapati; Ross, Bruce S.; Wang, Peiyuan; Zhang, Hai-Ren; Bansal, Shalini; Espiritu, Christine; Keilman, Meg; Lam, Angela M.; Steuer, Holly M. Micolochick; Niu, Congrong; Otto, Michael J.; Furman, Phillip A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7202-7218</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) is a global health problem requiring novel approaches for effective treatment of this disease.  The HCV NS5B polymerase has been demonstrated to be a viable target for the development of HCV therapies.  β-D-2'-Deoxy-2'-α-fluoro-2'-β-C-Me nucleosides are selective inhibitors of the HCV NS5B polymerase and have demonstrated potent activity in the clinic.  Phosphoramidate prodrugs of the 5'-phosphate deriv. of the β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine nucleoside were prepd. and showed significant potency in the HCV subgenomic replicon assay (<1 μM) and produced high levels of triphosphate 6 in primary hepatocytes and in the livers of rats, dogs, and monkeys when administered in vivo.  The single diastereomer 51 of diastereomeric mixt. 14 was crystd., and an X-ray structure was detd. establishing the phosphoramidate stereochem. as Sp, thus correlating for the first time the stereochem. of a phosphoramidate prodrug with biol. activity.  51 (PSI-7977) was selected as a clin. development candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWAkLi9-odWbVg90H21EOLACvtfcHk0liUX4hv30xSmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtb%252FO&md5=33d371e557e9d70562a326f97798f45c</span></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=10.1021%2Fjm100863x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100863x%26sid%3Dliteratum%253Aachs%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DBao%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DNagaratham%26aufirst%3DD.%26aulast%3DRachakonda%26aufirst%3DS.%26aulast%3DReddy%26aufirst%3DP.%2BG.%26aulast%3DRoss%26aufirst%3DB.%2BS.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DH.-R.%26aulast%3DBansal%26aufirst%3DS.%26aulast%3DEspiritu%26aufirst%3DC.%26aulast%3DKeilman%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DSteuer%26aufirst%3DH.%2BM.%2BM.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DDiscovery%2520of%2520a%2520%25CE%25B2-d-2%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-%25CE%25B1-fluoro-2%25E2%2580%25B2-%25CE%25B2-C-methyluridine%2520nucleotide%2520prodrug%2520%2528PSI-7977%2529%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7202%26epage%3D7218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madela, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aljarah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernachio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorovits, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganguly, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolykhalov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muhammad, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patti, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, G.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of a novel double prodrug: INX-08189. A new clinical candidate for hepatitis C virus</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4850</span><span class="NLM_x">–</span> <span class="NLM_lpage">4854</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4850-4854&author=C.+McGuiganauthor=K.+Madelaauthor=M.+Aljarahauthor=A.+Gillesauthor=A.+Brancaleauthor=N.+Zontaauthor=S.+Chamberlainauthor=J.+Vernachioauthor=J.+Hutchinsauthor=A.+Hallauthor=B.+Amesauthor=E.+Gorovitsauthor=B.+Gangulyauthor=A.+Kolykhalovauthor=J.+Wangauthor=J.+Muhammadauthor=J.+M.+Pattiauthor=G.+Henson&title=Design%2C+synthesis+and+evaluation+of+a+novel+double+prodrug%3A+INX-08189.+A+new+clinical+candidate+for+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DMadela%26aufirst%3DK.%26aulast%3DAljarah%26aufirst%3DM.%26aulast%3DGilles%26aufirst%3DA.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DZonta%26aufirst%3DN.%26aulast%3DChamberlain%26aufirst%3DS.%26aulast%3DVernachio%26aufirst%3DJ.%26aulast%3DHutchins%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DA.%26aulast%3DAmes%26aufirst%3DB.%26aulast%3DGorovits%26aufirst%3DE.%26aulast%3DGanguly%26aufirst%3DB.%26aulast%3DKolykhalov%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMuhammad%26aufirst%3DJ.%26aulast%3DPatti%26aufirst%3DJ.%2BM.%26aulast%3DHenson%26aufirst%3DG.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520a%2520novel%2520double%2520prodrug%253A%2520INX-08189.%2520A%2520new%2520clinical%2520candidate%2520for%2520hepatitis%2520C%2520virus%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4850%26epage%3D4854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kadow, J. F.; Gentles, R.; Ding, M.; Bender, J.; Bergstrom, C.; Grant-Young, K.; Hewawasam, P.; Hudyma, T.; Martin, S.; Nickel, A.; Regueiro-Ren, A.; Tu, Y.; Yang, Z.; Yeung, K.-S.; Zheng, X.; Chen, B.-C.; Chao, S.; Sun, J.-H.; Li, J.; Mathur, A.; Smith, D.; Wu, D.-R.; Beno, B.; Hanumegowda, U.; Knipe, J.; Parker, D. D.; Zhuo, X.; Lemm, J.; Liu, M.; Pelosi, L.; Rigat, K.; Voss, S.; Wang; Y.; Wang, Y.-K.; Colonno, R.; Gao, M.; Roberts, S. B.; Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Discovery of BMS-791325, an Allosteric NS5B Replicase Inhibitor for the Treatment of Hepatitis C</span>. Presented at the 243rd National Meeting of the American Chemical Society, San Diego, CA, March 25–29, 2012; MEDI-23.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kadow%2C+J.+F.%3B+Gentles%2C+R.%3B+Ding%2C+M.%3B+Bender%2C+J.%3B+Bergstrom%2C+C.%3B+Grant-Young%2C+K.%3B+Hewawasam%2C+P.%3B+Hudyma%2C+T.%3B+Martin%2C+S.%3B+Nickel%2C+A.%3B+Regueiro-Ren%2C+A.%3B+Tu%2C+Y.%3B+Yang%2C+Z.%3B+Yeung%2C+K.-S.%3B+Zheng%2C+X.%3B+Chen%2C+B.-C.%3B+Chao%2C+S.%3B+Sun%2C+J.-H.%3B+Li%2C+J.%3B+Mathur%2C+A.%3B+Smith%2C+D.%3B+Wu%2C+D.-R.%3B+Beno%2C+B.%3B+Hanumegowda%2C+U.%3B+Knipe%2C+J.%3B+Parker%2C+D.+D.%3B+Zhuo%2C+X.%3B+Lemm%2C+J.%3B+Liu%2C+M.%3B+Pelosi%2C+L.%3B+Rigat%2C+K.%3B+Voss%2C+S.%3B+Wang%3B+Y.%3B+Wang%2C+Y.-K.%3B+Colonno%2C+R.%3B+Gao%2C+M.%3B+Roberts%2C+S.+B.%3B+Meanwell%2C+N.+A.+Discovery+of+BMS-791325%2C+an+Allosteric+NS5B+Replicase+Inhibitor+for+the+Treatment+of+Hepatitis+C.+Presented+at+the+243rd+National+Meeting+of+the+American+Chemical+Society%2C+San+Diego%2C+CA%2C+March+25%E2%80%9329%2C+2012%3B+MEDI-23."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26atitle%3DDiscovery%2520of%2520BMS-791325%252C%2520an%2520Allosteric%2520NS5B%2520Replicase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Vendeville, S.; Lin, T.-I.; Hu, L.; Tahn, A.; MgGowan, D.; Cummings, M. D.; Amssoms, K.; Last, S.; Devogelaere, B.; Rouan, M.-C.; Vigen, L.; Berke, J. M.; Dehertogh, P.; Fransen, E.; Cleiren, E.; van der Heim, L.; Fanning, G.; Van Emeien, K.; Nyanguile, O.; Simmen, K.; Raboisson, P.</span><span> </span><span class="NLM_article-title">Discovery of the Clinical Candidate TMC 647055, a Non-Nucleoside Inhibitor of the Hepatitis C Virus NS5B Polymerase</span>. Presented at the 18th International Symposium on Hepatitis C Virus and Related Viruses, Seattle, WA, Sept 8–12, 2011; Abstract P1.33.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Vendeville%2C+S.%3B+Lin%2C+T.-I.%3B+Hu%2C+L.%3B+Tahn%2C+A.%3B+MgGowan%2C+D.%3B+Cummings%2C+M.+D.%3B+Amssoms%2C+K.%3B+Last%2C+S.%3B+Devogelaere%2C+B.%3B+Rouan%2C+M.-C.%3B+Vigen%2C+L.%3B+Berke%2C+J.+M.%3B+Dehertogh%2C+P.%3B+Fransen%2C+E.%3B+Cleiren%2C+E.%3B+van+der+Heim%2C+L.%3B+Fanning%2C+G.%3B+Van+Emeien%2C+K.%3B+Nyanguile%2C+O.%3B+Simmen%2C+K.%3B+Raboisson%2C+P.+Discovery+of+the+Clinical+Candidate+TMC+647055%2C+a+Non-Nucleoside+Inhibitor+of+the+Hepatitis+C+Virus+NS5B+Polymerase.+Presented+at+the+18th+International+Symposium+on+Hepatitis+C+Virus+and+Related+Viruses%2C+Seattle%2C+WA%2C+Sept+8%E2%80%9312%2C+2011%3B+Abstract+P1.33."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DVendeville%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520the%2520Clinical%2520Candidate%2520TMC%2520647055%252C%2520a%2520Non-Nucleoside%2520Inhibitor%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS5B%2520Polymerase" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Rosario, M.; Chauret, N.; George, S.; Kieffer, T. L.; Koziel, M. J.; Nicolas, O.; Proulx, L.</span><span> </span><span class="NLM_article-title">Therapies for Treating Hepatitis C Virus Infection</span>. Patent WO 2011/094489, August 4,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=M.+Rosario&author=N.+Chauret&author=S.+George&author=T.+L.+Kieffer&author=M.+J.+Koziel&author=O.+Nicolas&author=L.+Proulx&title=Therapies+for+Treating+Hepatitis+C+Virus+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRosario%26aufirst%3DM.%26atitle%3DTherapies%2520for%2520Treating%2520Hepatitis%2520C%2520Virus%2520Infection%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatlock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludlum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drowns, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahavendran, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skor, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlihy, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parge, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span> </span><span class="NLM_article-title">Discovery of (<i>R</i>)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5,<i>a</i>]-pyrimidin-2-yl)methyl-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1255</span><span class="NLM_x">–</span> <span class="NLM_lpage">1258</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8014537" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1255-1258&author=H.+Liauthor=J.+Tatlockauthor=A.+Lintonauthor=J.+Gonzalezauthor=T.+Jewellauthor=L.+Patelauthor=S.+Ludlumauthor=M.+Drownsauthor=S.+V.+Rahavendranauthor=H.+Skorauthor=R.+Hunterauthor=S.+T.+Shiauthor=K.+J.+Herlihyauthor=H.+Pargeauthor=M.+Hickeyauthor=X.+Yuauthor=F.+Chauauthor=J.+Nonomiyaauthor=C.+Lewis&title=Discovery+of+%28R%29-6-cyclopentyl-6-%282-%282%2C6-diethylpyridin-4-yl%29ethyl%29-3-%28%285%2C7-dimethyl-%5B1%2C2%2C4%5Dtriazolo%5B1%2C5%2Ca%5D-pyrimidin-2-yl%29methyl-4-hydroxy-5%2C6-dihydropyran-2-one+%28PF-00868554%29+as+a+potent+and+orally+available+hepatitis+C+virus+polymerase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24h&amp;dbid=16384&amp;doi=10.1021%2Fjm8014537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8014537%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DTatlock%26aufirst%3DJ.%26aulast%3DLinton%26aufirst%3DA.%26aulast%3DGonzalez%26aufirst%3DJ.%26aulast%3DJewell%26aufirst%3DT.%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DLudlum%26aufirst%3DS.%26aulast%3DDrowns%26aufirst%3DM.%26aulast%3DRahavendran%26aufirst%3DS.%2BV.%26aulast%3DSkor%26aufirst%3DH.%26aulast%3DHunter%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DS.%2BT.%26aulast%3DHerlihy%26aufirst%3DK.%2BJ.%26aulast%3DParge%26aufirst%3DH.%26aulast%3DHickey%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DChau%26aufirst%3DF.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520%2528R%2529-6-cyclopentyl-6-%25282-%25282%252C6-diethylpyridin-4-yl%2529ethyl%2529-3-%2528%25285%252C7-dimethyl-%255B1%252C2%252C4%255Dtriazolo%255B1%252C5%252Ca%255D-pyrimidin-2-yl%2529methyl-4-hydroxy-5%252C6-dihydropyran-2-one%2520%2528PF-00868554%2529%2520as%2520a%2520potent%2520and%2520orally%2520available%2520hepatitis%2520C%2520virus%2520polymerase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1255%26epage%3D1258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Tran, C. V.; Ruebsam, F.; Murphy, D. E.; Dragovich, P.; Zhou, Y.; Chen, L.; Kuccera, D.</span><span> </span><span class="NLM_article-title">5,6-Dihydro-1<i>H</i>-pyridin-2-one compounds</span>. Patent 7,939,524, May 10,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">, </span>(see also <a href="http://www.ama-assn.org/resources/doc/usan/lomibuvir.pdf" class="extLink">www.ama-assn.org/resources/doc/usan/lomibuvir.pdf</a>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=C.+V.+Tran&author=F.+Ruebsam&author=D.+E.+Murphy&author=P.+Dragovich&author=Y.+Zhou&author=L.+Chen&author=D.+Kuccera&title=5%2C6-Dihydro-1H-pyridin-2-one+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DC.%2BV.%26atitle%3D5%252C6-Dihydro-1H-pyridin-2-one%2520compounds%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellerin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thauvette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Specific inhibitors of HCV polymerase identified using a NS5B with lower affinity for template/primer substrate</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=422-431&author=G.+McKercherauthor=P.+L.+Beaulieuauthor=D.+Lamarreauthor=S.+LaPlanteauthor=S.+Lefebvreauthor=C.+Pellerinauthor=L.+Thauvetteauthor=G.+Kukolj&title=Specific+inhibitors+of+HCV+polymerase+identified+using+a+NS5B+with+lower+affinity+for+template%2Fprimer+substrate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DLaPlante%26aufirst%3DS.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DPellerin%26aufirst%3DC.%26aulast%3DThauvette%26aufirst%3DL.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DSpecific%2520inhibitors%2520of%2520HCV%2520polymerase%2520identified%2520using%2520a%2520NS5B%2520with%2520lower%2520affinity%2520for%2520template%252Fprimer%2520substrate%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2004%26volume%3D32%26spage%3D422%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bös, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellerin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=119-124&author=P.+L.+Beaulieuauthor=M.+B%C3%B6sauthor=Y.+Bousquetauthor=G.+Fazalauthor=J.+Gauthierauthor=J.+Gillardauthor=S.+Gouletauthor=S.+LaPlanteauthor=M.-A.+Poupartauthor=S.+Lefebvreauthor=G.+McKercherauthor=C.+Pellerinauthor=V.+Austelauthor=G.+Kukolj&title=Non-nucleoside+inhibitors+of+the+hepatitis+C+virus+NS5B+polymerase%3A+discovery+and+preliminary+SAR+of+benzimidazole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DB%25C3%25B6s%26aufirst%3DM.%26aulast%3DBousquet%26aufirst%3DY.%26aulast%3DFazal%26aufirst%3DG.%26aulast%3DGauthier%26aufirst%3DJ.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DLaPlante%26aufirst%3DS.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DPellerin%26aufirst%3DC.%26aulast%3DAustel%26aufirst%3DV.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DNon-nucleoside%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%253A%2520discovery%2520and%2520preliminary%2520SAR%2520of%2520benzimidazole%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D119%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Finger loop inhibitors of the HCV NS5B polymerase: discovery and prospects for new HCV therapy</span> <span class="citation_source-journal">Cur. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">626</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=8&amp;doi=10.1021%2Fjm3006788&amp;key=17002222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsFKnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=618-626&author=P.+L.+Beaulieu&title=Finger+loop+inhibitors+of+the+HCV+NS5B+polymerase%3A+discovery+and+prospects+for+new+HCV+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25cR"><div class="casContent"><span class="casTitleNuber">25c</span><div class="casTitle"><span class="NLM_cas:atitle">Finger loop inhibitors of the HCV NS5B polymerase: discovery and prospects for new HCV therapy</span></div><div class="casAuthors">Beaulieu, Pierre L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">618-626</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  The hepatitis C virus (HCV) infects millions of people worldwide and currently available therapies suffer from limited efficacy and severe side effects.  This review describes the discovery of a novel class of non-nucleoside HCV non-structural protein 5B (NS5B) polymerase inhibitors that inhibit the replication of viral RNA by binding to an allosteric site on the enzyme.  Initial lead compds. based on a benzimidazole scaffold were optimized yielding novel indole derivs. with sub-micromolar activity in a cell-based replicon assay.  X-ray crystallog. studies suggest that inhibitor binding interferes with the conformational movements of the protein that are necessary for enzyme activity.  Finger loop inhibitors of HCV NS5B show potential for the development of novel anti-HCV therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs1lsx4pWbFbVg90H21EOLACvtfcHk0liNkCCzYqAC-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsFKnur8%253D&md5=a4ad9761721b5f8078d39484850b0c3d</span></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DFinger%2520loop%2520inhibitors%2520of%2520the%2520HCV%2520NS5B%2520polymerase%253A%2520discovery%2520and%2520prospects%2520for%2520new%2520HCV%2520therapy%26jtitle%3DCur.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D9%26spage%3D618%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Hirashima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noji, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, H.</span><span> </span><span class="NLM_article-title">Benzimidazole derivatives bearing substituted biphenyls as hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors: structure–activity relationship studies and identification of a potent and highly selective inhibitor JTK-109</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4721</span><span class="NLM_x">–</span> <span class="NLM_lpage">4736</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060269e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4721-4736&author=S.+Hirashimaauthor=T.+Suzukiauthor=T.+Ishidaauthor=S.+Nojiauthor=S.+Yataauthor=I.+Andoauthor=M.+Komatsuauthor=S.+Ikedaauthor=H.+Hashimoto&title=Benzimidazole+derivatives+bearing+substituted+biphenyls+as+hepatitis+C+virus+NS5B+RNA-dependent+RNA+polymerase+inhibitors%3A+structure%E2%80%93activity+relationship+studies+and+identification+of+a+potent+and+highly+selective+inhibitor+JTK-109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25d&amp;dbid=16384&amp;doi=10.1021%2Fjm060269e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060269e%26sid%3Dliteratum%253Aachs%26aulast%3DHirashima%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DIshida%26aufirst%3DT.%26aulast%3DNoji%26aufirst%3DS.%26aulast%3DYata%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DI.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DH.%26atitle%3DBenzimidazole%2520derivatives%2520bearing%2520substituted%2520biphenyls%2520as%2520hepatitis%2520C%2520virus%2520NS5B%2520RNA-dependent%2520RNA%2520polymerase%2520inhibitors%253A%2520structure%25E2%2580%2593activity%2520relationship%2520studies%2520and%2520identification%2520of%2520a%2520potent%2520and%2520highly%2520selective%2520inhibitor%2520JTK-109%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4721%26epage%3D4736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Narjes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescenzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colarusso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Rosario, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stansfield, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conte, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ercolani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaramella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palumbi, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meuleman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux-Roels, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baiocco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span> </span><span class="NLM_article-title">Discovery of (7<i>R</i>)-14-cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl)amino}-7,8-dihydro-6<i>H</i>-indolo[1,2-<i>e</i>][1,5]benzoxazocine-1-carboxylic acid (MK-3281), a potent and orally bioavailable finger-loop inhibitor of the hepatitis C virus NS5B polymerase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013105" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=289-301&author=F.+Narjesauthor=B.+Crescenziauthor=M.+Ferraraauthor=J.+Habermannauthor=S.+Colarussoauthor=M.+del+Rosarioauthor=R.+Ferreiraauthor=I.+Stansfieldauthor=A.+C.+Mackayauthor=I.+Conteauthor=C.+Ercolaniauthor=S.+Zaramellaauthor=M.-C.+Palumbiauthor=P.+Meulemanauthor=G.+Leroux-Roelsauthor=C.+Guilianoauthor=F.+Fioreauthor=S.+Di+Marcoauthor=P.+Baioccoauthor=U.+Kochauthor=G.+Migliaccioauthor=S.+Altamuraauthor=R.+Lauferauthor=R.+De+Francescoauthor=M.+Rowley&title=Discovery+of+%287R%29-14-cyclohexyl-7-%7B%5B2-%28dimethylamino%29ethyl%5D%28methyl%29amino%7D-7%2C8-dihydro-6H-indolo%5B1%2C2-e%5D%5B1%2C5%5Dbenzoxazocine-1-carboxylic+acid+%28MK-3281%29%2C+a+potent+and+orally+bioavailable+finger-loop+inhibitor+of+the+hepatitis+C+virus+NS5B+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25e&amp;dbid=16384&amp;doi=10.1021%2Fjm1013105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013105%26sid%3Dliteratum%253Aachs%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DHabermann%26aufirst%3DJ.%26aulast%3DColarusso%26aufirst%3DS.%26aulast%3Ddel%2BRosario%26aufirst%3DM.%26aulast%3DFerreira%26aufirst%3DR.%26aulast%3DStansfield%26aufirst%3DI.%26aulast%3DMackay%26aufirst%3DA.%2BC.%26aulast%3DConte%26aufirst%3DI.%26aulast%3DErcolani%26aufirst%3DC.%26aulast%3DZaramella%26aufirst%3DS.%26aulast%3DPalumbi%26aufirst%3DM.-C.%26aulast%3DMeuleman%26aufirst%3DP.%26aulast%3DLeroux-Roels%26aufirst%3DG.%26aulast%3DGuiliano%26aufirst%3DC.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DDi%2BMarco%26aufirst%3DS.%26aulast%3DBaiocco%26aufirst%3DP.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DMigliaccio%26aufirst%3DG.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DRowley%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520%25287R%2529-14-cyclohexyl-7-%257B%255B2-%2528dimethylamino%2529ethyl%255D%2528methyl%2529amino%257D-7%252C8-dihydro-6H-indolo%255B1%252C2-e%255D%255B1%252C5%255Dbenzoxazocine-1-carboxylic%2520acid%2520%2528MK-3281%2529%252C%2520a%2520potent%2520and%2520orally%2520bioavailable%2520finger-loop%2520inhibitor%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D289%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudyma, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poss, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadow, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camac, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheriff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beno, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigat, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridell, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voss, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelosi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentles, R. G.</span><span> </span><span class="NLM_article-title">Syntheses and intitial evaluation of a series of indolo-fused heterocyclic inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virus</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2925</span><span class="NLM_x">–</span> <span class="NLM_lpage">2929</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2925-2929&author=X.+Zhengauthor=T.+W.+Hudymaauthor=S.+W.+Martinauthor=C.+Bergstromauthor=M.+Dingauthor=F.+Heauthor=J.+Romineauthor=M.+A.+Possauthor=J.+F.+Kadowauthor=C.-H.+Changauthor=J.+Wanauthor=M.+R.+Witmerauthor=P.+Morinauthor=D.+M.+Camacauthor=S.+Sheriffauthor=B.+R.+Benoauthor=K.+L.+Rigatauthor=Y.-K.+Wangauthor=F.+Fridellauthor=J.+Lemmauthor=D.+Qiuauthor=M.+Liuauthor=S.+Vossauthor=L.+Pelosiauthor=S.+B.+Robertsauthor=M.+Gaoauthor=J.+Knipeauthor=R.+G.+Gentles&title=Syntheses+and+intitial+evaluation+of+a+series+of+indolo-fused+heterocyclic+inhibitors+of+the+polymerase+enzyme+%28NS5B%29+of+the+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DHudyma%26aufirst%3DT.%2BW.%26aulast%3DMartin%26aufirst%3DS.%2BW.%26aulast%3DBergstrom%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DRomine%26aufirst%3DJ.%26aulast%3DPoss%26aufirst%3DM.%2BA.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26aulast%3DChang%26aufirst%3DC.-H.%26aulast%3DWan%26aufirst%3DJ.%26aulast%3DWitmer%26aufirst%3DM.%2BR.%26aulast%3DMorin%26aufirst%3DP.%26aulast%3DCamac%26aufirst%3DD.%2BM.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DRigat%26aufirst%3DK.%2BL.%26aulast%3DWang%26aufirst%3DY.-K.%26aulast%3DFridell%26aufirst%3DF.%26aulast%3DLemm%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DVoss%26aufirst%3DS.%26aulast%3DPelosi%26aufirst%3DL.%26aulast%3DRoberts%26aufirst%3DS.%2BB.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DKnipe%26aufirst%3DJ.%26aulast%3DGentles%26aufirst%3DR.%2BG.%26atitle%3DSyntheses%2520and%2520intitial%2520evaluation%2520of%2520a%2520series%2520of%2520indolo-fused%2520heterocyclic%2520inhibitors%2520of%2520the%2520polymerase%2520enzyme%2520%2528NS5B%2529%2520of%2520the%2520hepatitis%2520C%2520virus%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2925%26epage%3D2929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bös, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeRoy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valois, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">971</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=967-971&author=P.+L.+Beaulieuauthor=M.+B%C3%B6sauthor=Y.+Bousquetauthor=P.+DeRoyauthor=G.+Fazalauthor=J.+Gauthierauthor=J.+Gillardauthor=S.+Gouletauthor=G.+McKercherauthor=M.-A.+Poupartauthor=S.+Valoisauthor=G.+Kukolj&title=Non-nucleoside+inhibitors+of+the+hepatitis+C+virus+NS5B+polymerase%3A+discovery+of+benzimidazole+5-carboxylic+amide+derivatives+with+low-nanomolar+potency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DB%25C3%25B6s%26aufirst%3DM.%26aulast%3DBousquet%26aufirst%3DY.%26aulast%3DDeRoy%26aufirst%3DP.%26aulast%3DFazal%26aufirst%3DG.%26aulast%3DGauthier%26aufirst%3DJ.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DValois%26aufirst%3DS.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DNon-nucleoside%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%253A%2520discovery%2520of%2520benzimidazole%25205-carboxylic%2520amide%2520derivatives%2520with%2520low-nanomolar%2520potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D967%26epage%3D971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellerin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valois, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Non-nucleoside benzimidazole-based allosteric inhibitors of the hepatitis C virus NS5B polymerase: inhibition of subgenomic hepatitis C virus RNA replicons in Huh-7 cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6884</span><span class="NLM_x">–</span> <span class="NLM_lpage">6892</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040134d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6884-6892&author=P.+L.+Beaulieuauthor=Y.+Bousquetauthor=J.+Gauthierauthor=J.+Gillardauthor=M.+Marquisauthor=G.+McKercherauthor=C.+Pellerinauthor=S.+Valoisauthor=G.+Kukolj&title=Non-nucleoside+benzimidazole-based+allosteric+inhibitors+of+the+hepatitis+C+virus+NS5B+polymerase%3A+inhibition+of+subgenomic+hepatitis+C+virus+RNA+replicons+in+Huh-7+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1021%2Fjm040134d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040134d%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DBousquet%26aufirst%3DY.%26aulast%3DGauthier%26aufirst%3DJ.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DMarquis%26aufirst%3DM.%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DPellerin%26aufirst%3DC.%26aulast%3DValois%26aufirst%3DS.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DNon-nucleoside%2520benzimidazole-based%2520allosteric%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%253A%2520inhibition%2520of%2520subgenomic%2520hepatitis%2520C%2520virus%2520RNA%2520replicons%2520in%2520Huh-7%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6884%26epage%3D6892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakalian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubry, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferland, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Binding mode determination of benzimidazole inhibitors of the hepatitis C virus RNA polymerase by a structure and dynamics startegy</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4306</span><span class="NLM_x">–</span> <span class="NLM_lpage">4311</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=4306-4311&author=S.+R.+LaPlanteauthor=A.+Jakalianauthor=N.+Aubryauthor=Y.+Bousquetauthor=J.-M.+Ferlandauthor=J.+Gillardauthor=S.+Lefebvreauthor=M.+Poirierauthor=Y.+S.+Tsantrizosauthor=G.+Kukoljauthor=P.+L.+Beaulieu&title=Binding+mode+determination+of+benzimidazole+inhibitors+of+the+hepatitis+C+virus+RNA+polymerase+by+a+structure+and+dynamics+startegy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DJakalian%26aufirst%3DA.%26aulast%3DAubry%26aufirst%3DN.%26aulast%3DBousquet%26aufirst%3DY.%26aulast%3DFerland%26aufirst%3DJ.-M.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DBinding%2520mode%2520determination%2520of%2520benzimidazole%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520RNA%2520polymerase%2520by%2520a%2520structure%2520and%2520dynamics%2520startegy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2004%26volume%3D43%26spage%3D4306%26epage%3D4311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Discovery of benzimidazole-diamide finger loop (thumb pocket 1) allosteric inhibitors of HCV NS5B polymerase: implementing parallel synthesis for rapid linker optimization</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=196-200&author=S.+Gouletauthor=M.-A.+Poupartauthor=J.+Gillardauthor=M.+Poirierauthor=G.+Kukoljauthor=P.+L.+Beaulieu&title=Discovery+of+benzimidazole-diamide+finger+loop+%28thumb+pocket+1%29+allosteric+inhibitors+of+HCV+NS5B+polymerase%3A+implementing+parallel+synthesis+for+rapid+linker+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DDiscovery%2520of%2520benzimidazole-diamide%2520finger%2520loop%2520%2528thumb%2520pocket%25201%2529%2520allosteric%2520inhibitors%2520of%2520HCV%2520NS5B%2520polymerase%253A%2520implementing%2520parallel%2520synthesis%2520for%2520rapid%2520linker%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D196%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGibbon, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefèbvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thauvette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Binding site characterization and resistance to a class of non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">39260</span><span class="NLM_x">–</span> <span class="NLM_lpage">39267</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=39260-39267&author=G.+Kukoljauthor=G.+A.+McGibbonauthor=G.+McKercherauthor=M.+Marquisauthor=S.+Lef%C3%A8bvreauthor=L.+Thauvetteauthor=J.+Gauthierauthor=S.+Gouletauthor=M.-A.+Poupartauthor=P.+L.+Beaulieu&title=Binding+site+characterization+and+resistance+to+a+class+of+non-nucleoside+inhibitors+of+the+hepatitis+C+virus+NS5B+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DMcGibbon%26aufirst%3DG.%2BA.%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DMarquis%26aufirst%3DM.%26aulast%3DLef%25C3%25A8bvre%26aufirst%3DS.%26aulast%3DThauvette%26aufirst%3DL.%26aulast%3DGauthier%26aufirst%3DJ.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DBinding%2520site%2520characterization%2520and%2520resistance%2520to%2520a%2520class%2520of%2520non-nucleoside%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D39260%26epage%3D39267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolicoeur, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span> </span><span class="NLM_article-title">From benzimidazole to indole 5-carboxamide thumb pocket 1 inhibitors of HCV NS5B polymerase. Part 1: Indole C-2 SAR and discovery of diamide derivatives with nanomolar potency in cell-based subgenomic replicons</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3658</span><span class="NLM_x">–</span> <span class="NLM_lpage">3663</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3658-3663&author=P.+L.+Beaulieuauthor=J.+Gillardauthor=E.+Jolicoeurauthor=J.+Duanauthor=M.+Garneauauthor=G.+Kukoljauthor=M.-A.+Poupart&title=From+benzimidazole+to+indole+5-carboxamide+thumb+pocket+1+inhibitors+of+HCV+NS5B+polymerase.+Part+1%3A+Indole+C-2+SAR+and+discovery+of+diamide+derivatives+with+nanomolar+potency+in+cell-based+subgenomic+replicons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DJolicoeur%26aufirst%3DE.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DPoupart%26aufirst%3DM.-A.%26atitle%3DFrom%2520benzimidazole%2520to%2520indole%25205-carboxamide%2520thumb%2520pocket%25201%2520inhibitors%2520of%2520HCV%2520NS5B%2520polymerase.%2520Part%25201%253A%2520Indole%2520C-2%2520SAR%2520and%2520discovery%2520of%2520diamide%2520derivatives%2520with%2520nanomolar%2520potency%2520in%2520cell-based%2520subgenomic%2520replicons%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3658%26epage%3D3663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolicoeur, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stammers, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span> </span><span class="NLM_article-title">Indole 5-carboxamide thumb pocket 1 inhibitors of HCV NS5B polymerase with nanomolar potency in cell-based subgenomic replicons (part 2): central amino acid linker and right-hand-side SAR studies</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3664</span><span class="NLM_x">–</span> <span class="NLM_lpage">3670</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3664-3670&author=P.+L.+Beaulieuauthor=C.+Chabotauthor=J.+Duanauthor=M.+Garneauauthor=J.+Gillardauthor=E.+Jolicoeurauthor=M.+Poirierauthor=M.-A.+Poupartauthor=T.+A.+Stammersauthor=G.+Kukoljauthor=Y.+S.+Tsantrizos&title=Indole+5-carboxamide+thumb+pocket+1+inhibitors+of+HCV+NS5B+polymerase+with+nanomolar+potency+in+cell-based+subgenomic+replicons+%28part+2%29%3A+central+amino+acid+linker+and+right-hand-side+SAR+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DChabot%26aufirst%3DC.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DJolicoeur%26aufirst%3DE.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DStammers%26aufirst%3DT.%2BA.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26atitle%3DIndole%25205-carboxamide%2520thumb%2520pocket%25201%2520inhibitors%2520of%2520HCV%2520NS5B%2520polymerase%2520with%2520nanomolar%2520potency%2520in%2520cell-based%2520subgenomic%2520replicons%2520%2528part%25202%2529%253A%2520central%2520amino%2520acid%2520linker%2520and%2520right-hand-side%2520SAR%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3664%26epage%3D3670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakalian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubry, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulombe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brochu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Importance of ligand bioactive conformation in the discovery of potent indole-diamide inhibitors of the hepatitis C virus NS5B</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">15204</span><span class="NLM_x">–</span> <span class="NLM_lpage">15212</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja101358s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=15204-15212&author=S.+R.+LaPlanteauthor=J.+R.+Gillardauthor=A.+Jakalianauthor=N.+Aubryauthor=R.+Coulombeauthor=C.+Brochuauthor=Y.+S.+Tsantrizosauthor=M.+Poirierauthor=G.+Kukoljauthor=P.+L.+Beaulieu&title=Importance+of+ligand+bioactive+conformation+in+the+discovery+of+potent+indole-diamide+inhibitors+of+the+hepatitis+C+virus+NS5B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28c&amp;dbid=16384&amp;doi=10.1021%2Fja101358s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja101358s%26sid%3Dliteratum%253Aachs%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DGillard%26aufirst%3DJ.%2BR.%26aulast%3DJakalian%26aufirst%3DA.%26aulast%3DAubry%26aufirst%3DN.%26aulast%3DCoulombe%26aufirst%3DR.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DImportance%2520of%2520ligand%2520bioactive%2520conformation%2520in%2520the%2520discovery%2520of%2520potent%2520indole-diamide%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D15204%26epage%3D15212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Erhardt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forns, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pol, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calleja, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spangenberg, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Samaniego, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enriquez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiegand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nehmiz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffgen, J.</span><span> </span><span class="NLM_article-title">Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment</span> <span class="citation_source-journal">Antiviral Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=23-32&author=A.+Erhardtauthor=K.+Deterdingauthor=Y.+Benhamouauthor=M.+Reiserauthor=X.+Fornsauthor=S.+Polauthor=J.+L.+Callejaauthor=S.+Rossauthor=H.+C.+Spangenbergauthor=J.+Garcia-Samaniegoauthor=M.+Fuchsauthor=J.+Enriquezauthor=J.+Wiegandauthor=J.+Sternauthor=K.+Wuauthor=G.+Kukoljauthor=M.+Marquisauthor=P.+Beaulieuauthor=G.+Nehmizauthor=J.+Steffgen&title=Safety%2C+pharmacokinetics+and+antiviral+effect+of+BILB+1941%2C+a+novel+hepatitis+C+virus+RNA+polymerase+inhibitor%2C+after+5+days+oral+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DErhardt%26aufirst%3DA.%26aulast%3DDeterding%26aufirst%3DK.%26aulast%3DBenhamou%26aufirst%3DY.%26aulast%3DReiser%26aufirst%3DM.%26aulast%3DForns%26aufirst%3DX.%26aulast%3DPol%26aufirst%3DS.%26aulast%3DCalleja%26aufirst%3DJ.%2BL.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DSpangenberg%26aufirst%3DH.%2BC.%26aulast%3DGarcia-Samaniego%26aufirst%3DJ.%26aulast%3DFuchs%26aufirst%3DM.%26aulast%3DEnriquez%26aufirst%3DJ.%26aulast%3DWiegand%26aufirst%3DJ.%26aulast%3DStern%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DK.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DMarquis%26aufirst%3DM.%26aulast%3DBeaulieu%26aufirst%3DP.%26aulast%3DNehmiz%26aufirst%3DG.%26aulast%3DSteffgen%26aufirst%3DJ.%26atitle%3DSafety%252C%2520pharmacokinetics%2520and%2520antiviral%2520effect%2520of%2520BILB%25201941%252C%2520a%2520novel%2520hepatitis%2520C%2520virus%2520RNA%2520polymerase%2520inhibitor%252C%2520after%25205%2520days%2520oral%2520treatment%26jtitle%3DAntiviral%2520Ther.%26date%3D2009%26volume%3D14%26spage%3D23%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bykowski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brochu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansereau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duceppe, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haché, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakalian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacé, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perreault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stammers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thauvette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warrington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Improved replicon cellular activity of non-nucleoside allosteric inhibitors of HCV NS5B polymerase: from benzimidazole to indole scaffolds</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4987</span><span class="NLM_x">–</span> <span class="NLM_lpage">4993</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4987-4993&author=P.+L.+Beaulieuauthor=J.+Gillardauthor=D.+Bykowskiauthor=C.+Brochuauthor=N.+Dansereauauthor=J.-S.+Duceppeauthor=B.+Hach%C3%A9author=A.+Jakalianauthor=L.+Lagac%C3%A9author=S.+LaPlanteauthor=G.+McKercherauthor=E.+Moreauauthor=S.+Perreaultauthor=T.+Stammersauthor=L.+Thauvetteauthor=J.+Warringtonauthor=G.+Kukolj&title=Improved+replicon+cellular+activity+of+non-nucleoside+allosteric+inhibitors+of+HCV+NS5B+polymerase%3A+from+benzimidazole+to+indole+scaffolds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DBykowski%26aufirst%3DD.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DDansereau%26aufirst%3DN.%26aulast%3DDuceppe%26aufirst%3DJ.-S.%26aulast%3DHach%25C3%25A9%26aufirst%3DB.%26aulast%3DJakalian%26aufirst%3DA.%26aulast%3DLagac%25C3%25A9%26aufirst%3DL.%26aulast%3DLaPlante%26aufirst%3DS.%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DMoreau%26aufirst%3DE.%26aulast%3DPerreault%26aufirst%3DS.%26aulast%3DStammers%26aufirst%3DT.%26aulast%3DThauvette%26aufirst%3DL.%26aulast%3DWarrington%26aufirst%3DJ.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DImproved%2520replicon%2520cellular%2520activity%2520of%2520non-nucleoside%2520allosteric%2520inhibitors%2520of%2520HCV%2520NS5B%2520polymerase%253A%2520from%2520benzimidazole%2520to%2520indole%2520scaffolds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4987%26epage%3D4993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vernin, G.</span> In  <span class="citation_source-book">Thiazole and Its Derivatives</span>; <span class="NLM_contrib-group">Metzger, J. V.</span>, Ed.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1979</span><span class="NLM_x">; </span>Part 1, Chapter 2.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1979&author=G.+Verninauthor=J.+V.+Metzger&title=Thiazole+and+Its+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DVernin%26aufirst%3DG.%26btitle%3DThiazole%2520and%2520Its%2520Derivatives%26aulast%3DMetzger%26aufirst%3DJ.%2BV.%26pub%3DWiley%26date%3D1979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Paik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, T. H.</span><span> </span><span class="NLM_article-title">A facile synthesis of (−)-cucurbitine</span> <span class="citation_source-journal">Bull. Korean Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm3006788&amp;key=1%3ACAS%3A528%3ADC%252BD3cXpslGltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=131-132&author=S.+Paikauthor=H.+S.+Kwakauthor=T.+H.+Park&title=A+facile+synthesis+of+%28%E2%88%92%29-cucurbitine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A facile synthesis of (-)-cucurbitine</span></div><div class="casAuthors">Paik, Seunguk; Kwak, Hyung Sub; Park, Tae Ho</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the Korean Chemical Society</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">131-132</span>CODEN:
                <span class="NLM_cas:coden">BKCSDE</span>;
        ISSN:<span class="NLM_cas:issn">0253-2964</span>.
    
            (<span class="NLM_cas:orgname">Korean Chemical Society</span>)
        </div><div class="casAbstract">A practical stereoselective synthesis of cucurbitine is reported which uses trans-4-hydroxy-L-proline as chiral template, the Bucherer-Bergs reaction for the prepn. of the diastereoselective spirohydantoin of 4-oxoprolinate and selective decarboxylation of the proline unit.  The free amino and carboxylic groups of α-amino acid chains are essential for decarboxylation of intermediate spiroproline, which gives the pyrrolidine HCl salt (65%).  Hydrolysis of pyrrolidine hydrochloride provided synthetic (-)-cucurbitine (60% after ion chromatog.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxV1HWKUCqSLVg90H21EOLACvtfcHk0lgBbssJQ9IY-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXpslGltw%253D%253D&md5=29bb35cb69aea0e217c8af39b5c8f1e1</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaik%26aufirst%3DS.%26aulast%3DKwak%26aufirst%3DH.%2BS.%26aulast%3DPark%26aufirst%3DT.%2BH.%26atitle%3DA%2520facile%2520synthesis%2520of%2520%2528%25E2%2588%2592%2529-cucurbitine%26jtitle%3DBull.%2520Korean%2520Chem.%2520Soc.%26date%3D2000%26volume%3D21%26spage%3D131%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Rorrer, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connors, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. W.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uffelman, E. S.</span><span> </span><span class="NLM_article-title">A convenient new route to tetradentate and pentadentate macrocyclic tetraamide ligands</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1157</span><span class="NLM_x">–</span> <span class="NLM_lpage">1159</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol990155f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=1157-1159&author=L.+C.+Rorrerauthor=S.+D.+Hopkinsauthor=M.+K.+Connorsauthor=D.+W.+Leeauthor=M.+V.+Smithauthor=H.+J.+Rhodesauthor=E.+S.+Uffelman&title=A+convenient+new+route+to+tetradentate+and+pentadentate+macrocyclic+tetraamide+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fol990155f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol990155f%26sid%3Dliteratum%253Aachs%26aulast%3DRorrer%26aufirst%3DL.%2BC.%26aulast%3DHopkins%26aufirst%3DS.%2BD.%26aulast%3DConnors%26aufirst%3DM.%2BK.%26aulast%3DLee%26aufirst%3DD.%2BW.%26aulast%3DSmith%26aufirst%3DM.%2BV.%26aulast%3DRhodes%26aufirst%3DH.%2BJ.%26aulast%3DUffelman%26aufirst%3DE.%2BS.%26atitle%3DA%2520convenient%2520new%2520route%2520to%2520tetradentate%2520and%2520pentadentate%2520macrocyclic%2520tetraamide%2520ligands%26jtitle%3DOrg.%2520Lett.%26date%3D1999%26volume%3D1%26spage%3D1157%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Beaulieu, P. L.; Fazal, G.; Goulet, S.; Kukolj, G.; Poirier, M.; Tsantrizos, Y.; Jolicoeur, E.; Gillard, J.; Poupart, M.-A.; Rancourt, J.</span> Patent WO 03/010141,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Beaulieu%2C+P.+L.%3B+Fazal%2C+G.%3B+Goulet%2C+S.%3B+Kukolj%2C+G.%3B+Poirier%2C+M.%3B+Tsantrizos%2C+Y.%3B+Jolicoeur%2C+E.%3B+Gillard%2C+J.%3B+Poupart%2C+M.-A.%3B+Rancourt%2C+J.+Patent+WO+03%2F010141%2C+2003."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i40"><a href="/doi/suppl/10.1021/jm3006788">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_82745"></div></div></div></div></div><hr /></hr><p class="last">The enzymatic and 1b replicon potencies of all compounds displayed in graphical format in Figures <a id="rightTab-" class=" internalNav" href="#fig4">4</a> and <a id="rightTab-" class=" internalNav" href="#fig5">5</a>, human and rat liver microsome stability, Caco-2 permeability and plasma concentrations following oral dosing in rats, mass spectral and HPLC homogeneity data, and <sup>1</sup>H NMR spectra for all inhibitors. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3006788/suppl_file/jm3006788_si_001.pdf">jm3006788_si_001.pdf (3.49 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm3006788&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm3006788%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-17%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm3006788" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679995485e2f3cd6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
